<SEC-DOCUMENT>0001096906-18-000127.txt : 20180306
<SEC-HEADER>0001096906-18-000127.hdr.sgml : 20180306
<ACCEPTANCE-DATETIME>20180306153117
ACCESSION NUMBER:		0001096906-18-000127
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20171231
FILED AS OF DATE:		20180306
DATE AS OF CHANGE:		20180306

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12575
		FILM NUMBER:		18669718

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>utahmedical.htm
<DESCRIPTION>10K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">UNITED STATES</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Washington, D.C.&#160; 20549</div>

<div style="FONT-SIZE: 14pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">FORM 10-K</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">For the fiscal year ended<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"> December 31, 2017</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Commission File Number:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"> 001-12575</font></div>

<div style="TEXT-ALIGN: center; FONT: bold small-caps 18pt/1.25 'Times New Roman', Times, serif"><u>UTAH MEDICAL PRODUCTS, INC.</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Exact name of registrant as specified in its charter)</div>

<table id="zafa98fca61c44482977d27c299f6cfae" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>Utah</u></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>87-0342734</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(State or other jurisdiction of incorporation or organization)</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(I.R.S. Employer Identification No.)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: "></td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: "></td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>7043 S 300 W, Midvale Utah</u></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>84047</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Address of principal executive offices)</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Zip Code)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr style="HEIGHT: 13px">
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Registrant's telephone number, including area code:</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center">Telephone<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-STYLE: normal"><u> (801) 566-1200</u></font></td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center">&#160;</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Facsimile <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"><u>(801) 566-7305</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center">&#160;</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center">Securities registered pursuant to Section 12(b) of the Act:</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>Title of each class</u></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 50%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>Name of each exchange on which registered</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Common Stock, $.01 Par Value</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The NASDAQ Global Market</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Preferred Stock Purchase Rights</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Securities registered pursuant to Section 12(g) of the Act:</div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>(Title of Class)</u></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 4pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">None</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160; Yes&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font>&#160;&#160; No&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.&#160; Yes&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font>&#160;&#160; No&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;&#160;Yes&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font>&#160;&#160; No&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;&#160;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160; Yes&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font>&#160;&#160; No&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (Section 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&#160; See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z5b902d72da2b472a8a0df9c78ed5c1af" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 25.43%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Large accelerated filer&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>
</td>
<td style="WIDTH: 20.61%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Accelerated filer&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font></div>
</td>
<td style="WIDTH: 24.23%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Non-accelerated filer <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>
</td>
<td style="WIDTH: 29.73%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Smaller reporting company <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font></div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9744;</font>&#160;&#160; No&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#9746;</font></div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.&#160; As of June 30, 2017, the aggregate market value of the voting and nonvoting common equity held by non-affiliates of the registrant was $242,289,134.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">As of March 5, 2018, common shares outstanding were 3,725,763.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">DOCUMENTS INCORPORATED BY REFERENCE.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">The Company's definitive proxy statement for the Annual Meeting of Stockholders is incorporated by reference into Part III, Item 10, 11, 12, 13 and 14 of this Form 10-K.</font></div>

<div id="DSPFPageFooter">
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>INDEX TO FORM 10&#8209;K</u><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zb0b7d824258e4298940df0093f26f295" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 16px">
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PAGE</div>
</td>
</tr>

<tr>
<td style="WIDTH: 18.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PART I&#160;&#160;</div>
</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 1</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Business</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">1</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 1A</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Risk Factors</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">14</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 1B</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Unresolved Staff Comments</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">15</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 2</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Properties</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">15</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 3</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Legal Proceedings</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">16</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 4</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Reserved</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">16</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 18.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">PART II&#160;&#160;</div>
</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 5</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">17</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 6</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Selected Financial Data</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">18</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 7</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Management's Discussion and Analysis of Financial Condition and Results of Operations</div>
</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">19</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 7A</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Quantitative and Qualitative Disclosures About Market Risk</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">33</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 8</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Financial Statements and Supplementary Data</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">33</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 9</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">53</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 9A</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Controls and Procedures</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">54</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 9B</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Other Information</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">54</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 18.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">PART III&#160;&#160;</div>
</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 10</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Directors, Executive Officers and Corporate Governance</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">55</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 11</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Executive Compensation</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">55</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 12</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">55</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 13</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Certain Relationships and Related Transactions, and Director Independence</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">56</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 14</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Principal Accounting Fees and Services</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">56</div>
</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 90.51%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">PART IV&#160;&#160;</div>
</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Item 15</div>
</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Exhibits, Financial Statement Schedules</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">57</div>
</td>
</tr>

<tr style="HEIGHT: 8px">
<td style="WIDTH: 2.02%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 13.46%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 75.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 18.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">SIGNATURES&#160;&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 9.49%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="TEXT-ALIGN: center">59</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%1%%%-->
<div style="FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>PART I</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 1 &#8211; BUSINESS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Currency amounts throughout this report are in thousands except per-share amounts and where noted.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Utah Medical Products, Inc. ("UTMD" or "the Company") is in the business of producing high quality cost&#8209; effective medical devices that are predominantly proprietary, disposable and for hospital use.&#160; Success depends on 1) recognizing needs of clinicians and patients, 2) rapidly designing or acquiring economical solutions that gain premarketing regulatory concurrence, 3) reliably producing products that meet those clinical needs, and then 4) selling through</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="zd0e58c39dff448889c522dc18abd13ba" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">a)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">UTMD's own direct channels into markets where the Company enjoys an established reputation and has a critical mass of sales and support resources, or</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">b)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">relationships with other medical companies that have the resources to effectively distribute and support the Company's products.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's success in providing reliable solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, plastics processing and materials.&#160;&#160; The resulting differentiated devices represent significant incremental improvements in patient safety, clinical outcomes and/or total cost over preexisting clinical tools. UTMD's experience is that, in the case of labor&#8209;saving devices, the improvement in cost&#8209;effectiveness of clinical procedures also leads to an improvement in overall healthcare including lower risk of complications.&#160; UTMD markets a broad range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&amp;D) department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The opportunity to apply solutions to recognized needs results from an excellent core of practicing clinicians who introduce ideas to the Company, and key employees who are both clinical applications savvy and development engineering adept.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Domestically, except for the Filshie Clip System, UTMD's medical devices are sold directly to clinical end user facilities or their appointed stocking distributor.&#160; In addition, some of UTMD's devices are sold through specialty distributors, national hospital distribution companies and other medical device manufacturers.&#160; Outside the U.S. (OUS), products are sold directly to end users in Canada, the United Kingdom (UK), France, Ireland and Australia, and through other medical device companies and through independent medical products distributors in many other countries.&#160; UTMD has representation globally in the major developed countries as well as many underdeveloped countries through several hundred distributors, 128 of which purchased at least five thousand dollars in UTMD medical devices during 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD was formed as a Utah corporation in 1978.&#160; UTMD sold stock to the public one time in 1982 for $1,750 (before offering costs of $321).&#160; Since 1992, UTMD has returned $116,269 in the form of share repurchases, and an additional $50,939 in cash dividends, to its public stockholders.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 10.8pt">Utah Medical Products Ltd., a wholly-owned subsidiary with manufacturing located in Ireland, was formed in 1995 to better serve UTMD's OUS customers. In 1997, UTMD purchased Columbia Medical, Inc. (CMI), a company specializing in silicone injection molding, assembly and marketing vacuum-assisted obstetrical delivery systems.&#160; In 1998, UTMD acquired the neonatal product line of Gesco International, a subsidiary of Bard Access Systems and C.R. Bard, Inc.&#160; In 2004, UTMD acquired Abcorp, Inc., its supplier of fetal monitoring belts.&#160; In 2011, UTMD purchased all of the common shares of Femcare Holdings Ltd (Femcare) of the United Kingdom, and its subsidiaries. The addition of Femcare provided product and distribution channel diversification and expansion.&#160; Sales of the products, or derivatives of the products, from the four acquisitions noted above, comprised 63% of UTMD's consolidated 2017 sales.&#160; In late 2016, UTMD formed Utah Medical Products Canada Ltd (dba Femcare Canada) as a sales and distribution operation to directly serve Canadian medical facilities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's corporate headquarters are located at 7043 South 300 West, Midvale, Utah 84047 USA.&#160; The corporate office telephone number is 01 (801) 566&#8209;1200.&#160; Ireland operations are located at Athlone Business and Technology Park, Athlone, County Westmeath, Ireland.&#160; The Ireland telephone number is 353 (90) 647-3932.&#160; United Kingdom operations are located at 32 Premier Way, Romsey, Hampshire SO51 9DQ, United Kingdom.&#160; The UK phone number is 44 (179) 452-5100.&#160; Australia operations are located at Unit 12, 5 Gladstone Road, Castle Hill, NSW 2154, Australia.&#160; The Australia phone number is 612 9045 4110.&#160; Canada operations are located at 6355 Kennedy Road #15, Mississauga, ON L5T 2L5, Canada. The Canada phone number is 01 (905) 795-1102.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">1</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>PRODUCTS</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>More complete descriptions including part numbers and pictures of UTMD's devices can be conveniently obtained at </u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">www.utahmed.com</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u> and www.femcare-nikomed.co.uk.</u></font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>Labor and Delivery/ Obstetrics</u></font>:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Fetal Monitoring Accessories.</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Electronic Fetal Monitoring (EFM) is the standard of care in labor and delivery throughout the modern world.&#160; While not all pregnancies are high risk,&#160;fetal&#160;emergencies can occur suddenly in seemingly normal labors.&#160; The use of EFM allows conservation of nursing personnel and has virtually eliminated intrapartum fetal death.&#160; Accurate determination of contraction strength increases the safety of labor augmentation and reduces the need for Cesarean section for desultory labor. Infusion of fluid through an intrauterine catheter may cushion the umbilical cord and improve oxygenation of the fetus.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">To assist the physician in controlling the effectiveness of administration of oxytocin and monitoring effects of amnioinfusion, contraction intensities, uterine resting tones and peak contraction pressures are closely monitored through the use of an invasive intrauterine pressure catheter system.&#160; In addition, to help identify the possible onset of fetal hypoxia, correlation of the changes in fetal heart rate (FHR) relative to the frequency and duration of contractions are often electronically monitored.&#160; UTMD's intrauterine pressure (IUP) catheters provide for clinician choices from a traditional fluid-filled system to INTRAN&#174; PLUS, for over twenty-five years the most widely accepted transducer-tipped system.&#160; In addition, adjunct toco belts and chart paper are provided by UTMD to provide a package of fetal monitoring supplies.&#160; UTMD's IUP catheters include:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z24f8ad5877fa470b9b6c9ddebe694ef0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">IUP&#8209;075 and UTMD's other custom fluid-filled clear catheter kits utilize a saline&#8209;filled catheter that is placed within the uterine cavity, connected to a separate external reusable or disposable transducer.&#160; This product package, utilizing double lumen catheters, was the traditional mode of intrauterine monitoring prior to the introduction of INTRAN.&#160; An intrauterine pressure change is transmitted through the fluid column to the external pressure transducer.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Introduced in 1987, INTRAN was the first disposable intrauterine pressure catheter that placed the pressure transducer at the pressure source within the uterine cavity.&#160; This design eliminated the complicated setup of fluid&#8209;filled systems and provided more accurate pressure waveforms.&#160; INTRAN I was discontinued in 1995 in favor of the more widely preferred INTRAN PLUS.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">INTRAN PLUS was introduced in 1991.&#160; The INTRAN PLUS catheter combines the transducer tip concept of INTRAN I with a refined tip design, a zeroing switch or button that allows the clinician to reset the reference of the monitor, and a dedicated amniolumen which provides access to the amniotic fluid environment which may be helpful in the diagnosis and intervention of certain fetal conditions.&#160; In 1996, a viewport enhancement which allows physicians to observe amniotic fluid in a closed system was added to INTRAN PLUS.&#160; In 1997, UTMD introduced several variations to allow user preferences in tip size, zero switch/button location and amniotic fluid visualization.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD markets tocodynamometer belts, catheters and accessories as outlined above, but does not market electronic monitors, the capital equipment that processes the electrical signals.&#160; In addition to products currently offered, UTMD has continued to investigate the feasibility of tools that enhance fetal monitoring techniques.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Vacuum-Assisted Delivery Systems (VAD).</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's VAD Systems include CMI&#174; soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps which are the safest products available for use in vacuum-assisted operative deliveries. UTMD's soft silicone cup is a bell-shaped cup design that should be preferred for fetal well-being in low or outlet fetal stations with occiput anterior presentations, which represent more than 90% of the cases where VAD is indicated.&#160; Operative vaginal deliveries using forceps or vacuum-assisted delivery systems provide knowledgeable physicians with a trial vaginal operative delivery prior to a more invasive C-section intervention. Although there are risks associated with vaginal operative deliveries which may currently represent 3-4% of all U.S. hospital births, the procedures are generally regarded as safer long term for the mother, and at least as safe for the fetus, as abdominal (Cesarean) delivery in comparable clinical situations.&#160; UTMD's bell-shaped soft silicone TENDER TOUCH&#174; cups enjoy a low reported complication rate compared to other vacuum cup designs, as evidenced by the FDA Medical Device Reporting System (MAUDE) which publicly lists serious injuries reported by hospitals using specific brand names of products.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Other Labor &amp; Delivery Tools.</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">AROM-COT&#8482; is a finger cover with a patented prong design to rupture maternal membranes with less patient pain and anxiety.&#160; MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections.&#160; CORDGUARD&#174; is a product which unifies the multiple steps of clamping the neonate's cord close to the umbilicus, severing the cord without splattering blood, drawing a clean cord blood sample and assisting in the removal of the placenta.&#160; CORDGUARD's sharpless, closed system reduces the risk of exposure to potentially infected blood, and consequently reduces the high cost of exposure treatment under OSHA and CDC guidelines. In addition, CORDGUARD facilitates obtaining neonatal blood that is otherwise hard to obtain safely and cleanly. BT-CATH&#174; is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. Its benefits include the ease of rapid deployment and ability to monitor further bleeding after the tamponade has been placed. Abcorp toco belts and straps for fetal monitoring by an external tocodynamometer are provided in latex-free form in several configurations.&#160; In 2014, UTMD extended the product line to include Bari-Belts&#8482; and Bari-Bands&#8482;, a series of abdominal belts designed specifically for bariatric patients and bands to accommodate patients of all shapes and sizes.&#160; In 2015, UTMD obtained FDA clearance to market <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a new mechanical cervical ripening device, the CVX-RIPE&#8482; catheter, designed to mechanically improve the favorability of the cervix of pregnant patients at term gestation, for whom induction of labor is medically indicated. The CVX-Ripe utilizes two adjacent conical silicone balloons, similar to the shape of an hourglass.&#160; This design is intended to allow the clinician to gently apply internal pressure to the cervical canal, as well as both the internal and external os, to reduce the time needed to allow induction as well as the total time to achieve a successful vaginal delivery.&#160; </font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>Neonatal Intensive Care</u></font>:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>DISPOSA-HOOD&#8482;</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The DISPOSA-HOOD is an infant respiratory hood that is used in the NICU to administer oxygen to neonates and flush CO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2</font> (carbon dioxide) while maintaining a neutral thermal environment (NTE) critical to proper physiologic responses.&#160; The DISPOSA-HOOD, placed over the infant's head, incorporates a round diffusor connection specifically designed to disperse the incoming gases along the inner surfaces of the hood, rather than allowing them to blow directly on the infant's head.&#160; The design allows more precise FIO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2</font> (fractional inspired oxygen) control, minimizes convective heat loss from the head, provides optimum flows for elimination of CO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2</font> by ventilation and allows for humidification. DISPOSA-HOOD, in contrast to an incubator, allows for excellent access to and visualization of the underdeveloped infant.&#160; Because it is a disposable product, it also prevents potential cross&#8209;contamination that might occur with an incubator. Less invasive than nasal cannulae, Disposa-Hood avoids potential damage to fragile premature neonatal nasal/ orotracheal tissues, as well as facial tissues as cannulae are often secured with tape.&#160;&#160; A nasal cannula by itself cannot provide a NTE.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>DELTRAN&#174; PLUS</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's DELTRAN blood pressure monitoring system has been adapted specifically for use in the NICU.&#160; The streamlined version eliminates needles used for blood sampling, avoids the loss of scarce neonatal blood volume and provides a closed system that reduces the risk of infection.&#160; The system features excellent visualization of clearing volume, and one-handed use.&#160; UTMD continues its customization of Deltran kits for specific hospital applications.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>GESCO&#174;</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In the third quarter of 1998, UTMD acquired the neonatal product line of Gesco International.&#160; GESCO, best known for optimally biocompatible silicone catheters, gained an early distinctive reputation for its focus on the special developmental needs of tiny, critically-ill babies.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">A class of catheters called umbilical vessel catheters (UVCs) are specially designed for administering vital medications and fluids immediately following birth through the infant's umbilical vessel into the inferior vena cava.&#160; Because of the neonate's small size and lack of vascular development, there is no better access to vital organs.&#160; The catheters are also called umbilical artery catheters (UACs) when placed in one of the umbilical arteries to measure blood pressure or monitor metabolic processes through blood analysis.&#160; In developing its UMBILI-CATH&#8482; product line, Gesco pioneered the use of soft, biocompatible silicone catheters, helping to reduce the number of insertions required as well as other complications associated with invasive applications.&#160; UTMD has expanded the UVC product line to include catheters made from a proprietary thermosensitive polyurethane (Tecoflex&#174;) that offers many of the flexibility and biocompatibility advantages of silicone after insertion, with the greater rigidity of polyurethane preferred by many clinicians for insertion. In addition, GESCO provides a convenient catheterization procedure tray of instruments and supplies necessary to place UVC catheters, as well as perform other similar procedures.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;The primary distinction of GESCO products is that they were developed with the special needs of the neonate in mind, not just cut-down or smaller versions of adult devices.&#160; For example, in the case of invasive catheters, the introducer, the soft rounded distal tip, mode of securing to the patient after insertion to avoid migration, luer-locking hub with minimal dead space, number of lumens, catheter radiopaque striping for visualization, variations in catheter lengths and diameters and special packaging are all features specially designed for neonates. UTMD continues to modify product features to incorporate current neonatal practitioner preferences.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The soft, biocompatible silicone catheter concept had important advantages in other applications including peripherally inserted central venous catheters (PICC lines), enteral feeding tubes, urinary drainage catheters and chest drainage tubes.&#160; GESCO developed and marketed initial versions of all of these neonatal products.&#160; In order to keep pace with the trend of caring for smaller babies, UTMD has added smaller diameter versions of its URI-CATH&#174; and NUTRI-CATH&#174; products. At the request of customers who prefer a stiffer catheter for insertion, UTMD added a Tecoflex polyurethane oral-connection only Nutri-Cath series in 2009.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In 2000, UTMD gained FDA premarketing clearance of a PICC family of products specifically designed to minimize trauma to the critically ill neonate, named PICC-NATE&#174;.&#160; The PICC-NATE product line was designed with the input of experienced neonatal medical practitioners for use as a long-term indwelling catheter system for single-use, therapeutic central venous infusion of drug solutions, blood products or other fluids and for blood sampling.&#160; The soft, strong silicone PICC-Nate comes in two diameter sizes and two hub configurations.&#160; In early 2003, UTMD added a Tecoflex polyurethane version that offers many of the flexibility and biocompatibility advantages of silicone after insertion, with the greater rigidity of polyurethane preferred by many clinicians for insertion.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In 2006, UTMD developed a unique enteral feeding-only extension set named NUTRI-LOK&#174; that addresses important safety risks in the NICU &#8211; inadvertent connections with IV lines and inadvertent disconnections of components of the system spanning the dispensing container through the infusion catheter.&#160; &#160; In October 2007, UTMD added dispensing syringes with interlocking connectors to its NUTRI-CATH/NUTRI-LOK family of enteral feeding devices.&#160; In 2008, UTMD expanded the NUTRI-LOK system with specialty extension sets for GI tubes and for continuous connection to a fluid pump. In 2009, UTMD added a Kangaroo bag for larger feeds along with other NUTRI-LOK accessories.&#160; In 2011, UTMD added variations in adapters and extension sets used with NUTRI-CATH.&#160; Recognizing the important need to prevent misadministration of enteral feeding or medication by the wrong route, the FDA in February 2015 released its final guidance, "Safety Considerations to Mitigate the Risks of Misconnections with Small Bore Connectors Intended for Enteral Applications."&#160; The guidance includes compliance with ISO 80369-3 standard connectors. This new standard was released to create a universal connection that is not compatible with a luer connection or any other type of small bore medical connector.&#160; In 2016, UTMD introduced an alternative enteral feeding family of devices incorporating ENFit&#8482; ISO 80369-3 compliant connectors.&#160; These purple connectors replace the current Nutri-Lok connectors on catheters and extension sets.&#160;UTMD also distributes ENFit oral syringes.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In 2006, UTMD completed the replacement of all DEHP plasticizer PVC materials in its Gesco product line that may come in contact with neonatal patients, addressing another safety concern related specifically to the possible maldevelopment of male neonates.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Other GESCO specialty products include a disposable peritoneal dialysis (PD) set that is a pre-assembled, sterile, closed system, called DIALY-NATE&#174;.&#160; PD is an ideal method to aid compromised renal function in a neonate because critically-ill pediatric patients may not have sufficient blood volume to support hemodialysis. DIALY-NATE is provided in a form that allows timely PD implementation.&#160; In 2008, UTMD added a DIALY-NATE version that can be used with a variety of fluid warming systems.&#160; In 2010, UTMD introduced a bifurcated system that allows for higher volume manual PD applications.&#160; Since 2013, additional custom configurations have been added to satisfy specific clinical preferences.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Other specialty NICU devices include a silicone oral protection device used to prevent palatal soft tissue injury by orotracheal tubes, called PALA-NATE&#174;; a pre-assembled, closed urinary drainage system, called URI-CATH&#174;, which reduces risk of infection and valuable nursing time, and a lumbar sampling kit with a tiny, specially-beveled needle for obtaining cerebral spinal fluid samples, called MYELO-NATE&#174;.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">GESCO's first patented product, HEMO-NATE&#174;, is a disposable filter designed to remove microaggregates from stored blood prior to transfusion into a neonate where any deficiency can have an overwhelmingly negative impact on a neonate's chances for survival, given an under-developed vasculature and small total blood volume.&#160; In 2001, UTMD introduced a new filter and an improved blood bag spike for HEMO-NATE, and a needleless version.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD expects to continue to improve and expand its neonatal product line, seeking to reinforce a reputation as having the most reliable and developmentally-friendly specialty products available for the NICU.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>Gynecology /Urology /Electrosurgery</u></font>:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>LETZ&#174; System</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The LETZ System (loop excision of the transformation zone) is used to excise cervical intraepithelial neoplasia (CIN) and other lower genital tract lesions related to human papilloma virus (HPV) infections.&#160; The electrosurgery procedure with hemostasis has become the standard of care for HPV cervical infection treatment, replacing cold knife scalpel, laser and cryotherapy procedural approaches because it is economical, safe, effective, quick and easy to perform, has fewer potential side effects and requires little physician training.&#160; A major incentive for performing the LETZ procedure is that it may be performed using local anesthetic in a physician's office, eliminating the time and expense of hospital or surgical center admittance.&#160; Most importantly clinically, in contrast to laser (tissue ablation) and cryotherapy (freezing of tissue), LETZ provides a fine tissue specimen for pathological assessment.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's LETZ System includes disposable electrodes, the FINESSE&#174; electrosurgical generator and other miscellaneous components.&#160; A disposable loop electrode used to excise the tissue specimen is a pencil&#8209;like tube with a thin tungsten wire loop attached.&#160; The loop is available in varying sizes and includes a Safe&#8209;T&#8209;Gauge&#174; that can be positioned so the physician can accurately monitor and control the amount of tissue being excised. Excising too much tissue can compromise fertility and result in premature birth. UTMD continues to augment its specialty electrodes. For example, the Company introduced a patented conization electrode for deep endocervical disease called C-LETZ&#174;, designed to limit the removal of healthy tissue margins that might compromise adequate cervical function. UTMD also will continue to provide other components to augment the use of its market-leading specialty electrodes with other manufacturers' electrosurgical generators.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">After more than 20 years on the market, in 2012 UTMD completed a significant redesign, and achieved certification to the latest EN 60601 international safety standards, for a FINESSE+ electrosurgical generator.&#160; The FINESSE+ design includes dispersive pad contact monitoring for improved patient safety, improved circuitry for computer controlled-output that provides a precise tissue specimen for histopathology, a more efficient output stage resulting in less heat generation and longer electronic component life, an update to electronic components which reduces the number of required components and increases service life, and an easy change internal filter for integral smoke evacuation, a unique feature of FINESSE.&#160; UTMD obtained FDA premarketing clearance for FINESSE+ in January 2013.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>FINESSE+ Generator; Specialty Loop, Ball, and Needle Electrodes; FILTRESSE&#174; Evacuator; Other Specialty Electrodes; Other UTMD Supplies and Gynecologic Tools; Femcare Trocars and Cannulae; and Femcare Laparoscopic Instruments and accessories.</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD has FDA clearance to market its electrosurgical system and tools for use in general surgery applications, including dermatology, plastic surgery and otolaryngology.&#160; In 2002, UTMD introduced a product line of ultra-fine tipped microdissection needles, called OptiMicro&#8482; Needles.&#160; These electrosurgical needles are particularly useful in small-scale plastic and reconstructive surgery applications.&#160; In 2009, UTMD added extended length OptiMicro needle versions useful in certain head and neck procedures. FILTRESSE is a stand-alone surgical smoke filtration system that combines high filtration efficiency, low cost and convenient use in a surgical office setting. Other electrosurgery tools and accessories include disposable electrosurgical pens, dispersive pads, footswitches, filter packs, speculums, retractors, forceps, tenacula and hooks.&#160; UTMD acquired the distribution rights to a unique reusable four-way expander system which facilitates access to, and visualization of, the cervix, eliminating the need for less effective specula and lateral retractors.&#160; In 2007, UTMD developed OptiSpec&#174;, a patented ultra-bright light for cervical visualization without physician distraction during exams, pap smears and other vaginal procedures requiring direct cervical visualization without the use of a colposcope.&#160; In 2011, UTMD acquired Femcare's single patient use trocars and cannulae available in shielded, bladeless, optical bladeless, blunt and thoracic designs.&#160; In addition, UTMD acquired Femcare's laparoscopic instrument range and accessories which includes instruments suitable for all routine laparoscopic procedures requiring dissection, cutting, grasping and coagulation, e.g., monopolar scissors, various grasping forceps, dissecting forceps, L and J hooks, spatulae, Veress needles, suction and irrigation tubing, insufflation tubing and connectors, pressure infusor bags and control valves.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>EPITOME&#174;</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">EPITOME is an electrosurgical scalpel which delivers precise performance in surgical incision and excision with hemostasis while minimizing thermal side effects.&#160; Where rapid yet precise dissection of dense tissue is necessary, such as in mammaplasty or abdominoplasty, UTMD believes that EPITOME has no close substitute.&#160; Furthermore, an independent study concludes that the EPITOME scalpel provides a significant improvement over other devices in wound healing.&#160; EPITOME allows a rapid incision without countertraction, yielding limited morbidity, less post-surgical pain and cosmetically superior results.&#160;&#160; EPITOME is useful where minimization of thermal tissue injury is important but control of bleeding needed. A bendable version of EPITOME with a smaller active electrode was introduced in 1998.&#160; Designed to significantly reduce the chance of tissue burns due to inadvertent electrode contact and where a smaller, bent scalpel tip is needed, the bendable EPITOME is of particular value, e.g., to thoracic surgeons in harvesting the internal mammary artery during coronary artery bypass surgery, as well as to otolaryngologists for tonsillectomies or uvulopalatoplasties.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>FILSHIE CLIP System</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;UTMD acquired the Filshie Clip System as part of its acquisition of Femcare in March 2011. In 2017, sales of Filshie Clips, applicators and accessories represented 36% of UTMD's total U.S. Dollar denominated sales. The Filshie Clip is a female surgical contraception device used for tubal ligation, i.e., placed on the fallopian tubes, generally laparoscopically, but also post partum during a C-Section procedure. The Filshie Clip, in use for over 30 years, is the safest and most effective tubal occlusive device, is as easy or easier to place as any of the alternative surgical techniques, and has a substantially higher probability of reversibility when compared to all of the other approaches for women who later decide they may like to get pregnant. Femcare has obtained numerous regulatory approvals for the Filshie Clip System, which in 2017 was sold directly by UTMD to medical facilities in Canada, Ireland, France, the UK and Australia, and through specialty distributors in many other countries.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;There are several tubal ligation methods with varying degrees of effectiveness, safety and opportunity to be reversed.&#160; The traditional tubal ligation approach, informally known as "getting one's tubes tied", is a form of female sterilization in which the fallopian tubes are severed and sealed, permanently occluded or pinched shut.&#160; If the sterilization procedure is carried out postpartum, the Pomeroy technique is often adopted. During this procedure a small loop of the fallopian tube is tied with a suture and the top section removed by cutting. A traditional method for interval sterilization is with the use of Bipolar Cautery (electrocautery). With this method, a current flows between the tips of forceps when applied to the fallopian tube. This current then "burns" a portion of the fallopian tube shut. Although these common methods are relatively easy to perform, the failure rate of these methods, defined as the percentage of patients having undergone the procedure who subsequently get pregnant, has been reported to be about 3%. The Filshie Clip, which can be used at either interval or post-partum, is at least as easy to use and has a failure rate an order of magnitude less than Bipolar Cautery and the Pomeroy technique.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;Apart from Bipolar Cautery and the Pomeroy technique, other mechanical devices are the Falope Ring (or Yoon Ring) and the Hulka Clip. Both these older methods have a higher failure rate than the Filshie Clip, are associated with more post-operative pain and have generally been abandoned in favor of other sterilization techniques. Sterilization carried out with the Falope Ring also reduces the chances of a successful reversal being carried out.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;In more recent years, hysteroscopic sterilization was introduced as an alternative to laparoscopic tubal ligation. The competing device is the ESSURE by Conceptus, Inc. (acquired by Bayer AG in 2013).&#160; Although Bayer stopped marketing the device outside the U.S. in late 2016 and early 2017, it remains available for use in the U.S.&#160; The device, considered a permanent implant, is inserted transvaginally.&#160; Bayer reports that Essure is similar to the Filshie Clip in its sterilization effectiveness as measured after successful application, but Essure's "typical" effectiveness including reported misapplication rate has been documented in the medical literature to be substantially lower. Filshie Clips are immediately effective upon application and do not require follow-up physician visits. Essure takes some time after placement to become effective, requiring interim alternative contraception and an additional subsequent procedure to confirm that the tubes are blocked.&#160; Essure is not reversible (allowing later pregnancy) without significant surgical intervention and post-operative patient pain is reportedly significantly greater than using Filshie Clips.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The U.S. FDA released the Filshie Clip for marketing in 1996 after a Femcare PMA submission. Now the Filshie Clip is effectively marketed in the U.S. through an exclusive distribution agreement with CooperSurgical Inc. (CSI).&#160; In 2017, sales to CSI by Femcare represented 25% of total global Filshie Clip System sales.&#160; In late 2016, the FDA approved the use of Femcare's Sterishot single use applicator for applying Filshie clips. An applicator is a precision instrument which closes the implanted Filshie clip on the Fallopian tube to achieve proper permanent tubal ligation. Reused applicators require extra handling, cleaning, resterilization and storage which have the potential to damage or misalign the delicate mechanism. Timely periodic servicing and recalibration is needed.&#160; In addition, the reuse of a surgical instrument introduces the possibility of infection if not properly cleaned and resterilized between procedures.&#160; The precalibrated, single use sterile Sterishot eliminates these safety, effectiveness and cost exposures. CSI began purchasing Sterishot kits in 2017. After more than eight years since being introduced outside the U.S. (OUS), the patented Sterishot is used in the majority of Filshie clip ligation procedures OUS.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>PATHFINDER PLUS&#8482;</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">PATHFINDER PLUS is a proprietary endoscopic irrigation device that allows a uro/gyn surgeon to precisely irrigate, clearing the visual field, with the same hand that controls the endoscope, eliminating the need for a separate assistant to irrigate without visualization.&#160; An example of a procedure where Pathfinder has found success is ureteroscopic stone ablation.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>SUPRAPUBIC CATHETERIZATION</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Add-a-Cath introducer is a Femcare device designed for easy and safe suprapubic introduction of a catheter for bladder drainage.&#160; Suprapubic catheterization is generally well-recognized as a drainage method with fewer complications than with urethral catheterization.&#160;&#160; In 2013, UTMD introduced suprapubic catheterization procedure kits featuring the Add-a-Cath introducer, which UTMD now distributes directly to end users in the U.S. under the trade name "Supra-Foley".</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>LIBERTY&#174; System</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">LIBERTY is a device for the conservative treatment and effective control of urinary incontinence in women.&#160; UTMD believes that LIBERTY is the easiest-to-use, most cost effective incontinence treatment available that yields a therapeutic effect, not just a cover-up. LIBERTY consists of a battery operated electrical stimulation unit and an intravaginal electrode probe.&#160; This physiotherapy technique, which can be done in the privacy of the home, involves passive strengthening of the periurethral muscles.&#160; Pulsed, low voltage, high frequency current is applied primarily to the pudendal neuromuscular tissue causing the pelvic area muscles to contract, leading to better muscle tone.&#160; Because electrical stimulation has no known adverse side effects, LIBERTY provides women suffering from mild to moderate incontinence an effective, lower cost and lower risk alternative to more traumatic treatments such as surgery and drug therapy.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>ENDOCURETTE</u></font><a name="OLE_LINK1"><!--Anchor--></a><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>&#8482;</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In cooperation with Mayo Clinic, UTMD developed an advanced curette for uterine endometrial tissue sampling in the doctor's office.&#160; The sampling procedure is intended primarily to rule out precancer or cancerous change of the uterus in premenopausal women with abnormal uterine bleeding, or women with postmenopausal bleeding.&#160; The device is part of a class of catheters designed to be used without dilatation of the cervix and without general anesthetic.&#160; The inherent weakness of this type of device, which is related to its small size, is that it may not remove enough tissue of the endometrium for an accurate histologic assessment, in contrast to a more invasive D&amp;C hospital procedure.&#160; The tip of the EndoCurette was specially designed to obtain a more thorough tissue specimen compared to other catheters used without the need for dilatation, and without an increase in patient discomfort.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>TVUS/HSG-Cath&#8482;</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In order to further assess persistent abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus, or as a next step after endometrial tissue sampling with an EndoCurette, gynecologists may utilize transvaginal ultrasound imaging of the uterus.&#160; UTMD's TVUS/HSG-Cath was designed and released for marketing in 2007 to provide effective cervical occlusion that allows distention of the uterus to differentiate anterior and posterior endometrium, among other irregularities, together with minimal visual obstruction of the uterus near the internal os.&#160; In addition, the TVUS/HSG-Cath may be used in hysterosalpingography radiographic procedures to assess the patency of fallopian tubes.&#160; A related device acquired in 2011 is Femcare's Spackman Style uterine cannula designed for the manipulation of the uterus and injection of fluid to test the patency of the fallopian tubes.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>LUMIN&#174;</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">LUMIN&#174; is a gynecological tool developed by UTMD for reliably and safely manipulating the uterus in laparoscopic procedures.&#160; LUMIN combines the strength, range of motion and versatility of the higher end reusable instruments with the lower cost and cleanliness of the inexpensive less functional disposable instruments presently on the market, while at the same time reducing the number of tools needed to move and secure the uterus.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Blood Pressure Monitoring:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>DELTRAN&#174; Disposable Pressure Transducer (DPT)</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In pressure monitoring, a transducer is used to convert physiological (mechanical) pressure into an electrical signal that is displayed on electronic monitoring equipment.&#160; UTMD developed and is now distributing its disposable transducer as a stand&#8209;alone product, and as a component in sterile blood pressure monitoring kits through direct representatives and other medical companies in the U.S., as well as independent distributors and other medical device companies OUS.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company believes that the DELTRAN DPT which it designed over thirty years ago and currently manufactures, remains the standard in terms of accuracy, reliability and ease of use.&#160;&#160; Introduced in 1998, the DELTRAN PLUS provides a closed system for blood sampling, without the use of needles, reducing the risk of an unwanted infection for both the patient and the practitioner.&#160; In 2009, in conjunction with its other NICU devices, UTMD continued to configure neonatal Deltran custom kits which satisfy the special needs of conserving limited blood volume and protecting the neonate from infection.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Pressure Monitoring Accessories, Components and Other Molded Parts.</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Components included in blood pressure monitoring kit configurations include flush devices, stopcocks, fluid administration sets, caps, pressure tubing, interface cables and organizers.&#160; The Company sells similar components designed for other medical device company applications which incorporate UTMD's technologies and designs.&#160; DELTA-CAL&#8482; is a calibration device used to check proper functioning of an arterial pressure system.&#160; In addition, UTMD sells plastic molded parts on a subcontract basis to a number of medical and non-medical device companies.&#160; In addition, partly as a result of its excellent quality system and ISO13485 certification, UTMD performs subcontract assembly, testing and packaging of components that are proprietary to other medical device firms.&#160; UTMD believes that this practice helps better utilize its investment in fixed plant and equipment, and spreads overhead costs resulting in better gross profit margins on finished device sales.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>MARKETING and COMPETITION</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD divides its sales into "domestic" U.S. sales and "outside the U.S." sales, which are finished device and component sales to entities outside the U.S.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">1)&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Domestic sales</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">For domestic sales to end-users of finished devices, marketing efforts are complex and fragmented.&#160; UTMD's marketing focus is with clinicians who take responsibility for obtaining optimal patient care outcomes, primarily through clinical meetings, trade shows and the Internet.&#160; In competitive bidding processes, UTMD works primarily with administrators who are responsible for hospital purchasing decisions.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD competes primarily on the basis of improved patient safety and reliable device performance in the hands of a trained clinician.&#160; A number of UTMD's devices are strong brands because they are well-recognized by clinicians as clinically different and have been in use for decades.&#160; UTMD's broad offering of finished devices is comprised of dozens of specialty device types.&#160; Although there may be only a few competitors for each type, in the aggregate UTMD has dozens of U.S. medical device competitors.&#160; There are at least two competitors with significant market share for each of UTMD's device types.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">As a general rule, because of UTMD's differences in design and reliability, competitors' devices represent substitutes rather than equivalent devices.&#160; The Company's primary marketing challenge is to keep its customers focused on those differences and their important clinical benefits.&#160; In recent years, UTMD's access to U.S. hospital clinicians has become increasingly restricted and the involvement of clinicians in medical device purchasing decisions, which is critical to the Company's success, has declined.&#160; To the degree that U.S. hospitals become less focused on patient safety and clinical outcomes and more on out-of-pocket unit price, UTMD's competitive position weakens.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In 2017, UTMD sold components and finished devices to 148 other companies in the U.S. (OEM sales). For over 39 years, the Company has utilized its manufacturing capabilities and engineering know-how to produce high quality components and finished devices for other companies.&#160; For U.S. companies which wish to distribute their products outside the U.S., UTMD's maintenance of certification to current ISO 13485 medical device quality standards is an important benefit.&#160; UTMD's website, which lists its capabilities, is often the basis for contacts for new OEM work.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Although there are other manufacturers in the U.S. with similar manufacturing capabilities, UTMD's primary competition comes from East Europe, India and China device component manufacturers which have much lower wage rate structures. To the extent that the U.S. Dollar (USD) gains strength in any period of time against foreign currencies, UTMD's ability to be cost-competitive with foreign manufacturers is diminished.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2)&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Outside the U.S. (OUS) sales</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">OUS sales in 2017, as a percentage of consolidated total USD sales, represented 51% compared to 50% in 2016.&#160; In contrast to the previous three years when the USD consistently and significantly strengthened relative to other currencies, the net negative impact of FX changes in 2017 was minimal.&#160; Prior to 2011, with only a few exceptions, UTMD's OUS sales were to other medical device companies and distributors, not to clinical end user facilities. After the acquisition of Femcare in 2011, UTMD began a transition to marketing directly to end users in countries where the Filshie Clip System had achieved significant acceptance. This also allows increased distribution opportunities for other UTMD devices which previously did not have significant third party distributor interest.&#160; In 2017, UTMD distributed directly to medical facilities in Canada, the UK, France, Ireland and Australia. The Company's devices are also sold OUS through over 270 independent regional distributors. UTMD's website provides information that frequently results in unsolicited contacts from OUS entities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>DISTRIBUTION</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">An important success factor in the medical device industry is access to medical practitioners.&#160; In the U.S., the hospital supplier environment has consolidated as a result of group purchasing organizations (GPOs), or their equivalents.&#160; It is UTMD's assessment that U.S. hospitals are not currently saving costs under GPO contracts when it comes to specialty medical devices that can reduce complications, utilization rates, clinician time and unwanted side effects, because administrators are focused purely on out-of-pocket costs and miss the broader total cost of care issues.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The longer term overall cost of care in the U.S. will continue to increase, with quality of care lower, as innovative suppliers are excluded from participating in the marketplace as a result of unnecessary regulatory and other purely administrative burdens. The length of time and number of administrative steps required in evaluating new products for use in hospitals has grown substantially. As a potential negative factor to future performance, as UTMD introduces new products it believes are safer and more effective, it may find itself excluded from certain customers because of the existence of long term supply agreements for existing products. UTMD may also be unable to establish viable relationships with other medical device companies that do have access to users but lack an interest in the Company's approach or demand too great a financial or administrative burden.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">When U.S. hospital customers request it, UTMD provides its devices through national distribution companies, also known as Med/Surg distributors.&#160; Sales to Med/Surg distributors in 2017 comprised 14% of total domestic direct sales (excluding Filshie Clip System sales to CSI).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;In the U.S., Canada, Ireland, France, the UK and Australia, UTMD sells its products with the support of its own directly employed customer service and sales force, independent consultants and selective independent manufacturer representatives.&#160; Direct sales representatives focus on applications for UTMD devices where customer training and support may be important. The direct sales force is comprised both of "outside" representatives operating remotely in specific geographic areas, and "inside" representatives who operate primarily by telephone from corporate offices.&#160; Direct representatives are trained to understand the medical procedures being performed within UTMD's clinical focus. Through the use of its one-on-one contacts with physicians and other clinical practitioners directly involved in patient care, the direct sales force positions UTMD to gain market leadership with specific solutions to clinical issues. In addition to its direct representatives, UTMD utilizes third party consulting clinical specialists to augment its customer training programs.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Additionally, UTMD sells component parts as well as finished devices to other companies for use with their product lines.&#160; This OEM distribution channel is simply maximizing utilization of manufacturing capabilities that are otherwise needed for UTMD's primary business, and does not compete with or dilute UTMD's direct distribution and marketing programs.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">OUS, the Company distributes directly to end user facilities in Canada, the UK, France, Ireland and Australia, and sells to over 270 regional distributors and OEMs (other medical device manufacturers and/or distributors) in over a hundred countries. Ten percent of UTMD's independent OUS distributors represented 79% of UTMD's indirect OUS sales in the years of 2015 - 2017.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>NEW PRODUCT DEVELOPMENT</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">New product development has been a key ingredient to UTMD's market identity.&#160; Product development takes several interrelated forms: 1) improvements, enhancements and extensions of current product lines in response to clinical needs or clinician requests, 2) introduction of new or augmented devices that represent a significant improvement in safety, effectiveness and/or total cost of care, and 3) acquisitions of products or technology from others.&#160; Manufacturing process development is an equally important aspect that cannot be separated from the successful design and development of devices.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Because of UTMD's reputation as a focused product developer, its financial strength and its established clinician user base, it enjoys a substantial inflow of new product development ideas.&#160; Internal development, joint development, product acquisitions and licensing arrangements are all included as viable options in the investigation of opportunities.&#160; Only a small percentage of ideas survive feasibility screening.&#160; For internal development purposes, projects are assigned to a project manager who assembles an interdisciplinary, cross-functional development team.&#160; The team's objective is to have a clinically acceptable, manufacturable and regulatory-released product ready for marketing by a specific date.&#160; Several projects, depending on the level of resources required, are underway at UTMD at any given time. Only a few assigned projects succeed in attaining a product that meets all of the Company's criteria. In particular, this includes a product that is highly reliable, easy to use, cost-effective, safe, useful and differentiated from the competition. Once a product is developed, tooled, fully tested and cleared for marketing by the applicable regulatory entity(ies) in the U.S. and/or other countries, there remains a reasonable probability it cannot be successfully marketed for any number of reasons, not the least of which is being beaten to the market by a competitor with a better solution, or not having access to users because of limitations in marketing and distribution resources or exclusionary contracts of GPOs.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's current product and process development projects are in the following areas: 1) augmentation and internal manufacturing of existing UTMD devices, 2) neonatal intensive care, 3) specialized procedures for the assessment and treatment of cervical/uterine disease, 4) labor and delivery procedures, and 5) product and process development for OEM customers. Internal product development expenses are expected to remain in the range of 1-2% of sales.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>EMPLOYEES AND OTHERS</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">At December 31, 2017, the Company had 172 employees, eight regular consultants, 21 independent manufacturer's sales representatives and an additional eleven subcontract production employees in Utah.&#160; The subcontract employees represent UTMD's desire to provide handicapped persons additional work opportunities, hired through the Utah state-supported Work Activity Center.&#160; The Company utilizes independent consultants, some of which were prior employees. Almost all of UTMD's internally-manufactured devices are made either in Utah or in Ireland. The average tenure with the Company of the 125 employees in the U.S. is over fifteen years, and the tenure of the 28 employees in Ireland is over fourteen years. This experience conveys an important benefit due to the level of training required to produce consistently high quality medical devices and appreciation of how UTMD's devices provide unique benefits for clinicians and patients.&#160; The Company's continued success will depend to a large extent upon its ability to retain skilled and experienced employees and consultants.&#160; No assurances can be given that the Company will be able to retain or attract such people in the future, although management is committed to providing an environment in which reliable, creative and high achieving people wish to work.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">None of the Company's officers or directors is bound by restrictive covenants from prior employers that limit their ability to contribute to UTMD's programs.&#160; All professional employees agree to a code of conduct and sign a strict confidentiality agreement as a condition of employment, and as consideration for receipt of stock option awards and participation in the annual sales and management bonus program.&#160; All employees participate in contemporaneous performance&#8209;based bonus programs.&#160; None of the Company's employees is represented by labor unions or other collective bargaining groups.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>PATENTS, TRADEMARKS AND TECHNOLOGY LICENSES</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company currently owns eleven unexpired and one pending U.S. patents, numerous associated patents in sovereignties OUS and is the licensee of certain other technology. There can be no assurance, however, that patents will be issued with respect to any pending applications, that marketable products will result from the patents or that issued patents can be successfully defended in a patent infringement situation.&#160; The Company also owns thirty-two U.S. registered trademarks which have achieved significant brand recognition. The Company believes that its trademarks and tradenames, many of which have become well known in the global medical community through decades of successful use of the associated medical devices, likely have and will continue to have substantially more intangible value than its patents.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The ability of the Company to achieve commercial success depends in part on the protection afforded by its patents and trademarks.&#160; However, UTMD believes that the protections afforded by patents and trademarks are less important&#160; to&#160; UTMD's business, taken as a whole,&#160; than a medical device's established incremental clinical utility, which may be dominated by a number of other factors including relative cost, ease of use, ease of training/adoption, perceived clinical value of different design features, risk of use in applicable procedures, the reliability of achieving a desired outcome in the hands of different users and market access to potential users.&#160; In cases where competitors introduce products that may infringe on UTMD's technology or trademarks, the Company has an obligation to its stockholders to defend its intangible property to the extent that it can afford to do so, and that it is material to the Company's success. The Company must also defend itself when competitors allege that UTMD may be infringing their technologies.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">As a matter of policy, UTMD has acquired and will continue to acquire the use of technology from third parties that can be synergistically combined with UTMD proprietary product ideas.&#160; During 2017, royalties included in cost of goods sold were $204.&#160; Other royalties have been previously paid as a lump sum, or were incorporated into the price of acquisitions or into the cost of purchased components which practice certain patents of third parties.&#160; Also as a matter of policy, UTMD licenses its proprietary technology to others in circumstances where licensing does not directly compete with UTMD's own marketing initiatives.&#160; UTMD's future financial performance may also depend on the marketing ability of other companies that license UTMD's technology.&#160; During 2017 the Company received $86 in royalty income, compared to $91 in 2016 and $93 in 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>GOVERNMENT REGULATION</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's products and manufacturing processes are subject to regulation by the U.S. Food &amp; Drug Administration ("FDA"), as well as other regulatory entities globally.&#160; The FDA has authority to regulate the marketing, manufacturing, labeling, packaging and distribution of medical devices in the U.S.&#160; In addition, requirements exist under other federal laws and under state, local and foreign statutes that may apply to the manufacturing and marketing of the Company's medical devices.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">All manufacturers of medical devices must register with the FDA and list all medical devices produced by them.&#160;&#160; In addition, prior to commercial distribution of some devices for human use, a manufacturer must file a notice with the FDA, setting forth certain information regarding the safety and effectiveness of the device that is acceptable in content to the FDA.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Devices which are classified in Class I are subject only to the general controls concerning adulteration, misbranding, good manufacturing practices, record keeping and reporting requirements.&#160; Devices classified in Class II must, in addition, comply with special controls or performance standards promulgated by the FDA.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Except for the Filshie Clip System, all of UTMD's present devices are unclassified, Class I or Class II devices.&#160; The Filshie Clip System is a Class III device which has more stringent regulatory controls. The Company is in compliance with all applicable U.S. regulatory standards including CFR Part 820, the FDA Quality System Regulation (QSR) effective in 1997, also known as cGMPs (current good manufacturing practices).&#160;&#160; The Company's most recent FDA inspection was in July 2014, which did not result in the issuance of any FDA-483 observations.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In 1994, UTMD received certification of its quality system under the ISO9001/EN46001 standards ("ISO" stands for "International Organization of Standardization") which it maintained until December 2003.&#160; In October 2003, UTMD's Utah facility was certified under the more stringent ISO13485 standard for medical devices. UTMD's Ireland facility was certified under the concomitant ISO13488 standard.&#160; In July 2006, both facility ISO certifications were upgraded to the even more stringent ISO13485:2003 standard.&#160; Currently, UTMD's facilities in the UK, Ireland and Utah are all certified under the most recent ISO13485:2012 standard. UTMD remains on a continuous periodic audit schedule by its independent notified body in order to stay current with international regulatory standards, and retain its certifications. UTMD has received CE Mark certifications (demonstrates proof of compliance with the European Community's ISO standards) for essentially all of its products. The U.S. FDA QSR was developed in harmony with the ISO standards.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>SOURCES AND AVAILABILITY OF RAW MATERIALS</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Most of the components which the Company purchases from various vendors are readily available from a number of sources.&#160; That notwithstanding, the Company maintains safety stocks that anticipate the time required to source and qualify new vendors.&#160; Alternative sourcing of various components is continually underway.&#160; Vendors are qualified by Corporate Quality Assurance. In the few cases where the Company has a sole source, it either maintains or has agreement with the supplier to maintain excess safety stocks that would cover the time required to develop and qualify a new source. The Company has a vendor quality monitoring program that includes routinely checking incoming material for conformance to specifications, as required per written procedures.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>U.S. EXPORTS</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD regards the OUS marketplace as an important element of its growth strategy. UTMD is keenly aware that not only are OUS markets different from the U.S. market, but also that each country has its own set of driving influences that affects the dynamics of the nature of care given and medical devices used.&#160; The Company operates four OUS facilities; in Romsey, Hampshire, England; in Castle Hill, NSW, Australia; in Mississauga, Ontario, Canada and in Athlone, County Westmeath, Ireland.&#160; These facilities offer a number of advantages: 1) from a marketing point of view, better response to Europe, Asia, Africa and Australia customers, including a better understanding of customer needs, less costly distribution and, in the EU, duty-free access to 500 million patients; 2) from a regulatory point of view, faster new product introductions; and 3) from a manufacturing point of view, reduced dependence on one manufacturing site and increased capacity for meeting customer needs.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Total 2017 trade revenues in USD terms from customers OUS were $21,129 (51% of total sales), compared to $19,809 (50% of total sales) in 2016 and $19,793 (49% of total sales) in 2015.&#160; OUS trade sales (U.S. exports) from the U.S. to OUS customers were $5,357 in 2017, $5,587 in 2016 and $5,714 in 2015.&#160; U.S. exports represented 25%, 28% and 29% of total OUS trade sales in 2017, 2016 and 2015, respectively.&#160; The U.S. export numbers exclude Utah intercompany sales of components and finished devices to UTMD foreign subsidiaries, which then distribute U.S.-made components and finished devices as part of their sales to OUS customers.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">For sales by OUS geographic area, please see note 10 to the Consolidated Financial Statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>BACKLOG</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Backlog is defined as orders received and accepted by UTMD which have not shipped yet.&#160; As a supplier of primarily disposable hospital products, the nature of UTMD's non-distributor or non-OEM business requires fast response to customer orders.&#160; Virtually all direct shipments to end user facilities are accomplished within a few days of acceptance of purchase orders. Consequently, UTMD's backlog at any point in time is comprised mainly of orders from OEM and independent distributors, which purchase in larger quantities at less frequent intervals. Backlog shippable in less than 90 days was $3,140 as of January 1, 2018, $1,774 as of January 1, 2017 and $2,463 as of January 1, 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>SEASONAL ASPECTS</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company's business is generally not affected by seasonal factors, but it is affected by uneven purchasing patterns of OEM customers and independent distributors.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>PRODUCT LIABILITY RISK MANAGEMENT</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The risk of product liability lawsuits is a negative factor in the medical device industry because devices are frequently used in inherently risky situations to help clinicians achieve a more positive outcome than what might otherwise be the case.&#160; In any lawsuit against a company where an individual plaintiff suffers permanent physical injury, a possibility of a large award for damages exists whether or not a causal relationship exists. However, no such damages have been awarded against UTMD in its 39-year history of shipping many millions of devices.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Except for the Filshie Clip System, UTMD is self-insured for product liability risk, and reserves funds against its current performance on an ongoing basis to provide for its costs of defense should any lawsuits be filed. The Company's average cost of defense over the last twenty-five years was $18 per year, well below the deductible level of product liability insurance policies. This experience validates that the most important aspect of product liability risk management is the safe design and reliable integrity of manufactured products, not a third party insurance contract.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;The best defense the Company believes that it has is the consistent conformance to specifications of its proven safe and effective products.&#160; Over the time span of the last twenty-five years, UTMD has been named as a defendant in a total of eight lawsuits.&#160; Four lawsuits involved a patient injury related to operative vaginal deliveries where a UTMD VAD birthing cup or hand pump was used. The VADS devices in all four cases did conform to specifications. UTMD was ultimately dismissed as a defendant in all four VADS lawsuits, and legal costs were not material to performance. In the first of the other two lawsuits not involving a Femcare device, regarding the use of EndoCurette, there was no evidence of patient injury. The lawsuit was settled in 2010 for an immaterial amount to avoid the diversion of management time and substantial costs of litigation, even though UTMD was confident that the case was without merit. In the second, UTMD was brought into a lawsuit by a defendant physician, speculating a design deficiency in a Finesse electrosurgical generator (ESU) which had been in use for eighteen years before the injury event, and used successfully by the same physician in multiple procedures after the event. The injured patient did not allege any fault by UTMD.&#160; The case was settled in 2012 without any UTMD involvement or liability.&#160; Excluding the Filshie Clip System acquired in 2011, there have been no product liability lawsuits during the last six years.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;Because the Filshie Clip is a Class III device, Femcare does further insure its product liability risk through a third-party insurance company at a cost of about &#163;54 per year. The deductible level of the Femcare policy is $150 per claim for the U.S. and Canada, and &#163;50 elsewhere in the world.&#160; Since acquiring Femcare in 2011, UTMD has had to defend two U.S. claims for failed sterilizations (not serious injuries), during which time approximately two million clips were used.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;In 2014, a patient claimed damages for becoming pregnant eight years after the placement of Filshie Clips. Her medical record indicated that she chose to employ Filshie Clips after being advised by her physician that he believed there would be a 1% chance of pregnancy.&#160; The case was dismissed after the patient who was also a malpractice attorney declined to respond in discovery.&#160; In 2017, UTMD was served with a complaint by a patient who had experienced an uncomplicated pregnancy and childbirth.&#160; A malpractice lawsuit had been filed against the attending physician in 2015, but the physician's insurance company subsequently went bankrupt.&#160; Discovery in the case is presently on stay until insurance coverage obligations can be sorted out.&#160; To UTMD's knowledge, there is no evidence of defective clips. A claim of defective design doesn't have merit, either, supported by the successful use of millions of clips. A claim of failure to properly warn of a remote chance of pregnancy doesn't have merit as UTMD's IFU is clear that there is such a risk.&#160; The Company expects that the case will be resolved, consistent with its past experience, at an immaterial cost.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;In summary, during the last twenty-five year period of time during which over forty million finished devices were distributed by UTMD, there have been no judgments resulting from a claim of defect in UTMD's design or manufacture of its devices, or a fault in its informational materials. In the current tort system in the U.S., meritless product liability cases do get filed where aggressive attorneys calculate that a company will find it cheaper to settle for some nominal amount in lieu of potentially substantial defense costs of going to court.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>FORWARD LOOKING INFORMATION</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">This report contains certain forward-looking statements and information relating to the Company that are based on the beliefs of management as well as assumptions made by management based on information currently available.&#160; When used in this document, the words "anticipate," "believe," "project," "estimate," "expect," "intend" and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements.&#160; Such statements reflect the current view of the Company respecting future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties stated throughout the document.&#160; Although the Company has attempted to identify important factors that could cause the actual results to differ materially, there may be other factors that cause the forward statement not to come true as anticipated, believed, projected, expected, or intended.&#160; Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those described herein as anticipated, believed, projected, estimated, expected or intended.&#160; Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and the Company assumes no obligation to update or disclose revisions to those estimates.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 1A &#8211; RISK FACTORS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Legislative healthcare reform in the United States, as embodied in The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (the "Acts") added a substantial excise tax (MDET)&#160; in 2013-2015 that&#160; increased administrative costs and has led to decreased revenues in the U.S.:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The voluminous Acts, administrative rules to enforce the Acts and promised efforts to reform the Acts, make the U.S. medical device marketplace unpredictable, particularly for the thousands of small medical device manufacturers including UTMD that do not have the overhead structure that the larger medical device companies can afford.&#160; Fortunately, the U.S. Congress suspended the MDET for the years of 2016-2019. To the extent that the Acts will in the future continue to place additional burdens on small medical device companies in the form of the excise tax on medical device sales, additional oversight of marketing and sales activities and new reporting requirements, the result is likely to continue to be negative for UTMD's ability to effectively compete and support continued investments in new product development and marketing of specialty devices in the U.S.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Increasing regulatory burdens including premarketing approval delays may result in significant loss of revenue, unpredictable costs and loss of management focus on helping the Company proactively conform with requirements and thrive:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company's experience in 2001-2005, when the FDA improperly sought to shut it down, highlights the ongoing risk of being subject to a regulatory environment which can be arbitrary and capricious. The risks associated with such a circumstance relate not only to the substantial costs of litigation in millions of dollars, but also loss of business, the diversion of attention of key employees for an extended period of time, including new product development and routine quality control management activities, and a tremendous psychological and emotional toll on dedicated and diligent employees.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Since the FDA reserves to itself the interpretation of which vague industry standards comprise law at any point in time, it is impossible for any medical device manufacturer to ever be confident that it is operating within the Agency's version of the law.&#160; The unconstitutional result is that all companies, including UTMD, are considered guilty prior to proving their innocence.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Premarketing submission administrative burdens and substantial increases in "user fees" increase product development costs and result in delays to revenues from new or improved devices.&#160; It recently took two and a half years to gain FDA approval of the use of a clearly safer single use Filshie Clip applicator, which had been in use for over seven years OUS, in lieu of a reused applicator approved in the U.S. since 1996, made of substantially equivalent materials for the same intended use applying the same implanted clip.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>The growth of Group Purchasing Organizations (GPOs) adds non-productive costs, typically weakens the Company's marketing and sales efforts and may result in lower revenues:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">GPOs, theoretically acting as bargaining agents for member hospitals, but actually collecting revenues from the companies that they are negotiating with, have made a concerted effort to turn medical devices that convey special patient safety advantages and better health outcomes, like UTMD's, into undifferentiated commodities. GPOs have been granted an antitrust exemption by the U.S. Congress. Otherwise, their business model based on "kickbacks" would be a violation of law.&#160; These bureaucratic entities do not recognize or understand the overall cost of care as it relates to safety and effectiveness of devices, and they create a substantial administrative burden that is primarily related to collection of their administrative fees.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>The Company's business strategy may not be successful in the future:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 8.55pt">As the level of complexity and uncertainty in the medical device industry increases, evidenced, for example, by the unpredictable regulatory environment, the Company's views of the future and product/ market strategy may not yield financial results consistent with the past.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>As the healthcare industry becomes increasingly bureaucratic it puts smaller companies like UTMD at a competitive disadvantage:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">An aging population is placing greater burdens on healthcare systems, particularly hospitals. The length of time and number of administrative steps required in adopting new products for use in hospitals has grown substantially in recent years.&#160; Smaller companies like UTMD typically do not have the administrative resources to deal with broad new administrative requirements, resulting in either loss of revenue or increased costs.&#160; As UTMD introduces new products it believes are safer and more effective, it may find itself excluded from certain clinical users because of the existence of long term supply agreements for preexisting products, particularly from competitors which offer hospitals a broader range of products and services.&#160; Restrictions used by hospital administrators to limit clinician involvement in device purchasing decisions makes communicating UTMD's clinical advantages much more difficult.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>A product liability lawsuit could result in significant legal expenses and a large award against the Company:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's devices are frequently used in inherently risky situations to help physicians achieve a more positive outcome than what might otherwise be the case.&#160; In any lawsuit where an individual plaintiff suffers permanent physical injury, the possibility of a large award for damages exists whether or not a causal relationship exists.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>The Company's reliance on third party distributors in some markets may result in less predictable revenues:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's distributors have varying expertise in marketing and selling specialty medical devices.&#160; They also sell other devices that may result in less focus on the Company's products.&#160; In some countries, notably China, Pakistan and India not subject to similarly rigorous standards, a distributor of UTMD's products may eventually become a competitor with a cheaper but lower quality version of UTMD's devices.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>The loss of one or more key employees could negatively affect UTMD performance:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In a small company with limited resources, the distraction or loss of key personnel at any point in time may be disruptive to performance.&#160; The Company's benefits programs are key to recruiting and retaining talented employees.&#160; An increase in UTMD's employee healthcare plan costs, for example, may cause the Company to have to reduce coverages which in turn represents a risk to retaining key employees.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Fluctuations in foreign currencies relative to the USD can result in significant differences in period to period financial results:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Since a significant portion of UTMD's sales are invoiced in foreign currencies and consolidated financial results are reported in USD terms, a stronger USD can have negative revenue effects. Conversely, a weaker USD would increase foreign subsidiary operating costs in USD terms. For the portion of sales to foreign entities made in fixed USD terms, a stronger USD makes the devices more expensive and weakens demand.&#160; For the portion invoiced in a foreign currency, not only USD-denominated sales are reduced, but also gross profits may be reduced because finished distributed products and/or U.S. made raw materials and components are likely being purchased in fixed USD.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 1B &#8211; UNRESOLVED STAFF COMMENTS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">None</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 2 &#8209; PROPERTIES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Office and Manufacturing Facilities.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD is a vertically&#8209;integrated manufacturing company.&#160; Capabilities include silicone and plastics-forming operations including injection molding, insert and over-molding, thermoforming and extrusion; sensor production; manual and automated assembly of mechanical, electrical and electronic components; parts printing; various testing modalities; advanced packaging in clean room conditions; and a machine shop for mold&#8209;making and fabrication of assembly tools and fixtures.&#160; Capabilities also include an R&amp;D laboratory for both electronic and chemical processes, software development resources, communications and computer systems networked real time OUS, and administrative offices.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">At the beginning of 2018, the Company's operations were located in 110,000 square feet of facilities near Salt Lake City, Utah, a 77,000 square foot facility in Athlone, County Westmeath, Ireland, a 38,600<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #00ccff">&#160;</font>square foot facility in Romsey, Hampshire, England, a 3,200 square foot facility in Castle Hill NSW, Australia, and a 4,700 square foot facility in Mississauga, Ontario, Canada.&#160; Manufacturing is currently carried out primarily in the Utah and Ireland facilities, with some in the UK.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In late 2016 UTMD purchased a 38,600 square foot in Romsey and subsequently fitted-out the building in 2017. In November 2017, Femcare UK's operations moved into the refurbished building.&#160; UTMD now owns all of its facilities.&#160; The prior UK lease and all associated potential liabilities have been terminated. UTMD owns its property and facilities with the exception of a long&#8209;term lease with 15 years remaining on one section of its Midvale parking lot.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 3 &#8209; LEGAL PROCEEDINGS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company may be a party from time to time in litigation incidental to its business.&#160; Presently, there is no litigation or threatened litigation for which the Company believes the outcome may be material to its financial results.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 4 &#8209; RESERVED</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>PART II</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">ITEM 5 &#8209; MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Market Information.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's common stock trades on the NASDAQ Global Market (symbol:UTMD).&#160; The following table sets forth the high and low sales price information as reported by NASDAQ for the periods indicated:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 1px; WIDTH: 31.5pt; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"></div>

<table id="z262856808ff143d1b31e11e93aa4c37e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="6">&#160;2017&#160;&#160;&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="6">&#160;2016</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">High</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Low</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">High</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Low</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">1st Quarter</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">73.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">63.61</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">54.20</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2nd Quarter</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">73.05</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">59.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68.90</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">61.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">3rd Quarter</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">75.45</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68.10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68.53</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">57.21</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">4th Quarter</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">85.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">73.05</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">75.00</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56.30</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stockholders.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The approximate number of beneficial stockholders of UTMD's common stock as of March 6, 2018 was 4,000.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dividends.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The following sets forth cash dividends paid during the past two years:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zad5fc24e20e94c2685a1078f4536323c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><u>Record Date</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><u>Payable Date</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Per Share </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 18, 2016</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">April 6, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.26</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">June 17, 2016</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">July 6, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.26</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 16, 2016</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">October 4, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.26</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">December 16, 2016</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">December 30, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 17, 2017</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">April 4, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">June 16, 2017</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">July 6, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 15, 2017</div>
</td>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">October 3, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z0d00065aee764441a31f66eec3748634" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2016 total cash dividends paid per share</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.045</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2017 total cash dividends paid per share</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.795</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">*A dividend of $0.27 per share, with a record date of December 15, 2017, was paid on January 3, 2018.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">Issuer Purchases of Equity Securities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">UTMD did not purchase any of its own securities during 2017.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">17</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 6 &#8209; SELECTED FINANCIAL DATA</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dollar amounts are in thousands, except per share data.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The following selected consolidated financial data of UTMD and its subsidiaries for the five years ended December 31, 2017, are derived from the audited financial statements and notes of UTMD and its subsidiaries, certain of which are included in this report.&#160; The selected consolidated financial data should be read in conjunction with UTMD's Consolidated Financial Statements and the notes included elsewhere in this report.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zbdde561f62194fea9e13766aa6ae8633" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="18">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year Ended December 31&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2014</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2013</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Sales</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41,414</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,298</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">40,157</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41,278</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">40,493</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,843</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,378</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,406</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Earnings Per Common Share (Diluted)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.28</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.14</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.02</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.02</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total Assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">92,745</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">76,191</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">79,175</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">81,076</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">80,711</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Working Capital</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">43,909</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,451</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28,807</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,704</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,675</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long-term Debt</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">973</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,065</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash Dividends Per Common Share</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.065</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.045</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.025</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.005</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.985</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z9cc62c19ee1a4be888ca62af3f9f94d3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="14">Quarterly Data for 2017</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">First </div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Second</div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Third </div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fourth </div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Sales</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,259</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,829</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,125</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,201</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gross Profit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,535</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,893</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,496</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,470</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 12px">
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Income (Loss)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,536</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,870</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,622</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,522</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Earnings (Loss) Per Common Share (Diluted)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.95</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.04</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.97</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(.67</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z9d5448dafe2447beb0af4d31f0aa6c40" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="14">Quarterly Data for 2016</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">First </div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Second </div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Third</div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;Quarter</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fourth </div>

<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Quarter</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Sales</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,301</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,490</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,655</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,852</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gross Profit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,223</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,252</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,775</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,440</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,217</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,259</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,935</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,717</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Earnings Per Common Share (Diluted)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.85</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.86</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.78</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.72</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">18</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 7 &#8209; MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Currency amounts are in thousands except per-share amounts and where noted.&#160; Currencies are abbreviated as follows: the U.S. Dollar (USD or $), the Great Britain Pound (GBP or &#163;), the Euro (EUR or &#8364;), the Australian Dollar (AUD or A$) and the Canadian Dollar (CAD or C$).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The following comments should be read in conjunction with the accompanying financial statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Overview</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Excellent growth in year 2017 financial results were accomplished primarily as a result of Utah Medical Products, Inc. (UTMD) converting from distributing the Filshie Clip System in the countries of Canada and France through third party distributors to selling directly to medical facility users. Although UTMD substantially exceeded management expectations for 2017 financial performance, the results became masked by the recognition of a one-time repatriation tax (REPAT) on foreign subsidiary cash and cumulative earnings (E&amp;P).&#160; The REPAT impact of the U.S. "Tax Cuts and Jobs Act", which was enacted in December 2017, is included in 2017 results according to U.S. Generally Accepted Accounting Principles (GAAP).&#160; All income statement categories of UTMD's 2017 operating performance were unaffected by the REPAT tax except for provision for income taxes, Net Income (NI) and Earnings Per Share (EPS).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Income statement results in 2017 compared to 2016 were as follows:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="zfa25eea27c6e4744979c0c08aac5aea3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Change</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Net Sales</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41,414</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,298</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+5.4</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Gross Profit (GP)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,395</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,690</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+11.4</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Operating Income (OI)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,011</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,187</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+17.4</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Income Before Tax (EBT)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,082</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,422</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+16.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; FONT-STYLE: italic; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>NI Before REPAT Tax</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">14,562</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">+20.1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>NI per GAAP</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; FONT-STYLE: italic; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>EPS Before REPAT Tax</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">3.897</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">3.220</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">+21.0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>EPS per GAAP</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.276</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.220</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The estimated REPAT tax booked in the 2017 income statement tax provision according to GAAP was $6,288.&#160; As a result of the REPAT tax provision, GAAP NI and EPS in 2017 compared to 2016 were 30% and 29% lower respectively.&#160; In UTMD management's view, comparing GAAP NI and EPS between 2017 and 2016 does not provide stockholders with any meaningful insight about UTMD's financial performance.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The associated key 2017 profit margins (profits as a percentage of sales) compared to the prior calendar year improved as follows:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="z9ef96e6022a14c89b3e040b13f7d39ad" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr style="HEIGHT: 22px">
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Gross Profit Margin (GPM)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">63.7</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">60.3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Operating Income Margin (OIM)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45.9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Income Before Tax Margin (EBTM)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">46.1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41.8</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>NIM (before REPAT)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30.9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;The 2017 GPM expansion of 3.4 percentage points leveraged the GP contribution to OI by $1.4 million. In addition, even though UTMD assumed direct sales and marketing (S&amp;M) roles and launched an additional facility in Canada, the Company was able to reduce consolidated operating expenses (OE), which further leveraged OI to a total increase of $2.8 million with only a $2.1 million increase in consolidated sales.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">US GAAP NI for the 2017 calendar year was $8,505 including the one-time $6,288 REPAT tax and a $228 reduction to the income tax provision due to a net reduction in deferred tax liabilities (DTL) and deferred tax assets (DTA) from the U.S. enacting lower future income tax rates. The 2017 U.S. GAAP $8,505 NI compares to $12,128 in 2016. The 2016 NI included, as stockholders may recall, a $123 reduction to the income tax provision in fourth quarter (4Q) 2016 (resulting in a $123 increase to 2016 NI) due to a reduction in the DTL from the UK enacting lower future income tax rates. Because the REPAT tax and net DTL adjustment are one-time tax events not related to normal operations, UTMD management believes that the presentation of results excluding the 2016 favorable adjustment in DTL, and the 2017 unfavorable REPAT tax provision offset slightly by the favorable DTL adjustment, provides meaningful supplemental information to both management and investors that is more clearly indicative of UTMD's operating results in 2017 compared to 2016.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">19</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The resulting non-GAAP NI and EPS excluding the 2017 REPAT provision and DTL adjustment, and the prior 2016 DTL adjustment, follow:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="z05ebc2fa1f5e40b59b4fe35b94520cb3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr style="HEIGHT: 21px">
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Change</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NI&#160; (non-GAAP)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,562</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,004</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+ 21</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">EPS (non-GAAP)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.897</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.188</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+ 22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In summary, UTMD achieved <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">$3.90</font> in "normal" 2017 EPS compared to <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">$3.19</font> in 2016. For the year 2017, a 5% increase in sales yielded a 21% increase in (non-GAAP) NI and a 22% increase in (non-GAAP) EPS.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The Company's continued excellent positive cash flow in 2017 allowed it to increase cash dividends paid to stockholders and use $1.6 million in cash for investment in Property, Plant and Equipment (PP&amp;E), primarily to fit-out a 38,600 square foot owned facility in the UK to replace its previously leased facility.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Measures of the Company's liquidity and overall financial condition improved as of the end of 2017 compared to the end of 2016 as the result of continued strong positive cash flow from normal operations, but were diluted by the assessment of the REPAT tax. UTMD increased its cash balances to $40 million at the end of 2017 compared to $26 million at the end of 2016.&#160; Current assets increased 43% and total assets increased 22%.&#160; Although the Company remained without debt, total liabilities increased $7,676.&#160; The accrued REPAT tax added $6,288, and delaying the payment date of the 4Q 2017 dividend from late December to early January added another $1,005 to accrued liabilities. As a result, UTMD's total debt ratio (total liabilities to total assets) was 16% at the end of 2017 compared to 9% at the end of 2016.&#160; Stockholders' Equity increased to $78.1 million from $69.2 million at the end of 2016 largely from $8.5 million in GAAP NI. The return on average Stockholders' Equity (ROE) prior to the payment of dividends was 11.5% in 2017 compared to 17.5% in 2016. Excluding the effect of the REPAT tax on NI and average stockholders' equity and before dividends, UTMD's 2017 ROE was 19% compared to 17% in 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Productivity of Assets and Working Capital Assets.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Assets.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Year-end 2017 total consolidated assets were $92,745 comprised of $49,188 in current assets, $11,621 in consolidated net PP&amp;E and $31,936 in net intangible assets.&#160; This compares to $76,191 total assets at the end of 2016 comprised of $34,474 in current assets, $9,966 in consolidated net PP&amp;E and $31,751 in net intangible assets. Total asset turns (total consolidated sales divided by average total assets for the year) in 2017 were 49%, compared to 50% in 2016.&#160; The 2017 increase in assets, primarily cash, was greater than the increase in sales.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;Current assets increased $14,714 due to a $13,595 increase in cash and investments, a $412 increase in accounts and other receivables and a $702 increase in year-end inventories. Year-end 2017 and 2016 cash and investment balances were $39,955 and $26,360, representing 43% and 35% of total assets, respectively.&#160; Net (after allowance for doubtful accounts) year-end trade accounts receivable (A/R) balances increased $412 due to $1,349 stronger 4Q 2017 sales than in 4Q 2016. Average days in A/R from date of invoice on December 31, 2017 were 32 days based on 4Q 2017 shipments, about the same aging as at the end of 2016.&#160; The Company believes any older A/R will be collected or are within its reserve balances for uncollectible amounts.&#160; Average 2017 consolidated inventory turns were 3.1 compared to 3.6 in 2016 based on the applicable year's cost of goods sold.&#160; The Company's cash reserves allowed it to increase inventories to take advantage of quantity discounts from vendors.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Working capital (current assets minus current liabilities) at year-end 2017 was 40% higher at $43,909 compared to $31,451 at year-end 2016.&#160; Consistent with Federal rules, 2017 ending current liabilities included $503 (8%) of the total REPAT tax liability which did not exist at the end of 2016.&#160; As the timing of the required payment of the State portion of the REPAT tax is still unknown, UTMD divided the estimated liability the same as for the Federal portion, i.e. 8% current.&#160; If all of the State REPAT tax becomes due within one year, current liabilities would be $979 higher.&#160; Even with $979 higher current liabilities, the end of 2017 working capital significantly exceeds UTMD's needs for normal operations, funding future growth and timely payment of accrued REPAT tax liabilities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">PP&amp;E includes Utah, Ireland and England manufacturing molds, production tooling and equipment, test equipment, and product development laboratory equipment.&#160; In addition, PP&amp;E includes computers and software, warehouse equipment, furniture and fixtures, facilities and real estate for all five locations in Utah, Ireland, UK, Canada and Australia, the fungible market value of which increases UTMD's enterprise value relative to most of its industry peers. In late 2017, UTMD in the UK finished set-up and seamlessly began operations in a 38,600 square foot facility in Romsey, Hampshire.&#160; The manufacturing facilities in Utah, Ireland and the UK are standalone buildings, whereas the distribution facilities in Australia and Canada are part of larger industrial condominiums.&#160; Ending 2017 net consolidated PP&amp;E (depreciated book value of all fixed assets) increased $1,655 as a result of capital expenditures of $1,597, depreciation of $660 and the effect of foreign currency exchange (FX) rates on year-end foreign subsidiary asset balances.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">20</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The following end-of-year FX rates in USD applied to assets and liabilities of each applicable foreign subsidiary:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">&#160;</div>

<table id="z3b3302bfacf4446585800a33867c8cbc" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 60%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr style="HEIGHT: 19px">
<td style="WIDTH: 35%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom">
<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">12-31-17</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">12-31-16</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 35%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">EUR</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.2021</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.0555</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 35%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">GBP</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.3523</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.2338</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 35%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">AUD</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.7815</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.7231</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 35%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CAD</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.7988</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 3.9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.7449</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; CLEAR: both; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The year-end 2017 net book value (after accumulated depreciation) of consolidated PP&amp;E was 36% of purchase cost.&#160; End-of-year PP&amp;E turns (Net Sales divided by Net PP&amp;E) was 3.6 in 2017 compared to 3.9 in 2016 due to the new facility in the UK and a weaker USD.&#160; The future leverage in productivity of fixed assets which will not have to be increased to support new business activity will be a source of future profitability.&#160; In 2018, PP&amp;E purchases to support ongoing operations are not expected to exceed depreciation of fixed assets.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;Net intangible assets (after accumulated amortization) are comprised of the capitalized costs of obtaining patents and other intellectual property, as well as the value of identifiable intangible assets (IIA) and goodwill resulting from acquisitions. Net intangible assets were $31,936 (34% of total assets) at the end of 2017 compared to $31,751 (42% of total assets) at the end of 2016.&#160; Per US GAAP, intangible assets are categorized as either 1) IIA, which are amortized over the estimated useful life of the assets, or 2) goodwill, which is not amortized or expensed until the associated economic value of the acquired asset becomes impaired. The two categories of Femcare intangibles at year-end 2017 were net IIA of $17,764 and goodwill of $6,900. The accumulated amortization of Femcare IIA as of December 31, 2017 since the March 18, 2011 acquisition was $14,785. UTMD's goodwill balance was $14,092 at the end of 2017, 44% of total net intangibles. Because the products associated with UTMD's acquisitions of Columbia Medical in 1997, Gesco in 1998, Abcorp in 2004 and Femcare in 2011 continue to be viable parts of UTMD's overall business, UTMD does not expect the current goodwill value associated with the four acquisitions to become impaired in 2018. Amortization of intangibles was $2,113 in 2017 compared to $2,223 in 2016. The 2017 non-cash amortization expense of Femcare IIA was $2,055 (&#163;1,595) compared to $2,167 (&#163;1,599) in 2016.&#160; The USD difference was essentially due to the change in USD/GBP FX rate. The 2018 non-cash amortization expense of Femcare IIA will again be &#163;1,595, or $2,201 if the USD/GBP average FX rate is 1.38.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Liabilities.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The $6,288 accrued REPAT tax liability resulting from the U.S. "Tax Cuts and Jobs Act" (the Tax Act), which was enacted in December 2017, is included in 2017 end liabilities. This liability was not present in the 2016 end balance sheet. The Federal payment requirement is 8% of the REPAT tax liability per year for the first five years, 15% in the sixth year, 20% in the seventh year and 25% in the eighth year. Because the State of Utah typically uses Federal taxable income as a basis, the REPAT provision includes an estimated $1,065 portion payable to the State.&#160; Consistent with Federal rules, eight percent of the total REPAT tax liability ($503) is included in UTMD's 2017 end current liabilities, with the remaining $5,785 in longer term liabilities. If the State, on a worst case basis for cash flow, decides that its entire REPAT tax levy is to be paid within one year, then the portion of the total REPAT tax liability included in 2017 end current liabilities would be $1,482 ($979 higher current liabilities and $979 lower long term liabilities). Slightly offsetting the REPAT tax liabilities was a $230 reduction in UTMD's U.S. deferred tax liability due to the Tax Act's enactment of a lower future income tax rate.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;In addition to the liability changes associated with the Tax Act, UTMD decided to delay the payment of its 4Q 2017 cash stockholder dividend from late December 2017 to early January 2018, which added another $1,005 to 2017 ending accrued liabilities that was not present in the year-end 2016 balance sheet.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;As a result of the above, using the Federal REPAT tax timing of payment rules, year-end 2017 current liabilities were $2,258 higher than at the end of 2016. Total liabilities were $7,676 higher at the end of 2017 compared to the end of 2016. The resulting 2017 year-end total debt ratio was 16% compared to 10% at the end of 2016.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">21</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;The year-end DTL balance created as a result of the fifteen year deferred tax consequence of the amortization of Femcare's IIA was $3,102, down from $3,209 at the end of 2016. The smaller decline in this DTL, despite $2,055 in 2017 amortization of IIA, was due to a 10% weaker USD compared to the GBP at the end of 2017 compared to the end of 2016.&#160;&#160; In addition to liabilities stated on the balance sheet, UTMD has operating lease and purchase obligations described in Note 7 to the financial statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Results of Operations.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 12.3pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Revenues</u></font>.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Under accounting standards applicable for 2017, the Company believed that revenue should be recognized at the time of shipment as title generally passes to the customer at the time of shipment, or completion of services performed under contract.&#160; Revenue recognized by UTMD is based upon documented arrangements and fixed contracts in which the selling price is fixed prior to acceptance and completion of an order.&#160; Revenue from product or service sales is generally recognized at the time the product is shipped or service completed and invoiced, and collectibility is reasonably assured.&#160; Over 99% of UTMD's revenue is recognized at the time UTMD ships a physical medical device to a customer, where the selling price for the item shipped was agreed prior to UTMD's acceptance and completion of the customer order. There are no post-shipment obligations which have been or are expected to be material to financial results.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 10.8pt">There are circumstances under which revenue may be recognized when product is not shipped, which have met the criteria of SAB 104:&#160; the Company provides engineering services, for example, design and production of manufacturing tooling that may be used in subsequent UTMD manufacturing of custom components for other companies.&#160; This revenue is recognized when UTMD's service has been completed according to a fixed contractual agreement.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;Beginning on January 1, 2018, the Company adopted ASU 2014-09, the new revenue recognition accounting standard.&#160; Management completed an extensive assessment and implementation of the standard, including UTMD's various contracts with customers and associated performance obligations and the Company's conclusions regarding its revenue recognition practices and procedures. Other items like commissions and rights of return were also evaluated by the Company. Management is confident that the Company has properly evaluated the standard's requirements and has arrived at appropriate conclusions in recognizing revenue in accordance with the new standard.&#160; Those practices and procedures the Company will use to recognize revenue under the new standard are not significantly different than the methods used previously since UTMD has traditionally recognized revenue upon shipping a physical product to a customer, which is also when the Company has met its performance obligations under contracts it has with its customers that represent over 99% of its revenue. While the Company's revenue not associated with shipping a physical product is immaterial, management believes the Company's practices in recognizing that revenue is also in accordance with ASU 2014-09.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Terms of sale are established in advance of UTMD's acceptance of customer orders.&#160; In the U.S., Ireland, UK and Australia prior to 2017, UTMD generally accepted orders directly from and shipped directly to end user clinical facilities, as well as third party medical/surgical distributors, under UTMD's Standard Terms and Conditions (T&amp;C) of Sale. The same was true in 2017 with the addition of direct shipments to end user facilities in Canada and France. About 14% of UTMD's domestic end user sales, excluding Femcare's Filshie Clip System sales to its exclusive U.S. distributor, CooperSurgical Inc. (CSI), go through third party med/surg distributors which contract separately with clinical facilities to provide purchasing, storage and scheduled delivery functions for the applicable facility.&#160; UTMD's T&amp;C of Sale to end user facilities are substantially the same in the U.S., Canada, Ireland, UK, France and Australia.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">UTMD may have separate discounted pricing agreements with a specific clinical facility or group of affiliated facilities based on volume of purchases.&#160; Pricing agreements which are documented arrangements with clinical facilities, or groups of affiliated facilities, if applicable, are established in advance of orders accepted or shipments made.&#160; For existing customers, past actual shipment volumes typically determine the fixed price by part number for the next agreement period of one year. For new customers, the customer's best estimate of volume is usually accepted by UTMD for determining the ensuing fixed prices for the agreement period. Prices are not adjusted after an order is accepted. For the sake of clarity, the separate pricing agreements with clinical facilities based on volume of purchases disclosure is not inconsistent with UTMD's disclosure above that the selling price is fixed prior to the acceptance of a specific customer order.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.1pt">UTMD's global consolidated trade sales are comprised of domestic and outside the U.S. (OUS) sales. Domestic sales include 1) direct domestic sales, sales of finished devices to end-user facilities and med/surg distributors in the U.S.; 2) domestic OEM sales, sales of components or finished products, which may not be medical devices, to other companies for inclusion in their products; and 3) sales of the Filshie Clip System by Femcare UK to CSI.&#160; OUS sales are export sales from UTMD in the U.S. to customers outside the U.S. invoiced in USD, and all sales from UTMD subsidiaries in Ireland, Canada, Australia and the UK (other than Femcare UK sales to CSI) which may be invoiced in EUR, GBP, CAD, AUD or USD.&#160; The term "trade" means sales to customers which are not part of UTMD.&#160; Each UTMD entity except Femcare Australia and Femcare Canada also had 2017 intercompany sales of components and/or finished devices to other UTMD entities.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">22</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Global consolidated trade sales in 2017 were $41,414 compared to $39,298 in 2016 and $40,157 in 2015.&#160; The primary contributors to the $2,117 (+5.4%) increase were 1) direct sales to end-user facilities in Canada and France, which were $1,850 higher than 2016 sales to UTMD's distributors in Canada and France, and 2) $832 (+28%) higher Filshie Clip System domestic sales to CSI;&#160; offset by 3) a loss of $516 in sales of BPM kits to an OEM distributor in Germany. In contrast to 2016 compared to 2015 when the negative impact of FX rates on sales lowered sales by $600, the negative $68 impact in 2017 was minimal.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Domestic Sales</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Total domestic U.S. sales were up $798 (+4%) in 2017, at $20,286 compared to $19,488 in 2016. Domestic sales in 2017 were 49% of total consolidated sales compared to 50% in 2016.&#160; The primary contributors to the 2017 higher domestic sales were $832 (+28%) higher sales to CSI, Femcare's US distributor of the Filshie Clip System, and $188 (+6%) higher sales of components and finished devices used in other companies' products (OEM customers).&#160; Direct sales of UTMD finished devices to domestic end-users were $223 (2%) lower.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In 2017, CSI for the first time purchased $476 in Sterishot single-use Filshie Clip applicator kits, approved by the U.S. FDA in December 2016. The Sterishot applicators have been widely accepted outside the U.S. since 2009 as a result of the obvious lower risk of infection that is inherent with reused surgical instruments in laparoscopic procedures, and the elimination of the need for recalibration and repair of delicate instruments. Conversion to single use applicators has an expansive impact on sales.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Domestic OEM sales in 2017 represented 8% of total sales compared to 7% in 2016.&#160; UTMD sold components and finished devices to 148 different U.S. companies in 2017 compared to 139 companies in 2016, for use in their product offerings.&#160; From a financial perspective, OEM sales help dilute manufacturing overhead and improve UTMD's GPM from better utilization of existing capabilities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Direct (non-CSI) domestic sales of UTMD finished devices to U.S. end user facilities were $13,401 (32% of total sales) compared to $13,624 (35% of total sales) in 2016.&#160; By product category, domestic direct sales of neonatal products were $4,049 (0% higher), labor &amp; delivery (L&amp;D) products $3,761 (3% lower), BPM products $934 (7% higher) and gynecology/urology products excluding the Filshie Clip System $4,657 (4% lower).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>OUS Sales</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;Total OUS sales were up $1,319 (+7%) in 2017, at $21,129 compared to $19,809 in 2016.&#160; Sixty-four percent of (USD denominated) 2017 OUS sales were invoiced in foreign currencies compared to 58% in 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">UTMD's FX rates for income statement purposes are transaction-weighted averages. The average FX rates from the applicable foreign currency to USD during 2017 compared to 2016 FX rates were:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">&#160;</div>

<table id="z41f0086ffe9b4b19a0e39d80b3a4af37" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 60%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 63.06%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 18px; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Change</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 63.06%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">GBP</div>
</td>
<td style="WIDTH: 18px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.290</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.360</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">( 5.1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 63.06%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">EUR</div>
</td>
<td style="WIDTH: 18px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.133</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.105</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">+2.5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 63.06%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">AUD</div>
</td>
<td style="WIDTH: 18px; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.767</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.745</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">+2.8</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">%</font></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Sales Weighted Average</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">( 0.6</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 63.06%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 18px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 63.06%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CAD</div>
</td>
<td style="WIDTH: 18px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.769</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">n/a</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;Because a significant portion of UTMD's sales are invoiced in foreign currencies, changes in FX rates can potentially have a material effect on period-to-period USD-denominated sales.&#160; In contrast to the previous three years when the USD consistently and significantly strengthened relative to other currencies, the combined net impact of FX changes in the full year of 2017 was minimal.&#160; Because of the BREXIT referendum in mid-2016, UTMD's first half (1H) 2017 sales were $282 lower than they would have been with the 1H 2016 GBP FX rate. After 4Q 2016, the GBP FX rate stabilized and gradually strengthened relative to the USD so that the negative GBP FX effect on sales in 2017 as a whole was only ($232). In contrast, the EUR and the AUD strengthened in 2017 compared to 2016, almost offsetting the negative GBP FX rate impact on sales. As a result, UTMD's total consolidated revenues for the year would have been up only another $68 with combined constant currency (same FX rates in 2017 as in 2016). Since there were no CAD sales in 2016, the CAD FX rate change had no impact on the sales comparison between 2017 and 2016.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">23</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;As a portion of total sales, 33% of UTMD's USD-equivalent 2017 sales were invoiced in foreign currencies compared to 29% in 2016.&#160; The increase was due to the addition of CAD sales for sales direct to end user facilities in Canada from UTMD's newly established distribution subsidiary, Utah Medical Products Canada, Inc. (dba Femcare Canada).&#160; Sales of the Filshie Clip System to Femcare's third party Canada distributor in 2016 were invoiced in EUR if manufactured and shipped by UTMD's Ireland subsidiary, or in GBP if shipped from UTMD's UK subsidiary. In 2017, the GBP, EUR, AUD and CAD converted sales represented 10%, 10%, 6% and 7% of total 2017 USD sales, respectively.&#160; This compares to 12% GBP, 11% EUR and 6% AUD of total 2016 USD sales. There were no CAD sales in 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;USD-denominated trade (excludes intercompany) sales of devices to OUS customers by UTMD's Ireland facility (UTMD Ltd) were $1,712 (25%) lower in 2017 compared to 2016 because 1) $1,390 in 2016 trade sales to UTMD distributors in Canada and France were converted to intercompany sales in 2017 (zero trade sales), and 2) BPM kit sales to UTMD's Germany OEM distributor, which were $516 in 2016, were discontinued in 2017 (zero trade sales).&#160; In EUR terms, UTMD Ltd 2017 sales including intercompany shipments were 15% lower for the year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">USD-denominated 2017 trade sales of devices to domestic UK, domestic France and international distributor customers of Femcare-Nikomed, Ltd (UK subsidiary), excluding intercompany sales, were $1,249 (+16%) higher compared to 2016, due to 1) the fact that 2017 direct trade sales in France exceeded sales to the France and Canada distributors in 2016 by $828, and 2) sales to CSI, Femcare's exclusive U.S. distributor of the Filshie Clip System, were $832 higher than in 2016.&#160; Sales to CSI were in USD currency, but UK subsidiary foreign currency sales were $157 lower compared to 2016 as a result of negative FX rates. In GBP terms, UK subsidiary 2017 sales including intercompany shipments were 24% higher for the year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">USD-denominated sales of devices to end-users in Australia by Femcare's Australia distribution subsidiary (Femcare Australia) were 4% lower in 2017 compared to 2016.&#160; AUD sales in 2017 were about 7% lower than in 2016.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Sales to distributors in Canada and France in 2016 included a $500 distributor marketing rights payment which was absent in 2017. Also, 2017 direct sales in Canada and France were reduced by a $25 repurchase of distributor inventory.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Looking forward, based on the end of 2017 FX rates, 2018 foreign currency sales on the whole should benefit in USD terms for the first time in several years because of a relative USD weakness compared at least to the first three quarters of 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">UTMD groups its sales into four general product categories:&#160; 1) obstetrics, comprised of labor and delivery management tools for monitoring fetal and maternal well-being, for reducing risk in performing difficult delivery procedures and for improving clinician and patient safety;&#160; 2) gynecology/ electrosurgery/ urology, comprised of tools for gynecological procedures associated primarily with cervical/ uterine disease including LETZ, endometrial tissue sampling, transvaginal uterine sonography, diagnostic laparoscopy, surgical contraception and other MIS procedures; specialty excision and incision tools; conservative urinary incontinence therapy devices; and urology surgical procedure devices;&#160; 3) neonatal critical care, comprised of devices that provide developmentally-friendly care to the most critically ill babies, including providing vascular access, enteral feeding, administering vital fluids, oxygen therapy while maintaining a neutral thermal environment, providing protection and assisting in specialized applications; and 4) blood pressure monitoring/ accessories/ other, comprised of specialized components as well as molded parts and assemblies sold on an OEM basis to other companies.&#160; In these four categories, UTMD's primary revenue contributors enjoy significant brand awareness by clinical users.</div>

<div style="LINE-HEIGHT: 1.25">
<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">24</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Global revenues by product category:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z712e7c464c0c40f7afa31603dc67c412" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 4%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 4%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 21px">
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Obstetrics</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,499</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,532</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,587</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gynecology/ Electrosurgery/ Urology</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,175</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">53</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,356</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Neonatal</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,154</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,007</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,299</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Blood Pressure Monitoring and Accessories*</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">7,586</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">8,076</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">20</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">6,915</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">17</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41,414</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,298</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">40,157</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">OUS revenues by product category:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z88da26c655d046459a159a22d297f650" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr style="HEIGHT: 16px">
<td style="WIDTH: 24%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 4%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 4%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Obstetrics</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">732</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">658</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">670</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Gynecology/ Electrosurgery/ Urology</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,759</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">70</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,851</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,534</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Neonatal</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,105</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,965</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,936</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 24%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Blood Pressure Monitoring and Accessories*</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">3,533</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">17</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">4,335</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">3,653</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal">1</font>9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 24%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Total:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,129</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,793</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25; TEXT-INDENT: 37.8pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25; TEXT-INDENT: 37.8pt">*includes molded components and finished medical and non-medical devices sold to OEM customers.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">As a summary description of revenues in the above tables:</div>

<table id="ze60fce8a149b4db3a507a85dd4b98c6b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">1.</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Obstetrics. Increases in sales of newer devices helped offset declines from competition with older devices.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2.</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The gynecology/ electrosurgery/ urology (ES/Gyn) product category includes the Filshie Clip System, which substantially benefited from direct end user sales in Canada and France, and higher sales to CSI in the U.S.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3.</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Neonatal intensive care unit (NICU) device sales are experiencing consistent growth OUS.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4.</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Global blood pressure monitoring and accessories (BPM) sales suffered a loss of $516 in sales of BPM kits to an OEM distributor in Germany, as predicted at the beginning of 2017.&#160; In addition, U.S. export sales to South America BPM distributors had a weak year.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">In calendar year 2018, for varying reasons, UTMD expects overall revenues about the same as in 2017.&#160; Lower sales to CSI will offset continued good growth in Filshie Clip System sales OUS, if CSI's beginning of year forecast becomes reality. An average weaker USD should help improve foreign currency sales. UTMD's China distributor of BPM kits has placed an annual order $0.8 million lower than in 2017.&#160; Neonatal ICU sales OUS are expected to achieve double-digit growth. Domestic direct sales of niche devices should remain about the same, while domestic OEM sales are expected to grow faster than in 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">b)&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Gross Profit (GP)</u></font>.&#160; UTMD's 2017 consolidated GP, the surplus after subtracting costs of manufacturing, which includes purchasing raw materials, forming components, assembling, inspecting, testing, packaging, sterilizing and shipping products, from net revenues, was $26,395 (63.7% of sales) compared to $23,690 (60.3% of sales) in 2016, and $24,185 (60.2% of sales) in 2015.&#160; The significant expansion in UTMD's 2017 average GPM was primarily the result of converting wholesale third party distributor sales into direct end user sales in Canada and France.&#160; There was an additional favorable mix change in that low margin BPM product sales to an international OEM, which represented 3% of total OUS&#160; sales in 2016, were replaced by higher margin other product sales.&#160; In Utah, manufacturing was simply able to get more done with fewer people, aided by another favorable experience year for Utah's self-insured health benefit plan.&#160; The Company also helped control raw materials (RM) costs by investing in increased RM inventory.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Because UTMD's medical devices are differentiated and not subject to GPO agreements or other significant commodity pricing pressures, the Company was generally able to avoid selling price reductions.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">UTMD's Ireland subsidiary's (UTMD Ltd's) GP was EUR 3,234 in 2017 compared to EUR 3,988 in 2016 and EUR 3,312 in 2015.&#160; The associated GPMs were 47.5% in 2017, 49.5% in 2016 and 48.5% in 2015.&#160; The lower GP in 2017 was due to the conversion of 2016 trade sales to distributors in Canada and France into intercompany sales in 2017, and to the lower absorption of overhead as a result of loss of substantial BPM sales to a Germany OEM customer. </div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Femcare UK GP was GBP 5,317 in 2017 compared to GBP 4,138 in 2016, and GBP 4,607 in 2015. The increase in 2017 was due to higher sales of Filshie Clip System sales to CSI in the U.S. and the conversion to selling direct to end users in France. The GPM improved to 71.7% in 2017 compared to 69.4% in 2016 and 68.8% in 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Femcare Australia and Femcare Canada are purely distribution operations for UTMD finished devices in their respective countries.&#160; Australia GP was AUD 1,846 in 2017 compared to AUD 2,049 in 2016 and AUD 1,971 in 2015.&#160; The respective Femcare Australia GPMs were 62.7% in 2017, 65.1% in 2016 and 58.4% in 2015.&#160; Canada GP was CAD 2,300 (60.2% of sales) in 2017.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">25</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">In the U.S., GP was $12,497 in 2017 compared to $12,547 in 2016 and $12,222 in 2015. GPMs were 55.0% in 2017, 54.3% in 2016 and 54.2% in 2015.&#160; The consistent U.S. GPs are largely a function of UTMD's experienced manufacturing personnel. The 2017 GPM improved somewhat from improved production planning and lower overhead expenses.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">A summation of the above 2017 GP of each subsidiary will not yield consolidated total GP because of elimination of profit in inventory of intercompany goods.&#160; With the same level of projected sales, UTMD does not expect to be able to maintain the same GPM in 2018 as in 2017. OUS manufacturing overhead costs will be higher in USD terms as a result of a weaker USD.&#160; U.S. manufacturing overhead costs will be higher due to an employee cost of living adjustment in mid-2017, and an already apparent vendor price increase trend.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;c) <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Operating Income (OI)</u></font>.&#160; OI results from subtracting OE from GP.&#160; OI in 2017 was $19,011 (45.9% of sales) compared to $16,187 in 2016 (41.2% of sales), and $15,651 (39.0% of sales) in 2015.&#160; The substantial improvement in 2017 OIM was due to 5% higher sales combined with an expanded GPM and 2% lower consolidated OE.&#160; The UTMD Ltd OIM in 2017 was 42.7% compared to 45.9% in 2016, and 44.5% in 2015.&#160; Femcare UK's 2017 OIM was 40.1% compared to 30.3% in 2016, and 32.5% in 2015. Femcare AUS's 2017 OIM was 50.0% compared to 54.3% in 2016, and 46.5% in 2015.&#160; Femcare Canada's 2017 OIM was 51.5%. UTMD U.S. OIM in 2017 was 39.8% compared to 38.1% in 2016, and 35.4% in 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">OE include sales and marketing (S&amp;M) expenses, product development (R&amp;D) expenses and general and administrative (G&amp;A) expenses. Consolidated OE were $7,385 (17.8% of sales) in 2017 compared to $7,503 (19.1% of sales) in 2016, and $8,534 (21.3% of sales) in 2015. The following table provides a comparison of OE categories for the last three years.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">
<div id="DSPFPageHeader"></div>

<div id="DSPFPageFooter" style="CLEAR: both"></div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">
<div id="DSPFPageHeader"></div>

<div id="DSPFPageFooter" style="CLEAR: both">
<div id="DSPFPageHeader"></div>

<table id="z5312628bab814317bdaa5d01eeffd7cf" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr style="HEIGHT: 18px">
<td style="WIDTH: 77px; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="WIDTH: 6px; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 50px; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 649px; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 785px; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">S&amp;M expenses excluding the MDET&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,544</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,673</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,881</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 785px; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">S&amp;M expense &#8211; U.S. MDET&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">283</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 785px; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">R&amp;D expenses&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">447</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">475</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">522</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 785px; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">G&amp;A expenses:&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">a</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">litigation expense provision</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">54</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">40</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">b</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">corporate legal</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">15</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">70</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">c</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">stock option compensation</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">129</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">92</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">87</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">d</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">management bonus accrual</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">430</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">445</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">465</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">e</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">outside accounting audit/tax</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">196</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">199</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">191</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">f</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">intangible asset amortization</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,113</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">2,223</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,528</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">g</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">property &amp; liability insurance premiums</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">155</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">178</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">231</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">h</div>
</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">all other G&amp;A expenses</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,309</font></div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,149</font></td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,236</font></div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 63.82%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">G&amp;A expenses &#8211; total&#160;&#160;&#160;&#160;</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">5,393</font></div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">5,355</font></td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">5,848</font></div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 63.82%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total Consolidated OE:&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,385</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,503</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,534</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6.26%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 4.07%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 52.76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Consolidated OE % of sales:</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17.8</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19.1</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 0.73%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.76%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21.3</div>
</td>
<td style="WIDTH: 0.98%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both">&#160;</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Description of OE Categories</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 31.5pt">i) S&amp;M expenses:&#160; S&amp;M expenses are the costs of communicating UTMD's differences and product advantages, providing training and other customer service in support of the use of UTMD's solutions, attending clinical meetings and medical trade shows, administering customer agreements, advertising, processing orders, shipping, paying commissions to outside independent representatives and, if applicable, paying the MDET in the U.S. In markets where UTMD sells directly to end-users, which in 2017 included the U.S., Ireland, UK, Australia, France and Canada, the largest components of S&amp;M expenses were the cost of employing direct sales representatives, including associated costs of travel, subsistence and communications and the cost of customer service required to timely process orders.&#160; The theoretical trade-off between higher gross profit margins for selling directly at end user prices is higher S&amp;M expenses as a percent of sales. However, the S&amp;M expenses associated with direct France sales were effectively absorbed by the UK subsidiary without increasing S&amp;M resources. The S&amp;M expenses associated with UTMD's new Canada subsidiary, Femcare Canada, in its first year were substantially absorbed by existing S&amp;M resources in the U.S.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">S&amp;M expenses include all customer support costs including training. In general, training is not required for UTMD's products since they are well-established and have been clinically widely used. Written "Instructions For Use" are packaged with all finished devices. Although UTMD does not have any explicit contracts with customers to provide training, it does provide hospital in-service and clinical training as required and reasonably requested.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">26</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">UTMD promises prospective customers that it will provide, at no charge in reasonable quantities, electronic media and other instructional materials developed for the use of its products. UTMD provides customer support from offices in the U.S., Canada, Ireland, UK and Australia by telephone to answer user questions and help troubleshoot any user issues. Occasionally, on a case-by-case basis, UTMD may utilize the services of an independent practitioner to provide educational assistance to clinicians. All in-service and training expenses are routinely expensed as they occur.&#160; Except for the consulting services of independent practitioners and occasional use of marketing consultants, all of these services are allocated from fixed S&amp;M overhead costs included in OE.&#160; Historically, marginal consulting costs have been immaterial to financial results, which is also UTMD's expectation for the future.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The MDET, a component of the Patient Protection and Affordable Care Act, (known commonly as Obamacare) was effective between 2013 and 2015. In December 2015, U.S. legislators suspended the MDET for 2016 and 2017, and in January 2018, further suspended it for 2018 and 2019. The excise tax was 2.3% of domestic sales of medical devices listed with the FDA. Medical devices designed for human use were taxed, whether or not they were sold for human use, e.g. veterinarian uses or laboratory use were also taxed.&#160; The impact of the tax was felt beyond 2.3%, as costs associated with administering, tracking, collecting and paying the tax were significant.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">S&amp;M expenses in 2017 were $1,544 (3.7% of 2017 sales) compared to $1,673 (4.3% of sales) in 2016, and $2,164 (5.4% of sales) in 2015. Lower USD S&amp;M expenses were due in part to the weaker GBP and in part to UTMD not hiring some replacements for sales reps in the U.S. that it had previously planned. S&amp;M OE excluding the MDET were 4.7% of sales in 2015. With the planned addition of S&amp;M resources in 2018 and a weaker USD, S&amp;M expenses as a percentage of total revenues are expected to increase.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 31.5pt">ii) R&amp;D expenses:&#160; R&amp;D expenses include the costs of investigating clinical needs, developing innovative concepts, testing concepts for viability, validating methods of manufacture, completing any necessary premarketing clinical trials, regulatory documentation and other activities required for design control, responding to customer requests for product enhancements, and assisting manufacturing engineering on an ongoing basis in developing new processes or improving existing processes. R&amp;D expenses were $447 (1.1% of sales) in 2017 compared to $475 (1.2% of sales) in 2016, and $522 (1.3% of sales) in 2015. Although no new UTMD devices were launched in 2017, R&amp;D played a significant and continuing role in manufacturing process improvements that became evident in improved 2017 GPMs, in addition to continuing work on new product projects. UTMD does not pre-announce new devices that are being developed. R&amp;D expenses in 2018 are expected to be higher than in 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">iii)&#160; G&amp;A expenses:&#160; G&amp;A expenses include the "front office" functional costs of executive management and outside directors, finance and accounting, corporate information systems, human resources, stockholder relations, corporate risk management, corporate governance, protection of intellectual property, amortization of identifiable intangibles and legal costs.&#160; G&amp;A expenses in 2017 were $5,393 (13.0% of sales) compared to $5,355 (13.6% of sales) in 2016, and $5,848 (14.6% of sales) in 2015.&#160; The table above helps clarify several specific categories of G&amp;A expenses. G&amp;A expenses in Canada's first year of operation were $160 higher than in 2016 during set-up. Amortization of the 2011 acquired Femcare IIA is part of G&amp;A expenses. Although the IIA amortization expense in 2017 was only &#163;4 lower than in 2016, because of the weaker GBP after the BREXIT referendum, the 2017 USD IIA amortization expense was $112 lower than in 2016.&#160; The resulting G&amp;A noncash amortization expense of Femcare IIA was 5.0% of total sales in 2017 compared to 5.5% of sales in 2016. The Femcare IIA amortization expense will continue until March 2026 (or until the value of any remaining IIA becomes impaired).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">In summary, in 2018 not including unforeseen litigation expenses or possible acquisition costs, UTMD expects OE to be higher than in 2017 due to 1) a weaker USD relative to all foreign currencies, rendering same level foreign subsidiary expenses higher in USD terms, 2) the addition of S&amp;M resources and 3) higher R&amp;D expenses.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">d)&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Non-operating Income (NOI), Non-operating Expense (NOE) and EBT</u></font>.&#160; NOI includes royalties from licensing UTMD's technology, rent from leasing underutilized property to others, income earned from investing the Company's excess cash and gains or losses from the sale of assets or remeasurement of foreign currency bank account balances into USD, offset by NOE which includes interest on bank loans, bank service fees and excise taxes. The period-to-period remeasured value of EUR cash balances held in the UK and GBP balances held in Ireland generates a gain or loss which is booked at reporting period end as NOI or NOE.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">27</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Net NOI (combination of NOE and NOI) was $71 in 2017 compared to Net NOI of $235 in 2016, and Net NOE of $105 in 2015. The primary cause of the $164 lower NOI in 2017 compared to 2016 was a &#163;95 lower gain in the remeasured value of EUR cash held in the UK, and $28 lower licensing royalties in the UK.&#160; A description of NOE and NOI components follows:</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">1)&#160; Interest Expense.&#160; There was no interest expense in 2017 or 2016.&#160; In 2015, $65 in interest expense was incurred on the remaining balances of loans needed to help acquire Femcare in 2011. Absent an acquisition or large repurchase of shares that requires new borrowing, UTMD does not expect any interest expense in 2018.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 45pt; LINE-HEIGHT: 1.25">2)&#160; Investment of excess cash.&#160; Consolidated investment income (including gains and losses on sales of investments) was $17 in 2017 compared to $12 in 2016, and $5 in 2015.&#160; Cash is generally currently held in non-interest bearing bank accounts because avoiding the bank operating fees which would result from lower balances offsets the interest that can be earned at current interest rates. UTMD estimates investment income will again be nominal in 2018.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 45.35pt; LINE-HEIGHT: 1.25">3)&#160; Royalties.&#160; Femcare receives a royalty from licensing the use of the Filshie Clip System intangibles to CSI as part of its U.S. exclusive distribution agreement. Royalties in 2017 were $86 compared to $91 in 2016 and $93 in 2015.&#160; UTMD expects to receive about $86 in CSI royalties in 2018.&#160; Presently, there are no arrangements under which UTMD is receiving royalties from other parties.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 45.35pt; LINE-HEIGHT: 1.25">4)&#160; Gains/ losses from remeasured currency in bank accounts.&#160; As noted above, UTMD recognized 2017 NOI of $4 and 2016 NOI of $129 from gains on remeasured foreign currency bank balances, compared to NOE of $141 in 2015 from losses on remeasured foreign currency bank balances. EUR and AUD currency cash balances in the UK, and GBP currency cash bank balances in Ireland, are subject to remeasured currency translation gains/ losses as a result of period to period changes in FX rates.&#160; Because of UTMD's subsidiaries' profitability, the subsidiaries may continue to accumulate cash until uses of cash that increase stockholder value are identified.&#160; The one-time REPAT tax implemented by the U.S. Congress in late 2017 imposed a 15.5% tax on all of UTMD's cash held OUS. Year-end 2017 foreign currency cash balances were valued at the following FX rates: 1.2021 USD/EUR; 0.7988 USD/CAD, 0.7815 USD/AUD and 1.3523 USD/GBP.&#160; No remeasured currency gains or losses are included in UTMD's projections for 2018.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 45.35pt; LINE-HEIGHT: 1.25">5)&#160; Other NOI.&#160; Income received from renting unused warehouse space in Ireland and parking lot space in Utah for a cell phone tower, offset by bank fees, miscellaneous non-operating expenses and non-MDET excise taxes resulted in a net NOE of $36 in 2017 compared to NOI of $3 in both 2016 and 2015. UTMD estimates Other NOI will be nominal in 2018.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Income before Taxes (EBT) results from adding net NOI or subtracting net NOE from OI. Consolidated EBT was $19,082 (46.1% of sales) in 2017 compared to $16,422 (41.8% of sales) in 2016, and $15,545 (38.7% of sales) in 2015.&#160; The EBT of UTMD Ltd. (Ireland) was &#8364;2,779 (40.8% of sales) in 2017, &#8364;3,489 (43.3% of sales) in 2016, and &#8364;2,890 (42.2% of sales) in 2015.&#160; Femcare UK's 2017 EBT was &#163;3,155 (42.5% of sales) compared to &#163;2,141 (35.9% of sales) in 2016, and &#163;2,243 (33.5% of sales) in 2015. Femcare AUS's 2017 EBT was AUD 1,473 (50.0% of sales) compared to AUD 1,713 (54.4% of sales) in 2016, and AUD 1,580 (46.8% of sales) in 2015. Femcare Canada's 2017 EBT was CAD 1,906 (49.9% of sales).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">As a side note for clarity of results, UTMD's 2017, 2016 and 2015 EBT, as well as all other income statement measures above the EBT line in the Income Statements, were unaffected by the 2017 accrual of the U.S. REPAT tax and the reduction in the DTL from the Tax Act enacted in late 2017, and the reduction in the DTL and income tax provision triggered as a result of changes in UK corporate income tax rates enacted in 2016 and 2015.&#160; Therefore, the year to year comparisons of GP, OI and EBT are good indicators of UTMD's operating performance.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Looking forward, UTMD's consistently high level of EBT will help maximize the benefit to stockholders of the lower U.S. corporate income tax rates recently enacted.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">e)&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Net Income (NI), EPS and ROE</u></font>.&#160; NI is EBT minus income taxes, often called the "bottom line". There were tax law changes enacted in the U.S. in 2017, and in the UK in both 2016 and 2015 which affected the income tax provisions in those periods. The lowering of a future income tax rate results in a reduction in DTL. According to US GAAP, the total effect of tax rate changes on DTL balances is recorded as a component of the income tax provision related to continuing operations in the period in which the law is enacted.&#160; The DTL adjustments which lowered the applicable year's consolidated income tax provision were $230 in 2017, $123 in 2016 and $351 in 2015.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">28</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;In addition, the U.S. "Tax Cuts and Jobs Act" enacted in December 2017 included a special levy on the cumulative income (E&amp;P) of UTMD's foreign subsidiaries. Foreign cash balances of $29 million were taxed at a 15.5% rate, and the remaining E&amp;P at an 8% rate for accrued Federal income tax purposes. Representatives of the State of Utah have indicated that the State will likely follow the Federal government and also levy a REPAT tax on half the E&amp;P at the State of Utah corporate income tax rate of 5%.&#160; UTMD's end of 2017 tax provision was increased by $6,288 to incorporate the total REPAT tax according to US GAAP, reducing 2017 NI and EPS accordingly.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;Because of the one-time REPAT tax in 2017 and DTL adjustments in each year, calculating and comparing period-to-period income tax provisions as a percentage of EBT does not provide meaningful information to stockholders, in UTMD's opinion. Therefore, NI and EPS are presented both according to US GAAP and also prior to recognition of the REPAT tax and DTL adjustments.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zbc1c6ddaccbb46e08f9b91b34d2961fd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 60%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>US GAAP</u></font>:</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NI</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,843</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NIM</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20.5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30.9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29.5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">EPS</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.276</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.220</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.140</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z588b6b4e821e44179a3cd0f96f0dd841" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 60%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Non-GAAP (prior to tax law changes)</u></font>:</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NI</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,562</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,004</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,493</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NIM</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35.2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30.5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28.6</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="WIDTH: 44%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">EPS</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.897</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.188</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.047</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Note:&#160; The tax provision adjustments only affected UTMD's income tax provision, NI and EPS, not consolidated revenues (sales), GP, OI or EBT.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;Ignoring the 2017 REPAT accrued tax provision of $6,288 and 2015 &#8211; 2017 DTL adjustments, the (non-US GAAP) consolidated combined income tax provision rate for 2017 was 23.7% of EBT compared to 26.9% in 2016, and 26.1% in 2015. The US GAAP consolidated income tax provision rate for 2017 was 55.4% of EBT compared to 26.1% in 2016, and 23.8% in 2015. The non-US GAAP difference in rates was due primarily to the tax deduction allowed in the UK and Ireland on the remeasured value of their USD cash balances, as well as the mix of income generated and actual tax provisions in sovereignties with varying tax rates. Both UK and Ireland subsidiaries experienced native currency losses on the value of their large USD cash balances in 2017. These currency translation losses are tax deductions in the applicable foreign jurisdiction, but do not affect UTMD's EBT (USD are USD).&#160; But the actual tax (lower) provisions of the OUS subsidiaries do become part of UTMD's consolidated income tax provision.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;In general, year to year fluctuations in the combined tax rate will result from variation in EBT contribution from subsidiaries in jurisdictions with different corporate income tax rates. The UK had an income tax rate of 20% in 1Q 2017 and a rate of 19% thereafter, compared to a rate of 20% in 2016 and a rate of 21% in 1Q 2015 and a rate of 20% thereafter.&#160; The UK also allows a tax deduction for sales of UK patented products which varies from year-to-year based on somewhat complicated rules which are sorted out for UTMD by independent tax accountants. The current UK income tax rate of 19% is scheduled to decline to 17% beginning April 1, 2020. The income tax rate for AUS has been and is planned to remain at 30%.&#160; The income tax rate for Canada was and is expected to remain at 25%. Profits of the Ireland subsidiary are taxed at a 12.5% rate on exported manufactured products, and a 25% rate on rental and other types of income including income from sales of medical devices in Ireland domestically.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Further Comments on the U.S. Corporate Tax Rate.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">For the benefit of stockholders, UTMD believes that further discussion of its current understanding of the impact of tax law changes resulting from the 2017 Act might be helpful.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">29</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD's effective Federal tax rate in the U.S. after allowable deductions was typically about 29.4% prior to the new tax law. The State of Utah adds a 5% income tax using the Federal taxable income as a basis. The predominant reason that UTMD's prior effective Federal rate was not 34% was a "manufacturing profit deduction" (MPD) which equated to about 8.1% of UTMD's U.S. EBT. There were other factors such as the R&amp;D tax credit and accelerated depreciation for tax purposes which helped reduce UTMD's effective income tax rates, and these other benefits will continue under the Tax Act. The MPD, however, has been discontinued under the Tax Act while the U.S. corporate tax rate has been reduced from 34% to 21%.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">As the State of Utah uses Federal taxable income as a taxable base, the State will receive a "windfall" tax increase going forward, because UTMD's EBT upon which the 5% rate is applied will be 8.8% higher due to the loss of the MPD.&#160; There is no present indication that the State of Utah will lower its corporate income tax rate, although they should follow the Tax Act in that regard, in UTMD's opinion, if they are going to also tax UTMD's cumulative foreign subsidiary E&amp;P.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">As a rough guideline to help stockholders estimate the effect of the new tax law looking forward, UTMD's effective income tax rate for U.S. EBT should be about 7.9 percentage points lower than in the past. UTMD's 2017 U.S. EBT was about 48% of total EBT (including the EBT of all OUS subsidiaries). Using 2017 EBT as a basis, UTMD's consolidated tax provision would be about 3.8 percentage points lower, equating to about $720 higher NI and $0.20 higher EPS.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">In other words, in exchange for $720 per year higher net income, UTMD stockholders incurred $786 per year loss if you spread the REPAT tax evenly over eight years. From an income statement point of view, the impact of the REPAT tax has already been incurred in 2017 GAAP results, and the impact of the lower tax rate will increase future NI and EPS results, and, of course, UTMD intends to continue its consistent growth in EBT.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;The Company believes that investors benefit from referring to the non-GAAP financial measures above in assessing UTMD's performance. The non-GAAP financial measures also facilitate management's internal comparisons for purposes of planning future performance. The non-GAAP financial measures disclosed by UTMD should not be considered a substitute for or superior to financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">EPS are NI divided by the number of shares of stock outstanding (diluted to take into consideration stock option awards which are "in the money," i.e., have exercise prices below the applicable period's weighted average market value).&#160; As noted above, diluted EPS were $2.276 in 2017 ($3.897 prior to the REPAT tax and DTL adjustment), $3.220 ($3.188 prior to the DTL adjustment) in 2016, and $3.140 ($3.047 prior to the DTL adjustment) in 2015.&#160; &#160; The 2017 non-GAAP results exceeded management's expectations for the year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The 2017-ending weighted average number of diluted common shares (the number used to calculate diluted EPS) was 3,737 (in thousands), compared to 3,766 shares in 2016 and 3,772 shares in 2015.&#160; EPS in 2017 benefited from UTMD's November 2016 repurchase of 50,000 shares from an institutional investor. Dilution for "in the money" unexercised options for the year 2017 was 19 shares, compared to 15 shares in 2016 and 20 in 2015.&#160; Actual outstanding common shares as of December 31, 2017 were 3,721.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">In summary, after an outstanding year of growth in 2017, UTMD management expects flatter revenues in 2018, with OI challenged by broadly higher costs. Helped by a lower combined income tax rate, UTMD management is targeting 2018 EPS between $3.80 and $3.90. UTMD's calendar year 2018 operating plan for conservative reasons excludes additional share repurchases, acquisitions and potential sales growth from unannounced new products.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Return on stockholders' equity (ROE) is the portion of NI retained by UTMD (after payment of dividends) to internally finance its growth, divided by the average accumulated stockholders' equity (ASE) during the applicable time period. ROE includes balance sheet measures as well as income statement measures.&#160; Maintaining a high ROE is a key management objective for UTMD in order to grow without diluting its stockholders' interest. ROE is the quotient of NI divided by ASE, but it is a function of NIM, productivity of assets and financial leverage. Although UTMD's high NIM is the primary factor that continues to drive its ROE, a repurchase of 50,000 shares for $2,850 in 4Q 2016, $3,960 in cash dividends to stockholders in 2017 and a reduction as a result of the REPAT tax, all helped lower ASE, reducing the denominator in calculating ROE.&#160; Although REPAT tax helped the denominator by lowering ASE $3.1 million, it harmed ROE more in 2017 by also lowering the NIM numerator from 35.2% to 20.5%.&#160; Average 2017 Stockholders' Equity was $73,683. Year-end 2017 Stockholders' Equity was $78,122. Year-end 2017 Stockholders' Equity increased $8,878 from a year earlier.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">30</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;UTMD's 2017 ROE was 6% including dividends and US GAAP NI, compared to 12% in both 2016 and 2015.&#160; Before dividends, UTMD's 2017 ROE was 12% compared to 17% in 2016, and 18% in 2015. Using Non-GAAP NI, excluding the effect of the REPAT tax and before dividends, UTMD's 2017 ROE was 19%.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Liquidity and Capital Resources</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Cash Flows</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Net cash provided by operating activities, including adjustments for depreciation and other non-cash operating expenses, along with changes in working capital and the tax benefit attributable to exercise of employee incentive stock options, totaled $16,908 in 2017, compared to $14,528 in 2016 and $13,801 in 2015.&#160; The largest changes in 2017 compared to 2016 were all related to the REPAT tax:&#160; the establishment of $5,785 in long-term repatriation tax payable, a decrease of $3,623 in net income, and a $2,213 benefit to cash from a $1,027 increase in accrued expenses following a $1,187 decrease in the prior year. The other significant contributor to the increase in accrued expenses was the $1,005 dividend payable at year-end 2017. A decrease in other receivables benefited cash by $895. Other changes were generally consistent with effective working capital management and sales activity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The Company's notes payable repayment of $4,777 in 2015 was the most significant use of cash that year. The loans were paid off in early 2015, so no loan principal payments were required in 2016 or 2017. Loans of $26,934 were obtained in 2011 to help finance the acquisition of Femcare. In investing activities, during 2017 UTMD used $1,597 for capital expenditures. During 2017 UTMD fitted-out the 38,600 square foot facility in the UK it purchased in late 2016 to replace its leased facility, and moved operations into the new facility late in the year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">In 2017, UTMD received $302 and issued 8,302 shares of stock upon the exercise of employee and director stock options.&#160; Employees and directors exercised a total of 8,638 option shares in 2017, with 336 shares immediately being retired as a result of optionees trading the shares in payment of the exercise price of the options.&#160; Option exercises in 2017 were at an average price of $37.83 per share.&#160; The Company received a $38 tax benefit from option exercises in 2017, which is only reflected in net income as a result of adopting a new accounting standard in 2017. UTMD did not repurchase any shares of its stock in the open market during 2017. In 2016, UTMD received $376 and issued 11,945 shares of stock upon the exercise of employee and director stock options.&#160; Employees and directors exercised a total of 12,806 option shares in 2016, with 861 shares immediately being retired as a result of optionees trading the shares in payment of the exercise price of the options.&#160; Option exercises in 2016 were at an average price of $33.68 per share.&#160; The Company received a $50 tax benefit from option exercises in 2016. UTMD repurchased 50,000 shares of stock in the open market at a cost of $2,850 during 2016, an average cost of $57.00 per share.&#160; By comparison, in 2015, UTMD received $343 and issued 15,786 shares of stock upon the exercise of employee and director stock options.&#160; Employees and directors exercised a total of 21,800 option shares in 2015, with 6,014 shares immediately being retired as a result of optionees trading the shares in payment of the exercise price of the options and related taxes.&#160; Option exercises in 2015 were at an average price of $29.36 per share.&#160; The Company received a $114 tax benefit from option exercises in 2015. UTMD repurchased 13,000 shares of stock in the open market at a cost of $683 during 2015, an average cost of $52.54 per share.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">UTMD did not borrow in any of the three years 2015-2017.&#160; Cash dividends paid were $2,955 in 2017, compared to $3,916 in 2016 and $3,846 in 2015. The $1,005 cash dividend declared for 4Q 2017 was paid in early January 2018, a change from the dividends declared in the 4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> quarters of 2016 and 2015, which were paid in late December.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Management believes that future income from operations and effective management of working capital will provide the liquidity needed to finance internal growth plans.&#160; In an uncertain economic environment, UTMD's cash balances allow management to operate with the long-term best interest of stockholders in mind.&#160; Planned 2018 capital expenditures for ongoing operations are expected to be less than depreciation of current PP&amp;E.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Management plans to utilize cash not needed to support normal operations in one or a combination of the following:&#160; 1) in general, to continue to invest at opportune times in ways that will enhance future profitability; 2) to make additional investments in new technology and/or processes; and/or 3) to acquire a product line or company that will augment revenue and EPS growth and better utilize UTMD's existing infrastructure.&#160; If there are no better strategic uses for UTMD's cash, the Company will continue to return cash to stockholders in the form of dividends and share repurchases when the stock appears undervalued.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">31</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Management's Outlook.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD is small, but its employees are experienced and remain diligent in their work. UTMD's passion is in providing innovative clinical solutions that will help improve the effectiveness of medical procedures and reduce health risks, particularly for women and their babies.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The safety, reliability and performance of UTMD's medical devices are high and represent significant clinical benefits while providing minimum total cost of care.&#160; UTMD will continue to leverage its reputation as a device innovator which will responsively take on challenges to work with clinicians who use its specialty devices.&#160; In doing so, UTMD will continue to differentiate itself, especially from commodity-oriented competitors.&#160; In 2018, UTMD plans to continue to</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="z3613e3894bdd46bda56c24cfd1aed7a0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">1)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">exploit distribution and manufacturing synergies by further integrating capabilities and resources in its multinational operations;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">introduce additional products helpful to clinicians through internal new product development;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">achieve excellent overall financial operating performance;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">utilize positive cash generation to continue providing cash dividends to stockholders and make open market share repurchases if/when the UTMD share price seems undervalued; and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">5)</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">be vigilant for accretive acquisition opportunities which may be increasingly brought about by difficult burdens on small, innovative companies.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company has a fundamental focus to do an excellent job in meeting clinicians' and patients' needs, while providing stockholders with excellent returns.&#160; In 2017, the value of UTMD's stock increased 12%, ending the year at $81.40/ share, while $1.065 in dividends/ share were paid. Taking a longer term view, as of the end of 2017 from the end of 1998, UTMD's share price increased 1,140%, representing a 14% annually compounded share price increase over the nineteen year time span. If additional returns to stockholders from cash dividends are added, stockholder value increased 1,343% over the nineteen year time span, representing 15% annually compounded growth in value. In comparison, the NASDAQ Composite Index was up 215%, the S&amp;P 500 Index was up 118% and the DJIA was up 169%.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;&#160;Combining share price appreciation as a result of a long term profitable financial performance and a capital allocation strategy that includes opportunistic share repurchases with steadily growing quarterly cash dividends paid to stockholders since 2004, longer term UTMD stockholders have experienced excellent returns. Management is committed to continue that performance.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Off Balance Sheet Arrangements</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">None</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Contractual Obligations</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">The following is a summary of UTMD's significant contractual obligations and commitments as of December 31, 2017:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">&#160;</div>

<table id="z3b3ccc54a14f4b5f9aad79d50708438a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>Contractual Obligations and Commitments</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">Total</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; LINE-HEIGHT: 1.25"></div>

<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">2018</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; LINE-HEIGHT: 1.25"></div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">2019-<font style="FONT-FAMILY: 'Times New Roman', Times, serif"> 2020</font></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; LINE-HEIGHT: 1.25"></div>

<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif">2021-2022</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; LINE-HEIGHT: 1.25"></div>

<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">2023 and</div>

<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;<font style="FONT-FAMILY: 'Times New Roman', Times, serif">thereafter</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Long-term debt obligations</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Operating lease obligations</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">661</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">83</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">90</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">90</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">398</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Purchase obligations</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">1,530</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">1,476</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">54</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 20.85pt">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,191</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">1,559</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">144</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">90</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">398</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Critical Accounting Policies and Estimates</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 9pt">The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as well as the reported amounts of revenues and expenses during the reporting period.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Management bases its estimates and judgments on historical experience, current economic and industry conditions and on various other factors that are believed to be reasonable under the circumstances. This forms the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Management has identified the following as the Company's most critical accounting policies which require significant judgment and estimates. Although management believes its estimates are reasonable, actual results may differ from these estimates under different assumptions or conditions.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">32</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<table id="z7eec6d2810024745bcce6e2180d8120d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Allowance for doubtful accounts: The majority of the Company's receivables are with healthcare facilities and medical device distributors.&#160; Although the Company has historically not had significant write-offs of bad debt, the possibility exists, particularly with foreign customers where collection efforts can be difficult or in the event of widespread U.S. hospital bankruptcies.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Inventory valuation reserves:&#160; The Company strives to maintain a good balance of inventory to 1) meet its customers' needs and 2) optimize manufacturing lot sizes while 3) not tying-up an unnecessary amount of the Company's capital increasing the possibility of, among other things, obsolescence.&#160; The Company believes its method of reviewing actual and projected demand for its existing inventory allows it to arrive at a fair inventory valuation reserve. While the Company has historically not had significant inventory write-offs, the possibility exists that one or more of its products may become unexpectedly obsolete for which a reserve has not previously been created. </font>The Company's historical write-offs have not been materially different from its estimates.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounting Policy Changes</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company's management has evaluated the recently issued accounting pronouncements through the filing date&#160;of these financial statements and has determined that the application of these pronouncements will not have a material impact on the Company's financial position and results of operations.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 7A &#8209; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The Company had manufacturing operations, including related assets, in the U.S. denominated in the U.S. Dollar (USD), in Ireland denominated in the Euro (EUR), and in England denominated in the British Pound (GBP). UTMD also has trading activities in the U.S. and in subsidiaries in other countries denominated in the USD, EUR, GBP, the Australian Dollar (AUD) and the Canadian Dollar (CAD).&#160; The currencies are subject to exchange rate fluctuations that are beyond the control of UTMD.&#160; The exchange rates were .8319, .9474 and .9203 EUR per USD as of December 31, 2017, 2016 and 2015, respectively.&#160; Exchange rates were .7395, .8105 and .6774 GBP per USD as of December 31, 2017, 2016 and 2015, respectively. Exchange rates were 1.2796, 1.3829 and 1.3710 AUD per USD on December 31, 2017, 2016 and 2015, respectively. Exchange rates were 1.2519 and 1.3425 CAD per USD on December 31, 2017 and 2016, respectively. Please see note 1 in Item, 8, below under "Translation of Foreign Currencies" for more information.&#160; UTMD manages its foreign currency risk without separate hedging transactions by either invoicing customers in the local currency where costs of production were incurred, or by converting currencies as transactions occur.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 8 &#8209; FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Currency amounts are in thousands except per-share amounts and where noted.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">TABLE OF CONTENTS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z599894c471364fa1ba0b07c842464c62" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 15px">
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Management's Report on Internal Control Over Financial Reporting</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">34</div>
</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Report of Independent Registered Public Accounting Firm on Financial Statements and the Company's Internal Control Over Financial Reporting</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">35</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Report of Independent Registered Public Accounting Firm on Financial Statements and the Company's Internal Control Over Financial Reporting</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">37</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Consolidated Balance Sheet</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">39</div>
</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Consolidated Statement of Income and Comprehensive Income</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">40</div>
</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Consolidated Statement of Cash Flow</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">41</div>
</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Consolidated Statement of Stockholders' Equity</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">42</div>
</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 92.72%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 42.3pt">Notes to Consolidated Financial Statements</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 7.28%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="TEXT-ALIGN: center">43</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">33</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">MANAGEMENT'S REPORT ON INTERNAL CONTROL</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">OVER FINANCIAL REPORTING</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules&#160;13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The Company's internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Company's internal control over financial reporting includes those policies and procedures that:</div>

<table id="z60d050a2d2b7447987c74cf0b17dd17a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company's management assessed the effectiveness of the Company's internal control over financial reporting as of December&#160;31, 2017. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Internal Control-Integrated Framework (1992)</font>.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Based on its assessment and those criteria, management believes that the Company maintained effective internal control over financial reporting as of December&#160;31, 2017.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 12pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company's independent registered public accounting firm, Jones Simkins LLC, has audited the Company's internal control over financial reporting as of December 31, 2017, and its report is shown on the next page.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Nortons Assurance Limited audited the internal control over financial reporting of Femcare Group Limited as of December 31, 2017, and its report follows the report of Jones Simkins LLC.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>

<table id="za44fe51224ac4b9fbcf973b2099a0887" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:</div>
</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>/s/ Kevin L. Cornwell</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Kevin L. Cornwell</div>
</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>
</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:</div>
</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>/s/ Paul O. Richins</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Paul O. Richins</div>
</td>
</tr>

<tr>
<td style="WIDTH: 3.58%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 96.42%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Principal Financial Officer</div>
</td>
</tr>
</table>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">34</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">To the Board of Directors and Stockholders<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> of Utah Medical Products, Inc.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Opinions on the Financial Statements and Internal Control over Financial Reporting</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We have audited the accompanying consolidated balance sheets of Utah Medical Products, Inc. as of December 31, 2017 and 2016, and the related consolidated statements of income and comprehensive income, stockholders' equity, and cash flows for each of the years in the three-year period ended December 31, 2017. We also have audited Utah Medical Products, Inc.'s internal control over financial reporting as of December 31, 2017, based on criteria established in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Internal Control&#8212;Integrated Framework (1992)</font> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In our opinion, based on our audits and the report of the other auditors, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Utah Medical Products, Inc. as of December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2017 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, based on our audit and the report of the other auditors, Utah Medical Products, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Internal Control&#8212;Integrated Framework (1992)</font>&#160; issued by COSO.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Basis for Opinion</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Utah Medical Products, Inc.'s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Management's Report on Internal Control Over Financial Reporting</font>. Our responsibility is to express an opinion on these consolidated financial statements and an opinion on Utah Medical Products, Inc.'s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to Utah Medical Products, Inc. in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We did not audit portions of the consolidated financial statements and we did not examine the effectiveness of internal control over financial reporting for portions of Femcare Group Limited, a wholly owned subsidiary. The portions not audited by us include assets of $26,564,000, and $19,412,000 as of December 31, 2017 and 2016, respectively, and total revenues of $11,371,000, $10,214,000, and $12,548,000, respectively for each of the years in the three-year period ended December 31, 2017. Those portions of the consolidated financial statements and the effectiveness of internal control over financial reporting were audited by other auditors whose reports have been furnished to us, and our opinions, insofar as they relate to the amounts included for Femcare Group Limited and the effectiveness of Femcare Group Limited's internal control over financial reporting, is based solely on the reports of the other auditors.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.&#160; Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall consolidated financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">35</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Definition and Limitations of Internal Control over Financial Reporting</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>/s/ Jones Simkins LLC</u></div>

<div style="MARGIN-BOTTOM: 12pt; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">JONES SIMKINS LLC</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We have served as Utah Medical Products, Inc.'s auditor since 2003.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Logan, Utah</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 5, 2018</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">36</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">To the Board of Directors and Stockholders<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> of Utah Medical Products, Inc.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Opinions on the Financial Statements and Internal Control over Financial Reporting</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We have audited the consolidated balance sheets of Femcare Group Limited (the Company), including its subsidiaries, as of December 31, 2017 and 2016, and the related consolidated statements of income, comprehensive income, stockholders' equity, and cash flows for each of the years in the three-year period ended December 31, 2017. We also have audited the Company's internal control over financial reporting as of December 31, 2017, based on criteria established in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Internal Control&#8212;Integrated Framework (1992)</font> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016 and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2017, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on criteria established in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Internal Control&#8212;Integrated Framework (1992)</font>&#160; issued by COSO.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Basis for Opinion</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's consolidated financial statements and an opinion on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.&#160; Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">37</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Definition and Limitations of Internal Control over Financial Reporting</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 12pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>/s/ Nortons Assurance Limited</u></div>

<div style="MARGIN-BOTTOM: 6pt; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NORTONS ASSURANCE LIMITED</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We have served as the Company's auditor since 2011.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Reading, United Kingdom</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 5, 2018</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">38</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z31bf521260fd447da2c909901e70a66e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="RANGE!A1:G45"><!--Anchor--></a><a name="RANGE!A1:G44"><!--Anchor--></a>UTAH MEDICAL PRODUCTS, INC.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSOLIDATED BALANCE SHEET</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31, 2017 and 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(In thousands)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="8">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>ASSETS</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,875</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,296</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Investments, available-for-sale (notes 3 and 4)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">80</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounts and other receivables, net (note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,623</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,211</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Inventories (note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,244</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,542</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Prepaid expenses and other current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">366</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">361</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49,188</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">34,474</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, net (notes 5 and 11)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,621</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,966</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Goodwill</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,092</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,487</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other intangible assets (note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">34,805</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,947</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other intangible assets - accumulated amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(16,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(13,683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other intangible assets - net (note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,844</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,264</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">92,745</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">76,191</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-ALIGN: center; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>LIABILITIES AND STOCKHOLDERS' EQUITY</u></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current liabilities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">934</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">906</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accrued expenses (note 2)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,346</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,116</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total current liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,280</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,022</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long Term income tax payable (note 8)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,785</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deferred tax liability - intangible assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,102</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,209</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deferred income taxes (note 8)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">456</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">716</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total liabilities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,623</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,947</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Commitments and contingencies (notes 7 and 13)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stockholders' equity:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Preferred stock, $.01 par value; 5,000 shares&#160;authorized, no shares issued and outstanding</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock, $.01 par value; 50,000 shares authorized, issued 3,721 shares in 2017 and&#160;3,713 shares in 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accumulated other comprehensive income (loss)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(8,341</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(12,243</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Additional paid-in capital</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">378</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Retained earnings</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">85,617</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">81,072</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total stockholders' equity</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">78,122</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">69,244</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total liabilities and stockholders' equity</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">92,745</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">76,191</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to financial statements.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">39</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z109045b26b9b4bf88f90f90d5a139782" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="RANGE!A1:I30"><!--Anchor--></a>UTAH MEDICAL PRODUCTS, INC.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSOLIDATED STATEMENT OF INCOME</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AND COMPREHENSIVE INCOME</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Years ended December 31, 2017, 2016 and 2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(In thousands, except per share amounts)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Sales, net (notes 10, 12 and 13)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41,414</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,298</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">40,157</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cost of goods sold</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,019</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,608</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,972</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 4%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gross profit</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,395</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,690</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,185</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Operating expense:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Sales and marketing</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,544</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,673</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,164</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and development</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">447</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">475</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">522</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">General and administrative</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,393</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,355</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,848</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Operating income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,011</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,187</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,651</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other income (expense):</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dividend and interest income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Royalty income (note 13)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">86</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">91</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">93</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Interest expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(65</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(32</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">132</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(139</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Income before provision for income taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,082</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,422</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,545</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Provision for income taxes (note 8)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,577</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,294</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,702</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,843</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Earnings per common share (basic) (note 1):</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.29</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.23</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.16</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Earnings per common share (diluted) (note 1):</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.28</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.14</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other comprehensive income:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign currency translation net of taxes of&#160;$0 in all periods</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,893</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,289</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,724</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized gain (loss) on investments net of&#160;taxes of $6, $3 and ($1)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; PADDING-LEFT: 4%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total comprehensive income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,408</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,844</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,117</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to financial statements.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">40</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z40fb26f8b89a4614b5a27803a82eb328" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="RANGE!A1:K60"><!--Anchor--></a>UTAH MEDICAL PRODUCTS, INC.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSOLIDATED STATEMENT OF CASH FLOW</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Years Ended December 31, 2017, 2016 and 2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(In thousands)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="12">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Cash flows from operating activities:</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,843</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Adjustments to reconcile net income to net cash provided by operating activities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Depreciation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">660</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">610</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">619</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,113</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,223</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,528</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Provision for (recovery of) losses on accounts receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Loss on disposal of assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deferred income taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(658</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(484</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(901</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock-based compensation expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">129</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">92</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">87</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Increase) decrease in:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounts receivable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(242</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">295</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">137</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other receivables</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">897</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(91</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Inventories</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(467</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(360</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">422</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Prepaid expenses and other current assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Increase (decrease) in:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounts payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">286</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(265</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,027</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,187</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(597</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long-term repatriation tax payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,785</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 7%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net cash provided by operating activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,908</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,528</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,801</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff"><u>Cash flows from investing activities:</u></font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Capital expenditures for:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 3%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,597</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,293</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(176</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 3%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Intangible assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(70</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 7%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net cash provided by (used in) investing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,597</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,302</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(246</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff"><u>Cash flows from financing activities:</u></font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Proceeds from issuance of common stock - options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">302</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">376</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">343</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock purchased and retired</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,850</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Payment of taxes for exchange of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(42</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Tax benefit attributable to exercise of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">114</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Repayments of notes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,777</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dividends paid</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,955</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,916</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,846</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 7%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net cash provided by (used in) financing activities</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,653</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,340</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(8,891</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Effect of exchange rate changes on cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">921</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,868</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(660</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 7%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net increase in cash and cash equivalents</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,579</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,018</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,004</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash at beginning of year</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,296</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,278</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,274</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash at end of year</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,875</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,296</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,278</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash paid during the year for:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Income taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,151</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,846</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,341</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 64%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 9pt">Interest</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">41</font>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always"><font id="DSPFPageNumber"></font>

<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="ze4541fc6404346a4b1bad338fc663ef3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="24">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">UTAH MEDICAL PRODUCTS, INC.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="24">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="24">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Years Ended December 31, 2017, 2016 and 2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="24">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(In thousands)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="24">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Additional</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Common Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Paid-in</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Comprehensive</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Retained</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Stockholders'</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Earnings</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance at December 31, 2014</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">3,748</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">37</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">2,890</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,234</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">64,863</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">64,556</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shares issued upon exercise of employee stock options for cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">640</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">640</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shares received and retired upon exercise&#160;of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(6</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(338</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(338</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Tax benefit attributable to appreciation&#160;of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">114</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">114</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock option compensation expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">87</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">87</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock purchased and retired</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(13</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign currency translation adjustment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(2,724</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(2,724</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(2</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock dividends</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,846</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,846</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">11,843</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">11,843</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance at December 31, 2015</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">3,751</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">38</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">2,710</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(5,961</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">72,861</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">69,648</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shares issued upon exercise of employee stock options for cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">13</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">431</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">431</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shares received and retired upon exercise&#160;of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(56</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(56</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Tax benefit attributable to appreciation of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock option compensation expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">92</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">92</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock purchased and retired</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(1</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(2,849</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(2,850</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign currency translation adjustment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(6,289</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(6,289</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock dividends</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,916</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,916</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">12,128</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance at December 31, 2016</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">3,713</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">37</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">378</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(12,243</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">81,072</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">69,244</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shares issued upon exercise of employee&#160;stock options for cash</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">327</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">327</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Shares received and retired upon exercise&#160;of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(0</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(25</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(25</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock option compensation expense</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">129</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">129</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock purchased and retired</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign currency translation adjustment</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">3,893</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">3,893</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Common stock dividends</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,960</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(3,960</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net income</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">8,505</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance at December 31, 2017</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">3,721</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">37</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">809</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">(8,341</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">85,617</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; LINE-HEIGHT: 1.25">78,122</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageFooter" style="CLEAR: both"></div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">See accompanying notes to financial statements.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">42</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Currency amounts are in thousands except per-share amounts and where noted.</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 1 &#8211; Summary of Significant Accounting Policies</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Organization</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Utah Medical Products, Inc. with headquarters in Midvale, Utah and its wholly-owned operating subsidiaries, Femcare Nikomed Ltd located in Romsey, Hampshire, England, Femcare Australia Pty Ltd located in Castle Hill, NSW, Australia, Utah Medical Products Canada, Inc. (dba Femcare Canada) located in Mississauga, Ontario, Canada and Utah Medical Products Ltd., which operates a manufacturing facility in Athlone, Ireland, (in the aggregate, the Company) are in the primary business of developing, manufacturing and globally distributing specialized medical devices for the healthcare industry.&#160; The Company's broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians' offices.&#160; Products are sold directly to end user facilities in the U.S., Ireland, UK, Canada, France and Australia, and through third party distributors in other outside the U.S. (OUS) markets.&#160; Domestically, UTMD has an exclusive distribution relationship with CooperSurgical, Inc. for the Filshie Clip System.&#160; UTMD also sells subcontract manufactured components and finished products to over 145 companies in the U.S. for their medical and non-medical products.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Use of Estimates in the Preparation of Financial Statements</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Although actual results could differ from those estimates, management believes it has considered and disclosed all relevant information in making its estimates that materially affect reported performance and current values.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Principles of Consolidation</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The consolidated financial statements include those of the Company and its subsidiaries.&#160; All intercompany accounts and transactions have been eliminated in consolidation.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Cash and Cash Equivalents</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">For purposes of the consolidated statement of cash flows, the Company considers cash on deposit and short-term investments with original maturities of three months or less to be cash and cash equivalents.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Investments</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company classifies its investments as "available-for-sale."&#160; Securities classified as "available-for-sale" are carried in the financial statements at fair value.&#160; Realized gains and losses, determined using the specific identification method, are included in operations; unrealized holding gains and losses are reported as a separate component of accumulated other comprehensive income.&#160; Declines in fair value below cost that are other than temporary are included in operations.&#160; As of December 31, 2017 the Company retained a freely tradeable investment in Citigroup (C) (see note 3)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Concentration of Credit Risk</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The primary concentration of credit risk consists of trade receivables.&#160; In the normal course of business, the Company provides credit terms to its customers.&#160; Accordingly, the Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses which, when realized, have been within the range of management's expectations as reflected by its reserves.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company's customer base consists of hospitals, medical device distributors, physician practices and others directly related to healthcare providers, as well as other manufacturing companies.&#160; Although the Company is affected by the well-being of the global healthcare industry, management does not believe significant trade receivable credit risk exists at December&#160;31, 2017 except under an extreme global financial crisis.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company maintains its cash in bank deposit accounts in addition to Fidelity Investment accounts.&#160; The Company has not experienced any losses in such accounts and believes it is not exposed to a significant credit risk on cash and cash equivalent balances.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">43</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 1 &#8211; Summary of Significant Accounting Policies</u></font> (continued)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Accounts Receivable</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Accounts receivable are amounts due on product sales and are unsecured.&#160; Accounts receivable are carried at their estimated collectible amounts.&#160; Credit is generally extended on a short-term basis; thus accounts receivable do not bear interest although a late charge may be applied to such receivables that are past the due date.&#160; Accounts receivable are periodically evaluated for collectibility based on past credit history of customers and current market conditions.&#160; Provisions for losses on accounts receivable are determined on the basis of loss experience, known and inherent risk in the account balance and current economic conditions (see note 2).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Inventories</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In 2017, the Company adopted Accounting Standard Update (ASU) 2015-11, "Inventory-Simplifying the Measurement of Inventory," which changed how inventory is valued.&#160; Finished products, work-in-process, raw materials and supplies inventories are stated at the lower of cost and net realizable value (NRV) computed on a first-in, first-out method.&#160; Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160; The adoption of ASU 2015-11 did not have an impact on the Company's financial statements (see note 2).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Property and Equipment</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Property and equipment are stated at cost.&#160; Depreciation and amortization are computed using the straight-line method over estimated useful lives as follows:</div>

<div id="DSPFPageHeader" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"></div>

<div>&#160;</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z62d2cc80f3d74d379e1083e3473db5d0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Building and improvements</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">15-40 years</div>
</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Furniture, equipment and tooling</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">3-10 years</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><u>Long-Lived Assets</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company evaluates its long-lived assets in accordance with Accounting Standards Codification (ASC) 360, "Accounting for the Impairment of Long-Lived Assets."&#160; Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable.&#160; When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts.&#160; Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets, and is recorded in the period in which the determination was made.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Intangible Assets</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Costs associated with the acquisition of patents, trademarks, trade names, customer relationships, regulatory approvals &amp; product certifications, license rights and non-compete agreements are capitalized, and are being amortized using the straight-line method over periods ranging from 5 to 20 years. UTMD's goodwill is tested for impairment annually, in the fourth quarter of each year, using a fair value measurement test, in accordance with ASC 350. UTMD also performs impairment tests contemporaneously, if circumstances change that would more than likely reduce the fair value of goodwill below its net book value.&#160; If UTMD determines that its goodwill is impaired, a second step is completed to measure the amount of the impairment loss. UTMD does not expect its goodwill to become impaired in the foreseeable future.&#160; Estimated future amortization expense on intangible assets currently held, using the 2017 year-end 1.3523 USD/GBP and .7815 USD/AUD currency exchange rates, is about $1,981 in 2018, $1,980 in 2019 and 2020, $1,974 in 2021, and $1,973 in 2022 (see note 2).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Stock-Based Compensation</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">At December 31, 2017, the Company has stock-based employee compensation plans, which are described more fully in note 9.&#160; The Company accounts for stock compensation under ASC 718, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Share-Based Payment</font>.&#160; This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors.&#160; In 2017, the Company recognized $129 in stock-based compensation cost compared to $92 in 2016 and $87 in 2015.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">44</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 1 &#8211; Summary of Significant Accounting Policies</u></font> (continued)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Revenue Recognition</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company recognizes revenue at the time of product shipment as UTMD meets its contractual performance obligations to the customer at the time of shipment. Revenue recognized by UTMD is based upon<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> the consideration to which UTMD is entitled from its customers as a result of shipping a physical product, in accordance with the </font>documented arrangements and fixed contracts in which the selling price was fixed prior to the Company's acceptance of an order. Revenue from service sales, which are immaterial to UTMD, is generally recognized when the service is completed and invoiced. As demonstrated by decades of experience in successful and consistent collections, there is very minor and insignificant uncertainty regarding the collectability of invoiced amounts reasonably within the terms of the Company's contracts. There are circumstances under which insignificant revenue may be recognized when product is not shipped, which meet the criteria of ASU 2014-09: the Company provides engineering services, for example, design and production of manufacturing tooling that may be used in subsequent UTMD manufacturing of custom components for other companies.&#160; This revenue is recognized when UTMD's performance obligations have been completed according to a fixed contractual agreement.&#160; UTMD includes handling fees charged to customers in revenues. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Income Taxes</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company accounts for income taxes under ASC 740, "Accounting for Income Taxes," whereby deferred taxes are computed under the asset and liability method.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In November 2015, the FASB released ASU 2015-17, Income Taxes (Topic 740):&#160; Balance Sheet classification of Deferred Taxes.&#160; ASU 2015-17 requires that all deferred income taxes are classified as noncurrent in a classified statement of financial position.&#160; The Company adopted ASU 2015-17 retrospectively effective January 1, 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On December 22, 2017 the U.S. Tax Cuts and Jobs Act of 2017 (Tax Act) was signed into law.&#160; As a result of the Tax Act, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes.&#160; ASC 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, UTMD was required to revalue its deferred tax assets and liabilities at December 31, 2017 at the new rate.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Tax Act contains a deemed repatriation transition tax (Transition Tax) on accumulated earnings and profits of the Company's non-U.S. subsidiaries that have not been subject to U.S. tax.&#160; The Company plans to elect to pay its net Transition Tax over eight years.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On December 22, 2017, the SEC issued SAB 118 which provides guidance on accounting for the impact of the Tax Act.&#160; SAB 118 provides a measurement period of up to one year from enactment for a company to complete its tax accounting under ASC 740.&#160; Once a company is able to make a reasonable estimate and record a provisional amount for effects of the Tax Act it is required to do so.&#160; Such provisional measurement amounts may change as remaining data is obtained, calculations are prepared and analysis and review are completed.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During the fourth quarter of 2017, the Company recorded a provisional tax charge for the Transition Tax of $6,288 and a provisional tax charge of $228 for the re-measurement of its U.S. deferred tax balances.&#160; Both provisional tax amounts are the Company's reasonable estimate of the impact of the Tax Act based on its understanding and available guidance.&#160; These provisional amounts may change as the Company receives additional clarification and implementation guidance.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-TOP: 6pt; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, in Utah, in the United Kingdom, in Australia, in Ireland and in Canada.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company recognizes interest accrued related to unrecognized tax benefits in interest expenses and any related penalties in income taxes. The Company did not recognize any tax-related interest expense or have any tax penalties in any of the three years 2015 through 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Legal Costs</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&#160; The Company maintains a reserve for legal costs which are probable and estimated based on previous experience and known risk.&#160; The reserve for legal costs at December 31, 2017 and 2016 was $182 and $134, respectively (see note 2).</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">45</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 1 &#8211; Summary of Significant Accounting Policies</u></font> (continued)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Earnings per Share</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The computation of basic earnings per common share is based on the weighted average number of shares outstanding during each year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The computation of earnings per common share assuming dilution is based on the weighted average number of shares outstanding during the year plus the weighted average common stock equivalents which would arise from the exercise of stock options outstanding using the treasury stock method and the average market price per share during the year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The shares (in thousands) used in the computation of the Company's basic and diluted earnings per share are reconciled as follows:</div>

<table id="ze2190bd982a94663989d478cba489d11" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Weighted average number of shares outstanding &#8211; basic</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,718</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,751</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,752</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dilutive effect of stock options</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">19</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">15</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">20</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Weighted average number of shares outstanding, assuming dilution</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">3,737</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">3,766</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">3,772</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Presentation of Sales and Similar Taxes</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Sales tax on revenue-producing transactions is recorded as a liability when the sale occurs.&#160; UTMD is not required to withhold sales tax on OUS sales, and at least 90% of domestic 2017 sales were to customers who are tax exempt or who are in jurisdictions where UTMD is not required to withhold sales tax.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Translation of Foreign Currencies</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Assets and liabilities of the Company's foreign subsidiaries are translated into U.S. dollars at the applicable exchange rates at year-end.&#160; Net gains or losses resulting from the translation of the Company's assets and liabilities are reflected as a separate component of stockholders' equity.&#160; A negative translation impact on stockholders' equity reflects a current relative U.S. Dollar value higher than at the point in time that assets were actually acquired in a foreign currency.&#160; A positive translation impact would result from a U.S. dollar weaker in value than at the point in time foreign assets were acquired.&#160; Year-end translation gains or losses of non-functional currency bank account balances, e.g. EUR and AUD balances held by the UK subsidiary, are recognized as non-operating income or expense, as applicable.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 2 &#8211; Detail of Certain Balance Sheet Accounts</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zd467ae52fd714eff82bfec613b96b67b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 126px; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="6">December&#160;&#160;&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 126px; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 15px; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accounts and other receivables:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="WIDTH: 126px; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Accounts receivable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,713</div>
</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,289</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Income tax receivable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Accrued interest and other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14</div>
</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Less allowance for doubtful accounts</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(104</font></div>
</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(96</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Total accounts and other receivables</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">3,623</font></div>
</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">3,211</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Inventories:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Finished products</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 112px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,313</div>
</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,327</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 74.07%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Work-in-process</div>
</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">1,270</td>
<td style="WIDTH: 1.22%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 10.08%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">942</div>
</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 74.07%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Raw materials</div>
</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">2,661</td>
<td style="WIDTH: 1.22%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 10.08%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">2,273</font></div>
</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 74.07%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 36pt">Total inventories</div>
</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9.11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">5,244</font></div>
</td>
<td style="WIDTH: 1.22%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 10.08%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">4,542</font></div>
</td>
<td style="WIDTH: 1.06%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">46</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 2 &#8211; Detail of Certain Balance Sheet Accounts</u></font> (continued)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zfd8995ba02a942aa9eb5f5afafecac13" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="6">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31,&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other intangible assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Patents</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,183</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,161</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Non-compete agreements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">135</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">123</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Trademarks &amp; trade names</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,921</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">9,074</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Customer relationships</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,669</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,822</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Regulatory approvals &amp; product certifications</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">12,897</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><u>11,767</u></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 36pt">Total other intangible assets</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">34,805</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,947</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Accumulated amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">(16,961</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">(13,683</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 36pt">Other intangible assets, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">17,844</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">18,264</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accrued expenses:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Income taxes payable</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,259</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">799</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Payroll and payroll taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,199</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,117</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Reserve for litigation costs</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">182</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">134</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-INDENT: 18pt">Other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">1,706</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">66</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-INDENT: 36pt">Total accrued expenses</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">4,346</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,116</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 3 &#8211; Investments</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The Company's investments, classified as available-for-sale consist of the following:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z3ab1c5591d8e47859ab9d7b083a41c5c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="7">
<div style="TEXT-ALIGN: center">December 31,&#160;&#160;</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Investments, at cost</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">42</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">42</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Equity securities:</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">-Unrealized holding gains</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">-Unrealized holding (losses)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Investments, at fair value</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">80</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">64</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">During the three years 2015 through 2017, UTMD did not have any proceeds from sales of available-for-sale securities.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 4 &#8211; Fair Value Measurements and Financial Instruments</u></font>&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.&#160; The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).&#160; A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company uses the following valuation techniques to measure fair value for its assets and liabilities:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z56bf47cb715f4b43ad39c7976ac15023" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 9.04%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 1 -</div>
</td>
<td style="WIDTH: 90.96%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Quoted market prices in active markets for identical assets or liabilities;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9.04%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 90.96%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9.04%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 2 -</div>
</td>
<td style="WIDTH: 90.96%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observ<a name="_GoBack"><!--Anchor--></a>able such as interest rate and yield curves, and market-corroborated inputs);</div>
</td>
</tr>

<tr>
<td style="WIDTH: 9.04%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 90.96%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 9.04%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 3 -</div>
</td>
<td style="WIDTH: 90.96%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The following table provides financial assets carried at fair value measured as of December 31 for the past two years:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z34a1d5260a344de8aa557a8c7b582a70" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="6">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 1</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="6">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Levels 2 &amp; 3</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="6">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 28%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Equities</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">80</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">80</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">64</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 28%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">80</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">64</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">80</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">64</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; CLEAR: both; LINE-HEIGHT: 1.25">None of the Company's financial instruments, which are current assets and liabilities that could be readily traded, are held for trading purposes.&#160; Detail on investments is provided in note 3 above.&#160; The Company estimates that the fair value of all financial instruments at December 31, 2017 does not differ materially from the aggregate carrying value of its financial instruments recorded in the accompanying consolidated balance sheet.<br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">47</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><u>Note 5 &#8211; Property and Equipment</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment consists of the following:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="ze1316ac6746b4584a3a656ecadcad595" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="6">December 31,</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="2">2016</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Land</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,339</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,289</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Buildings and improvements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,350</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,914</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Furniture, equipment and tooling</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,696</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,759</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Construction-in-progress</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">13</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,061</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">32,398</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,023</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accumulated depreciation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(20,777</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(20,057</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">11,621</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">9,966</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; CLEAR: both; LINE-HEIGHT: 1.25">Included in the Company's consolidated balance sheet are the assets of its manufacturing and administrative facilities in Utah, Canada, England, Australia and Ireland.&#160; Property and equipment, by geographic area, are as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z26de7d215608460f83d752e09673bd70" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="15">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31, 2017 </div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">U.S. &amp;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">England &amp;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Canada</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Australia</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Ireland</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Land</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">926</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">413</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,339</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Buildings and improvements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,583</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,361</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,406</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,350</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Furniture, equipment and tooling</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,124</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">427</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,145</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,696</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Construction-in-progress</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">10</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">3</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">13</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,643</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,791</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,964</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32,398</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accumulated depreciation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(17,270</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(346</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(3,161</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(20,777</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">4,<font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">373</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">4,445</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">2,803</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">11,621</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z44dd0883e5cb403d8463f25148e751ea" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="15">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31, 2016 </div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">U.S. &amp;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">England &amp;</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3"></td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">Canada</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Australia</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Ireland</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">Land</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">926</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">362</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">1,289</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Buildings and improvements</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,523</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">523</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,869</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,914</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Furniture, equipment and tooling</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,233</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">529</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">996</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,759</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Construction-in-progress</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">-</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,057</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">4</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">2,061</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,682</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,109</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,231</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,023</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accumulated depreciation</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(17,063</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(376</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(2,617</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">(20,057</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">4,619</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">2,733</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">2,614</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">9,966</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><u>Note 6 &#8211; Long-term Debt</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In March 2011, the Company obtained a $14,000 loan from JPMorgan Chase Bank, N.A. and a $12,934 loan from JP Morgan Chase, London Branch to help finance UTMD's purchase of Femcare. The notes were fully paid off in February 2015.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">48</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; MARGIN-BOTTOM: 6pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 7 &#8211; Commitments and Contingencies</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Operating Leases</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The Company has a lease agreement for land adjoining its Utah facility for a term of forty years commencing on September 1, 1991.&#160; On September 1, 2001 and subsequent to each fifth lease year, the basic rental was and will be adjusted for published changes in a price index.&#160; The Company also leases an automobile for an employee in Ireland, and prior to late 2017, leased its UK facility. Rent expense charged to operations under these operating lease agreements was approximately $160, $175 and $184 for the years ended December&#160;31, 2017, 2016 and 2015, respectively.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Future minimum lease payments under its lease obligations as of December 31, 2017 were as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zf22d9000f1c54c09ab53b4db9e0db498" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Years ending December 31:</u></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">2018</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">83</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">2019</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">2020</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">2021</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">2022</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Thereafter</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">398</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 88%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">Total future minimum lease payments</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">661</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Purchase Obligations</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company has obligations to purchase raw materials for use in its manufacturing operations.&#160; The Company has the right to make changes in, among other things, purchase quantities, delivery schedules and order acceptance.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Product Liability</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Except for its Filshie Clip System, the Company is self-insured for product liability risk. "Product liability" is an insurance industry term for the cost of legal defense and possible damages awarded as a result of use of a company's product during a procedure which results in an injury of a patient.&#160; The Company maintains a reserve for product liability litigation and damages consistent with its previous long-term experience.&#160; Actual product liability litigation costs and damages during the last three reporting years have been immaterial, which is consistent with the Company's overall history. Femcare's product liability indemnity limit through an independent insurer is &#163;5 million each claim and in the annual aggregate.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company absorbs the costs of clinical training and trouble-shooting in its on-going operating expenses.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Warranty Reserve</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company's published warranty is: "UTMD warrants its products to conform in all material respects to all published product specifications in effect on the date of shipment, and to be free from defects in material and workmanship for a period of thirty (30) days for supplies, or twenty-four (24) months for equipment, from date of shipment.&#160; During the warranty period UTMD shall, at its option, replace any products shown to UTMD's reasonable satisfaction to be defective at no expense to the Purchaser or refund the purchase price."</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">UTMD maintains a warranty reserve to provide for estimated costs which are likely to occur. The amount of this reserve is adjusted, as required, to reflect its actual experience. Based on its analysis of historical warranty claims and its estimate that existing warranty obligations are immaterial, no warranty reserve was made at December 31, 2017 or December 31, 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Litigation</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&#160; Presently, there is no litigation or threatened litigation for which the Company believes the outcome may be material to its financial results.&#160; The Company applies its accounting policy to accrue legal costs that can be reasonably estimated.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">49</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 8 &#8211; Income Taxes</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deferred tax assets (liabilities) consist of the following temporary differences:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z6dc53e487c35492186972ccec68b8785" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="6">December 31,</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Inventory write-downs and differences due to UNICAP</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">98</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Allowance for doubtful accounts</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accrued liabilities and reserves</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">89</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">147</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other - foreign</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Depreciation and amortization</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,789</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,277</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized investment gains</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">66</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">105</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="WIDTH: 76%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deferred income taxes, net</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">(3,558</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">(3,925</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">)</font></div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">The components of income tax expense are as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zb31a706921354cb988e8f3e7baa4289f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="11">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Years ended December 31, </div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 64%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,944</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,467</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,877</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 64%; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deferred</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(367</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,173</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,175</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 1%; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">10,577</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">4,294</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">3,702</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Income tax expense differed from amounts computed by applying the statutory federal rate to pretax income as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zcd49defc88814c04bc2741efe211125f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="10">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Years ended December 31, </div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Federal income tax expense at the statutory rate</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,086</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,998</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,704</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">State income taxes</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">299</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">291</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">262</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign income taxes (blended rate)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,444</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,270</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">990</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ETI, manufacturing deduction and tax credits</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(303</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(287</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(257</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Deemed repatriation transition tax</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,288</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Effective federal rate change</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(228</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal">(9</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal">)</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">10,577</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">4,294</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">3,702</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The domestic and foreign components of income before income tax expense were as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="ze569a48705d8412cbfb498cb9124ea58" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="11">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Years ended December 31,&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Domestic</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,124</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,688</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,973</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">9,958</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">7,734</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">7,572</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">19,082</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">16,422</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; BACKGROUND-COLOR: #cceeff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff">15,545</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 9 &#8211; Options</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company has stock option plans which authorize the grant of stock options to eligible employees, directors and other individuals to purchase up to an aggregate of 307 thousand shares of common stock, of which 54 thousand are outstanding as of December 31, 2017.&#160; All options granted under the plans are granted at current market value at the date of grant, and may be exercised between six months and ten years following the date of grant.&#160; The plans are intended to advance the interest of the Company by attracting and ensuring retention of competent directors, employees and executive personnel, and to provide incentives to those individuals to devote their utmost efforts to the advancement of stockholder value.&#160; Changes in stock options were as follows:</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">50</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 9 &#8211; Options</u></font> (continued)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zc5d2cd5cf5d24f89bd8816648cfbfc6c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr style="HEIGHT: 21px">
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Shares</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(000's)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="6">
<div>Price Range </div>

<div>Per Share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>&#160;2017</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Granted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-&#160; &#160; </td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expired or canceled</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Exercised</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total outstanding at December 31</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">54</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total exercisable at December 31</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>&#160;2016</u></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Granted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expired or canceled</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Exercised</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total outstanding at December 31</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">75</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58.50</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total exercisable at December 31</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">36</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">50.72</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>&#160;2015</u></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Granted</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-&#160;&#160;&#160; </div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expired or canceled</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26.58 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Exercised</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21.68 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">49.18</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total outstanding at December 31</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">50.72</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total exercisable at December 31</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">41</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 -</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">50.72</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">For the years ended December&#160;31, 2017, 2016 and 2015, the Company reduced current income taxes payable by $38, $50 and $114, respectively, for the income tax benefit attributable to sale by optionees of common stock received upon the exercise of stock options.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Stock-Based Compensation</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In 2017, the Company recognized $129 in equity compensation cost, compared to $92 in 2016 and $87 in 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z84e87600020547508e153b47e0192308" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: " valign="bottom"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="12">&#160;Years ended December 31,&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 137px; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 15px; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; WIDTH: 132px; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">2015</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="WIDTH: 137px; VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 132px; VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expected dividend amount per quarter</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9.19%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1.22%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">.2775</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Expected stock price volatility</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.19%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1.22%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">28.0</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">%</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Risk-free interest rate</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9.19%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1.22%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">1.30</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">%</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Expected life of options</div>
</td>
<td style="WIDTH: 137px; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="3"></td>
<td style="WIDTH: 15px; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 9px; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">4.7 years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The per share weighted average fair value of options granted during 2016 is $12.15. No options were granted in 2017 or 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">All UTMD options vest over a four-year service period.&#160; Expected dividend amounts were estimated based on the actual cash dividend rate at the time the options were granted and an estimate of future dividends based on past dividend rate changes as well as management's expectations of future dividend rates over the expected holding period of the options.&#160; Expected volatility is based on UTMD's historical volatility over recent periods of time and trends in that volatility, giving weight to more recent periods.&#160; Risk free interest rates were estimated based on actual U.S. Treasury Securities Interest rates as reported by the Federal Reserve Bank for periods of time equivalent to the holding periods estimated for the options on the dates the options were granted.&#160; Expected term of options were estimated based on historical holding periods for similar options previously granted by UTMD to employees and directors.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">51</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Note 9 &#8211; Options</u></font> (continued)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The following table summarizes information about stock options outstanding at December 31, 2017:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z48b173d1297242508c87ca137af3c2e0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="11">Options Outstanding&#160;&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="7">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Options Exercisable</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Weighted</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Average</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Remaining</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Weighted</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Weighted</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Range of</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Contractual</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Average</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="3">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Average</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exercise</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Life</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exercise</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exercise</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Prices</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Outstanding</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Years)</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Price</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exercisable</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24.00 - 33.30</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,361</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.92</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27.42</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,361</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27.72</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">49.18 - 58.50</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">37,979</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">7.44</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">53.28</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">22,264</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">51.02</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
</tr>

<tr>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">24.00 - 58.50</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">54,340</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">6.08</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">45.50</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">38,625</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">$</font></div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">41.02</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff">&#160;</font></td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 10 &#8211; Geographic Information</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company had sales in the following geographic areas based on the customer's country of domicile:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zbea6789f60214002be51533ed1bf81dd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="3">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" colspan="2">2015</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="3">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">United States</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">20,286</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">19,488</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">20,364</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Europe</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,519</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,989</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,720</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,609</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,821</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,073</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25"><u>Note 11 &#8211; Long-lived Assets by Geographic Area</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The Company's long-lived assets by geographic area were as follows:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z9c0c15d5d5194e4c8538676f68fa9832" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">
<div>&#160;</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">United States</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">10,866</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">11,151</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">11,097</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">England</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28,604</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,710</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,901</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Ireland</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,803</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,614</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,761</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Australia</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">525</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">513</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">543</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Canada</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">759</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">729</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 12 &#8211; Revenues by Product Category</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company had revenues in the following product categories:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zd1605c029c56482ba747855f0458bed6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Product Category</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: " valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: " valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Obstetrics</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,499</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,532</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,587</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gynecology/Electrosurgery/Urology</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,175</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,683</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,356</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Neonatal</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,154</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,007</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,299</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 64%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Blood Pressure Monitoring and Accessories</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,586</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,076</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,915</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Note 13 - Product Sale and Purchase Commitments</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The Company has had license agreements for the rights to develop and market certain products or technologies owned by unrelated parties.&#160; The confidential terms of such agreements are unique and varied, depending on many factors relating to the value and stage of development of the technology licensed.&#160; Royalties on future product sales are a normal component of such agreements and are included in the Company's cost of goods sold on an ongoing basis.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In 2017, 2016 and 2015, UTMD received royalties of $86, $91 and $93, respectively, for the use of intellectual property of Filshie Clip System as part of Femcare's exclusive U.S. distribution agreement with CooperSurgical Inc.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">UTMD had $2,191 in operating lease and purchase commitments <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">as of December 31, 2017.</font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">52</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Note 14 &#8211; Employee Benefit Plans</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company sponsors a contributory 401(k) savings plan for U.S. employees, and contributory retirement plans for Ireland, UK, Australia and Canada employees.&#160; The Company's matching contribution is determined annually by the board of directors.&#160; Company contributions were approximately $153, $151 and $161 for the years ended December 31, 2017, 2016 and 2015, respectively.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Note 15 &#8211; Recent Accounting Pronouncements</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In March 2016, new accounting guidance was issued to simplify several aspects of accounting for employee share-based payment (including stock option) transactions, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as classification in the statement of cash flows. Under the guidance, entities recognize all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement. UTMD adopted this standard on January 1, 2017, which had an insignificant impact on its consolidated financial statements. UTMD made a determination to continue to account for forfeitures by estimating the number of awards that are expected to vest.&#160; Because UTMD primarily issues incentive stock options, excess tax benefits and tax deficiencies have historically been minimal.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In May 2014, new accounting guidance (ASU 2014-09) was issued that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&#160; The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract.&#160; UTMD adopted this new standard on January 1, 2018, using a full retrospective approach. In accordance with ASU 2014-09, UTMDs revenue recognition is based on its contracts and the performance obligations identified in them. With very insignificant and limited exceptions, the Company's performance obligation is met when it ships a physical product to a customer. The basis on which UTMD recognizes revenue was updated on January 1, 2018, but it did not result in a change to the process and timing of revenue recognition, because the previous revenue recognition method complies with ASU 2014-09.&#160; Therefore, the adoption of ASU 2014-09 did not have an impact on UTMD's financial statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In February 2016, new accounting guidance was issued which requires recording most leases on the balance sheet. The new lease standard requires disclosure of key information about lease arrangements and aligns many of the underlying principles of this new model with those in the new revenue recognition standard noted above. This guidance becomes effective for annual reporting periods beginning after December 15, 2018, with early adoption permitted. UTMD has yet to assess the impact that this standard will have on its consolidated financial statements when it is adopted. The only significant lease the Company anticipates it will have at that time is for the parking lot at its Utah facility (see Note 7).</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><u>Note 16 &#8211; Subsequent Events</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company evaluated its December 31, 2017 financial statements for subsequent events through the date the financial statements were issued.&#160; The Company is not aware of any subsequent events which would require recognition or disclosure in the financial statements.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 9 &#8211; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">None.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">53</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 9A &#8211; CONTROLS AND PROCEDURES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Evaluation of Disclosure Controls and Procedures.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in the Securities Exchange Act of 1934 Rule 13a-15(e).&#160; UTMD's Board of Directors, operating through its Audit Committee, provides oversight to its financial reporting process.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">During 2017, UTMD evaluated the effectiveness of the design and operation of its disclosure controls and procedures. Based on that evaluation, UTMD's Chief Executive Officer and Principal Financial Officer concluded that, as of December 31, 2017, its disclosure controls and procedures were effective.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Management's Report on Internal Control Over Financial Reporting.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">Pursuant to Section&#160;404 of the Sarbanes-Oxley Act of 2002, the Company has included, as part of this Form&#160;10-K, a report of management's assessment of the effectiveness of its internal controls as of December&#160;31, 2017.&#160; Jones Simkins LLC, the independent registered public accounting firm of the Company, has audited the effectiveness of the Company's internal control over financial reporting. Nortons Assurance Limited, the independent registered public accounting firm of Femcare Group Limited (Femcare Group) has audited the effectiveness of Femcare Group's internal control over financial reporting. Management's report, and the reports of Jones Simkins LLC and Nortons Assurance Limited appear on pages&#160;35 through 38 of this Form&#160;10-K under the captions "Management's Report on Internal Control Over Financial Reporting" and "Report of Independent Registered Public Accounting Firm" and are incorporated herein by reference.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Changes in Internal Control Over Financial Reporting.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">There have been no changes in UTMD's internal control over financial reporting that materially affected, or were reasonably likely to materially affect, the Company's internal control over financial reporting during the fourth quarter of the fiscal year ended December 31, 2017, and there were no material weaknesses.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 9B &#8211; OTHER INFORMATION</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">None.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">54</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>PART III</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 10 &#8211; DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The information from the definitive proxy statement of the registrant for the 2018 annual meeting of stockholders under the captions,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="z363fef87bc614be989e071837e686e9a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">"PROPOSAL NO. 1. ELECTION OF DIRECTORS: General," and "Directors and Nominees,"</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">"SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN PERSONS," and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">"EXECUTIVE OFFICER COMPENSATION: 2017 Director Compensation,"</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">is incorporated herein by reference.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">UTMD adopted a Code of Ethics for its executive officers, including the Chief Executive Officer and outside directors, in October 2003.&#160; The Code of Ethics, along with UTMD's Code of Conduct, which covers all exempt employees (including all officers and outside directors) and certain non-exempt employees, is posted on UTMD's web site at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">www.utahmed.com</font>.&#160; UTMD intends to post on its website any waivers of or amendments to its Code of Ethics.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 11 - EXECUTIVE COMPENSATION</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The information from the definitive proxy statement of the registrant for the 2018 annual meeting of stockholders under the captions,</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z87b99abfc34b48f08e1b063fa58721be" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">"EXECUTIVE OFFICER COMPENSATION,"</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">COMPENSATION DISCUSSION AND ANALYSIS," and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">BOARD OF DIRECTORS AND OTHER BOARD COMMITTEE REPORTS: Compensation and Option Committee Interlocks and Insider Participation," specifically excluding the "Report of the Compensation Committee"</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">is incorporated herein by reference.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The information from the definitive proxy statement of the registrant for the 2018 annual meeting of stockholders under the captions,</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z5bd2c0238fa249c0967aac86131ba777" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">"SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN PERSONS" and</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">"DISCLOSURE RESPECTING THE COMPANY'S EQUITY COMPENSATION PLANS"</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">is incorporated herein by reference.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">55</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The information from the definitive proxy statement of the registrant for the 2018 annual meeting of stockholders under the captions,</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z6fcac533b6f4466693da5e3ce9bc5d32" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">"CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS"</div>
</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 6%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#183;</div>
</td>
<td style="WIDTH: 94%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">"BOARD OF DIRECTORS AND OTHER BOARD COMMITTEE REPORTS: Director Independence"</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">is incorporated herein by reference.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The information from the definitive proxy statement of the registrant for the 2018 annual meeting of stockholders in the first paragraph under the caption, "Report of the Audit Committee" is incorporated herein by reference.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 14 &#8211; PRINCIPAL ACCOUNTING FEES AND SERVICES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">The information from the definitive proxy statement of the registrant for the 2018 annual meeting of stockholders under the caption "PROPOSAL NO 2. RATIFICATION OF THE APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM: Fees billed by Jones Simkins LLC," "Audit Committee Policy and Approval," and "Auditor Independence" are incorporated herein by reference.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">56</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>PART IV</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ITEM 15 &#8211; EXHIBITS, FINANCIAL STATEMENT SCHEDULES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">(a)&#160; The following documents are filed as part of this report or incorporated herein by reference.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 15.3pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Financial Statements.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 22.5pt">(See Table of Contents to Item 8, above.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 15.3pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Supplemental Schedule.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 22.5pt">Financial Statement Schedules are omitted because they are inapplicable or the required information is otherwise included in the accompanying Financial Statements and the notes thereto.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 15.3pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Exhibits.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.2pt">&#160;</div>

<table id="z3bdd5acf87fa4109a10ef77e6c78e8c9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center">
<div style="LINE-HEIGHT: 1.25">Exhibit #</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SEC </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Reference </div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">#</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 63%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25">Title of Document</div>
</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; WIDTH: 18.41%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25">Location</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690605000089/utahmed10k12312004ex1.txt">Articles of Restatement of the Articles of Incorporation</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference (1)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690605000089/utahmed10k12312004ex2.txt">Articles of Correction to the Restated Articles of Incorporation</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference (1)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690614000174/exhibit99-1.htm">Bylaws</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(2)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690604000428/utahmed8k100104ex99-1.txt">Rights Agreement dated as of July 30, 2004, between Utah Medical Products, Inc., and Registrar and Transfer Company</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(4)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690614001444/exhibit4-1.htm">Extension of Shareholder Rights Agreement</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference (5)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">6</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">4</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Designation of Rights, Privileges, and Preferences of Series "A" Preferred Stock</div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(3)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">7</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690604000128/utmd10kdec2003ex-10.txt">Employment Agreement dated December 21, 1992 with Kevin L. Cornwell*</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(6)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">8</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690604000128/utmd10kdec2003ex10-2.txt">Amendment, effective May 15, 1998, to Employment Agreement dated December 21, 1992 with Kevin L. Cornwell*</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(6)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a name="_Hlk381340321"><!--Anchor--></a>9</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690603000132/utmdproxy_march2003.txt">Utah Medical Products, Inc., 2003 Employees' and Directors' Incentive Plan*</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(7)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 20px">
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="http://www.sec.gov/Archives/edgar/data/706698/000109690613000303/utahmedexh991.htm">Utah Medical Products, Inc., 2013 Employees' and Directors' Incentive Plan*</a></div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by Reference <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(8)</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Summary of Officer and Director Compensation</div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">12</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">21</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Subsidiaries of Utah Medical Products, Inc.</div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">13</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">23</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Consent of Jones Simkins LLC, Company's independent auditors for the years ended December 31, 2017, December 31, 2016 and December 31, 2015</div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">14</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">23</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Consent of Nortons Assurance Limited, Femcare Group Limited's independent auditors for the years ended December 31, 2017, December 31, 2016 and December 31, 2015</div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP-COLOR: ; WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: ; BORDER-BOTTOM-COLOR: ; BORDER-RIGHT-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">31</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of CEO pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
</td>
<td style="WIDTH: 18.41%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">57</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z478c7bb8ac1b4cb38b4baa4e84fe0499" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Exhibit #</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SEC</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Reference </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">#</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Title of Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Location</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">16</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">31</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">32</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of CEO pursuant to 18 U.S.C. &#167;1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">18</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">32</div>
</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Certification of Principal Financial Officer pursuant to 18 U.S.C. &#167;1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.ins</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Instance Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.xsd</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Schema Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.cal</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Calculation Linkbase Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.def</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Definition Linkbase Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.tab</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Label Linkbase Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">101.pre</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="WIDTH: 63%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">XBRL Taxonomy Extension Presentation Linkbase Document</div>
</td>
<td style="WIDTH: 18%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This Filing</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">* Management contract of compensatory plan or arrangement required to be filed pursuant to Item 14(c).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z11d557e71ea54197927fae72af547e91" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(1)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by reference from the Company's annual report on form 10-K filed with the Commission for the year ended December 31, 2004.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by reference from the Company's report on form 8-K filed with the Commission on February 13, 2014.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by reference from the Company's registration statement on form S-8 filed with the Commission effective February 10, 1995. The S-8 must have been filed on paper, rather than electronically.&#160; The SEC adopting release for this rule says that you could, but are not required to, refile it in electronic format. Which means that you can also leave it as it is.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by reference from the Company's report on form 8-K filed with the Commission on October 1, 2004.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(5)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by reference from the Company's report on form 8-K filed with the Commission on October 24, 2014.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(6)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Incorporated by reference from the Company's annual report on form 10-K filed with the Commission for the year ended December 31, 2003.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(7)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 40.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -40.5pt">Incorporated by reference from the Company's 2003 definitive proxy statement on form DEF 14A filed with the Commission on March 27, 2003.</div>
</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.99%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(8)</div>
</td>
<td style="WIDTH: 95.01%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 40.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -40.5pt">Incorporated by reference from the Company's 2013 definitive proxy statement on form DEF 14A filed with the Commission on March 7, 2013.</div>
</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; MARGIN-TOP: 10pt; CLEAR: both">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">58</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 40.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 40.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -40.5pt">SIGNATURES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 9pt">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned this 6th day of March, 2018.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">UTAH MEDICAL PRODUCTS, INC.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z52d5b2b5d2df44988b4cbee8936eea4d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Kevin L. Cornwell</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Kevin L. Cornwell</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; TEXT-INDENT: 9pt" colspan="2">&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on this 6th day of March, 2018.</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ James H. Beeson</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">James H. Beeson, Director</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Kevin L. Cornwell</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Kevin L. Cornwell, Chief Executive Officer &amp; Director</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Ernst G. Hoyer</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Ernst G. Hoyer, Director</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Barbara A. Payne</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Barbara A. Payne, Director</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Paul O. Richins</u></font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.62%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 95.38%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Paul O. Richins, Principal Financial and Accounting Officer &amp; Director</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 8pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">59</font></div>
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageFooter">&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>2
<FILENAME>exh10_5.htm
<DESCRIPTION>SUMMARY OF OFFICER AND DIRECTOR COMPENSATION
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 10.5</font>

<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 11</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SUMMARY OF OFFICER AND DIRECTOR COMPENSATION</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Employment Agreement in Exhibits 7 &amp; 8 of this report is the only written contractual compensation arrangement the Company has with any of its directors and Executive Officers.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During 2018, the Company's Chief Executive and Principal Financial Officers (the Company's "Named Executive Officers") are scheduled to receive the following compensation from the Company:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z21482cc14ac1498da67fde07c5d86d7f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 1.25"><u>Compensation Arrangement</u></div>
</td>
<td style="VERTICAL-ALIGN: top">
<div style="LINE-HEIGHT: 1.25"><u>2018 Scheduled Amount</u></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Base salary</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">$&#160; 156,000 (CEO); $108,000 (PFO)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">401(k) matching contributions</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6,480 (maximum)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Section 125 plan matching contributions <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(1)</font></div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;600 (maximum)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Management bonus</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">will be determined at year-end</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pet health benefits <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(1)</font></div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;500 (maximum)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Family medical benefits <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(1)</font></div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">will depend on future events</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Travel expense reimbursement <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(2)</font></div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;20,000 (CEO); 500 (PFO)</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; CLEAR: both; LINE-HEIGHT: 1.25">Paul Richins, the Company's PFO on the date of this report, is scheduled to retire in early April 2018.&#160; Thereafter, Brian Koopman will be the PFO.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">During 2018, the Company's Directors are scheduled to receive the following compensation from the Company:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z80d63b11a8b84d0da3728c8ef4276e89" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom"><u> </u>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Compensation Arrangement</u></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Ernst<font style="FONT-FAMILY: 'Times New Roman', Times, serif"> Hoyer</font></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Barbara<font style="FONT-FAMILY: 'Times New Roman', Times, serif"> Payne</font></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">James <font style="FONT-FAMILY: 'Times New Roman', Times, serif">Beeson</font></div>
</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: bottom; FONT-WEIGHT: normal; PADDING-BOTTOM: 2px; FONT-STYLE: normal; TEXT-ALIGN: center" valign="bottom">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom" colspan="2">
<div style="FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Paul<font style="FONT-FAMILY: 'Times New Roman', Times, serif"> Richins (</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif">3</font><font style="FONT-FAMILY: 'Times New Roman', Times, serif">)</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Base</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,750</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Executive Committee</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Audit Committee Chairman</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,000</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 52%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Travel Expense Reimbursement <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(2)</font></div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">500</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">700</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">500</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20</div>
</td>
<td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z6d4bfceb205246049954766443d4f2f9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 4.34%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(1)</div>
</td>
<td style="WIDTH: 95.66%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;CEO and PFO participate on the same basis as other eligible employees.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.34%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="WIDTH: 95.66%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;Estimated 2018 travel expenses on behalf of UTMD business.&#160; The Company reimburses its employees and directors for authorized business expenses.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.34%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="WIDTH: 95.66%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;&#160;Represents the amount Mr. Richins is scheduled to receive for his continued board service following his retirement as an employee of the Company on April 2.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageFooter">
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
<br style="LINE-HEIGHT: 1.25">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>3
<FILENAME>exh21.htm
<DESCRIPTION>SUBSIDIARIES OF UTAH MEDICAL PRODUCTS, INC.
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 21</font>

<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<br style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 12</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SUBSIDIARIES OF UTAH MEDICAL PRODUCTS, INC.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z44dfca6ae46744f4bcc80031662ec737" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Subsidiary Name</u></div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Jurisdiction of Organization</u></div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Business Name</u></div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products Ltd.</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Bermuda</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Columbia Medical &amp; Surgical, Inc.</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Oregon</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Abcorp Medical</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Florida</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Group Limited</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Group</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Holdings Limited</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">n/a &#8211; not a trading entity</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Nikomed Limited</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare-Nikomed</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Distribution Limited</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">n/a &#8211; not a trading entity</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Limited</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">n/a &#8211; not a trading entity</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Australia Ltd</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Australia</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Australia</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Urology Limited</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">n/a &#8211; not a trading entity</div>
</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 39.8%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products Canada Inc.</div>
</td>
<td style="WIDTH: 31.97%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Canada</div>
</td>
<td style="WIDTH: 28.22%; VERTICAL-ALIGN: top; BORDER-BOTTOM-COLOR: ; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Femcare Canada</div>
</td>
</tr>
</table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exh23_1.htm
<DESCRIPTION>CONSENT OF JONES SIMKINS LLC, COMPANY?S INDEPENDENT AUDITORS FOR THE YEARS ENDED DECEMBER 31, 2017, DECEMBER 31, 2016 AND DECEMBER 31, 2015
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 23.1</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 13</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products, Inc.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We consent to the incorporation by reference in Registration Statement Nos. 333-127946, 333-199337 (on Form S-8), and 333-182078 (on Form S-3) of Utah Medical Products, Inc. of our audit report dated March 5, 2018, on the consolidated financial statements and internal control over financial reporting of Utah Medical Products, Inc., which report appears in this annual report on Form 10-K of Utah Medical Products, Inc. for the years ended December 31, 2017, 2016, and 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>/s/ Jones Simkins LLC</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">JONES SIMKINS LLC</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Logan, Utah</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 5, 2018</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>exh23_2.htm
<DESCRIPTION>CONSENT OF NORTONS ASSURANCE LIMITED, FEMCARE GROUP LIMITED?S INDEPENDENT AUDITORS FOR THE YEARS ENDED DECEMBER 31, 2017, DECEMBER 31, 2016 AND DECEMBER 31, 2015
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 23.2</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 14</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Utah Medical Products, Inc.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We consent to the incorporation by reference in Registration Statement Nos. 333-127946, 333-199337 (on Form S-8), and 333-182078 (on Form S-3) of Utah Medical Products, Inc. of our audit reports dated March 5, 2018, on the financial statements and internal control over financial reporting of Femcare Group Limited, which reports appear in this annual report on Form 10-K of Utah Medical Products, Inc. for the years ended 31 December 2017, 2016 and 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>/s/ Nortons Assurance Limited</u></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nortons Assurance Limited</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chartered Accountants and Statutory Auditor</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Reading</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United Kingdom</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 5, 2018</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exh31_1.htm
<DESCRIPTION>CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 31.1</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 15</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION OF CEO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Kevin L. Cornwell, certify that:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this annual report on Form 10-K of Utah Medical Products, Inc.;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdbd92e7cd9bf4d7ea70ae3d42dabde6e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdf038672dfa6450cb54796bea3524632" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9806bfc878b0444b8aa10a823165dc8e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(c)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9200190dd3674dab9def98d011e07459" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):</font></div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd26c0470a4c14a489917a22fd4a1e405" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf0c1dafb12784146be7eb2282dec4946" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: March 6, 2018</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><u>/s/ Kevin L. Cornwell</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Kevin L. Cornwell</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exh31_2.htm
<DESCRIPTION>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 31.2</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 16</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION OF PRINCIPLE FINANCIAL OFFICER</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Paul O. Richins, certify that:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this annual report on Form 10-K of Utah Medical Products, Inc.;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z934e481ab6ab4c5db634e8b73735051d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za9fb2aafd89a4fcaa4efd1d3e8cfcfd6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za9a3b3371f7c434abf02eec4e2c67127" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(c)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z38b062a909bd4b2d912e96e4af1ca3cd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">(d)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.</font><font style="FONT-SIZE: 1px; WIDTH: 17.95pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):</font></div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3f4b1faae4164884b70f398e105fa873" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc43bb08cd5c44388a1dccccebeed48d0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 15.3pt; VERTICAL-ALIGN: top; align: right">b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: March 6, 2018</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><u>/s/ Paul O. Richins</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Paul O. Richins</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Principal Financial Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exh32_1.htm
<DESCRIPTION>CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. ?1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 32.1</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 17</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">18 U.S.C. SECTION 1350,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In connection with the Annual Report of Utah Medical Products, Inc. (the "Company") on Form 10-K for the fiscal year ending December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kevin L. Cornwell, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0e2bcc7e6fd34b178abb97cb030bff9d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 1.8pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 34.2pt; VERTICAL-ALIGN: top; align: right">(1)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zbf81814aee8b4f3381ef034e94a63f6c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 1.8pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 34.2pt; VERTICAL-ALIGN: top; align: right">(2)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><u>/s/ Kevin L. Cornwell</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Kevin L. Cornwell</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Executive Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 6, 2018</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exh32_2.htm
<DESCRIPTION>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. ?1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: southr1
    Document created using EDGARfilings PROfile 4.3.3.2
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" text="#000000" bgcolor="#ffffff">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 32.2</font><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">EXHIBIT 18</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">18 U.S.C. SECTION 1350,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AS ADOPTED PURSUANT TO</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In connection with the Annual Report of Utah Medical Products, Inc. (the "Company") on Form 10-K for the fiscal year ending December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Paul O. Richins, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3405bb758f34463eb1d416d30ec03e40" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 1.8pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 34.2pt; VERTICAL-ALIGN: top; align: right">(1)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z08d63b0c1eca4590b5481c3af65a053a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 1.8pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 34.2pt; VERTICAL-ALIGN: top; align: right">(2)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify">the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><u>/s/ Paul O. Richins</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Paul O. Richins</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Principal Financial Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 6, 2018</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageFooter">
<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>utmd-20171231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK9NDL3JZWVL2VG7W3]. www.edgarsuite.com -->
<xbrl xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2017-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:fil='http://www.utahmed.com/20171231' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:num='http://www.xbrl.org/dtr/type/numeric' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<link:schemaRef xlink:type='simple' xlink:href='utmd-20171231.xsd' />
	<us-gaap:InvestmentsFairValueDisclosure decimals='-3' contextRef='E17' unitRef='USD'>80000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure decimals='-3' contextRef='E16' unitRef='USD'>64000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:AccountsReceivableNetCurrent decimals='-3' contextRef='E17' unitRef='USD'>3623000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent decimals='-3' contextRef='E16' unitRef='USD'>3211000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:OtherAssetsCurrent decimals='-3' contextRef='E17' unitRef='USD'>366000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsCurrent decimals='-3' contextRef='E16' unitRef='USD'>361000</us-gaap:OtherAssetsCurrent>
	<us-gaap:AssetsCurrent decimals='-3' contextRef='E17' unitRef='USD'>49188000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='-3' contextRef='E16' unitRef='USD'>34474000</us-gaap:AssetsCurrent>
	<us-gaap:Goodwill decimals='-3' contextRef='E17' unitRef='USD'>14092000</us-gaap:Goodwill>
	<us-gaap:Goodwill decimals='-3' contextRef='E16' unitRef='USD'>13487000</us-gaap:Goodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill decimals='-3' contextRef='E17' unitRef='USD'>17844000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill decimals='-3' contextRef='E16' unitRef='USD'>18264000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:Assets decimals='-3' contextRef='E17' unitRef='USD'>92745000</us-gaap:Assets>
	<us-gaap:Assets decimals='-3' contextRef='E16' unitRef='USD'>76191000</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent decimals='-3' contextRef='E17' unitRef='USD'>934000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent decimals='-3' contextRef='E16' unitRef='USD'>906000</us-gaap:AccountsPayableCurrent>
	<us-gaap:LiabilitiesCurrent decimals='-3' contextRef='E17' unitRef='USD'>5280000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='-3' contextRef='E16' unitRef='USD'>3022000</us-gaap:LiabilitiesCurrent>
	<fil:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent decimals='-3' contextRef='E17' unitRef='USD'>5785000</fil:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets decimals='-3' contextRef='E17' unitRef='USD'>3102000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
	<us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets decimals='-3' contextRef='E16' unitRef='USD'>3209000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent decimals='-3' contextRef='E17' unitRef='USD'>456000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent decimals='-3' contextRef='E16' unitRef='USD'>716000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:Liabilities decimals='-3' contextRef='E17' unitRef='USD'>14623000</us-gaap:Liabilities>
	<us-gaap:Liabilities decimals='-3' contextRef='E16' unitRef='USD'>6947000</us-gaap:Liabilities>
	<us-gaap:CommitmentsAndContingencies xsi:nil='true' contextRef='E17' unitRef='USD' />
	<us-gaap:CommitmentsAndContingencies xsi:nil='true' contextRef='E16' unitRef='USD' />
	<us-gaap:PreferredStockValue xsi:nil='true' contextRef='E17' unitRef='USD' />
	<us-gaap:PreferredStockValue xsi:nil='true' contextRef='E16' unitRef='USD' />
	<us-gaap:CommonStockValue decimals='-3' contextRef='E17' unitRef='USD'>37000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue decimals='-3' contextRef='E16' unitRef='USD'>37000</us-gaap:CommonStockValue>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1 decimals='-3' contextRef='E17' unitRef='USD'>-8341000</us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1 decimals='-3' contextRef='E16' unitRef='USD'>-12243000</us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1>
	<us-gaap:AdditionalPaidInCapitalCommonStock decimals='-3' contextRef='E17' unitRef='USD'>809000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdditionalPaidInCapitalCommonStock decimals='-3' contextRef='E16' unitRef='USD'>378000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='-3' contextRef='E17' unitRef='USD'>85617000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='-3' contextRef='E16' unitRef='USD'>81072000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='-3' contextRef='E17' unitRef='USD'>92745000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='-3' contextRef='E16' unitRef='USD'>76191000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E17' unitRef='UsdPerShare'>0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized decimals='-3' contextRef='E17' unitRef='Shares'>5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized decimals='-3' contextRef='E16' unitRef='Shares'>5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued xsi:nil='true' contextRef='E17' unitRef='Shares' />
	<us-gaap:PreferredStockSharesIssued xsi:nil='true' contextRef='E16' unitRef='Shares' />
	<us-gaap:PreferredStockSharesOutstanding xsi:nil='true' contextRef='E17' unitRef='Shares' />
	<us-gaap:PreferredStockSharesOutstanding xsi:nil='true' contextRef='E16' unitRef='Shares' />
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E17' unitRef='UsdPerShare'>0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized decimals='-3' contextRef='E17' unitRef='Shares'>50000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized decimals='-3' contextRef='E16' unitRef='Shares'>50000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued decimals='-3' contextRef='E17' unitRef='Shares'>3721000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued decimals='-3' contextRef='E16' unitRef='Shares'>3713000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='-3' contextRef='E17' unitRef='Shares'>3721000</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding decimals='-3' contextRef='E16' unitRef='Shares'>3713000</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:SalesRevenueNet decimals='-3' contextRef='Y17' unitRef='USD'>41414000</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='-3' contextRef='Y16' unitRef='USD'>39298000</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='-3' contextRef='Y15' unitRef='USD'>40157000</us-gaap:SalesRevenueNet>
	<us-gaap:CostOfGoodsSold decimals='-3' contextRef='Y17' unitRef='USD'>15019000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold decimals='-3' contextRef='Y16' unitRef='USD'>15608000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold decimals='-3' contextRef='Y15' unitRef='USD'>15972000</us-gaap:CostOfGoodsSold>
	<us-gaap:GrossProfit decimals='-3' contextRef='Y17' unitRef='USD'>26395000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='-3' contextRef='Y16' unitRef='USD'>23690000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='-3' contextRef='Y15' unitRef='USD'>24185000</us-gaap:GrossProfit>
	<us-gaap:SellingAndMarketingExpense decimals='-3' contextRef='Y17' unitRef='USD'>1544000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SellingAndMarketingExpense decimals='-3' contextRef='Y16' unitRef='USD'>1673000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SellingAndMarketingExpense decimals='-3' contextRef='Y15' unitRef='USD'>2164000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='-3' contextRef='Y17' unitRef='USD'>447000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='-3' contextRef='Y16' unitRef='USD'>475000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='-3' contextRef='Y15' unitRef='USD'>522000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='-3' contextRef='Y17' unitRef='USD'>5393000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='-3' contextRef='Y16' unitRef='USD'>5355000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='-3' contextRef='Y15' unitRef='USD'>5848000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:OperatingIncomeLoss decimals='-3' contextRef='Y17' unitRef='USD'>19011000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss decimals='-3' contextRef='Y16' unitRef='USD'>16187000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss decimals='-3' contextRef='Y15' unitRef='USD'>15651000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OtherInterestAndDividendIncome decimals='-3' contextRef='Y17' unitRef='USD'>17000</us-gaap:OtherInterestAndDividendIncome>
	<us-gaap:OtherInterestAndDividendIncome decimals='-3' contextRef='Y16' unitRef='USD'>12000</us-gaap:OtherInterestAndDividendIncome>
	<us-gaap:OtherInterestAndDividendIncome decimals='-3' contextRef='Y15' unitRef='USD'>5000</us-gaap:OtherInterestAndDividendIncome>
	<us-gaap:InterestExpense decimals='-3' contextRef='Y15' unitRef='USD'>65000</us-gaap:InterestExpense>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='-3' contextRef='Y17' unitRef='USD'>-32000</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='-3' contextRef='Y16' unitRef='USD'>132000</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:OtherOperatingIncomeExpenseNet decimals='-3' contextRef='Y15' unitRef='USD'>-139000</us-gaap:OtherOperatingIncomeExpenseNet>
	<us-gaap:EarningsPerShareBasic decimals='INF' contextRef='Y17' unitRef='UsdPerShare'>2.29</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic decimals='INF' contextRef='Y16' unitRef='UsdPerShare'>3.23</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic decimals='INF' contextRef='Y15' unitRef='UsdPerShare'>3.16</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted decimals='INF' contextRef='Y17' unitRef='UsdPerShare'>2.28</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted decimals='INF' contextRef='Y16' unitRef='UsdPerShare'>3.22</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted decimals='INF' contextRef='Y15' unitRef='UsdPerShare'>3.14</us-gaap:EarningsPerShareDiluted>
	<us-gaap:ComprehensiveIncomeNetOfTax decimals='-3' contextRef='Y17' unitRef='USD'>12408000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax decimals='-3' contextRef='Y16' unitRef='USD'>5844000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax decimals='-3' contextRef='Y15' unitRef='USD'>9117000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax decimals='-3' contextRef='Y17' unitRef='USD'>0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax decimals='-3' contextRef='Y16' unitRef='USD'>0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax decimals='-3' contextRef='Y15' unitRef='USD'>0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax decimals='-3' contextRef='Y17' unitRef='USD'>6000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax decimals='-3' contextRef='Y16' unitRef='USD'>3000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax decimals='-3' contextRef='Y15' unitRef='USD'>-1000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
	<us-gaap:Depreciation decimals='-3' contextRef='Y17' unitRef='USD'>660000</us-gaap:Depreciation>
	<us-gaap:Depreciation decimals='-3' contextRef='Y16' unitRef='USD'>610000</us-gaap:Depreciation>
	<us-gaap:Depreciation decimals='-3' contextRef='Y15' unitRef='USD'>619000</us-gaap:Depreciation>
	<us-gaap:AdjustmentForAmortization decimals='-3' contextRef='Y17' unitRef='USD'>2113000</us-gaap:AdjustmentForAmortization>
	<us-gaap:AdjustmentForAmortization decimals='-3' contextRef='Y16' unitRef='USD'>2223000</us-gaap:AdjustmentForAmortization>
	<us-gaap:AdjustmentForAmortization decimals='-3' contextRef='Y15' unitRef='USD'>2528000</us-gaap:AdjustmentForAmortization>
	<us-gaap:ProvisionForDoubtfulAccounts decimals='-3' contextRef='Y17' unitRef='USD'>4000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts decimals='-3' contextRef='Y16' unitRef='USD'>0</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts decimals='-3' contextRef='Y15' unitRef='USD'>-10000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:GainLossOnDispositionOfAssets decimals='-3' contextRef='Y17' unitRef='USD'>-17000</us-gaap:GainLossOnDispositionOfAssets>
	<us-gaap:GainLossOnDispositionOfAssets decimals='-3' contextRef='Y16' unitRef='USD'>-5000</us-gaap:GainLossOnDispositionOfAssets>
	<us-gaap:GainLossOnDispositionOfAssets decimals='-3' contextRef='Y15' unitRef='USD'>-1000</us-gaap:GainLossOnDispositionOfAssets>
	<us-gaap:DeferredIncomeTaxExpenseBenefit decimals='-3' contextRef='Y17' unitRef='USD'>-658000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit decimals='-3' contextRef='Y16' unitRef='USD'>-484000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit decimals='-3' contextRef='Y15' unitRef='USD'>-901000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:ShareBasedCompensation decimals='-3' contextRef='Y17' unitRef='USD'>129000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='-3' contextRef='Y16' unitRef='USD'>92000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='-3' contextRef='Y15' unitRef='USD'>87000</us-gaap:ShareBasedCompensation>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='-3' contextRef='Y17' unitRef='USD'>242000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='-3' contextRef='Y16' unitRef='USD'>-295000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='-3' contextRef='Y15' unitRef='USD'>-137000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInOtherReceivables decimals='-3' contextRef='Y17' unitRef='USD'>-2000</us-gaap:IncreaseDecreaseInOtherReceivables>
	<us-gaap:IncreaseDecreaseInOtherReceivables decimals='-3' contextRef='Y16' unitRef='USD'>-897000</us-gaap:IncreaseDecreaseInOtherReceivables>
	<us-gaap:IncreaseDecreaseInOtherReceivables decimals='-3' contextRef='Y15' unitRef='USD'>91000</us-gaap:IncreaseDecreaseInOtherReceivables>
	<us-gaap:IncreaseDecreaseInInventories decimals='-3' contextRef='Y17' unitRef='USD'>467000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories decimals='-3' contextRef='Y16' unitRef='USD'>360000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories decimals='-3' contextRef='Y15' unitRef='USD'>-422000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='-3' contextRef='Y17' unitRef='USD'>-24000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='-3' contextRef='Y16' unitRef='USD'>-23000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='-3' contextRef='Y15' unitRef='USD'>-28000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='-3' contextRef='Y17' unitRef='USD'>9000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='-3' contextRef='Y16' unitRef='USD'>286000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable decimals='-3' contextRef='Y15' unitRef='USD'>-265000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='-3' contextRef='Y17' unitRef='USD'>1027000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='-3' contextRef='Y16' unitRef='USD'>-1187000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='-3' contextRef='Y15' unitRef='USD'>-597000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<fil:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense decimals='-3' contextRef='Y17' unitRef='USD'>5785000</fil:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='-3' contextRef='Y17' unitRef='USD'>16908000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='-3' contextRef='Y16' unitRef='USD'>14528000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities decimals='-3' contextRef='Y15' unitRef='USD'>13801000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals='-3' contextRef='Y17' unitRef='USD'>1597000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals='-3' contextRef='Y16' unitRef='USD'>3293000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals='-3' contextRef='Y15' unitRef='USD'>176000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquireIntangibleAssets decimals='-3' contextRef='Y16' unitRef='USD'>9000</us-gaap:PaymentsToAcquireIntangibleAssets>
	<us-gaap:PaymentsToAcquireIntangibleAssets decimals='-3' contextRef='Y15' unitRef='USD'>70000</us-gaap:PaymentsToAcquireIntangibleAssets>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='-3' contextRef='Y17' unitRef='USD'>-1597000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='-3' contextRef='Y16' unitRef='USD'>-3302000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='-3' contextRef='Y15' unitRef='USD'>-246000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='-3' contextRef='Y17' unitRef='USD'>302000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='-3' contextRef='Y16' unitRef='USD'>376000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='-3' contextRef='Y15' unitRef='USD'>343000</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<fil:PaymentOfTaxesForExchangeOfStockOptions decimals='-3' contextRef='Y15' unitRef='USD'>42000</fil:PaymentOfTaxesForExchangeOfStockOptions>
	<us-gaap:DeferredTaxExpenseFromStockOptionsExercised decimals='-3' contextRef='Y16' unitRef='USD'>50000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
	<us-gaap:DeferredTaxExpenseFromStockOptionsExercised decimals='-3' contextRef='Y15' unitRef='USD'>114000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
	<us-gaap:RepaymentsOfNotesPayable decimals='-3' contextRef='Y15' unitRef='USD'>4777000</us-gaap:RepaymentsOfNotesPayable>
	<us-gaap:PaymentsOfDividends decimals='-3' contextRef='Y17' unitRef='USD'>2955000</us-gaap:PaymentsOfDividends>
	<us-gaap:PaymentsOfDividends decimals='-3' contextRef='Y16' unitRef='USD'>3916000</us-gaap:PaymentsOfDividends>
	<us-gaap:PaymentsOfDividends decimals='-3' contextRef='Y15' unitRef='USD'>3846000</us-gaap:PaymentsOfDividends>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='-3' contextRef='Y17' unitRef='USD'>-2653000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='-3' contextRef='Y16' unitRef='USD'>-6340000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='-3' contextRef='Y15' unitRef='USD'>-8891000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents decimals='-3' contextRef='Y17' unitRef='USD'>921000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents decimals='-3' contextRef='Y16' unitRef='USD'>-1868000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents decimals='-3' contextRef='Y15' unitRef='USD'>-660000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='-3' contextRef='Y17' unitRef='USD'>13579000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='-3' contextRef='Y16' unitRef='USD'>3018000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals='-3' contextRef='Y15' unitRef='USD'>4004000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='-3' contextRef='E14' unitRef='USD'>19274000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='-3' contextRef='E17' unitRef='USD'>39875000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='-3' contextRef='E16' unitRef='USD'>26296000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='-3' contextRef='E15' unitRef='USD'>23278000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:IncomeTaxesPaid decimals='-3' contextRef='Y17' unitRef='USD'>5151000</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesPaid decimals='-3' contextRef='Y16' unitRef='USD'>4846000</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesPaid decimals='-3' contextRef='Y15' unitRef='USD'>5341000</us-gaap:IncomeTaxesPaid>
	<us-gaap:InterestPaid decimals='-3' contextRef='Y15' unitRef='USD'>65000</us-gaap:InterestPaid>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E14_StEqComps-CommonStock' unitRef='USD'>37000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E14_StEqComps-AddPaidInCap' unitRef='USD'>2890000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E14_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-3234000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E14_StEqComps-RetainedEarnings' unitRef='USD'>64863000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E14' unitRef='USD'>64556000</us-gaap:StockholdersEquity>
	<us-gaap:SharesIssued decimals='-3' contextRef='E14_StEqComps-CommonStock' unitRef='Shares'>3748000</us-gaap:SharesIssued>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y15_StEqComps-CommonStock' unitRef='USD'>0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y15_StEqComps-AddPaidInCap' unitRef='USD'>640000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y15' unitRef='USD'>640000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y15_StEqComps-CommonStock' unitRef='USD'>0</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y15_StEqComps-AddPaidInCap' unitRef='USD'>338000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y15' unitRef='USD'>338000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares decimals='-3' contextRef='Y15_StEqComps-CommonStock' unitRef='Shares'>6000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation decimals='-3' contextRef='Y15_StEqComps-AddPaidInCap' unitRef='USD'>114000</us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation decimals='-3' contextRef='Y15' unitRef='USD'>114000</us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation>
	<us-gaap:StockOptionPlanExpense decimals='-3' contextRef='Y15_StEqComps-AddPaidInCap' unitRef='USD'>-87000</us-gaap:StockOptionPlanExpense>
	<us-gaap:StockOptionPlanExpense decimals='-3' contextRef='Y15' unitRef='USD'>-87000</us-gaap:StockOptionPlanExpense>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue decimals='-3' contextRef='Y15_StEqComps-CommonStock' unitRef='USD'>0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue decimals='-3' contextRef='Y15_StEqComps-AddPaidInCap' unitRef='USD'>-683000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue decimals='-3' contextRef='Y15' unitRef='USD'>-683000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares decimals='-3' contextRef='Y15_StEqComps-CommonStock' unitRef='Shares'>13000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals='-3' contextRef='Y15_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-2724000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals='-3' contextRef='Y15' unitRef='USD'>-2724000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax decimals='-3' contextRef='Y15_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-2000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax decimals='-3' contextRef='Y15' unitRef='USD'>-2000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
	<us-gaap:DividendsCommonStockCash decimals='-3' contextRef='Y15_StEqComps-RetainedEarnings' unitRef='USD'>3846000</us-gaap:DividendsCommonStockCash>
	<us-gaap:DividendsCommonStockCash decimals='-3' contextRef='Y15' unitRef='USD'>3846000</us-gaap:DividendsCommonStockCash>
	<us-gaap:ProfitLoss decimals='-3' contextRef='Y15_StEqComps-RetainedEarnings' unitRef='USD'>11843000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='-3' contextRef='Y15' unitRef='USD'>11843000</us-gaap:ProfitLoss>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E15_StEqComps-CommonStock' unitRef='USD'>38000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E15_StEqComps-AddPaidInCap' unitRef='USD'>2710000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E15_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-5961000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E15_StEqComps-RetainedEarnings' unitRef='USD'>72861000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E15' unitRef='USD'>69648000</us-gaap:StockholdersEquity>
	<us-gaap:SharesIssued decimals='-3' contextRef='E15_StEqComps-CommonStock' unitRef='Shares'>3751000</us-gaap:SharesIssued>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>431000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y16' unitRef='USD'>431000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>0</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>56000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y16' unitRef='USD'>56000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares decimals='-3' contextRef='Y16_StEqComps-CommonStock' unitRef='Shares'>1000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation decimals='-3' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>50000</us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation decimals='-3' contextRef='Y16' unitRef='USD'>50000</us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation>
	<us-gaap:StockOptionPlanExpense decimals='-3' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>-92000</us-gaap:StockOptionPlanExpense>
	<us-gaap:StockOptionPlanExpense decimals='-3' contextRef='Y16' unitRef='USD'>-92000</us-gaap:StockOptionPlanExpense>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue decimals='-3' contextRef='Y16_StEqComps-CommonStock' unitRef='USD'>-1000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue decimals='-3' contextRef='Y16_StEqComps-AddPaidInCap' unitRef='USD'>-2849000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue decimals='-3' contextRef='Y16' unitRef='USD'>-2850000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares decimals='-3' contextRef='Y16_StEqComps-CommonStock' unitRef='Shares'>50000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals='-3' contextRef='Y16_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-6289000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals='-3' contextRef='Y16' unitRef='USD'>-6289000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax decimals='-3' contextRef='Y16_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>5000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax decimals='-3' contextRef='Y16' unitRef='USD'>5000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
	<us-gaap:DividendsCommonStockCash decimals='-3' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>3916000</us-gaap:DividendsCommonStockCash>
	<us-gaap:DividendsCommonStockCash decimals='-3' contextRef='Y16' unitRef='USD'>3916000</us-gaap:DividendsCommonStockCash>
	<us-gaap:ProfitLoss decimals='-3' contextRef='Y16_StEqComps-RetainedEarnings' unitRef='USD'>12128000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='-3' contextRef='Y16' unitRef='USD'>12128000</us-gaap:ProfitLoss>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E16_StEqComps-CommonStock' unitRef='USD'>37000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E16_StEqComps-AddPaidInCap' unitRef='USD'>378000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E16_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-12243000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E16_StEqComps-RetainedEarnings' unitRef='USD'>81072000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E16' unitRef='USD'>69244000</us-gaap:StockholdersEquity>
	<us-gaap:SharesIssued decimals='-3' contextRef='E16_StEqComps-CommonStock' unitRef='Shares'>3713000</us-gaap:SharesIssued>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y17_StEqComps-CommonStock' unitRef='USD'>0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y17_StEqComps-AddPaidInCap' unitRef='USD'>327000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised decimals='-3' contextRef='Y17' unitRef='USD'>327000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y17_StEqComps-CommonStock' unitRef='USD'>0</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y17_StEqComps-AddPaidInCap' unitRef='USD'>25000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions decimals='-3' contextRef='Y17' unitRef='USD'>25000</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptions>
	<fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares decimals='-3' contextRef='Y17_StEqComps-CommonStock' unitRef='Shares'>0</fil:CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares>
	<us-gaap:StockOptionPlanExpense decimals='-3' contextRef='Y17_StEqComps-AddPaidInCap' unitRef='USD'>-129000</us-gaap:StockOptionPlanExpense>
	<us-gaap:StockOptionPlanExpense decimals='-3' contextRef='Y17' unitRef='USD'>-129000</us-gaap:StockOptionPlanExpense>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals='-3' contextRef='Y17_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>3893000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals='-3' contextRef='Y17' unitRef='USD'>3893000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax decimals='-3' contextRef='Y17_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>10000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax decimals='-3' contextRef='Y17' unitRef='USD'>10000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
	<us-gaap:DividendsCommonStockCash decimals='-3' contextRef='Y17_StEqComps-RetainedEarnings' unitRef='USD'>3960000</us-gaap:DividendsCommonStockCash>
	<us-gaap:DividendsCommonStockCash decimals='-3' contextRef='Y17' unitRef='USD'>3960000</us-gaap:DividendsCommonStockCash>
	<us-gaap:ProfitLoss decimals='-3' contextRef='Y17_StEqComps-RetainedEarnings' unitRef='USD'>8505000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='-3' contextRef='Y17' unitRef='USD'>8505000</us-gaap:ProfitLoss>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E17_StEqComps-CommonStock' unitRef='USD'>37000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E17_StEqComps-AddPaidInCap' unitRef='USD'>809000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E17_StEqComps-AccumulatedOtherComprIncome' unitRef='USD'>-8341000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E17_StEqComps-RetainedEarnings' unitRef='USD'>85617000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity decimals='-3' contextRef='E17' unitRef='USD'>78122000</us-gaap:StockholdersEquity>
	<us-gaap:SharesIssued decimals='-3' contextRef='E17_StEqComps-CommonStock' unitRef='Shares'>3721000</us-gaap:SharesIssued>
	<dei:DocumentType contextRef='Y17'>10-K</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='Y17'>2017-12-31</dei:DocumentPeriodEndDate>
	<dei:AmendmentFlag contextRef='Y17'>false</dei:AmendmentFlag>
	<dei:EntityRegistrantName contextRef='Y17'>UTAH MEDICAL PRODUCTS INC</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='Y17'>0000706698</dei:EntityCentralIndexKey>
	<dei:TradingSymbol contextRef='Y17'>utmd</dei:TradingSymbol>
	<dei:CurrentFiscalYearEndDate contextRef='Y17'>--12-31</dei:CurrentFiscalYearEndDate>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='I180305' unitRef='Shares'>3725763</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityPublicFloat decimals='INF' contextRef='E17Q2' unitRef='USD'>242289134</dei:EntityPublicFloat>
	<dei:EntityFilerCategory contextRef='Y17'>Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityCurrentReportingStatus contextRef='Y17'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='Y17'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='Y17'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:DocumentFiscalYearFocus contextRef='Y17'>2017</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='Y17'>FY</dei:DocumentFiscalPeriodFocus>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 1 &amp;#150; Summary of Significant Accounting Policies&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Organization&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Utah Medical Products, Inc. with headquarters in Midvale, Utah and its wholly-owned operating subsidiaries, Femcare Nikomed Ltd located in Romsey, Hampshire, England, Femcare Australia Pty Ltd located in Castle Hill, NSW, Australia, Utah Medical Products Canada, Inc. (dba Femcare Canada) located in Mississauga, Ontario, Canada and Utah Medical Products Ltd., which operates a manufacturing facility in Athlone, Ireland, (in the aggregate, the Company) are in the primary business of developing, manufacturing and globally distributing specialized medical devices for the healthcare industry.&amp;#160; The Company&amp;#146;s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians&amp;#146; offices.&amp;#160; Products are sold directly to end user facilities in the U.S., Ireland, UK, Canada, France and Australia, and through third party distributors in other outside the U.S. (OUS) markets.&amp;#160; Domestically, UTMD has an exclusive distribution relationship with CooperSurgical, Inc. for the Filshie Clip System.&amp;#160; UTMD also sells subcontract manufactured components and finished products to over 145 companies in the U.S. for their medical and non-medical products.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Use of Estimates in the Preparation of Financial Statements&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&amp;#160; Although actual results could differ from those estimates, management believes it has considered and disclosed all relevant information in making its estimates that materially affect reported performance and current values.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The consolidated financial statements include those of the Company and its subsidiaries.&amp;#160; All intercompany accounts and transactions have been eliminated in consolidation. &lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;For purposes of the consolidated statement of cash flows, the Company considers cash on deposit and short-term investments with original maturities of three months or less to be cash and cash equivalents.&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Investments&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The Company classifies its investments as &amp;#147;available-for-sale.&amp;#148;&amp;#160; Securities classified as &amp;#147;available-for-sale&amp;#148; are carried in the financial statements at fair value.&amp;#160; Realized gains and losses, determined using the specific identification method, are included in operations; unrealized holding gains and losses are reported as a separate component of accumulated other comprehensive income.&amp;#160; Declines in fair value below cost that are other than temporary are included in operations.&amp;#160; As of December 31, 2017 the Company retained a freely tradeable investment in Citigroup (C) (see note 3). &lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Concentration of Credit Risk&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The primary concentration of credit risk consists of trade receivables.&amp;#160; In the normal course of business, the Company provides credit terms to its customers.&amp;#160; Accordingly, the Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses which, when realized, have been within the range of management&apos;s expectations as reflected by its reserves. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company&apos;s customer base consists of hospitals, medical device distributors, physician practices and others directly related to healthcare providers, as well as other manufacturing companies.&amp;#160; Although the Company is affected by the well-being of the global healthcare industry, management does not believe significant trade receivable credit risk exists at December&amp;nbsp;31, 2017 except under an extreme global financial crisis.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company maintains its cash in bank deposit accounts in addition to Fidelity Investment accounts.&amp;#160; The Company has not experienced any losses in such accounts and believes it is not exposed to a significant credit risk on cash and cash equivalent balances. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Accounts Receivable&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accounts receivable are amounts due on product sales and are unsecured.&amp;#160; Accounts receivable are carried at their estimated collectible amounts.&amp;#160; Credit is generally extended on a short-term basis; thus accounts receivable do not bear interest although a late charge may be applied to such receivables that are past the due date.&amp;#160; Accounts receivable are periodically evaluated for collectibility based on past credit history of customers and current market conditions.&amp;#160; Provisions for losses on accounts receivable are determined on the basis of loss experience, known and inherent risk in the account balance and current economic conditions (see note 2).&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Inventories&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;In 2017, the Company adopted Accounting Standard Update (ASU) 2015-11, &amp;#147;Inventory-Simplifying the Measurement of Inventory,&amp;#148; which changed how inventory is valued.&amp;#160; Finished products, work-in-process, raw materials and supplies inventories are stated at the lower of cost and net realizable value (NRV) computed on a first-in, first-out method.&amp;#160; Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&amp;#160; The adoption of ASU 2015-11 did not have an impact on the Company&amp;#146;s financial statements (see note 2). &lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Property and equipment are stated at cost.&amp;#160; Depreciation and amortization are computed using the straight-line method over estimated useful lives as follows:&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;522&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;522&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:391.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Building and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;124&quot; style=&apos;width:92.7pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;15 - 40 years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;124&quot; style=&apos;width:92.7pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;3 - 10 years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;&lt;font lang=&quot;EN-CA&quot;&gt;Long-Lived Assets&lt;/font&gt;&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;The Company evaluates its long-lived assets in accordance with Accounting Standards Codification (ASC) 360, &amp;#147;Accounting for the Impairment of Long-Lived Assets.&amp;#148;&amp;#160; Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable.&amp;#160; When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts.&amp;#160; Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets, and is recorded in the period in which the determination was made. &lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Intangible Assets&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Costs associated with the acquisition of patents, trademarks, trade names, customer relationships, regulatory approvals &amp;amp; product certifications, license rights and non-compete agreements are capitalized, and are being amortized using the straight-line method over periods ranging from 5 to 20 years. UTMD&amp;#146;s goodwill is tested for impairment annually, in the fourth quarter of each year, using a fair value measurement test, in accordance with ASC 350. UTMD also performs impairment tests contemporaneously, if circumstances change that would more than likely reduce the fair value of goodwill below its net book value.&amp;#160; If UTMD determines that its goodwill is impaired, a second step is completed to measure the amount of the impairment loss. UTMD does not expect its goodwill to become impaired in the foreseeable future.&amp;#160; Estimated future amortization expense on intangible assets currently held, using the 2017 year-end 1.3523 USD/GBP and.7815 USD/AUD currency exchange rates, is about $1,981 in 2018, $1,980 in 2019 and 2020, $1,974 in 2021, and&amp;#160; $1,973 in 2022 (see note 2).&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company recognizes revenue at the time of product shipment as UTMD meets its contractual performance obligations to the customer at the time of shipment. Revenue recognized by UTMD is based upon the consideration to which UTMD is entitled from its customers as a result of shipping a physical product, in accordance with the documented arrangements and fixed contracts in which the selling price was fixed prior to the Company&amp;#146;s acceptance of an order. Revenue from service sales, which are immaterial to UTMD, is generally recognized when the service is completed and invoiced. As demonstrated by decades of experience in successful and consistent collections, there is very minor and insignificant uncertainty regarding the collectability of invoiced amounts reasonably within the terms of the Company&amp;#146;s contracts. There are circumstances under which insignificant revenue may be recognized when product is not shipped, which meet the criteria of ASU 2014-09: the Company provides engineering services, for example, design and production of manufacturing tooling that may be used in subsequent UTMD manufacturing of custom components for other companies.&amp;#160; This revenue is recognized when UTMD&amp;#146;s performance obligations have been completed according to a fixed contractual agreement.&amp;#160; UTMD includes handling fees charged to customers in revenues. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company accounts for income taxes under ASC 740, &amp;#147;Accounting for Income Taxes,&amp;#148; whereby deferred taxes are computed under the asset and liability method. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In November 2015, the FASB released ASU 2015-17, Income Taxes (Topic 740):&amp;#160; Balance Sheet classification of Deferred Taxes.&amp;#160; ASU 2015-17 requires that all deferred income taxes are classified as noncurrent in a classified statement of financial position.&amp;#160; The Company adopted ASU 2015-17 retrospectively effective January 1, 2017.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;On December 22, 2017 the U.S. Tax Cuts and Jobs Act of 2017 (Tax Act) was signed into law.&amp;#160; As a result of the Tax Act, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes.&amp;#160; ASC 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, UTMD was required to revalue its deferred tax assets and liabilities at December 31, 2017 at the new rate.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Tax Act contains a deemed repatriation transition tax (Transition Tax) on accumulated earnings and profits of the Company&amp;#146;s non-U.S. subsidiaries that have not been subject to U.S. tax.&amp;#160; The Company plans to elect to pay its net Transition Tax over eight years.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;On December 22, 2017, the SEC issued SAB 118 which provides guidance on accounting for the impact of the Tax Act.&amp;#160; SAB 118 provides a measurement period of up to one year from enactment for a company to complete its tax accounting under ASC 740.&amp;#160; Once a company is able to make a reasonable estimate and record a provisional amount for effects of the Tax Act it is required to do so.&amp;#160; Such provisional measurement amounts may change as remaining data is obtained, calculations are prepared and analysis and review are completed.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;During the fourth quarter of 2017, the Company recorded a provisional tax charge for the Transition Tax of $6,288 and a provisional tax charge of $228 for the re-measurement of its U.S. deferred tax balances.&amp;#160; Both provisional tax amounts are the Company&amp;#146;s reasonable estimate of the impact of the Tax Act based on its understanding and available guidance.&amp;#160; These provisional amounts may change as the Company receives additional clarification and implementation guidance.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, in Utah, in the United Kingdom, in Australia, in Ireland and in Canada. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:6.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company recognizes interest accrued related to unrecognized tax benefits in interest expenses and any related penalties in income taxes. The Company did not recognize any tax-related interest expense or have any tax penalties in any of the three years 2015 through 2017. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Legal Costs&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&amp;#160; The Company maintains a reserve for legal costs which are probable and estimated based on previous experience and known risk.&amp;#160; The reserve for legal costs at December 31, 2017 and 2016 was &amp;#160;$182 and $134, respectively (see note 2).&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Earnings per Share&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The computation of basic earnings per common share is based on the weighted average number of shares outstanding during each year. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The computation of earnings per common share assuming dilution is based on the weighted average number of shares outstanding during the year plus the weighted average common stock equivalents which would arise from the exercise of stock options outstanding using the treasury stock method and the average market price per share during the year.&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in&apos;&gt;The shares (in thousands) used in the computation of the Company&amp;#146;s basic and diluted earnings per share are reconciled as follows:&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;586&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Weighted average number of shares outstanding &amp;#150; basic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,718&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,751&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,752&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Dilutive effect of stock options&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Weighted average number of shares outstanding, assuming dilution&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,737&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,766&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,772&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Presentation of Sales and Similar Taxes&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Sales tax on revenue-producing transactions is recorded as a liability when the sale occurs.&amp;#160; UTMD is not required to withhold sales tax on OUS sales, and at least 90% of domestic 2017 sales were to customers who are tax exempt or who are in jurisdictions where UTMD is not required to withhold sales tax.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Stock-Based Compensation &lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;At December 31, 2017, the Company has stock-based employee compensation plans, which are described more fully in note 9.&amp;#160; The Company accounts for stock compensation under ASC 718, &lt;i&gt;Share-Based Payment&lt;/i&gt;.&amp;#160; This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors.&amp;#160; In 2017, the Company recognized $129 in stock-based compensation cost compared to $92 in 2016 and $87 in 2015.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Translation of Foreign Currencies&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Assets and liabilities of the Company&amp;#146;s foreign subsidiaries are translated into U.S. dollars at the applicable exchange rates at year-end.&amp;#160; Net gains or losses resulting from the translation of the Company&amp;#146;s assets and liabilities are reflected as a separate component of stockholders&amp;#146; equity.&amp;#160; A negative translation impact on stockholders&amp;#146; equity reflects a current relative U.S. Dollar value higher than at the point in time that assets were actually acquired in a foreign currency.&amp;#160; A positive translation impact would result from a U.S. dollar weaker in value than at the point in time foreign assets were acquired.&amp;#160; Year-end translation gains or losses of non-functional currency bank account balances, e.g. EUR and AUD balances held by the UK subsidiary, are recognized as non-operating income or expense, as applicable.&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year. &lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Note 2 &amp;#150; Detail of Certain Balance Sheet Accounts&lt;/u&gt;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;146&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accounts and other receivables:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accounts receivable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,713&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,289&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Income tax receivable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accrued interest and other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;14&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less allowance for doubtful accounts&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(104)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(96)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total accounts and other receivables&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,623&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,211&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Inventories:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Finished products&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,313&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,327&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Work-in-process&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,270&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;942&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Raw materials&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,661&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,273&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total inventories&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,244&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,542&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Other intangible assets:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Patents&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,183&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,161&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Non-compete agreements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;135&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;123&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Trademarks &amp;amp; trade names&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,921&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,074&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Customer relationships&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,669&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,822&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Regulatory approvals &amp;amp; product certifications&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;12,897&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,767&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total other intangible assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;34,805&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;31,947&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accumulated amortization&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(16,961)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(13,683)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other intangible assets, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;17,844&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;18,264&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;#160;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Accrued expenses:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Income taxes payable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,259&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;799&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Payroll and payroll taxes&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,199&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,117&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Reserve for litigation costs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;182&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;134&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,706&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;66&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total accrued expenses&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,346&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,116&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
	<us-gaap:GainLossOnInvestmentsTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 3 &amp;#150; Investments&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company&amp;#146;s investments, classified as available-for-sale, consist of the following:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;146&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Investments, at cost&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;42&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;42&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Equity securities:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-Unrealized holding gains&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;38&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-Unrealized holding (losses)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Investments, at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;During the three years 2015 through 2017, UTMD did not have any proceeds from sales of available-for-sale securities.&lt;/p&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 4 &amp;#150; Fair Value Measurements and Financial Instruments&lt;/u&gt;&amp;nbsp; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:6.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt&apos;&gt;The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.&amp;#160; The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).&amp;#160; A financial instrument&amp;#146;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company uses the following valuation techniques to measure fair value for its assets and liabilities:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Level 1 - Quoted market prices in active markets for identical assets or liabilities;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-left:1.0in;text-indent:-1.0in&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Level 2 - Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-left:1.0in;text-indent:-1.0in&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Level 3 -&amp;#160; Unobservable inputs for the asset or liability, which are valued based on management&amp;#146;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The following table provides financial assets carried at fair value measured as of December 31 for the past two years:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;607&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;top&quot; style=&apos;width:2.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;108&quot; colspan=&quot;4&quot; valign=&quot;top&quot; style=&apos;width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Level 1&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;108&quot; colspan=&quot;4&quot; valign=&quot;top&quot; style=&apos;width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Levels 2 &amp;amp; 3&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;108&quot; colspan=&quot;4&quot; valign=&quot;top&quot; style=&apos;width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;top&quot; style=&apos;width:2.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;top&quot; style=&apos;width:2.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Equities&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;bottom&quot; style=&apos;width:2.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;None of the Company&amp;#146;s financial instruments, which are current assets and liabilities that could be readily traded, are held for trading purposes.&amp;#160; Detail on investments is provided in note 3 above.&amp;#160; The Company estimates that the fair value of all financial instruments at December 31, 2017 does not differ materially from the aggregate carrying value of its financial instruments recorded in the accompanying consolidated balance sheet.&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 5 &amp;#150; Property and Equipment&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment consists of the following:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;462&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;150&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:112.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Land&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,339&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,289&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Buildings and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,350&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,914&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,696&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,759&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Construction-in-progress&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;13&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,061&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;32,398&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;30,023&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accumulated depreciation&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,777)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,057)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,621&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,966&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Included in the Company&amp;#146;s consolidated balance sheet are the assets of its manufacturing and administrative facilities in Utah, Canada, England, Australia and Ireland.&amp;#160; Property and equipment, by geographic area, are as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;547&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;321&quot; colspan=&quot;10&quot; valign=&quot;top&quot; style=&apos;width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;December 31, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none;border-bottom:solid windowtext 1.0pt&apos;&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;U.S. &amp;amp; Canada &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;England &amp;amp; Australia &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Ireland&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Land&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;926&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;413&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,339&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Buildings and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,583&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,361&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,406&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,350&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;14,124&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;427&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,145&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,696&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Construction-in-progress&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;13&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;21,643&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,791&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,964&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;32,398&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accumulated depreciation&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(17,270)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(346)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,161)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,777)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,373&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,445&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,803&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,621&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;11&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;56&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;547&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;321&quot; colspan=&quot;10&quot; valign=&quot;top&quot; style=&apos;width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;December 31, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none;border-bottom:solid windowtext 1.0pt&apos;&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;bottom&quot; style=&apos;width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;U.S. &amp;amp; Canada&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;bottom&quot; style=&apos;width:14.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;England &amp;amp; Australia &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Ireland&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Land&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;926&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;362&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,289&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Buildings and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,523&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;523&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,869&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,914&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;14,233&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;529&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;996&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,759&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Construction-in-progress&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,057&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,061&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;21,682&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,109&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,231&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;30,023&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accumulated depreciation&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(17,063)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(376)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(2,617)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,057)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,619&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,733&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,614&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,966&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;11&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;57&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;56&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
	<us-gaap:LongTermDebtTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 6 &amp;#150; Long-term Debt&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In March 2011, the Company obtained a $14,000 loan from JPMorgan Chase Bank, N.A. and a $12,934 loan from JP Morgan Chase, London Branch to help finance UTMD&amp;#146;s purchase of Femcare.&amp;#160; The notes were fully paid off in February 2015.&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt&apos;&gt;&lt;u&gt;Note 7 &amp;#150; Commitments and Contingencies&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Operating Leases&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has a lease agreement for land adjoining its Utah facility for a term of forty years commencing on September 1, 1991.&amp;#160; On September 1, 2001 and subsequent to each fifth lease year, the basic rental was and will be adjusted for published changes in a price index.&amp;#160; The Company also leases an automobile for an employee in Ireland, and prior to late 2017, leased its UK facility. Rent expense charged to operations under these operating lease agreements was approximately $160, $175 and $184 for the years ended December&amp;nbsp;31, 2017, 2016 and 2015, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Future minimum lease payments under its lease obligations as of December 31, 2017 were as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;469&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Years ending December 31:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;bottom&quot; style=&apos;width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Amount&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2018&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;83&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2019&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2020&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2021&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2022&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Thereafter&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;398&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total future minimum lease payments&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;661&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Purchase Obligations&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has obligations to purchase raw materials for use in its manufacturing operations.&amp;#160; The Company has the right to make changes in, among other things, purchase quantities, delivery schedules and order acceptance.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Product Liability&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Except for its Filshie Clip System, the Company is self-insured for product liability risk. &amp;#147;Product liability&amp;#148; is an insurance industry term for the cost of legal defense and possible damages awarded as a result of use of a company&amp;#146;s product during a procedure which results in an injury of a patient.&amp;#160; The Company maintains a reserve for product liability litigation and damages consistent with its previous long-term experience.&amp;#160; Actual product liability litigation costs and damages during the last three reporting years have been immaterial, which is consistent with the Company&amp;#146;s overall history. Femcare&amp;#146;s product liability indemnity limit through an independent insurer is &amp;#163;5 million each claim and in the annual aggregate.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The Company absorbs the costs of clinical training and trouble-shooting in its on-going operating expenses.&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Warranty Reserve&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company&amp;#146;s published warranty is: &amp;#147;UTMD warrants its products to conform in all material respects to all published product specifications in effect on the date of shipment, and to be free from defects in material and workmanship for a period of thirty (30) days for supplies, or twenty-four (24) months for equipment, from date of shipment.&amp;#160; During the warranty period UTMD shall, at its option, replace any products shown to UTMD&apos;s reasonable satisfaction to be defective at no expense to the Purchaser or refund the purchase price.&amp;#148; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;UTMD maintains a warranty reserve to provide for estimated costs which are likely to occur. The amount of this reserve is adjusted, as required, to reflect its actual experience. Based on its analysis of historical warranty claims and its estimate that existing warranty obligations are immaterial, no warranty reserve was made at December 31, 2017 or December 31, 2016. &lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Litigation&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&amp;#160; Presently, there is no litigation or threatened litigation for which the Company believes the outcome may be material to its financial results. The Company applies its accounting policy to accrue legal costs that can be reasonably estimated.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 8 &amp;#150; Income Taxes&amp;#160; &lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;Deferred tax assets (liabilities) consist of the following temporary differences:&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;78%&quot; style=&apos;width:78.84%;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;144&quot; colspan=&quot;4&quot; style=&apos;width:107.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; style=&apos;width:31.5pt;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; style=&apos;width:31.45pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Inventory write-downs and differences due to UNICAP&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;56&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;98&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Allowance for doubtful accounts&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;25&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accrued liabilities and reserves&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;89&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;147&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Other - foreign&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(23)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Depreciation and amortization&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,789)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(4,277)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Unrealized investment gains&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;66&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;105&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Deferred income taxes, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,558)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,925)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The components of income tax expense are as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;249&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Current&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,944&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,467&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,877&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Deferred&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(367)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(1,173)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(1,175)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,577&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,294&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,702&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Income tax expense differed from amounts computed by applying the statutory federal rate to pretax income as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;249&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Federal income tax expense at the statutory rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,086&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,998&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,704&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;State income taxes&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;299&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;291&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;262&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Foreign income taxes (blended rate)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,444&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,270&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;990&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;ETI, manufacturing deduction and tax credits&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(303)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(287)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(257)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Deemed repatriation transition tax &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,288&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Effective federal rate change&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(228)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(9)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,577&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,294&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,702&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The domestic and foreign components of income before income tax expense were as follows:&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;249&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Domestic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,124&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,688&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,973&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Foreign&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,958&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,734&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,572&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19,082&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16,422&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,545&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 9 &amp;#150; Options&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has stock option plans which authorize the grant of stock options to eligible employees, directors and other individuals to purchase up to an aggregate of &amp;#160;307 thousand shares of common stock, of which 54 thousand are outstanding as of December 31, 2017.&amp;#160; All options granted under the plans are granted at current market value at the date of grant, and may be exercised between six months and ten years following the date of grant.&amp;#160; The plans are intended to advance the interest of the Company by attracting and ensuring retention of competent directors, employees and executive personnel, and to provide incentives to those individuals to devote their utmost efforts to the advancement of stockholder value.&amp;#160; Changes in stock options were as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Shares (000&amp;#146;s)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;157&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:118.1pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Price Range Per Share&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.8pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;- - -&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expired or canceled&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;12&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;49.18 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Exercised&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total outstanding at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;54&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total exercisable at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;39&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.8pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;28&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;58.50 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expired or canceled&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;3&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;49.18 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Exercised&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;13&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total outstanding at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;75&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total exercisable at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;36&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 50.72&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;- - -&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expired or canceled&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;7&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;26.58 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Exercised&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;22&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;21.68 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total outstanding at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;62&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 50.72&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total exercisable at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;41&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 50.72&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;48&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;43&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;36&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;11&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;37&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;5&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;43&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;For the years ended December&amp;nbsp;31, 2017, 2016 and 2015, the Company reduced current income taxes payable by $38, $50 and $114, respectively, for the income tax benefit attributable to sale by optionees of common stock received upon the exercise of stock options.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Stock-Based Compensation&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In 2017, the Company recognized $129 in equity compensation cost, compared to $92 in 2016 and $87 in 2015.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;264&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:198.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expected dividend amount per quarter&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;0.2775&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expected stock price volatility&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;28.0%&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Risk-free interest rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1.30%&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expected life of options&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4.7 years&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;The per share weighted average fair value of options granted during 2016 is $12.15. No options were granted in 2017 or 2015.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt&apos;&gt;All UTMD options vest over a four-year service period.&amp;#160; Expected dividend amounts were estimated based on the actual cash dividend rate at the time the options were granted and an estimate of future dividends based on past dividend rate changes as well as management&amp;#146;s expectations of future dividend rates over the expected holding period of the options.&amp;#160; Expected volatility is based on UTMD&amp;#146;s historical volatility over recent periods of time and trends in that volatility, giving weight to more recent periods.&amp;#160; Risk free interest rates were estimated based on actual U.S. Treasury Securities Interest rates as reported by the Federal Reserve Bank for periods of time equivalent to the holding periods estimated for the options on the dates the options were granted.&amp;#160; Expected term of options were estimated based on historical holding periods for similar options previously granted by UTMD to employees and directors.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The following table summarizes information about stock options outstanding at December 31, 2017:&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;604&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;90&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot; style=&apos;width:67.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;253&quot; colspan=&quot;6&quot; valign=&quot;bottom&quot; style=&apos;width:189.4pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Options Outstanding&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;165&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:123.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Options Exercisable&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;90&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot; style=&apos;width:67.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Range of Exercise Prices&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Number Outstanding&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Weighted Average Remaining Contractual Life (Years)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Weighted Average Exercise Price&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Number Exercisable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Weighted Average Exercise Price&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:27.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;bottom&quot; style=&apos;width:27.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;24.00&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:27.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;33.30&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16,361&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2.92 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;27.42&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16,361&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;27.72&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:27.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;37,979&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7.44&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;53.28&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22,264&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;51.02&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.65pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;24.00&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:27.35pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;54,340&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6.08&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;38,625&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;41.02&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;36&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;0&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;0&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;36&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;42&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
	<fil:GeographicInformationTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 10 &amp;#150; Geographic Information&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company had sales in the following geographic areas based on the customer&amp;#146;s country of domicile:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;United States&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20,286&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19,488&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20,364&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Europe&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,519&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,989&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,720&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;12,609&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,821&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;12,073&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </fil:GeographicInformationTextBlock>
	<fil:GeographicLongLivedAssetsInformationTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 11 &amp;#150; Long-lived Assets by Geographic Area&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company&amp;#146;s long-lived assets by geographic area were as follows:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;United States&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,866&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,151&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,097&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;England&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;28,604&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;26,710&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;31,901&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Ireland&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,803&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,614&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,761&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Australia&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;525&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;513&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;543&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Canada&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;759&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;729&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </fil:GeographicLongLivedAssetsInformationTextBlock>
	<fil:RevenuesByProductCategoryTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 12 &amp;#150; Revenues by Product Category&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company had revenues in the following product categories:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Product Category&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Obstetrics&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,499&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,532&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,587&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Gynecology/Electrosurgery/Urology&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;23,175&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20,683&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22,356&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Neonatal&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,154&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,007&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,299&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Blood Pressure Monitoring and Accessories&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,586&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,076&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,915&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </fil:RevenuesByProductCategoryTextBlock>
	<fil:ProductSaleAndPurchaseCommitmentsTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 13 - Product Sale and Purchase Commitments&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has had license agreements for the rights to develop and market certain products or technologies owned by unrelated parties.&amp;#160; The confidential terms of such agreements are unique and varied, depending on many factors relating to the value and stage of development of the technology licensed.&amp;#160; Royalties on future product sales are a normal component of such agreements and are included in the Company&amp;#146;s cost of goods sold on an ongoing basis.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In 2017, 2016 and 2015, UTMD received royalties of $86, $91 and $93, respectively, for the use of intellectual property of Filshie Clip System as part of Femcare&amp;#146;s exclusive U.S. distribution agreement with CooperSurgical Inc. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;UTMD had $2,191 in operating lease and purchase commitments as of December 31, 2017.&lt;/p&gt;</fil:ProductSaleAndPurchaseCommitmentsTextBlock>
	<us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 14 &amp;#150; Employee Benefit Plans&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company sponsors a contributory 401(k) savings plan for U.S. employees, and contributory retirement plans for Ireland, UK, Australia and Canada employees.&amp;#160; The Company&amp;#146;s matching contribution is determined annually by the board of directors.&amp;#160; Company contributions were approximately $153, $151 and $161 for the years ended December 31, 2017, 2016 and 2015, respectively.&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
	<us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Note 15 &amp;#150; Recent Accounting Pronouncements&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In March 2016, new accounting guidance was issued to simplify several aspects of accounting for employee share-based payment (including stock option) transactions, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as classification in the statement of cash flows. Under the guidance, entities recognize all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement. UTMD adopted this standard on January 1, 2017, which had an insignificant impact on its consolidated financial statements. UTMD made a determination to continue to account for forfeitures by estimating the number of awards that are expected to vest.&amp;#160; Because UTMD primarily issues incentive stock options, excess tax benefits and tax deficiencies have historically been minimal.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In May 2014, new accounting guidance (ASU 2014-09) was issued that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&amp;nbsp; The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract.&amp;nbsp; UTMD adopted this new standard on January 1, 2018, using a full retrospective approach. In accordance with ASU 2014-09, UTMDs revenue recognition is based on its contracts and the performance obligations identified in them. With very insignificant and limited exceptions, the Company&amp;#146;s performance obligation is met when it ships a physical product to a customer. The basis on which UTMD recognizes revenue was updated on January 1, 2018, but it did not result in a change to the process and timing of revenue recognition, because the previous revenue recognition method complies with ASU 2014-09.&amp;#160; Therefore, the adoption of ASU 2014-09 did not have an impact on UTMD&amp;#146;s financial statements.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In February 2016, new accounting guidance was issued which requires recording most leases on the balance sheet. The new lease standard requires disclosure of key information about lease arrangements and aligns many of the underlying principles of this new model with those in the new revenue recognition standard noted above. This guidance becomes effective for annual reporting periods beginning after December 15, 2018, with early adoption permitted. UTMD has yet to assess the impact that this standard will have on its consolidated financial statements when it is adopted. The only significant lease the Company anticipates it will have at that time is for the parking lot at its Utah facility (see Note 7).&lt;/p&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
	<us-gaap:SubsequentEventsTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt&apos;&gt;&lt;u&gt;Note 16 &amp;#150; Subsequent Events&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company evaluated its December 31, 2017 financial statements for subsequent events through the date the financial statements were issued.&amp;#160; The Company is not aware of any subsequent events which would require recognition or disclosure in the financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:UseOfEstimates contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Use of Estimates in the Preparation of Financial Statements&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&amp;#160; Although actual results could differ from those estimates, management believes it has considered and disclosed all relevant information in making its estimates that materially affect reported performance and current values.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:ConsolidationPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The consolidated financial statements include those of the Company and its subsidiaries.&amp;#160; All intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
	<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;For purposes of the consolidated statement of cash flows, the Company considers cash on deposit and short-term investments with original maturities of three months or less to be cash and cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
	<us-gaap:InvestmentPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Investments&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The Company classifies its investments as &amp;#147;available-for-sale.&amp;#148;&amp;#160; Securities classified as &amp;#147;available-for-sale&amp;#148; are carried in the financial statements at fair value.&amp;#160; Realized gains and losses, determined using the specific identification method, are included in operations; unrealized holding gains and losses are reported as a separate component of accumulated other comprehensive income.&amp;#160; Declines in fair value below cost that are other than temporary are included in operations.&amp;#160; As of December 31, 2017 the Company retained a freely tradeable investment in Citigroup (C) (see note 3).&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
	<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Concentration of Credit Risk&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The primary concentration of credit risk consists of trade receivables.&amp;#160; In the normal course of business, the Company provides credit terms to its customers.&amp;#160; Accordingly, the Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses which, when realized, have been within the range of management&apos;s expectations as reflected by its reserves. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company&apos;s customer base consists of hospitals, medical device distributors, physician practices and others directly related to healthcare providers, as well as other manufacturing companies.&amp;#160; Although the Company is affected by the well-being of the global healthcare industry, management does not believe significant trade receivable credit risk exists at December&amp;nbsp;31, 2017 except under an extreme global financial crisis.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company maintains its cash in bank deposit accounts in addition to Fidelity Investment accounts.&amp;#160; The Company has not experienced any losses in such accounts and believes it is not exposed to a significant credit risk on cash and cash equivalent balances.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
	<us-gaap:ReceivablesPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Accounts Receivable&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accounts receivable are amounts due on product sales and are unsecured.&amp;#160; Accounts receivable are carried at their estimated collectible amounts.&amp;#160; Credit is generally extended on a short-term basis; thus accounts receivable do not bear interest although a late charge may be applied to such receivables that are past the due date.&amp;#160; Accounts receivable are periodically evaluated for collectibility based on past credit history of customers and current market conditions.&amp;#160; Provisions for losses on accounts receivable are determined on the basis of loss experience, known and inherent risk in the account balance and current economic conditions (see note 2).&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
	<us-gaap:InventoryPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Inventories&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;In 2017, the Company adopted Accounting Standard Update (ASU) 2015-11, &amp;#147;Inventory-Simplifying the Measurement of Inventory,&amp;#148; which changed how inventory is valued.&amp;#160; Finished products, work-in-process, raw materials and supplies inventories are stated at the lower of cost and net realizable value (NRV) computed on a first-in, first-out method.&amp;#160; Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&amp;#160; The adoption of ASU 2015-11 did not have an impact on the Company&amp;#146;s financial statements (see note 2).&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
	<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Property and equipment are stated at cost.&amp;#160; Depreciation and amortization are computed using the straight-line method over estimated useful lives as follows:&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;522&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;522&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:391.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Building and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;124&quot; style=&apos;width:92.7pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;15 - 40 years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;124&quot; style=&apos;width:92.7pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;3 - 10 years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
	<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;&lt;font lang=&quot;EN-CA&quot;&gt;Long-Lived Assets&lt;/font&gt;&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;The Company evaluates its long-lived assets in accordance with Accounting Standards Codification (ASC) 360, &amp;#147;Accounting for the Impairment of Long-Lived Assets.&amp;#148;&amp;#160; Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable.&amp;#160; When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts.&amp;#160; Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets, and is recorded in the period in which the determination was made.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Intangible Assets&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Costs associated with the acquisition of patents, trademarks, trade names, customer relationships, regulatory approvals &amp;amp; product certifications, license rights and non-compete agreements are capitalized, and are being amortized using the straight-line method over periods ranging from 5 to 20 years. UTMD&amp;#146;s goodwill is tested for impairment annually, in the fourth quarter of each year, using a fair value measurement test, in accordance with ASC 350. UTMD also performs impairment tests contemporaneously, if circumstances change that would more than likely reduce the fair value of goodwill below its net book value.&amp;#160; If UTMD determines that its goodwill is impaired, a second step is completed to measure the amount of the impairment loss. UTMD does not expect its goodwill to become impaired in the foreseeable future.&amp;#160; Estimated future amortization expense on intangible assets currently held, using the 2017 year-end 1.3523 USD/GBP and.7815 USD/AUD currency exchange rates, is about $1,981 in 2018, $1,980 in 2019 and 2020, $1,974 in 2021, and&amp;#160; $1,973 in 2022 (see note 2).&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
	<us-gaap:RevenueRecognitionPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company recognizes revenue at the time of product shipment as UTMD meets its contractual performance obligations to the customer at the time of shipment. Revenue recognized by UTMD is based upon the consideration to which UTMD is entitled from its customers as a result of shipping a physical product, in accordance with the documented arrangements and fixed contracts in which the selling price was fixed prior to the Company&amp;#146;s acceptance of an order. Revenue from service sales, which are immaterial to UTMD, is generally recognized when the service is completed and invoiced. As demonstrated by decades of experience in successful and consistent collections, there is very minor and insignificant uncertainty regarding the collectability of invoiced amounts reasonably within the terms of the Company&amp;#146;s contracts. There are circumstances under which insignificant revenue may be recognized when product is not shipped, which meet the criteria of ASU 2014-09: the Company provides engineering services, for example, design and production of manufacturing tooling that may be used in subsequent UTMD manufacturing of custom components for other companies.&amp;#160; This revenue is recognized when UTMD&amp;#146;s performance obligations have been completed according to a fixed contractual agreement.&amp;#160; UTMD includes handling fees charged to customers in revenues.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
	<us-gaap:IncomeTaxPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company accounts for income taxes under ASC 740, &amp;#147;Accounting for Income Taxes,&amp;#148; whereby deferred taxes are computed under the asset and liability method. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;In November 2015, the FASB released ASU 2015-17, Income Taxes (Topic 740):&amp;#160; Balance Sheet classification of Deferred Taxes.&amp;#160; ASU 2015-17 requires that all deferred income taxes are classified as noncurrent in a classified statement of financial position.&amp;#160; The Company adopted ASU 2015-17 retrospectively effective January 1, 2017.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;On December 22, 2017 the U.S. Tax Cuts and Jobs Act of 2017 (Tax Act) was signed into law.&amp;#160; As a result of the Tax Act, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes.&amp;#160; ASC 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, UTMD was required to revalue its deferred tax assets and liabilities at December 31, 2017 at the new rate.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Tax Act contains a deemed repatriation transition tax (Transition Tax) on accumulated earnings and profits of the Company&amp;#146;s non-U.S. subsidiaries that have not been subject to U.S. tax.&amp;#160; The Company plans to elect to pay its net Transition Tax over eight years.&amp;#160; &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;On December 22, 2017, the SEC issued SAB 118 which provides guidance on accounting for the impact of the Tax Act.&amp;#160; SAB 118 provides a measurement period of up to one year from enactment for a company to complete its tax accounting under ASC 740.&amp;#160; Once a company is able to make a reasonable estimate and record a provisional amount for effects of the Tax Act it is required to do so.&amp;#160; Such provisional measurement amounts may change as remaining data is obtained, calculations are prepared and analysis and review are completed.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;During the fourth quarter of 2017, the Company recorded a provisional tax charge for the Transition Tax of $6,288 and a provisional tax charge of $228 for the re-measurement of its U.S. deferred tax balances.&amp;#160; Both provisional tax amounts are the Company&amp;#146;s reasonable estimate of the impact of the Tax Act based on its understanding and available guidance.&amp;#160; These provisional amounts may change as the Company receives additional clarification and implementation guidance.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, in Utah, in the United Kingdom, in Australia, in Ireland and in Canada. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:6.0pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company recognizes interest accrued related to unrecognized tax benefits in interest expenses and any related penalties in income taxes. The Company did not recognize any tax-related interest expense or have any tax penalties in any of the three years 2015 through 2017.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
	<us-gaap:LegalCostsPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Legal Costs&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&amp;#160; The Company maintains a reserve for legal costs which are probable and estimated based on previous experience and known risk.&amp;#160; The reserve for legal costs at December 31, 2017 and 2016 was &amp;#160;$182 and $134, respectively (see note 2).&lt;/p&gt;</us-gaap:LegalCostsPolicyTextBlock>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Earnings per Share&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The computation of basic earnings per common share is based on the weighted average number of shares outstanding during each year. &lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;The computation of earnings per common share assuming dilution is based on the weighted average number of shares outstanding during the year plus the weighted average common stock equivalents which would arise from the exercise of stock options outstanding using the treasury stock method and the average market price per share during the year.&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in&apos;&gt;The shares (in thousands) used in the computation of the Company&amp;#146;s basic and diluted earnings per share are reconciled as follows:&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;586&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Weighted average number of shares outstanding &amp;#150; basic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,718&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,751&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,752&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Dilutive effect of stock options&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Weighted average number of shares outstanding, assuming dilution&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,737&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,766&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,772&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:EarningsPerSharePolicyTextBlock>
	<fil:PresentationOfSalesAndSimilarTaxesTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Presentation of Sales and Similar Taxes&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Sales tax on revenue-producing transactions is recorded as a liability when the sale occurs.&amp;#160; UTMD is not required to withhold sales tax on OUS sales, and at least 90% of domestic 2017 sales were to customers who are tax exempt or who are in jurisdictions where UTMD is not required to withhold sales tax.&lt;/p&gt;</fil:PresentationOfSalesAndSimilarTaxesTextBlock>
	<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&lt;u&gt;Stock-Based Compensation &lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;At December 31, 2017, the Company has stock-based employee compensation plans, which are described more fully in note 9.&amp;#160; The Company accounts for stock compensation under ASC 718, &lt;i&gt;Share-Based Payment&lt;/i&gt;.&amp;#160; This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors.&amp;#160; In 2017, the Company recognized $129 in stock-based compensation cost compared to $92 in 2016 and $87 in 2015.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
	<us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;u&gt;Translation of Foreign Currencies&lt;/u&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Assets and liabilities of the Company&amp;#146;s foreign subsidiaries are translated into U.S. dollars at the applicable exchange rates at year-end.&amp;#160; Net gains or losses resulting from the translation of the Company&amp;#146;s assets and liabilities are reflected as a separate component of stockholders&amp;#146; equity.&amp;#160; A negative translation impact on stockholders&amp;#146; equity reflects a current relative U.S. Dollar value higher than at the point in time that assets were actually acquired in a foreign currency.&amp;#160; A positive translation impact would result from a U.S. dollar weaker in value than at the point in time foreign assets were acquired.&amp;#160; Year-end translation gains or losses of non-functional currency bank account balances, e.g. EUR and AUD balances held by the UK subsidiary, are recognized as non-operating income or expense, as applicable.&lt;/p&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
	<us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;586&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Weighted average number of shares outstanding &amp;#150; basic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,718&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,751&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,752&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Dilutive effect of stock options&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;398&quot; valign=&quot;top&quot; style=&apos;width:4.15in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt; Weighted average number of shares outstanding, assuming dilution&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,737&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,766&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,772&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
	<us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;146&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accounts and other receivables:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accounts receivable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,713&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,289&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Income tax receivable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accrued interest and other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;14&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Less allowance for doubtful accounts&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(104)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(96)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total accounts and other receivables&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,623&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,211&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
	<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef='Y17'>&lt;!--egx--&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Inventories:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Finished products&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,313&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,327&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Work-in-process&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,270&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;942&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Raw materials&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,661&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,273&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total inventories&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,244&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,542&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
	<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Other intangible assets:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Patents&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,183&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,161&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Non-compete agreements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;135&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;123&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Trademarks &amp;amp; trade names&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,921&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,074&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Customer relationships&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,669&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,822&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Regulatory approvals &amp;amp; product certifications&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;12,897&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,767&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total other intangible assets&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;34,805&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;31,947&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Accumulated amortization&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(16,961)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(13,683)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other intangible assets, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;17,844&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;18,264&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
	<us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef='Y17'>&lt;!--egx--&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p align=&quot;left&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left&apos;&gt;Accrued expenses:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Income taxes payable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,259&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;799&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Payroll and payroll taxes&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,199&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,117&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Reserve for litigation costs&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;182&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;134&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,706&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;66&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total accrued expenses&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,346&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,116&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;599&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;146&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Investments, at cost&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;42&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;42&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Equity securities:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-Unrealized holding gains&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;38&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;-Unrealized holding (losses)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;442&quot; valign=&quot;top&quot; style=&apos;width:4.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Investments, at fair value&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;607&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;top&quot; style=&apos;width:2.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;108&quot; colspan=&quot;4&quot; valign=&quot;top&quot; style=&apos;width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Level 1&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;108&quot; colspan=&quot;4&quot; valign=&quot;top&quot; style=&apos;width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Levels 2 &amp;amp; 3&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;108&quot; colspan=&quot;4&quot; valign=&quot;top&quot; style=&apos;width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;top&quot; style=&apos;width:2.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;top&quot; style=&apos;width:2.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Equities&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;192&quot; valign=&quot;bottom&quot; style=&apos;width:2.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;29&quot; valign=&quot;top&quot; style=&apos;width:.3in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;80&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;38&quot; valign=&quot;top&quot; style=&apos;width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;64&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;462&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;150&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:112.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Land&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,339&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,289&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Buildings and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,350&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,914&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,696&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,759&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Construction-in-progress&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;13&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,061&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;32,398&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;30,023&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accumulated depreciation&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,777)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,057)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;282&quot; valign=&quot;top&quot; style=&apos;width:211.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,621&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; valign=&quot;top&quot; style=&apos;width:1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;30&quot; valign=&quot;top&quot; style=&apos;width:22.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,966&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<fil:PropertyPlantAndEquipmentByLocationTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;547&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;321&quot; colspan=&quot;10&quot; valign=&quot;top&quot; style=&apos;width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;December 31, 2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none;border-bottom:solid windowtext 1.0pt&apos;&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;U.S. &amp;amp; Canada &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;England &amp;amp; Australia &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Ireland&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Land&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;926&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;413&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,339&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Buildings and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,583&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,361&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,406&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,350&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;14,124&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;427&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,145&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,696&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Construction-in-progress&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;13&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;21,643&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,791&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,964&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;32,398&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accumulated depreciation&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(17,270)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(346)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,161)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,777)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,373&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,445&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,803&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,621&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;11&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;56&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;547&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;321&quot; colspan=&quot;10&quot; valign=&quot;top&quot; style=&apos;width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;December 31, 2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none;border-bottom:solid windowtext 1.0pt&apos;&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;bottom&quot; style=&apos;width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;U.S. &amp;amp; Canada&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;bottom&quot; style=&apos;width:14.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;England &amp;amp; Australia &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Ireland&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;bottom&quot; style=&apos;width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;bottom&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Land&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;926&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;362&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,289&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Buildings and improvements&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,523&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;523&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,869&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,914&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Furniture, equipment and tooling&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;14,233&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;529&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;996&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,759&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Construction-in-progress&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,057&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,061&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;21,682&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,109&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,231&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;30,023&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accumulated depreciation&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(17,063)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(376)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(2,617)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(20,057)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; valign=&quot;top&quot; style=&apos;width:2.1in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Property and equipment, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;11&quot; valign=&quot;top&quot; style=&apos;width:8.6pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.75pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;57&quot; valign=&quot;top&quot; style=&apos;width:42.95pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,619&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:14.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,733&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,614&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:.2in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;58&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,966&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;202&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;11&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;57&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;58&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;56&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;1&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt;</fil:PropertyPlantAndEquipmentByLocationTextBlock>
	<us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;469&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;bottom&quot; style=&apos;width:4.0in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Years ending December 31:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;bottom&quot; style=&apos;width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Amount&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2018&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;83&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2019&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2020&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2021&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;2022&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Thereafter&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;398&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;384&quot; valign=&quot;top&quot; style=&apos;width:4.0in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total future minimum lease payments&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.85pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;53&quot; valign=&quot;top&quot; style=&apos;width:.55in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;661&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
	<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;78%&quot; style=&apos;width:78.84%;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;144&quot; colspan=&quot;4&quot; style=&apos;width:107.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; style=&apos;width:31.5pt;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; style=&apos;width:31.45pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Inventory write-downs and differences due to UNICAP&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;56&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;98&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Allowance for doubtful accounts&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;25&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Accrued liabilities and reserves&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;89&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;147&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Other - foreign&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(23)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Depreciation and amortization&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,789)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(4,277)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Unrealized investment gains&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;66&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;105&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Deferred income taxes, net&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,558)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,925)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;249&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Current&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,944&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;5,467&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,877&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Deferred&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(367)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(1,173)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(1,175)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,577&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,294&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,702&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
	<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;249&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Federal income tax expense at the statutory rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,086&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,998&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,704&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;State income taxes&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;299&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;291&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;262&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Foreign income taxes (blended rate)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,444&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1,270&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;990&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;ETI, manufacturing deduction and tax credits&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(303)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(287)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(257)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Deemed repatriation transition tax &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,288&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Effective federal rate change&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(228)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(9)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,577&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,294&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,702&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
	<us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;249&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Domestic&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,124&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,688&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,973&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Foreign&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;9,958&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,734&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,572&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19,082&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16,422&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;15,545&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;#160;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Shares (000&amp;#146;s)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;157&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:118.1pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Price Range Per Share&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.8pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;- - -&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expired or canceled&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;12&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;49.18 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Exercised&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total outstanding at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;54&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total exercisable at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;39&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;3&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;596&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.8pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:31.5pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;28&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;58.50 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expired or canceled&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;3&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;49.18 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Exercised&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;13&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total outstanding at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;75&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total exercisable at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;36&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 50.72&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:.45in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Granted&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;- - -&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expired or canceled&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;7&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;26.58 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Exercised&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;22&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;21.68 - 49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total outstanding at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;62&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 50.72&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Total exercisable at December 31&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:36.35pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;41&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;43&quot; valign=&quot;top&quot; style=&apos;width:32.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;96&quot; colspan=&quot;5&quot; valign=&quot;top&quot; style=&apos;width:71.8pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;24.00 - 50.72&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;50&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:37.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;48&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;43&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;36&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;11&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;37&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;5&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;7&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;43&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
	<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;264&quot; colspan=&quot;7&quot; valign=&quot;top&quot; style=&apos;width:198.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Years ended December 31,&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expected dividend amount per quarter&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;0.2775&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expected stock price volatility&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;28.0%&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Risk-free interest rate&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;1.30%&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;336&quot; valign=&quot;top&quot; style=&apos;width:3.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Expected life of options&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;60&quot; valign=&quot;top&quot; style=&apos;width:45.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;54&quot; valign=&quot;top&quot; style=&apos;width:40.3pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4.7 years&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;59&quot; valign=&quot;top&quot; style=&apos;width:44.25pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;604&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;90&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot; style=&apos;width:67.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;253&quot; colspan=&quot;6&quot; valign=&quot;bottom&quot; style=&apos;width:189.4pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Options Outstanding&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;165&quot; colspan=&quot;4&quot; valign=&quot;bottom&quot; style=&apos;width:123.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Options Exercisable&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;90&quot; colspan=&quot;5&quot; valign=&quot;bottom&quot; style=&apos;width:67.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Range of Exercise Prices&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Number Outstanding&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Weighted Average Remaining Contractual Life (Years)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Weighted Average Exercise Price&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Number Exercisable&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;Weighted Average Exercise Price&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:27.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;#160; &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&apos;width:13.5pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;bottom&quot; style=&apos;width:27.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;bottom&quot; style=&apos;width:.7in;border:none;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;24.00&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:27.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;33.30&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16,361&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2.92 &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;27.42&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;16,361&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;27.72&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;49.18&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:27.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;37,979&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7.44&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;53.28&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22,264&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;51.02&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:9.0pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; valign=&quot;top&quot; style=&apos;width:26.65pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;24.00&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;18&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:13.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;36&quot; colspan=&quot;2&quot; valign=&quot;top&quot; style=&apos;width:27.35pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;58.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;42&quot; valign=&quot;top&quot; style=&apos;width:31.7pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;54,340&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;20&quot; valign=&quot;top&quot; style=&apos;width:15.2pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6.08&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;45.50&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;38,625&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;19&quot; valign=&quot;top&quot; style=&apos;width:14.35pt;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;67&quot; valign=&quot;top&quot; style=&apos;width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;41.02&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;36&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;0&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;18&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;0&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;36&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;42&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;20&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;19&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;12&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;td width=&quot;67&quot; style=&apos;border:none&apos;&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
	<fil:ScheduleOfGeographicInformationTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;United States&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20,286&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;19,488&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20,364&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Europe&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,519&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,989&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,720&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Other&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;12,609&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,821&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;12,073&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</fil:ScheduleOfGeographicInformationTextBlock>
	<fil:ScheduleOfLongLivedAssetsByGeographicAreaTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;bottom&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;United States&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;10,866&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,151&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;11,097&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;England&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;28,604&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;26,710&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;31,901&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Ireland&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,803&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,614&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;2,761&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Australia&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;525&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;513&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;543&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Canada&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;759&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;729&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;-&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;264&quot; valign=&quot;top&quot; style=&apos;width:2.75in;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;24&quot; valign=&quot;top&quot; style=&apos;width:.25in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:white;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:white;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</fil:ScheduleOfLongLivedAssetsByGeographicAreaTextBlock>
	<fil:ScheduleOfRevenuesByProductCategoryTextBlock contextRef='Y17'>&lt;!--egx--&gt;&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border-collapse:collapse&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Product Category&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2017&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2016&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;2015&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Obstetrics&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;border:none;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,499&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,532&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,587&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Gynecology/Electrosurgery/Urology&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;23,175&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;20,683&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;22,356&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Neonatal&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,154&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,007&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;background:#CCEEFF;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,299&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;240&quot; valign=&quot;top&quot; style=&apos;width:2.5in;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;Blood Pressure Monitoring and Accessories&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;7,586&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;31&quot; valign=&quot;top&quot; style=&apos;width:23.05pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;8,076&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;37&quot; valign=&quot;top&quot; style=&apos;width:28.1pt;padding:0&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;12&quot; valign=&quot;top&quot; style=&apos;width:8.65pt;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;48&quot; valign=&quot;top&quot; style=&apos;width:.5in;padding:0&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;6,915&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</fil:ScheduleOfRevenuesByProductCategoryTextBlock>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef='Y17_PpeByType-BuildingAndBuildingImprovements_Range-Minimum'>P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef='Y17_PpeByType-BuildingAndBuildingImprovements_Range-Maximum'>P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef='Y17_PpeByType-Equipment_Range-Minimum'>P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef='Y17_PpeByType-Equipment_Range-Maximum'>P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<fil:ForeignCurrencyExchangeRateTranslationGBPtoUSD decimals='INF' contextRef='E17' unitRef='Pure'>1.3523</fil:ForeignCurrencyExchangeRateTranslationGBPtoUSD>
	<fil:ForeignCurrencyExchangeRateTranslationAUDtoUSD decimals='INF' contextRef='E17' unitRef='Pure'>0.7815</fil:ForeignCurrencyExchangeRateTranslationAUDtoUSD>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths decimals='-3' contextRef='E17' unitRef='USD'>1981000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo decimals='-3' contextRef='E17' unitRef='USD'>1980000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree decimals='-3' contextRef='E17' unitRef='USD'>1980000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour decimals='-3' contextRef='E17' unitRef='USD'>1974000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive decimals='-3' contextRef='E17' unitRef='USD'>1973000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:LitigationReserve decimals='-3' contextRef='E17' unitRef='USD'>182000</us-gaap:LitigationReserve>
	<us-gaap:LitigationReserve decimals='-3' contextRef='E16' unitRef='USD'>134000</us-gaap:LitigationReserve>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='-3' contextRef='Y17' unitRef='Shares'>3718000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='-3' contextRef='Y16' unitRef='Shares'>3751000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals='-3' contextRef='Y15' unitRef='Shares'>3752000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals='-3' contextRef='Y17' unitRef='Shares'>19000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals='-3' contextRef='Y16' unitRef='Shares'>15000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals='-3' contextRef='Y15' unitRef='Shares'>20000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='-3' contextRef='Y17' unitRef='Shares'>3737000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='-3' contextRef='Y16' unitRef='Shares'>3766000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals='-3' contextRef='Y15' unitRef='Shares'>3772000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:AccountsReceivableGrossCurrent decimals='-3' contextRef='E17' unitRef='USD'>3713000</us-gaap:AccountsReceivableGrossCurrent>
	<us-gaap:AccountsReceivableGrossCurrent decimals='-3' contextRef='E16' unitRef='USD'>3289000</us-gaap:AccountsReceivableGrossCurrent>
	<us-gaap:IncomeTaxesReceivable decimals='-3' contextRef='E16' unitRef='USD'>7000</us-gaap:IncomeTaxesReceivable>
	<us-gaap:InterestReceivableAndOtherAssets decimals='-3' contextRef='E17' unitRef='USD'>14000</us-gaap:InterestReceivableAndOtherAssets>
	<us-gaap:InterestReceivableAndOtherAssets decimals='-3' contextRef='E16' unitRef='USD'>11000</us-gaap:InterestReceivableAndOtherAssets>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent decimals='-3' contextRef='E17' unitRef='USD'>104000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent decimals='-3' contextRef='E16' unitRef='USD'>96000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AccountsAndOtherReceivablesNetCurrent decimals='-3' contextRef='E17' unitRef='USD'>3623000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
	<us-gaap:AccountsAndOtherReceivablesNetCurrent decimals='-3' contextRef='E16' unitRef='USD'>3211000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
	<us-gaap:InventoryFinishedGoodsNetOfReserves decimals='-3' contextRef='E17' unitRef='USD'>1313000</us-gaap:InventoryFinishedGoodsNetOfReserves>
	<us-gaap:InventoryFinishedGoodsNetOfReserves decimals='-3' contextRef='E16' unitRef='USD'>1327000</us-gaap:InventoryFinishedGoodsNetOfReserves>
	<us-gaap:InventoryWorkInProcess decimals='-3' contextRef='E17' unitRef='USD'>1270000</us-gaap:InventoryWorkInProcess>
	<us-gaap:InventoryWorkInProcess decimals='-3' contextRef='E16' unitRef='USD'>942000</us-gaap:InventoryWorkInProcess>
	<us-gaap:InventoryRawMaterials decimals='-3' contextRef='E17' unitRef='USD'>2661000</us-gaap:InventoryRawMaterials>
	<us-gaap:InventoryRawMaterials decimals='-3' contextRef='E16' unitRef='USD'>2273000</us-gaap:InventoryRawMaterials>
	<us-gaap:InventoryNet decimals='-3' contextRef='E17' unitRef='USD'>5244000</us-gaap:InventoryNet>
	<us-gaap:InventoryNet decimals='-3' contextRef='E16' unitRef='USD'>4542000</us-gaap:InventoryNet>
	<us-gaap:FiniteLivedPatentsGross decimals='-3' contextRef='E17' unitRef='USD'>2183000</us-gaap:FiniteLivedPatentsGross>
	<us-gaap:FiniteLivedPatentsGross decimals='-3' contextRef='E16' unitRef='USD'>2161000</us-gaap:FiniteLivedPatentsGross>
	<us-gaap:FiniteLivedNoncompeteAgreementsGross decimals='-3' contextRef='E17' unitRef='USD'>135000</us-gaap:FiniteLivedNoncompeteAgreementsGross>
	<us-gaap:FiniteLivedNoncompeteAgreementsGross decimals='-3' contextRef='E16' unitRef='USD'>123000</us-gaap:FiniteLivedNoncompeteAgreementsGross>
	<us-gaap:FiniteLivedTrademarksGross decimals='-3' contextRef='E17' unitRef='USD'>9921000</us-gaap:FiniteLivedTrademarksGross>
	<us-gaap:FiniteLivedTrademarksGross decimals='-3' contextRef='E16' unitRef='USD'>9074000</us-gaap:FiniteLivedTrademarksGross>
	<us-gaap:FiniteLivedCustomerRelationshipsGross decimals='-3' contextRef='E17' unitRef='USD'>9669000</us-gaap:FiniteLivedCustomerRelationshipsGross>
	<us-gaap:FiniteLivedCustomerRelationshipsGross decimals='-3' contextRef='E16' unitRef='USD'>8822000</us-gaap:FiniteLivedCustomerRelationshipsGross>
	<fil:FiniteLivedRegulatoryApprovalsAndProductCertificationsGross decimals='-3' contextRef='E17' unitRef='USD'>12897000</fil:FiniteLivedRegulatoryApprovalsAndProductCertificationsGross>
	<fil:FiniteLivedRegulatoryApprovalsAndProductCertificationsGross decimals='-3' contextRef='E16' unitRef='USD'>11767000</fil:FiniteLivedRegulatoryApprovalsAndProductCertificationsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross decimals='-3' contextRef='E17' unitRef='USD'>34805000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross decimals='-3' contextRef='E16' unitRef='USD'>31947000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals='-3' contextRef='E17' unitRef='USD'>16961000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals='-3' contextRef='E16' unitRef='USD'>13683000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsNet decimals='-3' contextRef='E17' unitRef='USD'>17844000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet decimals='-3' contextRef='E16' unitRef='USD'>18264000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:AccruedIncomeTaxesCurrent decimals='-3' contextRef='E17' unitRef='USD'>1259000</us-gaap:AccruedIncomeTaxesCurrent>
	<us-gaap:AccruedIncomeTaxesCurrent decimals='-3' contextRef='E16' unitRef='USD'>799000</us-gaap:AccruedIncomeTaxesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent decimals='-3' contextRef='E17' unitRef='USD'>1199000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent decimals='-3' contextRef='E16' unitRef='USD'>1117000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:LitigationReserveCurrent decimals='-3' contextRef='E17' unitRef='USD'>182000</us-gaap:LitigationReserveCurrent>
	<us-gaap:LitigationReserveCurrent decimals='-3' contextRef='E16' unitRef='USD'>134000</us-gaap:LitigationReserveCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent decimals='-3' contextRef='E17' unitRef='USD'>1706000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent decimals='-3' contextRef='E16' unitRef='USD'>66000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='-3' contextRef='E17' unitRef='USD'>4346000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='-3' contextRef='E16' unitRef='USD'>2116000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost decimals='-3' contextRef='E17' unitRef='USD'>42000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAmortizedCost decimals='-3' contextRef='E16' unitRef='USD'>42000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax decimals='-3' contextRef='E17' unitRef='USD'>-38000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax decimals='-3' contextRef='E16' unitRef='USD'>-22000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleSecuritiesEquitySecurities decimals='-3' contextRef='E17' unitRef='USD'>80000</us-gaap:AvailableForSaleSecuritiesEquitySecurities>
	<us-gaap:AvailableForSaleSecuritiesEquitySecurities decimals='-3' contextRef='E16' unitRef='USD'>64000</us-gaap:AvailableForSaleSecuritiesEquitySecurities>
	<us-gaap:EquityFairValueDisclosure decimals='-3' contextRef='E17_FvByFvHierarchyLevel-FvInputsLevel1' unitRef='USD'>80000</us-gaap:EquityFairValueDisclosure>
	<us-gaap:EquityFairValueDisclosure decimals='-3' contextRef='E16_FvByFvHierarchyLevel-FvInputsLevel1' unitRef='USD'>64000</us-gaap:EquityFairValueDisclosure>
	<us-gaap:EquityFairValueDisclosure decimals='-3' contextRef='E17_FvByMeasurementFrequency-FvMeasurementsRecurring' unitRef='USD'>80000</us-gaap:EquityFairValueDisclosure>
	<us-gaap:EquityFairValueDisclosure decimals='-3' contextRef='E16_FvByMeasurementFrequency-FvMeasurementsRecurring' unitRef='USD'>64000</us-gaap:EquityFairValueDisclosure>
	<us-gaap:Land decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>926000</us-gaap:Land>
	<us-gaap:Land decimals='-3' contextRef='E17_StGeo-Ireland' unitRef='USD'>413000</us-gaap:Land>
	<us-gaap:Land decimals='-3' contextRef='E17' unitRef='USD'>1339000</us-gaap:Land>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>6583000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E17_StGeo-EnglandAndAustralia' unitRef='USD'>4361000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E17_StGeo-Ireland' unitRef='USD'>4406000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E17' unitRef='USD'>15350000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>14124000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E17_StGeo-EnglandAndAustralia' unitRef='USD'>427000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E17_StGeo-Ireland' unitRef='USD'>1145000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E17' unitRef='USD'>15696000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:ConstructionInProgressGross decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>10000</us-gaap:ConstructionInProgressGross>
	<us-gaap:ConstructionInProgressGross decimals='-3' contextRef='E17_StGeo-EnglandAndAustralia' unitRef='USD'>3000</us-gaap:ConstructionInProgressGross>
	<us-gaap:ConstructionInProgressGross decimals='-3' contextRef='E17' unitRef='USD'>13000</us-gaap:ConstructionInProgressGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>21643000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E17_StGeo-EnglandAndAustralia' unitRef='USD'>4791000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E17_StGeo-Ireland' unitRef='USD'>5964000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E17' unitRef='USD'>32398000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>17270000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E17_StGeo-EnglandAndAustralia' unitRef='USD'>346000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E17_StGeo-Ireland' unitRef='USD'>3161000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E17' unitRef='USD'>20777000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E17_StGeo-U.S.AndCanada' unitRef='USD'>4373000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E17_StGeo-EnglandAndAustralia' unitRef='USD'>4445000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E17_StGeo-Ireland' unitRef='USD'>2803000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E17' unitRef='USD'>11621000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:Land decimals='-3' contextRef='E16_StGeo-U.S.AndCanada' unitRef='USD'>926000</us-gaap:Land>
	<us-gaap:Land decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>362000</us-gaap:Land>
	<us-gaap:Land decimals='-3' contextRef='E16' unitRef='USD'>1289000</us-gaap:Land>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E16_StGeo-U.S.AndCanada' unitRef='USD'>6523000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E16_StGeo-EnglandAndAustralia' unitRef='USD'>523000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>3869000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross decimals='-3' contextRef='E16' unitRef='USD'>10914000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E16_StGeo-U.S.AndCanada' unitRef='USD'>14233000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E16_StGeo-EnglandAndAustralia' unitRef='USD'>529000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>996000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:MachineryAndEquipmentGross decimals='-3' contextRef='E16' unitRef='USD'>15759000</us-gaap:MachineryAndEquipmentGross>
	<us-gaap:ConstructionInProgressGross decimals='-3' contextRef='E16_StGeo-EnglandAndAustralia' unitRef='USD'>2057000</us-gaap:ConstructionInProgressGross>
	<us-gaap:ConstructionInProgressGross decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>4000</us-gaap:ConstructionInProgressGross>
	<us-gaap:ConstructionInProgressGross decimals='-3' contextRef='E16' unitRef='USD'>2061000</us-gaap:ConstructionInProgressGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E16_StGeo-U.S.AndCanada' unitRef='USD'>21682000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E16_StGeo-EnglandAndAustralia' unitRef='USD'>3109000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>5231000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross decimals='-3' contextRef='E16' unitRef='USD'>30023000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E16_StGeo-U.S.AndCanada' unitRef='USD'>17063000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E16_StGeo-EnglandAndAustralia' unitRef='USD'>376000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>2617000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals='-3' contextRef='E16' unitRef='USD'>20057000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E16_StGeo-U.S.AndCanada' unitRef='USD'>4619000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E16_StGeo-EnglandAndAustralia' unitRef='USD'>2733000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E16_StGeo-Ireland' unitRef='USD'>2614000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='-3' contextRef='E16' unitRef='USD'>9966000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:DebtInstrumentFaceAmount decimals='-3' contextRef='E17_LongtermDebtType-JPMorganChaseBankNAChaseNote' unitRef='USD'>14000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount decimals='-3' contextRef='E17_LongtermDebtType-JPMorganChaseLondonBranchNote' unitRef='USD'>12934000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:OperatingLeasesRentExpenseNet decimals='-3' contextRef='Y17' unitRef='USD'>160000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLeasesRentExpenseNet decimals='-3' contextRef='Y16' unitRef='USD'>175000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLeasesRentExpenseNet decimals='-3' contextRef='Y15' unitRef='USD'>184000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent decimals='-3' contextRef='E17' unitRef='USD'>83000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears decimals='-3' contextRef='E17' unitRef='USD'>45000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears decimals='-3' contextRef='E17' unitRef='USD'>45000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears decimals='-3' contextRef='E17' unitRef='USD'>45000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears decimals='-3' contextRef='E17' unitRef='USD'>45000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter decimals='-3' contextRef='E17' unitRef='USD'>398000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDue decimals='-3' contextRef='E17' unitRef='USD'>661000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
	<us-gaap:DeferredTaxAssetsInventory decimals='-3' contextRef='E17' unitRef='USD'>56000</us-gaap:DeferredTaxAssetsInventory>
	<us-gaap:DeferredTaxAssetsInventory decimals='-3' contextRef='E16' unitRef='USD'>98000</us-gaap:DeferredTaxAssetsInventory>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts decimals='-3' contextRef='E17' unitRef='USD'>16000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts decimals='-3' contextRef='E16' unitRef='USD'>25000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities decimals='-3' contextRef='E17' unitRef='USD'>89000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities decimals='-3' contextRef='E16' unitRef='USD'>147000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
	<us-gaap:DeferredTaxAssetsOther decimals='-3' contextRef='E17' unitRef='USD'>4000</us-gaap:DeferredTaxAssetsOther>
	<us-gaap:DeferredTaxAssetsOther decimals='-3' contextRef='E16' unitRef='USD'>-23000</us-gaap:DeferredTaxAssetsOther>
	<fil:DeferredTaxLiabilitiesDepreciationAndAmortization decimals='-3' contextRef='E17' unitRef='USD'>3789000</fil:DeferredTaxLiabilitiesDepreciationAndAmortization>
	<fil:DeferredTaxLiabilitiesDepreciationAndAmortization decimals='-3' contextRef='E16' unitRef='USD'>4277000</fil:DeferredTaxLiabilitiesDepreciationAndAmortization>
	<fil:UnrealizedInvestmentLoss decimals='-3' contextRef='E17' unitRef='USD'>66000</fil:UnrealizedInvestmentLoss>
	<fil:UnrealizedInvestmentLoss decimals='-3' contextRef='E16' unitRef='USD'>105000</fil:UnrealizedInvestmentLoss>
	<us-gaap:DeferredTaxAssetsLiabilitiesNet decimals='-3' contextRef='E17' unitRef='USD'>-3558000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
	<us-gaap:DeferredTaxAssetsLiabilitiesNet decimals='-3' contextRef='E16' unitRef='USD'>-3925000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
	<us-gaap:CurrentIncomeTaxExpenseBenefit decimals='-3' contextRef='Y17' unitRef='USD'>10944000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit decimals='-3' contextRef='Y16' unitRef='USD'>5467000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit decimals='-3' contextRef='Y15' unitRef='USD'>4877000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<fil:DeferredIncomeTaxExpense decimals='-3' contextRef='Y17' unitRef='USD'>-367000</fil:DeferredIncomeTaxExpense>
	<fil:DeferredIncomeTaxExpense decimals='-3' contextRef='Y16' unitRef='USD'>-1173000</fil:DeferredIncomeTaxExpense>
	<fil:DeferredIncomeTaxExpense decimals='-3' contextRef='Y15' unitRef='USD'>-1175000</fil:DeferredIncomeTaxExpense>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate decimals='-3' contextRef='Y17' unitRef='USD'>3086000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate decimals='-3' contextRef='Y16' unitRef='USD'>2998000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate decimals='-3' contextRef='Y15' unitRef='USD'>2704000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes decimals='-3' contextRef='Y17' unitRef='USD'>299000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes decimals='-3' contextRef='Y16' unitRef='USD'>291000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes decimals='-3' contextRef='Y15' unitRef='USD'>262000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential decimals='-3' contextRef='Y17' unitRef='USD'>1444000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential decimals='-3' contextRef='Y16' unitRef='USD'>1270000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential decimals='-3' contextRef='Y15' unitRef='USD'>990000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities decimals='-3' contextRef='Y17' unitRef='USD'>303000</us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities>
	<us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities decimals='-3' contextRef='Y16' unitRef='USD'>287000</us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities>
	<us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities decimals='-3' contextRef='Y15' unitRef='USD'>257000</us-gaap:IncomeTaxReconciliationDeductionsQualifiedProductionActivities>
	<fil:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount decimals='-3' contextRef='Y17' unitRef='USD'>6288000</fil:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount>
	<fil:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit decimals='-3' contextRef='Y17' unitRef='USD'>-228000</fil:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments decimals='-3' contextRef='Y17' unitRef='USD'>-9000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments decimals='-3' contextRef='Y16' unitRef='USD'>22000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments decimals='-3' contextRef='Y15' unitRef='USD'>3000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxExpenseBenefit decimals='-3' contextRef='Y17' unitRef='USD'>10577000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit decimals='-3' contextRef='Y16' unitRef='USD'>4294000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit decimals='-3' contextRef='Y15' unitRef='USD'>3702000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic decimals='-3' contextRef='Y17' unitRef='USD'>9124000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic decimals='-3' contextRef='Y16' unitRef='USD'>8688000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic decimals='-3' contextRef='Y15' unitRef='USD'>7973000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign decimals='-3' contextRef='Y17' unitRef='USD'>9958000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign decimals='-3' contextRef='Y16' unitRef='USD'>7734000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign decimals='-3' contextRef='Y15' unitRef='USD'>7572000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments decimals='-3' contextRef='Y17' unitRef='USD'>19082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments decimals='-3' contextRef='Y16' unitRef='USD'>16422000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments decimals='-3' contextRef='Y15' unitRef='USD'>15545000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized decimals='-3' contextRef='E17' unitRef='Shares'>307000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
	<fil:PriceRangePerShareGranted contextRef='Y17'>- - -</fil:PriceRangePerShareGranted>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod decimals='-3' contextRef='Y17' unitRef='Shares'>12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
	<fil:PriceRangePerShareExpired contextRef='Y17'>49.18 - 58.50</fil:PriceRangePerShareExpired>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised decimals='-3' contextRef='Y17_StEqComps-CommonStock' unitRef='Shares'>9000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<fil:PriceRangePerShareExercised contextRef='Y17'>24.00 - 49.18</fil:PriceRangePerShareExercised>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber decimals='-3' contextRef='E17' unitRef='Shares'>54000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<fil:PriceRangePerShareOutstanding contextRef='Y17'>24.00 - 58.50</fil:PriceRangePerShareOutstanding>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber decimals='-3' contextRef='E17' unitRef='Shares'>39000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<fil:PriceRangePerShareTotalExercisable contextRef='Y17'>24.00 - 58.50</fil:PriceRangePerShareTotalExercisable>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod decimals='-3' contextRef='Y16' unitRef='Shares'>28000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<fil:PriceRangePerShareGranted contextRef='Y16'>58.50 - 58.50</fil:PriceRangePerShareGranted>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod decimals='-3' contextRef='Y16' unitRef='Shares'>3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
	<fil:PriceRangePerShareExpired contextRef='Y16'>49.18 - 49.18</fil:PriceRangePerShareExpired>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised decimals='-3' contextRef='Y16_StEqComps-CommonStock' unitRef='Shares'>13000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<fil:PriceRangePerShareExercised contextRef='Y16'>24.00 - 49.18</fil:PriceRangePerShareExercised>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber decimals='-3' contextRef='E16' unitRef='Shares'>75000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<fil:PriceRangePerShareOutstanding contextRef='Y16'>24.00 - 58.50</fil:PriceRangePerShareOutstanding>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber decimals='-3' contextRef='E16' unitRef='Shares'>36000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<fil:PriceRangePerShareTotalExercisable contextRef='Y16'>24.00 - 50.72</fil:PriceRangePerShareTotalExercisable>
	<fil:PriceRangePerShareGranted contextRef='Y15'>- - -</fil:PriceRangePerShareGranted>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod decimals='-3' contextRef='Y15' unitRef='Shares'>7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
	<fil:PriceRangePerShareExpired contextRef='Y15'>26.58 - 49.18</fil:PriceRangePerShareExpired>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised decimals='-3' contextRef='Y15_StEqComps-CommonStock' unitRef='Shares'>22000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<fil:PriceRangePerShareExercised contextRef='Y15'>21.68 - 49.18</fil:PriceRangePerShareExercised>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber decimals='-3' contextRef='E15' unitRef='Shares'>62000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<fil:PriceRangePerShareOutstanding contextRef='Y15'>24.00 - 50.72</fil:PriceRangePerShareOutstanding>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber decimals='-3' contextRef='E15' unitRef='Shares'>41000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<fil:PriceRangePerShareTotalExercisable contextRef='Y15'>24.00 - 50.72</fil:PriceRangePerShareTotalExercisable>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions decimals='-3' contextRef='Y17' unitRef='USD'>38000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions decimals='-3' contextRef='Y16' unitRef='USD'>50000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions decimals='-3' contextRef='Y15' unitRef='USD'>114000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
	<us-gaap:AllocatedShareBasedCompensationExpense decimals='-3' contextRef='Y17' unitRef='USD'>129000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense decimals='-3' contextRef='Y16' unitRef='USD'>92000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense decimals='-3' contextRef='Y15' unitRef='USD'>87000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments decimals='INF' contextRef='Y16' unitRef='USD'>0.2775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate decimals='INF' contextRef='Y16' unitRef='Pure'>0.2800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate decimals='INF' contextRef='Y16' unitRef='Pure'>0.0130</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef='Y16'>P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue decimals='INF' contextRef='Y16' unitRef='UsdPerShare'>12.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit decimals='INF' contextRef='Y17_StScenario-Range1' unitRef='UsdPerShare'>24.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit decimals='INF' contextRef='Y17_StScenario-Range1' unitRef='UsdPerShare'>33.30</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions decimals='INF' contextRef='E17_StScenario-Range1' unitRef='Shares'>16361</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
	<fil:WeightedAverageRemainingContractualLifeYears decimals='INF' contextRef='E17_StScenario-Range1' unitRef='Pure'>2.92</fil:WeightedAverageRemainingContractualLifeYears>
	<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 decimals='INF' contextRef='E17_StScenario-Range1' unitRef='UsdPerShare'>27.42</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions decimals='INF' contextRef='E17_StScenario-Range1' unitRef='Shares'>16361</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
	<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 decimals='INF' contextRef='E17_StScenario-Range1' unitRef='UsdPerShare'>27.72</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit decimals='INF' contextRef='Y17_StScenario-Range2' unitRef='UsdPerShare'>49.18</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit decimals='INF' contextRef='Y17_StScenario-Range2' unitRef='UsdPerShare'>58.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions decimals='INF' contextRef='E17_StScenario-Range2' unitRef='Shares'>37979</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
	<fil:WeightedAverageRemainingContractualLifeYears decimals='INF' contextRef='E17_StScenario-Range2' unitRef='Pure'>7.44</fil:WeightedAverageRemainingContractualLifeYears>
	<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 decimals='INF' contextRef='E17_StScenario-Range2' unitRef='UsdPerShare'>53.28</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions decimals='INF' contextRef='E17_StScenario-Range2' unitRef='Shares'>22264</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
	<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 decimals='INF' contextRef='E17_StScenario-Range2' unitRef='UsdPerShare'>51.02</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit decimals='INF' contextRef='Y17' unitRef='UsdPerShare'>24.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit decimals='INF' contextRef='Y17' unitRef='UsdPerShare'>58.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions decimals='INF' contextRef='E17' unitRef='Shares'>54340</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
	<fil:WeightedAverageRemainingContractualLifeYears decimals='INF' contextRef='E17' unitRef='Pure'>6.08</fil:WeightedAverageRemainingContractualLifeYears>
	<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 decimals='INF' contextRef='E17' unitRef='UsdPerShare'>45.50</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions decimals='INF' contextRef='E17' unitRef='Shares'>38625</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
	<us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 decimals='INF' contextRef='E17' unitRef='UsdPerShare'>41.02</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
	<fil:CompanySalesInTheUnitedStates decimals='-3' contextRef='Y17' unitRef='USD'>20286000</fil:CompanySalesInTheUnitedStates>
	<fil:CompanySalesInTheUnitedStates decimals='-3' contextRef='Y16' unitRef='USD'>19488000</fil:CompanySalesInTheUnitedStates>
	<fil:CompanySalesInTheUnitedStates decimals='-3' contextRef='Y15' unitRef='USD'>20364000</fil:CompanySalesInTheUnitedStates>
	<fil:CompanySalesInEurope decimals='-3' contextRef='Y17' unitRef='USD'>8519000</fil:CompanySalesInEurope>
	<fil:CompanySalesInEurope decimals='-3' contextRef='Y16' unitRef='USD'>7989000</fil:CompanySalesInEurope>
	<fil:CompanySalesInEurope decimals='-3' contextRef='Y15' unitRef='USD'>7720000</fil:CompanySalesInEurope>
	<fil:CompanySalesOther decimals='-3' contextRef='Y17' unitRef='USD'>12609000</fil:CompanySalesOther>
	<fil:CompanySalesOther decimals='-3' contextRef='Y16' unitRef='USD'>11821000</fil:CompanySalesOther>
	<fil:CompanySalesOther decimals='-3' contextRef='Y15' unitRef='USD'>12073000</fil:CompanySalesOther>
	<fil:LongLivedAssetsInTheUnitedStates decimals='-3' contextRef='E17' unitRef='USD'>10866000</fil:LongLivedAssetsInTheUnitedStates>
	<fil:LongLivedAssetsInTheUnitedStates decimals='-3' contextRef='E16' unitRef='USD'>11151000</fil:LongLivedAssetsInTheUnitedStates>
	<fil:LongLivedAssetsInTheUnitedStates decimals='-3' contextRef='E15' unitRef='USD'>11097000</fil:LongLivedAssetsInTheUnitedStates>
	<fil:LongLivedAssetsInEngland decimals='-3' contextRef='E17' unitRef='USD'>28604000</fil:LongLivedAssetsInEngland>
	<fil:LongLivedAssetsInEngland decimals='-3' contextRef='E16' unitRef='USD'>26710000</fil:LongLivedAssetsInEngland>
	<fil:LongLivedAssetsInEngland decimals='-3' contextRef='E15' unitRef='USD'>31901000</fil:LongLivedAssetsInEngland>
	<fil:LongLivedAssetsInIreland decimals='-3' contextRef='E17' unitRef='USD'>2803000</fil:LongLivedAssetsInIreland>
	<fil:LongLivedAssetsInIreland decimals='-3' contextRef='E16' unitRef='USD'>2614000</fil:LongLivedAssetsInIreland>
	<fil:LongLivedAssetsInIreland decimals='-3' contextRef='E15' unitRef='USD'>2761000</fil:LongLivedAssetsInIreland>
	<fil:LongLivedAssetsInAustralia decimals='-3' contextRef='E17' unitRef='USD'>525000</fil:LongLivedAssetsInAustralia>
	<fil:LongLivedAssetsInAustralia decimals='-3' contextRef='E16' unitRef='USD'>513000</fil:LongLivedAssetsInAustralia>
	<fil:LongLivedAssetsInAustralia decimals='-3' contextRef='E15' unitRef='USD'>543000</fil:LongLivedAssetsInAustralia>
	<fil:LongLivedAssetsInCanada decimals='-3' contextRef='E17' unitRef='USD'>759000</fil:LongLivedAssetsInCanada>
	<fil:LongLivedAssetsInCanada decimals='-3' contextRef='E16' unitRef='USD'>729000</fil:LongLivedAssetsInCanada>
	<fil:CompanyRevenueObstetrics decimals='-3' contextRef='Y17' unitRef='USD'>4499000</fil:CompanyRevenueObstetrics>
	<fil:CompanyRevenueObstetrics decimals='-3' contextRef='Y16' unitRef='USD'>4532000</fil:CompanyRevenueObstetrics>
	<fil:CompanyRevenueObstetrics decimals='-3' contextRef='Y15' unitRef='USD'>4587000</fil:CompanyRevenueObstetrics>
	<fil:CompanyRevenueGynecologyElectrosurgeryUrology decimals='-3' contextRef='Y17' unitRef='USD'>23175000</fil:CompanyRevenueGynecologyElectrosurgeryUrology>
	<fil:CompanyRevenueGynecologyElectrosurgeryUrology decimals='-3' contextRef='Y16' unitRef='USD'>20683000</fil:CompanyRevenueGynecologyElectrosurgeryUrology>
	<fil:CompanyRevenueGynecologyElectrosurgeryUrology decimals='-3' contextRef='Y15' unitRef='USD'>22356000</fil:CompanyRevenueGynecologyElectrosurgeryUrology>
	<fil:CompanyRevenueNeonatal decimals='-3' contextRef='Y17' unitRef='USD'>6154000</fil:CompanyRevenueNeonatal>
	<fil:CompanyRevenueNeonatal decimals='-3' contextRef='Y16' unitRef='USD'>6007000</fil:CompanyRevenueNeonatal>
	<fil:CompanyRevenueNeonatal decimals='-3' contextRef='Y15' unitRef='USD'>6299000</fil:CompanyRevenueNeonatal>
	<fil:CompanyRevenueBloodPressureMonitoringAndAccessories decimals='-3' contextRef='Y17' unitRef='USD'>7586000</fil:CompanyRevenueBloodPressureMonitoringAndAccessories>
	<fil:CompanyRevenueBloodPressureMonitoringAndAccessories decimals='-3' contextRef='Y16' unitRef='USD'>8076000</fil:CompanyRevenueBloodPressureMonitoringAndAccessories>
	<fil:CompanyRevenueBloodPressureMonitoringAndAccessories decimals='-3' contextRef='Y15' unitRef='USD'>6915000</fil:CompanyRevenueBloodPressureMonitoringAndAccessories>
	<us-gaap:RoyaltyIncomeNonoperating decimals='-3' contextRef='Y17' unitRef='USD'>86000</us-gaap:RoyaltyIncomeNonoperating>
	<us-gaap:RoyaltyIncomeNonoperating decimals='-3' contextRef='Y16' unitRef='USD'>91000</us-gaap:RoyaltyIncomeNonoperating>
	<us-gaap:RoyaltyIncomeNonoperating decimals='-3' contextRef='Y15' unitRef='USD'>93000</us-gaap:RoyaltyIncomeNonoperating>
	<us-gaap:ContractualObligation decimals='-3' contextRef='E17' unitRef='USD'>2191000</us-gaap:ContractualObligation>
	<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount decimals='-3' contextRef='Y17' unitRef='USD'>153000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
	<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount decimals='-3' contextRef='Y16' unitRef='USD'>151000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
	<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount decimals='-3' contextRef='Y15' unitRef='USD'>161000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
	<context id='E14'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<instant>2014-12-31</instant>
		</period>
	</context>
	<context id='E14_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2014-12-31</instant>
		</period>
	</context>
	<context id='E14_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2014-12-31</instant>
		</period>
	</context>
	<context id='E14_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2014-12-31</instant>
		</period>
	</context>
	<context id='E14_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2014-12-31</instant>
		</period>
	</context>
	<context id='Y15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<startDate>2015-01-01</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='E15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='Y15_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-01</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='Y15_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-01</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='Y15_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-01</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='Y15_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2015-01-01</startDate>
			<endDate>2015-12-31</endDate>
		</period>
	</context>
	<context id='E15_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E15_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E15_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E15_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='Y16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='E16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='Y16_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='Y16_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='Y16_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='Y16_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-12-31</endDate>
		</period>
	</context>
	<context id='E16_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_FvByFvHierarchyLevel-FvInputsLevel1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_FvByMeasurementFrequency-FvMeasurementsRecurring'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByMeasurementFrequencyAxis'>us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StGeo-Ireland'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementGeographicalAxis'>fil:IrelandMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='Y17'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='E17Q2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<instant>2017-06-30</instant>
		</period>
	</context>
	<context id='E17'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='Y17_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='Y17_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='Y17_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='Y17_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='E17_StEqComps-CommonStock'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_StEqComps-AddPaidInCap'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_StEqComps-AccumulatedOtherComprIncome'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_StEqComps-RetainedEarnings'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementEquityComponentsAxis'>us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_FvByFvHierarchyLevel-FvInputsLevel1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByFairValueHierarchyLevelAxis'>us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_FvByMeasurementFrequency-FvMeasurementsRecurring'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:FairValueByMeasurementFrequencyAxis'>us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_StGeo-Ireland'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementGeographicalAxis'>fil:IrelandMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_LongtermDebtType-JPMorganChaseBankNAChaseNote'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:JPMorganChaseBankNAChaseNoteMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_LongtermDebtType-JPMorganChaseLondonBranchNote'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:LongtermDebtTypeAxis'>fil:JPMorganChaseLondonBranchNoteMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='Y17_StScenario-Range1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementScenarioAxis'>fil:Range1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='E17_StScenario-Range1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementScenarioAxis'>fil:Range1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='Y17_StScenario-Range2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementScenarioAxis'>fil:Range2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='E17_StScenario-Range2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementScenarioAxis'>fil:Range2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_StGeo-U.S.AndCanada'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementGeographicalAxis'>fil:U.S.AndCanadaMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E17_StGeo-EnglandAndAustralia'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementGeographicalAxis'>fil:EnglandAndAustraliaMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-12-31</instant>
		</period>
	</context>
	<context id='E16_StGeo-U.S.AndCanada'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementGeographicalAxis'>fil:U.S.AndCanadaMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='E16_StGeo-EnglandAndAustralia'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:StatementGeographicalAxis'>fil:EnglandAndAustraliaMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='Y17_PpeByType-BuildingAndBuildingImprovements_Range-Minimum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MinimumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='Y17_PpeByType-BuildingAndBuildingImprovements_Range-Maximum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MaximumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='Y17_PpeByType-Equipment_Range-Minimum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MinimumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='Y17_PpeByType-Equipment_Range-Maximum'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:PropertyPlantAndEquipmentByTypeAxis'>us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension='us-gaap:RangeAxis'>us-gaap:MaximumMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-12-31</endDate>
		</period>
	</context>
	<context id='I180305'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000706698</identifier>
		</entity>
		<period>
			<instant>2018-03-05</instant>
		</period>
	</context>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='Shares'>
		<measure>shares</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>shares</measure>
			</unitDenominator>
		</divide>
	</unit>
	<unit id='Pure'>
		<measure>pure</measure>
	</unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>utmd-20171231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK9NDL3JZWVL2VG7W3]. www.edgarsuite.com -->
<schema xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2017-01-31' xmlns:fil='http://www.utahmed.com/20171231' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' xmlns:num='http://www.xbrl.org/dtr/type/numeric' targetNamespace='http://www.utahmed.com/20171231' xmlns:link='http://www.xbrl.org/2003/linkbase' elementFormDefault='qualified' xmlns:xbrli='http://www.xbrl.org/2003/instance' attributeFormDefault='unqualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20171231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20171231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20171231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20171231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote15RecentAccountingPronouncements" id="idr_DisclosureNote15RecentAccountingPronouncements">
				<link:definition>000220 - Disclosure - Note 15 - Recent Accounting Pronouncements</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies">
				<link:definition>000270 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Investments (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables" id="idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables">
				<link:definition>000540 - Disclosure - Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies">
				<link:definition>000400 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Translation of Foreign Currencies (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies">
				<link:definition>000250 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables" id="idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables">
				<link:definition>000530 - Disclosure - Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables">
				<link:definition>000450 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans" id="idr_DisclosureNote14EmployeeBenefitPlans">
				<link:definition>000210 - Disclosure - Note 14 - Employee Benefit Plans</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables" id="idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables">
				<link:definition>000510 - Disclosure - Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails" id="idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails">
				<link:definition>000710 - Disclosure - Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables">
				<link:definition>000410 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables" id="idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables">
				<link:definition>000490 - Disclosure - Note 5 - Property and Equipment: Property Plant and Equipment by Location (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsDetails" id="idr_DisclosureNote9OptionsDetails">
				<link:definition>000820 - Disclosure - Note 9 - Options (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails">
				<link:definition>000640 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Legal Costs (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
				<link:definition>000610 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies">
				<link:definition>000260 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategory" id="idr_DisclosureNote12RevenuesByProductCategory">
				<link:definition>000190 - Disclosure - Note 12 - Revenues by Product Category</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies">
				<link:definition>000340 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables" id="idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables">
				<link:definition>000520 - Disclosure - Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical" id="idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical">
				<link:definition>000030 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET (Parenthetical)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical" id="idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical">
				<link:definition>000050 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (Parenthetical)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables">
				<link:definition>000440 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies">
				<link:definition>000290 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Accounts Receivable (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
				<link:definition>000800 - Disclosure - Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables" id="idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables">
				<link:definition>000550 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW" id="idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW">
				<link:definition>000060 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF CASH FLOW</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies">
				<link:definition>000350 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Income Taxes (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" id="idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails">
				<link:definition>000790 - Disclosure - Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables" id="idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables">
				<link:definition>000600 - Disclosure - Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails">
				<link:definition>000650 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables" id="idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables">
				<link:definition>000590 - Disclosure - Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies">
				<link:definition>000320 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Long-lived Assets (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments" id="idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments">
				<link:definition>000110 - Disclosure - Note 4 - Fair Value Measurements and Financial Instruments</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails">
				<link:definition>000660 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables" id="idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables">
				<link:definition>000560 - Disclosure - Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPolicies">
				<link:definition>000080 - Disclosure - Note 1 - Summary of Significant Accounting Policies</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables" id="idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables">
				<link:definition>000470 - Disclosure - Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails" id="idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails">
				<link:definition>000830 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails" id="idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails">
				<link:definition>000850 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" id="idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails">
				<link:definition>000810 - Disclosure - Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" id="idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
				<link:definition>000770 - Disclosure - Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails">
				<link:definition>000700 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformation" id="idr_DisclosureNote11GeographicLongLivedAssetsInformation">
				<link:definition>000180 - Disclosure - Note 11 - Geographic Long-Lived Assets Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxes" id="idr_DisclosureNote8IncomeTaxes">
				<link:definition>000150 - Disclosure - Note 8 - Income Taxes</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" id="idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME">
				<link:definition>000040 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" id="idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails">
				<link:definition>000840 - Disclosure - Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables" id="idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables">
				<link:definition>000570 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails">
				<link:definition>000690 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables" id="idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables">
				<link:definition>000500 - Disclosure - Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts">
				<link:definition>000090 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails">
				<link:definition>000680 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt" id="idr_DisclosureNote6LongTermDebt">
				<link:definition>000130 - Disclosure - Note 6 - Long-term Debt</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables" id="idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables">
				<link:definition>000460 - Disclosure - Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies">
				<link:definition>000310 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails" id="idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails">
				<link:definition>000870 - Disclosure - Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipment" id="idr_DisclosureNote5PropertyAndEquipment">
				<link:definition>000120 - Disclosure - Note 5 - Property and Equipment</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies">
				<link:definition>000280 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Concentration of Credit Risk (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlansDetails" id="idr_DisclosureNote14EmployeeBenefitPlansDetails">
				<link:definition>000900 - Disclosure - Note 14 - Employee Benefit Plans (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies">
				<link:definition>000360 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Legal Costs (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" id="idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
				<link:definition>000070 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS&apos; EQUITY</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
				<link:definition>000780 - Disclosure - Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies">
				<link:definition>000370 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Earnings Per Share (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments" id="idr_DisclosureNote13ProductSaleAndPurchaseCommitments">
				<link:definition>000200 - Disclosure - Note 13 - Product Sale and Purchase Commitments</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies">
				<link:definition>000330 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails">
				<link:definition>000670 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies">
				<link:definition>000240 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Use of Estimates in The Preparation of Financial Statements (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables">
				<link:definition>000420 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables" id="idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables">
				<link:definition>000430 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies">
				<link:definition>000380 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Presentation of Sales and Similar Taxes (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails" id="idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails">
				<link:definition>000730 - Disclosure - Note 5 - Property and Equipment: Property, Plant and Equipment (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables" id="idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables">
				<link:definition>000480 - Disclosure - Note 5 - Property and Equipment: Property, Plant and Equipment (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingencies" id="idr_DisclosureNote7CommitmentsAndContingencies">
				<link:definition>000140 - Disclosure - Note 7 - Commitments and Contingencies</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails" id="idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails">
				<link:definition>000890 - Disclosure - Note 13 - Product Sale and Purchase Commitments (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3Investments" id="idr_DisclosureNote3Investments">
				<link:definition>000100 - Disclosure - Note 3 - Investments</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesDetails" id="idr_DisclosureNote7CommitmentsAndContingenciesDetails">
				<link:definition>000760 - Disclosure - Note 7 - Commitments and Contingencies (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebtDetails" id="idr_DisclosureNote6LongTermDebtDetails">
				<link:definition>000750 - Disclosure - Note 6 - Long-term Debt (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables" id="idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables">
				<link:definition>000580 - Disclosure - Note 10 - Geographic Information: Schedule Of Geographic Information (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies">
				<link:definition>000390 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET" id="idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET">
				<link:definition>000020 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies">
				<link:definition>000300 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Inventories (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9Options" id="idr_DisclosureNote9Options">
				<link:definition>000160 - Disclosure - Note 9 - Options</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails" id="idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails">
				<link:definition>000880 - Disclosure - Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote16SubsequentEvents" id="idr_DisclosureNote16SubsequentEvents">
				<link:definition>000230 - Disclosure - Note 16 - Subsequent Events</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" id="idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
				<link:definition>000720 - Disclosure - Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails" id="idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails">
				<link:definition>000740 - Disclosure - Note 5 - Property and Equipment: Property Plant and Equipment by Location (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails">
				<link:definition>000630 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Income Taxes (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails" id="idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails">
				<link:definition>000860 - Disclosure - Note 10 - Geographic Information: Schedule Of Geographic Information (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails" id="idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails">
				<link:definition>000620 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformation" id="idr_DisclosureNote10GeographicInformation">
				<link:definition>000170 - Disclosure - Note 10 - Geographic Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import namespace='http://fasb.org/us-gaap/2017-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2014-01-31' schemaLocation='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_DocumentAndEntityInformationAbstract' name='DocumentAndEntityInformationAbstract' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_IrelandMember' name='IrelandMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_JPMorganChaseBankNAChaseNoteMember' name='JPMorganChaseBankNAChaseNoteMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_JPMorganChaseLondonBranchNoteMember' name='JPMorganChaseLondonBranchNoteMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Range1Member' name='Range1Member' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Range2Member' name='Range2Member' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_PaymentOfTaxesForExchangeOfStockOptions' name='PaymentOfTaxesForExchangeOfStockOptions' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' name='CommonStockReceivedAndRetiredUponExerciseOfStockOptions' />
	<element nillable='true' type='xbrli:sharesItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' name='CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_OtherComprehensiveIncomeAbstract' name='OtherComprehensiveIncomeAbstract' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' name='FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_DeferredTaxLiabilitiesDepreciationAndAmortization' name='DeferredTaxLiabilitiesDepreciationAndAmortization' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_UnrealizedInvestmentLoss' name='UnrealizedInvestmentLoss' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_DeferredIncomeTaxExpense' name='DeferredIncomeTaxExpense' />
	<element nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PriceRangePerShareGranted' name='PriceRangePerShareGranted' />
	<element nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PriceRangePerShareExpired' name='PriceRangePerShareExpired' />
	<element nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PriceRangePerShareExercised' name='PriceRangePerShareExercised' />
	<element nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PriceRangePerShareOutstanding' name='PriceRangePerShareOutstanding' />
	<element nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PriceRangePerShareTotalExercisable' name='PriceRangePerShareTotalExercisable' />
	<element nillable='true' type='xbrli:decimalItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_WeightedAverageRemainingContractualLifeYears' name='WeightedAverageRemainingContractualLifeYears' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanySalesInTheUnitedStates' name='CompanySalesInTheUnitedStates' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanySalesInEurope' name='CompanySalesInEurope' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanySalesOther' name='CompanySalesOther' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LongLivedAssetsInTheUnitedStates' name='LongLivedAssetsInTheUnitedStates' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LongLivedAssetsInEngland' name='LongLivedAssetsInEngland' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LongLivedAssetsInIreland' name='LongLivedAssetsInIreland' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanyRevenueObstetrics' name='CompanyRevenueObstetrics' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanyRevenueGynecologyElectrosurgeryUrology' name='CompanyRevenueGynecologyElectrosurgeryUrology' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanyRevenueNeonatal' name='CompanyRevenueNeonatal' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='credit' id='fil_CompanyRevenueBloodPressureMonitoringAndAccessories' name='CompanyRevenueBloodPressureMonitoringAndAccessories' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LongLivedAssetsInAustralia' name='LongLivedAssetsInAustralia' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' name='ForeignCurrencyExchangeRateTranslationAUDtoUSD' />
	<element nillable='true' type='xbrli:pureItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' id='fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' name='ForeignCurrencyExchangeRateTranslationGBPtoUSD' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_LongLivedAssetsInCanada' name='LongLivedAssetsInCanada' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='credit' id='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' name='TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' name='TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' name='EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_U.S.AndCanadaMember' name='U.S.AndCanadaMember' />
	<element nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_EnglandAndAustraliaMember' name='EnglandAndAustraliaMember' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' xbrli:balance='debit' id='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' name='TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_GeographicInformationTextBlock' name='GeographicInformationTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_GeographicLongLivedAssetsInformationTextBlock' name='GeographicLongLivedAssetsInformationTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_RevenuesByProductCategoryTextBlock' name='RevenuesByProductCategoryTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ProductSaleAndPurchaseCommitmentsTextBlock' name='ProductSaleAndPurchaseCommitmentsTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PresentationOfSalesAndSimilarTaxesTextBlock' name='PresentationOfSalesAndSimilarTaxesTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_PropertyPlantAndEquipmentByLocationTextBlock' name='PropertyPlantAndEquipmentByLocationTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfGeographicInformationTextBlock' name='ScheduleOfGeographicInformationTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' name='ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' />
	<element nillable='true' type='nonnum:textBlockItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_ScheduleOfRevenuesByProductCategoryTextBlock' name='ScheduleOfRevenuesByProductCategoryTextBlock' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>utmd-20171231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK9NDL3JZWVL2VG7W3]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.utahmed.com/20171231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross' xlink:label='us-gaap_FiniteLivedIntangibleAssetsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:to='us-gaap_FiniteLivedIntangibleAssetsGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill' xlink:label='us-gaap_Goodwill'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_Goodwill' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AssetsCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_AccountsReceivableNetCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_InventoryNet' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure' xlink:label='us-gaap_InvestmentsFairValueDisclosure'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_InvestmentsFairValueDisclosure' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent' xlink:label='us-gaap_OtherAssetsCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_OtherAssetsCurrent' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_DeferredTaxLiabilitiesNoncurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' xlink:label='us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' xlink:label='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' use='optional' order='3.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_Liabilities' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_StockholdersEquity' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock' xlink:label='us-gaap_AdditionalPaidInCapitalCommonStock'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_AdditionalPaidInCapitalCommonStock' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_CommonStockValue' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_PreferredStockValue' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquity' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='5.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_GrossProfit' xlink:to='us-gaap_SalesRevenueNet' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold' xlink:label='us-gaap_CostOfGoodsSold'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_GrossProfit' xlink:to='us-gaap_CostOfGoodsSold' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherInterestAndDividendIncome' xlink:label='us-gaap_OtherInterestAndDividendIncome'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_OtherInterestAndDividendIncome' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet' xlink:label='us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_OtherOperatingIncomeExpenseNet' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating' xlink:label='us-gaap_RoyaltyIncomeNonoperating'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_RoyaltyIncomeNonoperating' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_InterestExpense' use='optional' order='5.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_ProfitLoss' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_ProfitLoss' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='2.0' weight='-1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='us-gaap_GrossProfit' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='us-gaap_ResearchAndDevelopmentExpense' use='optional' order='3.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense' xlink:label='us-gaap_SellingAndMarketingExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='us-gaap_SellingAndMarketingExpense' use='optional' order='4.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_ComprehensiveIncomeNetOfTax' xlink:to='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_ComprehensiveIncomeNetOfTax' xlink:to='us-gaap_ProfitLoss' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_ComprehensiveIncomeNetOfTax' xlink:to='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' use='optional' order='3.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_ProceedsFromIssuanceOfCommonStock' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised' xlink:label='us-gaap_DeferredTaxExpenseFromStockOptionsExercised'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_DeferredTaxExpenseFromStockOptionsExercised' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividends' xlink:label='us-gaap_PaymentsOfDividends'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_PaymentsOfDividends' use='optional' order='4.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:label='fil_PaymentOfTaxesForExchangeOfStockOptions'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='fil_PaymentOfTaxesForExchangeOfStockOptions' use='optional' order='5.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_RepaymentsOfNotesPayable' use='optional' order='6.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets' xlink:label='us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_PaymentsToAcquireIntangibleAssets' use='optional' order='1.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization' xlink:label='us-gaap_AdjustmentForAmortization'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_AdjustmentForAmortization' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_DeferredIncomeTaxExpenseBenefit' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_Depreciation' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayable' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' xlink:label='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_ProfitLoss' use='optional' order='7.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='8.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_ShareBasedCompensation' use='optional' order='9.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='10.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='11.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables' xlink:label='us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInOtherReceivables' use='optional' order='12.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' order='13.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets' xlink:label='us-gaap_GainLossOnDispositionOfAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='us-gaap_GainLossOnDispositionOfAssets' use='optional' order='14.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' use='optional' order='1.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='2.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='3.0' weight='1.0'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' xlink:label='us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:to='us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:to='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:label='us-gaap_AccountsAndOtherReceivablesNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent' xlink:label='us-gaap_AccountsReceivableGrossCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:to='us-gaap_AccountsReceivableGrossCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable' xlink:label='us-gaap_IncomeTaxesReceivable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:to='us-gaap_IncomeTaxesReceivable' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestReceivableAndOtherAssets' xlink:label='us-gaap_InterestReceivableAndOtherAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:to='us-gaap_InterestReceivableAndOtherAssets' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:to='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' use='optional' order='4.0' weight='-1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves' xlink:label='us-gaap_InventoryFinishedGoodsNetOfReserves'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_InventoryNet' xlink:to='us-gaap_InventoryFinishedGoodsNetOfReserves' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterials' xlink:label='us-gaap_InventoryRawMaterials'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_InventoryNet' xlink:to='us-gaap_InventoryRawMaterials' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess' xlink:label='us-gaap_InventoryWorkInProcess'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_InventoryNet' xlink:to='us-gaap_InventoryWorkInProcess' use='optional' order='3.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet' xlink:label='us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross' xlink:label='us-gaap_FiniteLivedIntangibleAssetsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsNet' xlink:to='us-gaap_FiniteLivedIntangibleAssetsGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsNet' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedCustomerRelationshipsGross' xlink:label='us-gaap_FiniteLivedCustomerRelationshipsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsGross' xlink:to='us-gaap_FiniteLivedCustomerRelationshipsGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross' xlink:label='us-gaap_FiniteLivedNoncompeteAgreementsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsGross' xlink:to='us-gaap_FiniteLivedNoncompeteAgreementsGross' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedPatentsGross' xlink:label='us-gaap_FiniteLivedPatentsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsGross' xlink:to='us-gaap_FiniteLivedPatentsGross' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedTrademarksGross' xlink:label='us-gaap_FiniteLivedTrademarksGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsGross' xlink:to='us-gaap_FiniteLivedTrademarksGross' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' xlink:label='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_FiniteLivedIntangibleAssetsGross' xlink:to='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' use='optional' order='5.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent' xlink:label='us-gaap_AccruedIncomeTaxesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='us-gaap_AccruedIncomeTaxesCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent' xlink:label='us-gaap_EmployeeRelatedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='us-gaap_EmployeeRelatedLiabilitiesCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationReserveCurrent' xlink:label='us-gaap_LitigationReserveCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='us-gaap_LitigationReserveCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent' xlink:label='us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='us-gaap_OtherAccruedLiabilitiesCurrent' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:label='us-gaap_AvailableForSaleSecuritiesEquitySecurities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' xlink:label='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:to='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost' xlink:label='us-gaap_AvailableForSaleSecuritiesAmortizedCost'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:to='us-gaap_AvailableForSaleSecuritiesAmortizedCost' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' xlink:label='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:to='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' use='optional' order='3.0' weight='-1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land' xlink:label='us-gaap_Land'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_Land' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_MachineryAndEquipmentGross' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land' xlink:label='us-gaap_Land'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_Land' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='us-gaap_MachineryAndEquipmentGross' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:label='us-gaap_DeferredTaxAssetsLiabilitiesNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsInventory' xlink:label='us-gaap_DeferredTaxAssetsInventory'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='us-gaap_DeferredTaxAssetsInventory' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther' xlink:label='us-gaap_DeferredTaxAssetsOther'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='us-gaap_DeferredTaxAssetsOther' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' xlink:label='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' xlink:label='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_UnrealizedInvestmentLoss' xlink:label='fil_UnrealizedInvestmentLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='fil_UnrealizedInvestmentLoss' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:label='fil_DeferredTaxLiabilitiesDepreciationAndAmortization'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='fil_DeferredTaxLiabilitiesDepreciationAndAmortization' use='optional' order='6.0' weight='-1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:label='us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='us-gaap_CurrentIncomeTaxExpenseBenefit' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DeferredIncomeTaxExpense' xlink:label='fil_DeferredIncomeTaxExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='fil_DeferredIncomeTaxExpense' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:label='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:label='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' xlink:label='us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' xlink:label='us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments' xlink:label='us-gaap_IncomeTaxReconciliationOtherAdjustments'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='us-gaap_IncomeTaxReconciliationOtherAdjustments' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' xlink:label='us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' xlink:label='us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' use='optional' order='7.0' weight='-1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>utmd-20171231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK9NDL3JZWVL2VG7W3]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.utahmed.com/20171231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DocumentDocumentAndEntityInformation"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember' xlink:label='us-gaap_AdditionalPaidInCapitalMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_AdditionalPaidInCapitalMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_AccumulatedOtherComprehensiveIncomeMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember' xlink:label='us-gaap_RetainedEarningsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_RetainedEarningsMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockholdersEquity' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesIssued' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:label='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:label='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' xlink:label='us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense' xlink:label='us-gaap_StockOptionPlanExpense'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockOptionPlanExpense' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodShares'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash' xlink:label='us-gaap_DividendsCommonStockCash'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DividendsCommonStockCash' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ProfitLoss' use='optional' order='14.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3Investments" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3Investments"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3Investments"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipment" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipment"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipment"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote6LongTermDebt"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingencies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingencies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingencies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxes" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxes"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxes"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9Options" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9Options"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9Options"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformation" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote10GeographicInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformation"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformation" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote11GeographicLongLivedAssetsInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformation"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategory" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote12RevenuesByProductCategory"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategory"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote13ProductSaleAndPurchaseCommitments"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote14EmployeeBenefitPlans"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote15RecentAccountingPronouncements" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote15RecentAccountingPronouncements"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote15RecentAccountingPronouncements"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote16SubsequentEvents" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote16SubsequentEvents"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote16SubsequentEvents"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_PropertyPlantAndEquipmentByTypeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_PropertyPlantAndEquipmentTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_PropertyPlantAndEquipmentTypeDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember' xlink:label='us-gaap_BuildingAndBuildingImprovementsMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-gaap_BuildingAndBuildingImprovementsMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquipmentMember' xlink:label='us-gaap_EquipmentMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='us-gaap_EquipmentMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RangeAxis' use='optional' order='2.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RangeMember' xlink:to='us-gaap_MinimumMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RangeMember' xlink:to='us-gaap_MaximumMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife' xlink:label='us-gaap_PropertyPlantAndEquipmentUsefulLife'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentUsefulLife' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member' xlink:label='us-gaap_FairValueInputsLevel1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='us-gaap_FairValueInputsLevel1Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis' xlink:label='us-gaap_FairValueByMeasurementFrequencyAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByMeasurementFrequencyAxis' use='optional' order='2.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain' xlink:label='us-gaap_FairValueMeasurementFrequencyDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_FairValueByMeasurementFrequencyAxis' xlink:to='us-gaap_FairValueMeasurementFrequencyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain' xlink:label='us-gaap_FairValueMeasurementFrequencyDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_FairValueByMeasurementFrequencyAxis' xlink:to='us-gaap_FairValueMeasurementFrequencyDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember' xlink:label='us-gaap_FairValueMeasurementsRecurringMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_FairValueMeasurementFrequencyDomain' xlink:to='us-gaap_FairValueMeasurementsRecurringMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityFairValueDisclosure' xlink:label='us-gaap_EquityFairValueDisclosure'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_EquityFairValueDisclosure' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis' xlink:label='us-gaap_StatementGeographicalAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementGeographicalAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain' xlink:label='us-gaap_SegmentGeographicalDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='us-gaap_SegmentGeographicalDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain' xlink:label='us-gaap_SegmentGeographicalDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='us-gaap_SegmentGeographicalDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_U.S.AndCanadaMember' xlink:label='fil_U.S.AndCanadaMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SegmentGeographicalDomain' xlink:to='fil_U.S.AndCanadaMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EnglandAndAustraliaMember' xlink:label='fil_EnglandAndAustraliaMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SegmentGeographicalDomain' xlink:to='fil_EnglandAndAustraliaMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_IrelandMember' xlink:label='fil_IrelandMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SegmentGeographicalDomain' xlink:to='fil_IrelandMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land' xlink:label='us-gaap_Land'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_Land' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_MachineryAndEquipmentGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='7.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebtDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote6LongTermDebtDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebtDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LongtermDebtTypeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_JPMorganChaseBankNAChaseNoteMember' xlink:label='fil_JPMorganChaseBankNAChaseNoteMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_JPMorganChaseBankNAChaseNoteMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_JPMorganChaseLondonBranchNoteMember' xlink:label='fil_JPMorganChaseLondonBranchNoteMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='fil_JPMorganChaseLondonBranchNoteMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingenciesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_EquityComponentDomain' xlink:to='us-gaap_CommonStockMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareGranted' xlink:label='fil_PriceRangePerShareGranted'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareGranted' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareExpired' xlink:label='fil_PriceRangePerShareExpired'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareExpired' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareExercised' xlink:label='fil_PriceRangePerShareExercised'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareExercised' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareOutstanding' xlink:label='fil_PriceRangePerShareOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareTotalExercisable' xlink:label='fil_PriceRangePerShareTotalExercisable'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareTotalExercisable' use='optional' order='10.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis' xlink:label='us-gaap_StatementScenarioAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementScenarioAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain' xlink:label='us-gaap_ScenarioUnspecifiedDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_StatementScenarioAxis' xlink:to='us-gaap_ScenarioUnspecifiedDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain' xlink:label='us-gaap_ScenarioUnspecifiedDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_StatementScenarioAxis' xlink:to='us-gaap_ScenarioUnspecifiedDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_Range1Member' xlink:label='fil_Range1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_ScenarioUnspecifiedDomain' xlink:to='fil_Range1Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_Range2Member' xlink:label='fil_Range2Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_ScenarioUnspecifiedDomain' xlink:to='fil_Range2Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_WeightedAverageRemainingContractualLifeYears' xlink:label='fil_WeightedAverageRemainingContractualLifeYears'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WeightedAverageRemainingContractualLifeYears' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' xlink:label='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' xlink:label='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' use='optional' order='7.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails"/>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote14EmployeeBenefitPlansDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlansDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>utmd-20171231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK9NDL3JZWVL2VG7W3]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.utahmed.com/20171231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount' xlink:label='us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount' xlink:to='lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareOutstanding' xlink:label='fil_PriceRangePerShareOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price Range Per Share Outstanding</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareOutstanding' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the description of Price Range Per Share Outstanding, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRangePerShareOutstanding' xlink:to='lab_fil_PriceRangePerShareOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_UnrealizedInvestmentLoss' xlink:label='fil_UnrealizedInvestmentLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnrealizedInvestmentLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unrealized investment loss</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_UnrealizedInvestmentLoss' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of deferred tax asset attributable to deductible temporary differences from unrealized investment loss.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_UnrealizedInvestmentLoss' xlink:to='lab_fil_UnrealizedInvestmentLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent' xlink:label='us-gaap_EmployeeRelatedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EmployeeRelatedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Employee-related Liabilities, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EmployeeRelatedLiabilitiesCurrent' xlink:to='lab_us-gaap_EmployeeRelatedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross' xlink:label='us-gaap_FiniteLivedNoncompeteAgreementsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedNoncompeteAgreementsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Noncompete Agreements, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedNoncompeteAgreementsGross' xlink:to='lab_us-gaap_FiniteLivedNoncompeteAgreementsGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable' xlink:label='us-gaap_IncomeTaxesReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxesReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Taxes Receivable, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxesReceivable' xlink:to='lab_us-gaap_IncomeTaxesReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock' xlink:label='us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Income before Income Tax, Domestic and Foreign</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockMember' xlink:to='lab_us-gaap_CommonStockMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase (decrease) in accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Foreign currency translation tax adjustment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax' xlink:to='lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' xlink:label='us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred tax liability - intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' xlink:to='lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Cash</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>CASH AT BEGINNING OF YEAR</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>CASH AT END OF YEAR</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueNeonatal' xlink:label='fil_CompanyRevenueNeonatal'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueNeonatal' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Revenue Neonatal</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueNeonatal' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services in the Neonatal category during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyRevenueNeonatal' xlink:to='lab_fil_CompanyRevenueNeonatal'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' xlink:label='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' xlink:to='lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConstructionInProgressGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Construction in Progress, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConstructionInProgressGross' xlink:to='lab_us-gaap_ConstructionInProgressGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:label='us-gaap_AvailableForSaleSecuritiesEquitySecurities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Available-for-sale Securities, Equity Securities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Available-for-sale Securities, Equity Securities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:to='lab_us-gaap_AvailableForSaleSecuritiesEquitySecurities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' xlink:label='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' xlink:to='lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense' xlink:label='us-gaap_AllocatedShareBasedCompensationExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AllocatedShareBasedCompensationExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allocated Share-based Compensation Expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AllocatedShareBasedCompensationExpense' xlink:to='lab_us-gaap_AllocatedShareBasedCompensationExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Type [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock' xlink:label='us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Translation of Foreign Currencies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock' xlink:to='lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 8 - Income Taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxDisclosureTextBlock' xlink:to='lab_us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfNotesPayable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Repayments of notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepaymentsOfNotesPayable' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Repayments of notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RepaymentsOfNotesPayable' xlink:to='lab_us-gaap_RepaymentsOfNotesPayable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of common stock - options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:to='lab_us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Increase) decrease in accounts receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>(Increase) decrease in accounts receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet' xlink:label='us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherOperatingIncomeExpenseNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherOperatingIncomeExpenseNet' xlink:to='lab_us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold' xlink:label='us-gaap_CostOfGoodsSold'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfGoodsSold' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cost of goods sold</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfGoodsSold' xlink:to='lab_us-gaap_CostOfGoodsSold'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies' xlink:label='us-gaap_CommitmentsAndContingencies'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingencies' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Commitments and contingencies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingencies' xlink:to='lab_us-gaap_CommitmentsAndContingencies'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and equipment - net</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Property and equipment - net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueBloodPressureMonitoringAndAccessories' xlink:label='fil_CompanyRevenueBloodPressureMonitoringAndAccessories'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueBloodPressureMonitoringAndAccessories' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Revenue Blood Pressure Monitoring and Accessories</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueBloodPressureMonitoringAndAccessories' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services in the Blood Pressure Monitoring and Accessories category during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyRevenueBloodPressureMonitoringAndAccessories' xlink:to='lab_fil_CompanyRevenueBloodPressureMonitoringAndAccessories'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanySalesInTheUnitedStates' xlink:label='fil_CompanySalesInTheUnitedStates'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySalesInTheUnitedStates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Sales in the United States</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySalesInTheUnitedStates' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services to customers in the United States during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySalesInTheUnitedStates' xlink:to='lab_fil_CompanySalesInTheUnitedStates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther' xlink:label='us-gaap_DeferredTaxAssetsOther'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsOther' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Tax Assets, Other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsOther' xlink:to='lab_us-gaap_DeferredTaxAssetsOther'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_JPMorganChaseLondonBranchNoteMember' xlink:label='fil_JPMorganChaseLondonBranchNoteMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_JPMorganChaseLondonBranchNoteMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>JP Morgan Chase London Branch Note</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_JPMorganChaseLondonBranchNoteMember' xlink:to='lab_fil_JPMorganChaseLondonBranchNoteMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BuildingsAndImprovementsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Buildings and Improvements, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BuildingsAndImprovementsGross' xlink:to='lab_us-gaap_BuildingsAndImprovementsGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' xlink:label='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' xlink:to='lab_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent' xlink:label='us-gaap_AccruedIncomeTaxesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedIncomeTaxesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued Income Taxes, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedIncomeTaxesCurrent' xlink:to='lab_us-gaap_AccruedIncomeTaxesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PropertyPlantAndEquipmentByLocationTextBlock' xlink:label='fil_PropertyPlantAndEquipmentByLocationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyPlantAndEquipmentByLocationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property Plant and Equipment by Location</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PropertyPlantAndEquipmentByLocationTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Tabular disclosure by location of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PropertyPlantAndEquipmentByLocationTextBlock' xlink:to='lab_fil_PropertyPlantAndEquipmentByLocationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by (used in) investing activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash provided by (used in) investing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Capital expenditures for property and equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Capital expenditures for property and equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:to='lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProvisionForDoubtfulAccounts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Provision for (recovery of) losses on accounts receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProvisionForDoubtfulAccounts' xlink:to='lab_us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-US'>Unrealized gain (loss) on investments net of taxes of $6, $3, and $(1)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:to='lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Earnings per common share (diluted)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareDiluted' xlink:to='lab_us-gaap_EarningsPerShareDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestExpense' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Interest expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestExpense' xlink:to='lab_us-gaap_InterestExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Par Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis' xlink:label='us-gaap_StatementScenarioAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementScenarioAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Scenario [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementScenarioAxis' xlink:to='lab_us-gaap_StatementScenarioAxis'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareExercised' xlink:label='fil_PriceRangePerShareExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price Range Per Share Exercised</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareExercised' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the description of Price Range Per Share Exercised, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRangePerShareExercised' xlink:to='lab_fil_PriceRangePerShareExercised'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:label='fil_DeferredTaxLiabilitiesDepreciationAndAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Tax Liabilities Depreciation and Amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Deferred Tax Liabilities Depreciation and Amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Deferred tax liabilities from depreciation and amortization of property, plant, equipment, and intangible assets.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:to='lab_fil_DeferredTaxLiabilitiesDepreciationAndAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentFaceAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Face Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentFaceAmount' xlink:to='lab_us-gaap_DebtInstrumentFaceAmount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis' xlink:label='us-gaap_StatementGeographicalAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementGeographicalAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Geographical [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='lab_us-gaap_StatementGeographicalAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MinimumMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MinimumMember' xlink:to='lab_us-gaap_MinimumMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Share-based Compensation, Stock Options, Activity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock' xlink:label='us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Effective Income Tax Rate Reconciliation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock' xlink:label='us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Accounts and Other Receivables</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock' xlink:to='lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxPolicyTextBlock' xlink:to='lab_us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DisclosureTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='lab_us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred income taxes {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Deferred income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProfitLoss' xlink:to='lab_us-gaap_ProfitLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Shares Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesIssued' xlink:to='lab_us-gaap_PreferredStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions' xlink:label='us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Employee Service Share-based Compensation, Tax Benefit from Exercise of Stock Options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions' xlink:to='lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' xlink:label='us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' xlink:to='lab_us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' xlink:label='us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' xlink:to='lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain' xlink:label='us-gaap_FairValueMeasurementFrequencyDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementFrequencyDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Measurement Frequency</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementFrequencyDomain' xlink:to='lab_us-gaap_FairValueMeasurementFrequencyDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MaximumMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MaximumMember' xlink:to='lab_us-gaap_MaximumMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RangeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RangeAxis' xlink:to='lab_us-gaap_RangeAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock' xlink:label='us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Components of Income Tax Expense (Benefit)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TableTextBlockSupplementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tables/Schedules</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='lab_us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock' xlink:label='us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-lived Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock' xlink:to='lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock' xlink:label='us-gaap_ReceivablesPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ReceivablesPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ReceivablesPolicyTextBlock' xlink:to='lab_us-gaap_ReceivablesPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' xlink:label='us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tax benefit attributable to appreciation of stock options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' xlink:to='lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividends' xlink:label='us-gaap_PaymentsOfDividends'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsOfDividends' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Dividends paid</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsOfDividends' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Dividends paid</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsOfDividends' xlink:to='lab_us-gaap_PaymentsOfDividends'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase (decrease) in accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInventories' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Increase) decrease in inventories</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInventories' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>(Increase) decrease in inventories</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInInventories' xlink:to='lab_us-gaap_IncreaseDecreaseInInventories'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock-based compensation expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensation' xlink:to='lab_us-gaap_ShareBasedCompensation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Gross profit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Gross profit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GrossProfit' xlink:to='lab_us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SalesRevenueNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Sales, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SalesRevenueNet' xlink:to='lab_us-gaap_SalesRevenueNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent' xlink:label='us-gaap_OtherAssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid expenses and other current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAssetsCurrent' xlink:to='lab_us-gaap_OtherAssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueObstetrics' xlink:label='fil_CompanyRevenueObstetrics'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueObstetrics' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Revenue Obstetrics</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueObstetrics' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services in the Obstetrics category during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyRevenueObstetrics' xlink:to='lab_fil_CompanyRevenueObstetrics'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_WeightedAverageRemainingContractualLifeYears' xlink:label='fil_WeightedAverageRemainingContractualLifeYears'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageRemainingContractualLifeYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Remaining Contractual Life (Years)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_WeightedAverageRemainingContractualLifeYears' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Weighted Average Remaining Contractual Life (Years), as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_WeightedAverageRemainingContractualLifeYears' xlink:to='lab_fil_WeightedAverageRemainingContractualLifeYears'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' xlink:to='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:to='lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Allowance for Doubtful Accounts Receivable, Current</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Allowance for Doubtful Accounts Receivable, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:to='lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationReserve' xlink:label='us-gaap_LitigationReserve'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LitigationReserve' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Estimated Litigation Liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LitigationReserve' xlink:to='lab_us-gaap_LitigationReserve'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquipmentMember' xlink:label='us-gaap_EquipmentMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquipmentMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquipmentMember' xlink:to='lab_us-gaap_EquipmentMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 7 - Commitments and Contingencies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:to='lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:label='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock received and retired upon exercise of stock options, shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Common stock received and retired upon exercise of stock options, shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Common stock received and retired upon exercise of stock options, shares (number of shares), during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:to='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock issued upon exercise of employee stock options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' xlink:to='lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Increase) decrease in prepaid expenses and other current assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>(Increase) decrease in prepaid expenses and other current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:to='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization' xlink:label='us-gaap_AdjustmentForAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentForAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentForAmortization' xlink:to='lab_us-gaap_AdjustmentForAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense' xlink:label='us-gaap_SellingAndMarketingExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SellingAndMarketingExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Sales and marketing</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SellingAndMarketingExpense' xlink:to='lab_us-gaap_SellingAndMarketingExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Retained earnings</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInEngland' xlink:label='fil_LongLivedAssetsInEngland'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInEngland' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-lived assets in England</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInEngland' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in England.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongLivedAssetsInEngland' xlink:to='lab_fil_LongLivedAssetsInEngland'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DeferredIncomeTaxExpense' xlink:label='fil_DeferredIncomeTaxExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredIncomeTaxExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Income Tax Expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_DeferredIncomeTaxExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Deferred Income Tax Expense, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DeferredIncomeTaxExpense' xlink:to='lab_fil_DeferredIncomeTaxExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MachineryAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Machinery and Equipment, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MachineryAndEquipmentGross' xlink:to='lab_us-gaap_MachineryAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess' xlink:label='us-gaap_InventoryWorkInProcess'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryWorkInProcess' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory, Work in Process, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryWorkInProcess' xlink:to='lab_us-gaap_InventoryWorkInProcess'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:label='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective Income Tax Rate Reconciliation TaxCuts And Jobs Act Of 2017 Transition Tax On Accumulated Foreign Earnings Amount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:to='lab_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Table]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables' xlink:label='us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOtherReceivables' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>(Increase) decrease in other receivables</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOtherReceivables' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>(Increase) decrease in other receivables</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOtherReceivables' xlink:to='lab_us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets' xlink:label='us-gaap_GainLossOnDispositionOfAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnDispositionOfAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on disposal of assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnDispositionOfAssets' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Loss on disposal of assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainLossOnDispositionOfAssets' xlink:to='lab_us-gaap_GainLossOnDispositionOfAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Earnings per common shares (basic)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasic' xlink:to='lab_us-gaap_EarningsPerShareBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating expense:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='lab_us-gaap_OperatingExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure' xlink:label='us-gaap_InvestmentsFairValueDisclosure'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentsFairValueDisclosure' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investments, available-for-sale</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InvestmentsFairValueDisclosure' xlink:to='lab_us-gaap_InvestmentsFairValueDisclosure'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract' xlink:label='us-gaap_StatementOfFinancialPositionAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfFinancialPositionAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement of Financial Position</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='lab_us-gaap_StatementOfFinancialPositionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Central Index Key</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInCanada' xlink:label='fil_LongLivedAssetsInCanada'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInCanada' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-lived assets in Canada</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInCanada' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in Canada.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongLivedAssetsInCanada' xlink:to='lab_fil_LongLivedAssetsInCanada'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanySalesOther' xlink:label='fil_CompanySalesOther'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySalesOther' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Sales Other</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySalesOther' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services to customers outside of the United States and Europe during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySalesOther' xlink:to='lab_fil_CompanySalesOther'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EnglandAndAustraliaMember' xlink:label='fil_EnglandAndAustraliaMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_EnglandAndAustraliaMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>England and Australia</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_EnglandAndAustraliaMember' xlink:to='lab_fil_EnglandAndAustraliaMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain' xlink:label='us-gaap_SegmentGeographicalDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SegmentGeographicalDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Segment, Geographical</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SegmentGeographicalDomain' xlink:to='lab_us-gaap_SegmentGeographicalDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent' xlink:label='us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock' xlink:label='us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Finite-Lived Intangible Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock' xlink:label='us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenueRecognitionPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenue Recognition</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenueRecognitionPolicyTextBlock' xlink:to='lab_us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:label='us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Intangible Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:to='lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:label='us-gaap_ConcentrationRiskDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Concentration of Credit Risk</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:to='lab_us-gaap_ConcentrationRiskDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_GeographicLongLivedAssetsInformationTextBlock' xlink:label='fil_GeographicLongLivedAssetsInformationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GeographicLongLivedAssetsInformationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 11 - Geographic Long-Lived Assets Information</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GeographicLongLivedAssetsInformationTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Geographic Long-Lived Assets Information.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GeographicLongLivedAssetsInformationTextBlock' xlink:to='lab_fil_GeographicLongLivedAssetsInformationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongTermDebtTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 6 - Long-term Debt</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongTermDebtTextBlock' xlink:to='lab_us-gaap_LongTermDebtTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:label='fil_PaymentOfTaxesForExchangeOfStockOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payment of taxes for exchange of stock options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Payment of taxes for exchange of stock options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Payment of taxes for exchange of stock options, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:to='lab_fil_PaymentOfTaxesForExchangeOfStockOptions'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Depreciation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Depreciation' xlink:to='lab_us-gaap_Depreciation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherInterestAndDividendIncome' xlink:label='us-gaap_OtherInterestAndDividendIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherInterestAndDividendIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Dividend and interest income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherInterestAndDividendIncome' xlink:to='lab_us-gaap_OtherInterestAndDividendIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesOutstanding' xlink:to='lab_us-gaap_PreferredStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock, $.01 par value; 50,000 shares authorized, issued 3,721 shares in 2017 and 3,713 shares in 2016</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' xlink:to='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:label='us-gaap_DeferredTaxAssetsLiabilitiesNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Tax Assets, Net</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Deferred Tax Assets, Net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:to='lab_us-gaap_DeferredTaxAssetsLiabilitiesNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongtermDebtTypeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term Debt, Type [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='lab_us-gaap_LongtermDebtTypeAxis'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_IrelandMember' xlink:label='fil_IrelandMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_IrelandMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Ireland</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_IrelandMember' xlink:to='lab_fil_IrelandMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Measurements, Fair Value Hierarchy</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:to='lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedPatentsGross' xlink:label='us-gaap_FiniteLivedPatentsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedPatentsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Patents, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedPatentsGross' xlink:to='lab_us-gaap_FiniteLivedPatentsGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Number of Shares Outstanding, Diluted</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Weighted Average Number of Shares Outstanding, Diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:to='lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Number of Shares Outstanding, Basic</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:to='lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RangeMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RangeMember' xlink:to='lab_us-gaap_RangeMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ScheduleOfGeographicInformationTextBlock' xlink:label='fil_ScheduleOfGeographicInformationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfGeographicInformationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule Of Geographic Information</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfGeographicInformationTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Schedule Of Geographic Sales Information.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfGeographicInformationTextBlock' xlink:to='lab_fil_ScheduleOfGeographicInformationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Deferred Tax Assets and Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:label='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and Cash Equivalents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:to='lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PolicyTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='lab_us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SignificantAccountingPoliciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 1 - Summary of Significant Accounting Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SignificantAccountingPoliciesTextBlock' xlink:to='lab_us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Balance, shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesIssued' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance, shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesIssued' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance, shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharesIssued' xlink:to='lab_us-gaap_SharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Line Items]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated Other Comprehensive Income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedOtherComprehensiveIncomeMember' xlink:to='lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised' xlink:label='us-gaap_DeferredTaxExpenseFromStockOptionsExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxExpenseFromStockOptionsExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tax benefit attributable to exercise of stock options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxExpenseFromStockOptionsExercised' xlink:to='lab_us-gaap_DeferredTaxExpenseFromStockOptionsExercised'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Unrealized gain (loss) on investments tax adjustment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax' xlink:to='lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Foreign currency translation adjustment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:role='http://www.xbrl.org/2003/role/verboseLabel' xml:lang='en-US'>Foreign currency translation net of taxes of $0 in all periods</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:to='lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating' xlink:label='us-gaap_RoyaltyIncomeNonoperating'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RoyaltyIncomeNonoperating' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Royalty income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RoyaltyIncomeNonoperating' xlink:to='lab_us-gaap_RoyaltyIncomeNonoperating'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherIncomeAndExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other income (expense):</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherIncomeAndExpensesAbstract' xlink:to='lab_us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Par Value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred stock, $.01 par value; 5,000 shares authorized, no shares issued and outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockValue' xlink:to='lab_us-gaap_PreferredStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill' xlink:label='us-gaap_Goodwill'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Goodwill' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Goodwill</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Goodwill' xlink:to='lab_us-gaap_Goodwill'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current assets:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_DocumentAndEntityInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document and Entity Information:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='lab_fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' xlink:to='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareTotalExercisable' xlink:label='fil_PriceRangePerShareTotalExercisable'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareTotalExercisable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price Range Per Share Total Exercisable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareTotalExercisable' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the description of Price Range Per Share Total Exercisable, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRangePerShareTotalExercisable' xlink:to='lab_fil_PriceRangePerShareTotalExercisable'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareExpired' xlink:label='fil_PriceRangePerShareExpired'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareExpired' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price Range Per Share Expired</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareExpired' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the description of Price Range Per Share Expired, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRangePerShareExpired' xlink:to='lab_fil_PriceRangePerShareExpired'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' xlink:label='us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' xlink:to='lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' xlink:label='us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' xlink:to='lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments Due</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterials' xlink:label='us-gaap_InventoryRawMaterials'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryRawMaterials' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory, Raw Materials, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryRawMaterials' xlink:to='lab_us-gaap_InventoryRawMaterials'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' xlink:label='us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' xlink:to='lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember' xlink:label='us-gaap_BuildingAndBuildingImprovementsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BuildingAndBuildingImprovementsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Building and Building Improvements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BuildingAndBuildingImprovementsMember' xlink:to='lab_us-gaap_BuildingAndBuildingImprovementsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentPolicyTextBlock' xlink:label='us-gaap_InvestmentPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investments {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Investments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InvestmentPolicyTextBlock' xlink:to='lab_us-gaap_InvestmentPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 15 - Recent Accounting Pronouncements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock issued upon exercise of employee stock options, shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:to='lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComprehensiveIncomeNetOfTax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total comprehensive income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ComprehensiveIncomeNetOfTax' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total comprehensive income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ComprehensiveIncomeNetOfTax' xlink:to='lab_us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesIssued' xlink:to='lab_us-gaap_CommonStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross' xlink:label='us-gaap_FiniteLivedIntangibleAssetsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other intangible assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsGross' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Other intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsGross' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventories</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryNet' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Inventories</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryNet' xlink:to='lab_us-gaap_InventoryNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanySalesInEurope' xlink:label='fil_CompanySalesInEurope'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySalesInEurope' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Sales in Europe</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanySalesInEurope' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services to customers in Europe during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanySalesInEurope' xlink:to='lab_fil_CompanySalesInEurope'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' xlink:label='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' xlink:to='lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_Range1Member' xlink:label='fil_Range1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Range1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range 1</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Range1Member' xlink:to='lab_fil_Range1Member'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_U.S.AndCanadaMember' xlink:label='fil_U.S.AndCanadaMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_U.S.AndCanadaMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>U.S. and Canada</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_U.S.AndCanadaMember' xlink:to='lab_fil_U.S.AndCanadaMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedTrademarksGross' xlink:label='us-gaap_FiniteLivedTrademarksGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedTrademarksGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Trademarks, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedTrademarksGross' xlink:to='lab_us-gaap_FiniteLivedTrademarksGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves' xlink:label='us-gaap_InventoryFinishedGoodsNetOfReserves'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryFinishedGoodsNetOfReserves' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory, Finished Goods, Net of Reserves</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryFinishedGoodsNetOfReserves' xlink:to='lab_us-gaap_InventoryFinishedGoodsNetOfReserves'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PresentationOfSalesAndSimilarTaxesTextBlock' xlink:label='fil_PresentationOfSalesAndSimilarTaxesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PresentationOfSalesAndSimilarTaxesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Presentation of Sales and Similar Taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PresentationOfSalesAndSimilarTaxesTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Presentation of Sales and Similar Taxes.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PresentationOfSalesAndSimilarTaxesTextBlock' xlink:to='lab_fil_PresentationOfSalesAndSimilarTaxesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerSharePolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Earnings Per Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerSharePolicyTextBlock' xlink:to='lab_us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock' xlink:label='us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 9 - Options</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock' xlink:to='lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense' xlink:label='us-gaap_StockOptionPlanExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockOptionPlanExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock option compensation expense</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockOptionPlanExpense' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Stock option compensation expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockOptionPlanExpense' xlink:to='lab_us-gaap_StockOptionPlanExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfCashFlowsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement of Cash Flows</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='lab_us-gaap_StatementOfCashFlowsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesAuthorized' xlink:to='lab_us-gaap_PreferredStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsReceivableNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts &amp; other receivables - net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsReceivableNetCurrent' xlink:to='lab_us-gaap_AccountsReceivableNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Current Reporting Status</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ContractualObligation' xlink:label='us-gaap_ContractualObligation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ContractualObligation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Contractual Obligation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ContractualObligation' xlink:to='lab_us-gaap_ContractualObligation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain' xlink:label='us-gaap_ScenarioUnspecifiedDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScenarioUnspecifiedDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Scenario, Unspecified</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScenarioUnspecifiedDomain' xlink:to='lab_us-gaap_ScenarioUnspecifiedDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsInventory' xlink:label='us-gaap_DeferredTaxAssetsInventory'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsInventory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Tax Assets, Inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsInventory' xlink:to='lab_us-gaap_DeferredTaxAssetsInventory'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityFairValueDisclosure' xlink:label='us-gaap_EquityFairValueDisclosure'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquityFairValueDisclosure' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity, Fair Value Disclosure</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquityFairValueDisclosure' xlink:to='lab_us-gaap_EquityFairValueDisclosure'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Hierarchy [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='lab_us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' xlink:label='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Regulatory approvals &amp; product certifications</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Gross carrying amount before accumulated amortization as of the balance sheet date of regulatory approvals and product certifications.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' xlink:to='lab_fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestReceivableAndOtherAssets' xlink:label='us-gaap_InterestReceivableAndOtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestReceivableAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest Receivable and Other Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestReceivableAndOtherAssets' xlink:to='lab_us-gaap_InterestReceivableAndOtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' xlink:label='fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Foreign Currency Exchange Rate Translation GBP to USD</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Foreign exchange rate used to translate amounts denominated in functional currency GBP to reporting currency USD.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' xlink:to='lab_fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' xlink:label='fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule Of Long-Lived Assets By Geographic Area</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Schedule Of Long-lived Assets By Geographic Area.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' xlink:to='lab_fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock' xlink:to='lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock' xlink:label='us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Available-for-sale Securities Reconciliation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Accrued Expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Use of Estimates in The Preparation of Financial Statements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock' xlink:label='us-gaap_GainLossOnInvestmentsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnInvestmentsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 3 - Investments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainLossOnInvestmentsTextBlock' xlink:to='lab_us-gaap_GainLossOnInvestmentsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodShares'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock purchased and retired, shares</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Common stock purchased and retired, shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' xlink:to='lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember' xlink:label='us-gaap_AdditionalPaidInCapitalMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapitalMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional Paid-In Capitol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapitalMember' xlink:to='lab_us-gaap_AdditionalPaidInCapitalMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>General and administrative</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_GeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract' xlink:label='us-gaap_IncomeStatementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeStatementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Statement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='lab_us-gaap_IncomeStatementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued expenses</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Accrued expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_AccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LongtermDebtTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-term Debt, Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LongtermDebtTypeDomain' xlink:to='lab_us-gaap_LongtermDebtTypeDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:to='lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationReserveCurrent' xlink:label='us-gaap_LitigationReserveCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LitigationReserveCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Estimated Litigation Liability, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LitigationReserveCurrent' xlink:to='lab_us-gaap_LitigationReserveCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet' xlink:label='us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Intangible Assets, Net</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsNet' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Finite-Lived Intangible Assets, Net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsNet' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent' xlink:label='us-gaap_AccountsReceivableGrossCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsReceivableGrossCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts Receivable, Gross, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsReceivableGrossCurrent' xlink:to='lab_us-gaap_AccountsReceivableGrossCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife' xlink:label='us-gaap_PropertyPlantAndEquipmentUsefulLife'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentUsefulLife' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Useful Life</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentUsefulLife' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentUsefulLife'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock' xlink:label='us-gaap_LegalCostsPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LegalCostsPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Legal Costs</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LegalCostsPolicyTextBlock' xlink:to='lab_us-gaap_LegalCostsPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock' xlink:label='us-gaap_FairValueDisclosuresTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueDisclosuresTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 4 - Fair Value Measurements and Financial Instruments</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueDisclosuresTextBlock' xlink:to='lab_us-gaap_FairValueDisclosuresTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock' xlink:label='us-gaap_SupplementalBalanceSheetDisclosuresTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 2 - Detail of Certain Balance Sheet Accounts</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SupplementalBalanceSheetDisclosuresTextBlock' xlink:to='lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash' xlink:label='us-gaap_DividendsCommonStockCash'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DividendsCommonStockCash' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock dividends</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DividendsCommonStockCash' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Common stock dividends</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DividendsCommonStockCash' xlink:to='lab_us-gaap_DividendsCommonStockCash'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract' xlink:label='us-gaap_StatementOfStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementOfStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement of Stockholders&apos; Equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementOfStockholdersEquityAbstract' xlink:to='lab_us-gaap_StatementOfStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by (used in) financing activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash provided by (used in) financing activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income before provision for income taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Income before provision for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesOutstanding' xlink:to='lab_us-gaap_CommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesAuthorized' xlink:to='lab_us-gaap_CommonStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock' xlink:label='us-gaap_AdditionalPaidInCapitalCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapitalCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional paid-in capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapitalCommonStock' xlink:to='lab_us-gaap_AdditionalPaidInCapitalCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated other comprehensive income (loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' xlink:to='lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' xlink:label='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long Term income tax payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017, classified as noncurrent.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' xlink:to='lab_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Voluntary Filers</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInAustralia' xlink:label='fil_LongLivedAssetsInAustralia'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInAustralia' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-lived assets in Australia</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInAustralia' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in Australia.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongLivedAssetsInAustralia' xlink:to='lab_fil_LongLivedAssetsInAustralia'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInIreland' xlink:label='fil_LongLivedAssetsInIreland'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInIreland' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-lived assets in Ireland</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInIreland' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in Ireland.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongLivedAssetsInIreland' xlink:to='lab_fil_LongLivedAssetsInIreland'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments' xlink:label='us-gaap_IncomeTaxReconciliationOtherAdjustments'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxReconciliationOtherAdjustments' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxReconciliationOtherAdjustments' xlink:to='lab_us-gaap_IncomeTaxReconciliationOtherAdjustments'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet' xlink:label='us-gaap_OperatingLeasesRentExpenseNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesRentExpenseNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Rent Expense, Net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesRentExpenseNet' xlink:to='lab_us-gaap_OperatingLeasesRentExpenseNet'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_JPMorganChaseBankNAChaseNoteMember' xlink:label='fil_JPMorganChaseBankNAChaseNoteMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_JPMorganChaseBankNAChaseNoteMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>JP Morgan Chase Bank NA (Chase) Note</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_JPMorganChaseBankNAChaseNoteMember' xlink:to='lab_fil_JPMorganChaseBankNAChaseNoteMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property, Plant and Equipment, Gross</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentGross' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Property, Plant and Equipment, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentGross' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:label='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TaxCuts And Jobs Act Of 2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>TaxCuts And Jobs Act Of 2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:to='lab_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ScheduleOfRevenuesByProductCategoryTextBlock' xlink:label='fil_ScheduleOfRevenuesByProductCategoryTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfRevenuesByProductCategoryTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule Of Revenues By Product Category</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ScheduleOfRevenuesByProductCategoryTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Schedule Of Revenues By Product Category.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ScheduleOfRevenuesByProductCategoryTextBlock' xlink:to='lab_fil_ScheduleOfRevenuesByProductCategoryTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock' xlink:label='us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Weighted Average Number of Shares</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:label='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock-based Compensation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:to='lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ConsolidationPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Principles of Consolidation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ConsolidationPolicyTextBlock' xlink:to='lab_us-gaap_ConsolidationPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock' xlink:label='us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 14 - Employee Benefit Plans</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock' xlink:to='lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_RevenuesByProductCategoryTextBlock' xlink:label='fil_RevenuesByProductCategoryTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_RevenuesByProductCategoryTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 12 - Revenues by Product Category</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_RevenuesByProductCategoryTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Revenues by Product Category.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_RevenuesByProductCategoryTextBlock' xlink:to='lab_fil_RevenuesByProductCategoryTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EquityComponentDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Component</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EquityComponentDomain' xlink:to='lab_us-gaap_EquityComponentDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementEquityComponentsAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Equity Components [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='lab_us-gaap_StatementEquityComponentsAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock purchased and retired</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:to='lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ResearchAndDevelopmentExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and development</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ResearchAndDevelopmentExpense' xlink:to='lab_us-gaap_ResearchAndDevelopmentExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:to='lab_us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' xlink:to='lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareGranted' xlink:label='fil_PriceRangePerShareGranted'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareGranted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Price Range Per Share Granted</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_PriceRangePerShareGranted' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the description of Price Range Per Share Granted, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_PriceRangePerShareGranted' xlink:to='lab_fil_PriceRangePerShareGranted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost' xlink:label='us-gaap_AvailableForSaleSecuritiesAmortizedCost'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Available-for-sale Securities, Amortized Cost Basis</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AvailableForSaleSecuritiesAmortizedCost' xlink:to='lab_us-gaap_AvailableForSaleSecuritiesAmortizedCost'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Effect of exchange rate changes on cash</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:to='lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net cash provided by operating activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net cash provided by operating activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' xlink:label='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Increase (decrease) in Long-term repatriation tax payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' xlink:to='lab_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating income</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Operating income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingIncomeLoss' xlink:to='lab_us-gaap_OperatingIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total stockholders&apos; equity</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total stockholders&apos; equity</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Balance, value</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Balance, value</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquity' xlink:to='lab_us-gaap_StockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableCurrent' xlink:to='lab_us-gaap_AccountsPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other intangible assets - net</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Other intangible assets - net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:to='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInTheUnitedStates' xlink:label='fil_LongLivedAssetsInTheUnitedStates'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInTheUnitedStates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-lived assets in the United States</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_LongLivedAssetsInTheUnitedStates' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in the United States.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_LongLivedAssetsInTheUnitedStates' xlink:to='lab_fil_LongLivedAssetsInTheUnitedStates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' xlink:label='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' xlink:to='lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:to='lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis' xlink:label='us-gaap_FairValueByMeasurementFrequencyAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueByMeasurementFrequencyAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Measurement Frequency [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueByMeasurementFrequencyAxis' xlink:to='lab_us-gaap_FairValueByMeasurementFrequencyAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member' xlink:label='us-gaap_FairValueInputsLevel1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueInputsLevel1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Inputs, Level 1</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueInputsLevel1Member' xlink:to='lab_us-gaap_FairValueInputsLevel1Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedCustomerRelationshipsGross' xlink:label='us-gaap_FiniteLivedCustomerRelationshipsGross'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedCustomerRelationshipsGross' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Finite-Lived Customer Relationships, Gross</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedCustomerRelationshipsGross' xlink:to='lab_us-gaap_FiniteLivedCustomerRelationshipsGross'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:label='us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Inventory, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ProductSaleAndPurchaseCommitmentsTextBlock' xlink:label='fil_ProductSaleAndPurchaseCommitmentsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProductSaleAndPurchaseCommitmentsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 13 - Product Sale and Purchase Commitments</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ProductSaleAndPurchaseCommitmentsTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Product Sale and Purchase Commitments.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ProductSaleAndPurchaseCommitmentsTextBlock' xlink:to='lab_fil_ProductSaleAndPurchaseCommitmentsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid' xlink:label='us-gaap_IncomeTaxesPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxesPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid during the year for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxesPaid' xlink:to='lab_us-gaap_IncomeTaxesPaid'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets' xlink:label='us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Capital expenditures for intangible assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireIntangibleAssets' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Capital expenditures for intangible assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquireIntangibleAssets' xlink:to='lab_us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_OtherComprehensiveIncomeAbstract' xlink:label='fil_OtherComprehensiveIncomeAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_OtherComprehensiveIncomeAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other comprehensive income:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_OtherComprehensiveIncomeAbstract' xlink:to='lab_fil_OtherComprehensiveIncomeAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stockholders&apos; equity:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other intangible assets - accumulated amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Other intangible assets - accumulated amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:to='lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Period End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueGynecologyElectrosurgeryUrology' xlink:label='fil_CompanyRevenueGynecologyElectrosurgeryUrology'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueGynecologyElectrosurgeryUrology' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Company Revenue Gynecology/Electrosurgery/Urology</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CompanyRevenueGynecologyElectrosurgeryUrology' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Total revenue from sales of goods and services in the Gynecology/Electrosurgery/Urology category during the period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CompanyRevenueGynecologyElectrosurgeryUrology' xlink:to='lab_fil_CompanyRevenueGynecologyElectrosurgeryUrology'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' xlink:label='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' xlink:to='lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_Range2Member' xlink:label='fil_Range2Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Range2Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range 2</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Range2Member' xlink:to='lab_fil_Range2Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:label='us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Income Tax Expense (Benefit)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land' xlink:label='us-gaap_Land'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Land' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Land</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Land' xlink:to='lab_us-gaap_Land'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember' xlink:label='us-gaap_FairValueMeasurementsRecurringMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueMeasurementsRecurringMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value, Measurements, Recurring</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueMeasurementsRecurringMember' xlink:to='lab_us-gaap_FairValueMeasurementsRecurringMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:label='us-gaap_AccountsAndOtherReceivablesNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts and Other Receivables, Net, Current</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Accounts and Other Receivables, Net, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:to='lab_us-gaap_AccountsAndOtherReceivablesNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' xlink:label='fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Foreign Currency Exchange Rate Translation AUD to USD</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Foreign exchange rate used to translate amounts denominated in functional currency AUD to reporting currency USD.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' xlink:to='lab_fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock' xlink:label='us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryPolicyTextBlock' xlink:label='us-gaap_InventoryPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventories {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Inventories</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryPolicyTextBlock' xlink:to='lab_us-gaap_InventoryPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 16 - Subsequent Events</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsTextBlock' xlink:to='lab_us-gaap_SubsequentEventsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_GeographicInformationTextBlock' xlink:label='fil_GeographicInformationTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_GeographicInformationTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 10 - Geographic Information</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_GeographicInformationTextBlock' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Geographic Sales Information.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_GeographicInformationTextBlock' xlink:to='lab_fil_GeographicInformationTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 5 - Property and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:label='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common stock received and retired upon exercise of stock options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Common stock received and retired upon exercise of stock options</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Common stock received and retired upon exercise of stock options, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:to='lab_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember' xlink:label='us-gaap_RetainedEarningsMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Retained Earnings</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsMember' xlink:to='lab_us-gaap_RetainedEarningsMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash paid during the year for interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPaid' xlink:to='lab_us-gaap_InterestPaid'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:to='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Provision for income taxes</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Provision for income taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_IncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Fiscal Year End Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>utmd-20171231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK9NDL3JZWVL2VG7W3]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.utahmed.com/20171231"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DocumentAndEntityInformationAbstract' xlink:label='fil_DocumentAndEntityInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentType' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_DocumentAndEntityInformationAbstract' xlink:to='dei_TradingSymbol' use='optional' order='15.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract' xlink:label='us-gaap_StatementOfFinancialPositionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AssetsAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure' xlink:label='us-gaap_InvestmentsFairValueDisclosure'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_InvestmentsFairValueDisclosure' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AccountsReceivableNetCurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent' xlink:label='us-gaap_OtherAssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_OtherAssetsCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill' xlink:label='us-gaap_Goodwill'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_Goodwill' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross' xlink:label='us-gaap_FiniteLivedIntangibleAssetsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsGross' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' use='optional' order='12.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='13.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_Assets' use='optional' order='14.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='19.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' xlink:label='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' xlink:label='us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent' xlink:label='us-gaap_DeferredTaxLiabilitiesNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_DeferredTaxLiabilitiesNoncurrent' use='optional' order='22.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_Liabilities' use='optional' order='23.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies' xlink:label='us-gaap_CommitmentsAndContingencies'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CommitmentsAndContingencies' use='optional' order='24.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='25.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_PreferredStockValue' use='optional' order='26.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='27.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1' use='optional' order='28.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock' xlink:label='us-gaap_AdditionalPaidInCapitalCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_AdditionalPaidInCapitalCommonStock' use='optional' order='29.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='30.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_StockholdersEquity' use='optional' order='31.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='32.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract' xlink:label='us-gaap_StatementOfFinancialPositionAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_PreferredStockSharesIssued' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfFinancialPositionAbstract' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='8.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract' xlink:label='us-gaap_IncomeStatementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_SalesRevenueNet' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold' xlink:label='us-gaap_CostOfGoodsSold'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_CostOfGoodsSold' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_GrossProfit' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OperatingExpensesAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense' xlink:label='us-gaap_SellingAndMarketingExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_SellingAndMarketingExpense' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_ResearchAndDevelopmentExpense' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss' xlink:label='us-gaap_OperatingIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OperatingIncomeLoss' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract' xlink:label='us-gaap_OtherIncomeAndExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherIncomeAndExpensesAbstract' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherInterestAndDividendIncome' xlink:label='us-gaap_OtherInterestAndDividendIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherInterestAndDividendIncome' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating' xlink:label='us-gaap_RoyaltyIncomeNonoperating'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_RoyaltyIncomeNonoperating' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense' xlink:label='us-gaap_InterestExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_InterestExpense' use='optional' order='12.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet' xlink:label='us-gaap_OtherOperatingIncomeExpenseNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherOperatingIncomeExpenseNet' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' use='optional' order='14.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_ProfitLoss' use='optional' order='16.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic' xlink:label='us-gaap_EarningsPerShareBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_EarningsPerShareBasic' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted' xlink:label='us-gaap_EarningsPerShareDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_EarningsPerShareDiluted' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_OtherComprehensiveIncomeAbstract' xlink:label='fil_OtherComprehensiveIncomeAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='fil_OtherComprehensiveIncomeAbstract' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' use='optional' order='20.0' preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' use='optional' order='21.0' preferredLabel='http://www.xbrl.org/2003/role/verboseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax' xlink:label='us-gaap_ComprehensiveIncomeNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_ComprehensiveIncomeNetOfTax' use='optional' order='22.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract' xlink:label='us-gaap_IncomeStatementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncomeStatementAbstract' xlink:to='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract' xlink:label='us-gaap_StatementOfCashFlowsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_ProfitLoss' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_Depreciation' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization' xlink:label='us-gaap_AdjustmentForAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_AdjustmentForAmortization' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts' xlink:label='us-gaap_ProvisionForDoubtfulAccounts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_ProvisionForDoubtfulAccounts' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets' xlink:label='us-gaap_GainLossOnDispositionOfAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_GainLossOnDispositionOfAssets' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit' xlink:label='us-gaap_DeferredIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_DeferredIncomeTaxExpenseBenefit' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_ShareBasedCompensation' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='10.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables' xlink:label='us-gaap_IncreaseDecreaseInOtherReceivables'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInOtherReceivables' use='optional' order='11.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='12.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' order='13.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayable' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' xlink:label='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivities' use='optional' order='17.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' xlink:label='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_PaymentsToAcquirePropertyPlantAndEquipment' use='optional' order='19.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets' xlink:label='us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_PaymentsToAcquireIntangibleAssets' use='optional' order='20.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='21.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' use='optional' order='22.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_ProceedsFromIssuanceOfCommonStock' use='optional' order='23.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' use='optional' order='24.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PaymentOfTaxesForExchangeOfStockOptions' xlink:label='fil_PaymentOfTaxesForExchangeOfStockOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='fil_PaymentOfTaxesForExchangeOfStockOptions' use='optional' order='25.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised' xlink:label='us-gaap_DeferredTaxExpenseFromStockOptionsExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_DeferredTaxExpenseFromStockOptionsExercised' use='optional' order='26.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfNotesPayable' xlink:label='us-gaap_RepaymentsOfNotesPayable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_RepaymentsOfNotesPayable' use='optional' order='27.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividends' xlink:label='us-gaap_PaymentsOfDividends'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_PaymentsOfDividends' use='optional' order='28.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='29.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' xlink:label='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents' use='optional' order='30.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease' use='optional' order='31.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='32.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue_1' use='optional' order='33.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid' xlink:label='us-gaap_IncomeTaxesPaid'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_IncomeTaxesPaid' use='optional' order='34.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfCashFlowsAbstract' xlink:to='us-gaap_InterestPaid' use='optional' order='35.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract' xlink:label='us-gaap_StatementOfStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementOfStockholdersEquityAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember' xlink:label='us-gaap_AdditionalPaidInCapitalMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_AdditionalPaidInCapitalMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember' xlink:label='us-gaap_AccumulatedOtherComprehensiveIncomeMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_AccumulatedOtherComprehensiveIncomeMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember' xlink:label='us-gaap_RetainedEarningsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_RetainedEarningsMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockholdersEquity' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesIssued' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' xlink:label='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' xlink:label='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' xlink:label='us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense' xlink:label='us-gaap_StockOptionPlanExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockOptionPlanExpense' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockRepurchasedAndRetiredDuringPeriodValue' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' xlink:label='us-gaap_StockRepurchasedAndRetiredDuringPeriodShares'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockRepurchasedAndRetiredDuringPeriodShares' use='optional' order='10.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' xlink:label='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash' xlink:label='us-gaap_DividendsCommonStockCash'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DividendsCommonStockCash' use='optional' order='13.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ProfitLoss' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity' xlink:label='us-gaap_StockholdersEquity_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockholdersEquity_1' use='optional' order='15.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesIssued_1' use='optional' order='16.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SignificantAccountingPoliciesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock' xlink:label='us-gaap_SupplementalBalanceSheetDisclosuresTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SupplementalBalanceSheetDisclosuresTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3Investments" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3Investments"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3Investments">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock' xlink:label='us-gaap_GainLossOnInvestmentsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_GainLossOnInvestmentsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock' xlink:label='us-gaap_FairValueDisclosuresTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_FairValueDisclosuresTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipment" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipment"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipment">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote6LongTermDebt"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtTextBlock' xlink:label='us-gaap_LongTermDebtTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_LongTermDebtTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingencies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingencies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingencies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' xlink:label='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_CommitmentsAndContingenciesDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxes" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxes"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxes">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock' xlink:label='us-gaap_IncomeTaxDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_IncomeTaxDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9Options" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9Options"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9Options">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock' xlink:label='us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformation" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote10GeographicInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformation">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_GeographicInformationTextBlock' xlink:label='fil_GeographicInformationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='fil_GeographicInformationTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformation" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote11GeographicLongLivedAssetsInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformation">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_GeographicLongLivedAssetsInformationTextBlock' xlink:label='fil_GeographicLongLivedAssetsInformationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='fil_GeographicLongLivedAssetsInformationTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategory" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote12RevenuesByProductCategory"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategory">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_RevenuesByProductCategoryTextBlock' xlink:label='fil_RevenuesByProductCategoryTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='fil_RevenuesByProductCategoryTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote13ProductSaleAndPurchaseCommitments"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ProductSaleAndPurchaseCommitmentsTextBlock' xlink:label='fil_ProductSaleAndPurchaseCommitmentsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='fil_ProductSaleAndPurchaseCommitmentsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote14EmployeeBenefitPlans"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock' xlink:label='us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote15RecentAccountingPronouncements" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote15RecentAccountingPronouncements"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote15RecentAccountingPronouncements">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote16SubsequentEvents" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote16SubsequentEvents"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote16SubsequentEvents">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SubsequentEventsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_UseOfEstimates' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock' xlink:label='us-gaap_ConsolidationPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ConsolidationPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock' xlink:label='us-gaap_CashAndCashEquivalentsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_CashAndCashEquivalentsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentPolicyTextBlock' xlink:label='us-gaap_InvestmentPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_InvestmentPolicyTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock' xlink:label='us-gaap_ConcentrationRiskDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ConcentrationRiskDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock' xlink:label='us-gaap_ReceivablesPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ReceivablesPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryPolicyTextBlock' xlink:label='us-gaap_InventoryPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_InventoryPolicyTextBlock' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock' xlink:label='us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' xlink:label='us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock' xlink:label='us-gaap_RevenueRecognitionPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_RevenueRecognitionPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock' xlink:label='us-gaap_IncomeTaxPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_IncomeTaxPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock' xlink:label='us-gaap_LegalCostsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_LegalCostsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_EarningsPerSharePolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PresentationOfSalesAndSimilarTaxesTextBlock' xlink:label='fil_PresentationOfSalesAndSimilarTaxesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='fil_PresentationOfSalesAndSimilarTaxesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' xlink:label='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock' xlink:label='us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock' xlink:label='us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock' xlink:label='us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock' xlink:label='us-gaap_ScheduleOfInventoryCurrentTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfInventoryCurrentTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock' xlink:label='us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock' xlink:label='us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock' xlink:label='us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock' xlink:label='us-gaap_PropertyPlantAndEquipmentTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PropertyPlantAndEquipmentByLocationTextBlock' xlink:label='fil_PropertyPlantAndEquipmentByLocationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='fil_PropertyPlantAndEquipmentByLocationTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' xlink:label='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' xlink:label='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock' xlink:label='us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock' xlink:label='us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock' xlink:label='us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock' xlink:label='us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ScheduleOfGeographicInformationTextBlock' xlink:label='fil_ScheduleOfGeographicInformationTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='fil_ScheduleOfGeographicInformationTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' xlink:label='fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ScheduleOfRevenuesByProductCategoryTextBlock' xlink:label='fil_ScheduleOfRevenuesByProductCategoryTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='fil_ScheduleOfRevenuesByProductCategoryTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:label='us-gaap_PropertyPlantAndEquipmentByTypeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_PropertyPlantAndEquipmentByTypeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain' xlink:label='us-gaap_PropertyPlantAndEquipmentTypeDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_PropertyPlantAndEquipmentTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember' xlink:label='us-gaap_BuildingAndBuildingImprovementsMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_BuildingAndBuildingImprovementsMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquipmentMember' xlink:label='us-gaap_EquipmentMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PropertyPlantAndEquipmentByTypeAxis' xlink:to='us-gaap_EquipmentMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RangeAxis' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_MinimumMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_MaximumMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife' xlink:label='us-gaap_PropertyPlantAndEquipmentUsefulLife'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentUsefulLife' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' xlink:label='fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' xlink:label='fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:label='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:label='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationReserve' xlink:label='us-gaap_LitigationReserve'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_LitigationReserve' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' xlink:label='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_WeightedAverageNumberOfSharesOutstandingBasic' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' xlink:label='us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' xlink:label='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense' xlink:label='us-gaap_AllocatedShareBasedCompensationExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AllocatedShareBasedCompensationExpense' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent' xlink:label='us-gaap_AccountsReceivableGrossCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AccountsReceivableGrossCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable' xlink:label='us-gaap_IncomeTaxesReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxesReceivable' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestReceivableAndOtherAssets' xlink:label='us-gaap_InterestReceivableAndOtherAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InterestReceivableAndOtherAssets' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' xlink:label='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent' xlink:label='us-gaap_AccountsAndOtherReceivablesNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AccountsAndOtherReceivablesNetCurrent' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves' xlink:label='us-gaap_InventoryFinishedGoodsNetOfReserves'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryFinishedGoodsNetOfReserves' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess' xlink:label='us-gaap_InventoryWorkInProcess'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryWorkInProcess' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterials' xlink:label='us-gaap_InventoryRawMaterials'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryRawMaterials' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedPatentsGross' xlink:label='us-gaap_FiniteLivedPatentsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedPatentsGross' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross' xlink:label='us-gaap_FiniteLivedNoncompeteAgreementsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedNoncompeteAgreementsGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedTrademarksGross' xlink:label='us-gaap_FiniteLivedTrademarksGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedTrademarksGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedCustomerRelationshipsGross' xlink:label='us-gaap_FiniteLivedCustomerRelationshipsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedCustomerRelationshipsGross' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' xlink:label='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross' xlink:label='us-gaap_FiniteLivedIntangibleAssetsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsGross' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' xlink:label='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet' xlink:label='us-gaap_FiniteLivedIntangibleAssetsNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_FiniteLivedIntangibleAssetsNet' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent' xlink:label='us-gaap_AccruedIncomeTaxesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AccruedIncomeTaxesCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent' xlink:label='us-gaap_EmployeeRelatedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_EmployeeRelatedLiabilitiesCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationReserveCurrent' xlink:label='us-gaap_LitigationReserveCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_LitigationReserveCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent' xlink:label='us-gaap_OtherAccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OtherAccruedLiabilitiesCurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost' xlink:label='us-gaap_AvailableForSaleSecuritiesAmortizedCost'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AvailableForSaleSecuritiesAmortizedCost' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' xlink:label='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' xlink:label='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecurities' xlink:label='us-gaap_AvailableForSaleSecuritiesEquitySecurities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AvailableForSaleSecuritiesEquitySecurities' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:label='us-gaap_FairValueByFairValueHierarchyLevelAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByFairValueHierarchyLevelAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain' xlink:label='us-gaap_FairValueMeasurementsFairValueHierarchyDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueMeasurementsFairValueHierarchyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member' xlink:label='us-gaap_FairValueInputsLevel1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByFairValueHierarchyLevelAxis' xlink:to='us-gaap_FairValueInputsLevel1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis' xlink:label='us-gaap_FairValueByMeasurementFrequencyAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_FairValueByMeasurementFrequencyAxis' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain' xlink:label='us-gaap_FairValueMeasurementFrequencyDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByMeasurementFrequencyAxis' xlink:to='us-gaap_FairValueMeasurementFrequencyDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember' xlink:label='us-gaap_FairValueMeasurementsRecurringMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_FairValueByMeasurementFrequencyAxis' xlink:to='us-gaap_FairValueMeasurementsRecurringMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityFairValueDisclosure' xlink:label='us-gaap_EquityFairValueDisclosure'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_EquityFairValueDisclosure' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land' xlink:label='us-gaap_Land'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_Land' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_MachineryAndEquipmentGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis' xlink:label='us-gaap_StatementGeographicalAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementGeographicalAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain' xlink:label='us-gaap_SegmentGeographicalDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='us-gaap_SegmentGeographicalDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_U.S.AndCanadaMember' xlink:label='fil_U.S.AndCanadaMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='fil_U.S.AndCanadaMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EnglandAndAustraliaMember' xlink:label='fil_EnglandAndAustraliaMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='fil_EnglandAndAustraliaMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_IrelandMember' xlink:label='fil_IrelandMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementGeographicalAxis' xlink:to='fil_IrelandMember' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land' xlink:label='us-gaap_Land'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_Land' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross' xlink:label='us-gaap_BuildingsAndImprovementsGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_BuildingsAndImprovementsGross' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MachineryAndEquipmentGross' xlink:label='us-gaap_MachineryAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_MachineryAndEquipmentGross' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressGross' xlink:label='us-gaap_ConstructionInProgressGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ConstructionInProgressGross' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross' xlink:label='us-gaap_PropertyPlantAndEquipmentGross'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentGross' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' xlink:label='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebtDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote6LongTermDebtDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebtDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis' xlink:label='us-gaap_LongtermDebtTypeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_LongtermDebtTypeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain' xlink:label='us-gaap_LongtermDebtTypeDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='us-gaap_LongtermDebtTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_JPMorganChaseBankNAChaseNoteMember' xlink:label='fil_JPMorganChaseBankNAChaseNoteMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_JPMorganChaseBankNAChaseNoteMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_JPMorganChaseLondonBranchNoteMember' xlink:label='fil_JPMorganChaseLondonBranchNoteMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LongtermDebtTypeAxis' xlink:to='fil_JPMorganChaseLondonBranchNoteMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingenciesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet' xlink:label='us-gaap_OperatingLeasesRentExpenseNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesRentExpenseNet' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue' xlink:label='us-gaap_OperatingLeasesFutureMinimumPaymentsDue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingLeasesFutureMinimumPaymentsDue' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsInventory' xlink:label='us-gaap_DeferredTaxAssetsInventory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DeferredTaxAssetsInventory' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' xlink:label='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' xlink:label='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther' xlink:label='us-gaap_DeferredTaxAssetsOther'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DeferredTaxAssetsOther' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DeferredTaxLiabilitiesDepreciationAndAmortization' xlink:label='fil_DeferredTaxLiabilitiesDepreciationAndAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_DeferredTaxLiabilitiesDepreciationAndAmortization' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_UnrealizedInvestmentLoss' xlink:label='fil_UnrealizedInvestmentLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_UnrealizedInvestmentLoss' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet' xlink:label='us-gaap_DeferredTaxAssetsLiabilitiesNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DeferredTaxAssetsLiabilitiesNet' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit' xlink:label='us-gaap_CurrentIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CurrentIncomeTaxExpenseBenefit' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_DeferredIncomeTaxExpense' xlink:label='fil_DeferredIncomeTaxExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_DeferredIncomeTaxExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' xlink:label='us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' xlink:label='us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' xlink:label='us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' xlink:label='us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' xlink:label='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' xlink:label='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments' xlink:label='us-gaap_IncomeTaxReconciliationOtherAdjustments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxReconciliationOtherAdjustments' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions' xlink:label='us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense' xlink:label='us-gaap_AllocatedShareBasedCompensationExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AllocatedShareBasedCompensationExpense' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis' xlink:label='us-gaap_StatementEquityComponentsAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementEquityComponentsAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain' xlink:label='us-gaap_EquityComponentDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_EquityComponentDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember' xlink:label='us-gaap_CommonStockMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementEquityComponentsAxis' xlink:to='us-gaap_CommonStockMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareGranted' xlink:label='fil_PriceRangePerShareGranted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareGranted' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareExpired' xlink:label='fil_PriceRangePerShareExpired'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareExpired' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' xlink:label='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareExercised' xlink:label='fil_PriceRangePerShareExercised'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareExercised' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareOutstanding' xlink:label='fil_PriceRangePerShareOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_PriceRangePerShareTotalExercisable' xlink:label='fil_PriceRangePerShareTotalExercisable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_PriceRangePerShareTotalExercisable' use='optional' order='10.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis' xlink:label='us-gaap_StatementScenarioAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementScenarioAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain' xlink:label='us-gaap_ScenarioUnspecifiedDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementScenarioAxis' xlink:to='us-gaap_ScenarioUnspecifiedDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_Range1Member' xlink:label='fil_Range1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementScenarioAxis' xlink:to='fil_Range1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_Range2Member' xlink:label='fil_Range2Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementScenarioAxis' xlink:to='fil_Range2Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_WeightedAverageRemainingContractualLifeYears' xlink:label='fil_WeightedAverageRemainingContractualLifeYears'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='fil_WeightedAverageRemainingContractualLifeYears' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' xlink:label='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' xlink:label='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' xlink:label='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1' use='optional' order='7.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanySalesInTheUnitedStates' xlink:label='fil_CompanySalesInTheUnitedStates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanySalesInTheUnitedStates' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanySalesInEurope' xlink:label='fil_CompanySalesInEurope'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanySalesInEurope' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanySalesOther' xlink:label='fil_CompanySalesOther'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanySalesOther' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInTheUnitedStates' xlink:label='fil_LongLivedAssetsInTheUnitedStates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_LongLivedAssetsInTheUnitedStates' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInEngland' xlink:label='fil_LongLivedAssetsInEngland'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_LongLivedAssetsInEngland' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInIreland' xlink:label='fil_LongLivedAssetsInIreland'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_LongLivedAssetsInIreland' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInAustralia' xlink:label='fil_LongLivedAssetsInAustralia'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_LongLivedAssetsInAustralia' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_LongLivedAssetsInCanada' xlink:label='fil_LongLivedAssetsInCanada'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_LongLivedAssetsInCanada' use='optional' order='5.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueObstetrics' xlink:label='fil_CompanyRevenueObstetrics'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanyRevenueObstetrics' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueGynecologyElectrosurgeryUrology' xlink:label='fil_CompanyRevenueGynecologyElectrosurgeryUrology'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanyRevenueGynecologyElectrosurgeryUrology' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueNeonatal' xlink:label='fil_CompanyRevenueNeonatal'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanyRevenueNeonatal' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='utmd-20171231.xsd#fil_CompanyRevenueBloodPressureMonitoringAndAccessories' xlink:label='fil_CompanyRevenueBloodPressureMonitoringAndAccessories'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CompanyRevenueBloodPressureMonitoringAndAccessories' use='optional' order='4.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating' xlink:label='us-gaap_RoyaltyIncomeNonoperating'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_RoyaltyIncomeNonoperating' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ContractualObligation' xlink:label='us-gaap_ContractualObligation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_ContractualObligation' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="utmd-20171231.xsd#idr_DisclosureNote14EmployeeBenefitPlansDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlansDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount' xlink:label='us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount' use='optional' order='1.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754039392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Mar. 05, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UTAH MEDICAL PRODUCTS INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000706698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,725,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,289,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">utmd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6752247472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 39,875<span></span>
</td>
<td class="nump">$ 26,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, available-for-sale</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts &amp; other receivables - net</a></td>
<td class="nump">3,623<span></span>
</td>
<td class="nump">3,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">5,244<span></span>
</td>
<td class="nump">4,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">49,188<span></span>
</td>
<td class="nump">34,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">11,621<span></span>
</td>
<td class="nump">9,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">14,092<span></span>
</td>
<td class="nump">13,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets</a></td>
<td class="nump">34,805<span></span>
</td>
<td class="nump">31,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Other intangible assets - accumulated amortization</a></td>
<td class="num">(16,961)<span></span>
</td>
<td class="num">(13,683)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">17,844<span></span>
</td>
<td class="nump">18,264<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">92,745<span></span>
</td>
<td class="nump">76,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">4,346<span></span>
</td>
<td class="nump">2,116<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,280<span></span>
</td>
<td class="nump">3,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent', window );">Long Term income tax payable</a></td>
<td class="nump">5,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Deferred tax liability - intangible assets</a></td>
<td class="nump">3,102<span></span>
</td>
<td class="nump">3,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">716<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,623<span></span>
</td>
<td class="nump">6,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value; 5,000 shares authorized, no shares issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value; 50,000 shares authorized, issued 3,721 shares in 2017 and 3,713 shares in 2016</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(8,341)<span></span>
</td>
<td class="num">(12,243)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">809<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">85,617<span></span>
</td>
<td class="nump">81,072<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">78,122<span></span>
</td>
<td class="nump">69,244<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 92,745<span></span>
</td>
<td class="nump">$ 76,191<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated equity from transactions and other events and circumstances from non-owner sources, including portion attributable to noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners (distributions to owners).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossBeforeTax1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82895926&amp;loc=d3e24584-111560<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6752287552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">3,721<span></span>
</td>
<td class="nump">3,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">3,721<span></span>
</td>
<td class="nump">3,713<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754445808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Sales, net</a></td>
<td class="nump">$ 41,414<span></span>
</td>
<td class="nump">$ 39,298<span></span>
</td>
<td class="nump">$ 40,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of goods sold</a></td>
<td class="nump">15,019<span></span>
</td>
<td class="nump">15,608<span></span>
</td>
<td class="nump">15,972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">26,395<span></span>
</td>
<td class="nump">23,690<span></span>
</td>
<td class="nump">24,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">1,544<span></span>
</td>
<td class="nump">1,673<span></span>
</td>
<td class="nump">2,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">5,393<span></span>
</td>
<td class="nump">5,355<span></span>
</td>
<td class="nump">5,848<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">19,011<span></span>
</td>
<td class="nump">16,187<span></span>
</td>
<td class="nump">15,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInterestAndDividendIncome', window );">Dividend and interest income</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other, net</a></td>
<td class="num">(32)<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before provision for income taxes</a></td>
<td class="nump">19,082<span></span>
</td>
<td class="nump">16,422<span></span>
</td>
<td class="nump">15,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">10,577<span></span>
</td>
<td class="nump">4,294<span></span>
</td>
<td class="nump">3,702<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 8,505<span></span>
</td>
<td class="nump">$ 12,128<span></span>
</td>
<td class="nump">$ 11,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common shares (basic)</a></td>
<td class="nump">$ 2.29<span></span>
</td>
<td class="nump">$ 3.23<span></span>
</td>
<td class="nump">$ 3.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share (diluted)</a></td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 3.22<span></span>
</td>
<td class="nump">$ 3.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation net of taxes of $0 in all periods</a></td>
<td class="nump">$ 3,893<span></span>
</td>
<td class="num">$ (6,289)<span></span>
</td>
<td class="num">$ (2,724)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on investments net of taxes of $6, $3, and $(1)</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">$ 12,408<span></span>
</td>
<td class="nump">$ 5,844<span></span>
</td>
<td class="nump">$ 9,117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e557-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=96948231&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInterestAndDividendIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInterestAndDividendIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640586080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation tax adjustment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on investments tax adjustment</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e,f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755081424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF CASH FLOW - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 8,505<span></span>
</td>
<td class="nump">$ 12,128<span></span>
</td>
<td class="nump">$ 11,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for (recovery of) losses on accounts receivable</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposal of assets</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(658)<span></span>
</td>
<td class="num">(484)<span></span>
</td>
<td class="num">(901)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) decrease in accounts receivable</a></td>
<td class="num">(242)<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">(Increase) decrease in other receivables</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">897<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Increase) decrease in inventories</a></td>
<td class="num">(467)<span></span>
</td>
<td class="num">(360)<span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">(Increase) decrease in prepaid expenses and other current assets</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (decrease) in accounts payable</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase (decrease) in accrued expenses</a></td>
<td class="nump">1,027<span></span>
</td>
<td class="num">(1,187)<span></span>
</td>
<td class="num">(597)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense', window );">Increase (decrease) in Long-term repatriation tax payable</a></td>
<td class="nump">5,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">16,908<span></span>
</td>
<td class="nump">14,528<span></span>
</td>
<td class="nump">13,801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures for property and equipment</a></td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(3,293)<span></span>
</td>
<td class="num">(176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Capital expenditures for intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(3,302)<span></span>
</td>
<td class="num">(246)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock - options</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">376<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock purchased and retired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,850)<span></span>
</td>
<td class="num">(683)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaymentOfTaxesForExchangeOfStockOptions', window );">Payment of taxes for exchange of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised', window );">Tax benefit attributable to exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,777)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(2,955)<span></span>
</td>
<td class="num">(3,916)<span></span>
</td>
<td class="num">(3,846)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(2,653)<span></span>
</td>
<td class="num">(6,340)<span></span>
</td>
<td class="num">(8,891)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">921<span></span>
</td>
<td class="num">(1,868)<span></span>
</td>
<td class="num">(660)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">13,579<span></span>
</td>
<td class="nump">3,018<span></span>
</td>
<td class="nump">4,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AT BEGINNING OF YEAR</a></td>
<td class="nump">26,296<span></span>
</td>
<td class="nump">23,278<span></span>
</td>
<td class="nump">19,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AT END OF YEAR</a></td>
<td class="nump">39,875<span></span>
</td>
<td class="nump">26,296<span></span>
</td>
<td class="nump">23,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the year for income taxes</a></td>
<td class="nump">$ 5,151<span></span>
</td>
<td class="nump">$ 4,846<span></span>
</td>
<td class="nump">5,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the year for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaymentOfTaxesForExchangeOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Payment of taxes for exchange of stock options, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PaymentOfTaxesForExchangeOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96864182&amp;loc=d3e11283-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxExpenseFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84176398&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest. Includes, but is not limited to, payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82913847&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755139408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capitol</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Dec. 31, 2014</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 2,890<span></span>
</td>
<td class="num">$ (3,234)<span></span>
</td>
<td class="nump">$ 64,863<span></span>
</td>
<td class="nump">$ 64,556<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2014</a></td>
<td class="nump">3,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options, shares</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions', window );">Common stock received and retired upon exercise of stock options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(338)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares', window );">Common stock received and retired upon exercise of stock options, shares</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation', window );">Tax benefit attributable to appreciation of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock purchased and retired</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(683)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(683)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common stock purchased and retired, shares</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,724)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,724)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,846)<span></span>
</td>
<td class="num">(3,846)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,843<span></span>
</td>
<td class="nump">11,843<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Dec. 31, 2015</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
<td class="num">(5,961)<span></span>
</td>
<td class="nump">72,861<span></span>
</td>
<td class="nump">69,648<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2015</a></td>
<td class="nump">3,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options, shares</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions', window );">Common stock received and retired upon exercise of stock options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares', window );">Common stock received and retired upon exercise of stock options, shares</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation', window );">Tax benefit attributable to appreciation of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock purchased and retired</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(2,849)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common stock purchased and retired, shares</a></td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,289)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,916)<span></span>
</td>
<td class="num">(3,916)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,128<span></span>
</td>
<td class="nump">12,128<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Dec. 31, 2016</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="num">(12,243)<span></span>
</td>
<td class="nump">81,072<span></span>
</td>
<td class="nump">69,244<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2016</a></td>
<td class="nump">3,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options, shares</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions', window );">Common stock received and retired upon exercise of stock options</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares', window );">Common stock received and retired upon exercise of stock options, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized holding gain (loss) from investments, available-for-sale, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Common stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,960)<span></span>
</td>
<td class="num">(3,960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,505<span></span>
</td>
<td class="nump">8,505<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, value at Dec. 31, 2017</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 809<span></span>
</td>
<td class="num">$ (8,341)<span></span>
</td>
<td class="nump">$ 85,617<span></span>
</td>
<td class="nump">$ 78,122<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="nump">3,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Common stock received and retired upon exercise of stock options, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Common stock received and retired upon exercise of stock options, shares (number of shares), during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CommonStockReceivedAndRetiredUponExerciseOfStockOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79981250&amp;loc=d3e23524-113945<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745341296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Note 1 - Summary of Significant Accounting Policies</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 1 &#150; Summary of Significant Accounting Policies</u></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Organization</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Utah Medical Products, Inc. with headquarters in Midvale, Utah and its wholly-owned operating subsidiaries, Femcare Nikomed Ltd located in Romsey, Hampshire, England, Femcare Australia Pty Ltd located in Castle Hill, NSW, Australia, Utah Medical Products Canada, Inc. (dba Femcare Canada) located in Mississauga, Ontario, Canada and Utah Medical Products Ltd., which operates a manufacturing facility in Athlone, Ireland, (in the aggregate, the Company) are in the primary business of developing, manufacturing and globally distributing specialized medical devices for the healthcare industry.&#160; The Company&#146;s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians&#146; offices.&#160; Products are sold directly to end user facilities in the U.S., Ireland, UK, Canada, France and Australia, and through third party distributors in other outside the U.S. (OUS) markets.&#160; Domestically, UTMD has an exclusive distribution relationship with CooperSurgical, Inc. for the Filshie Clip System.&#160; UTMD also sells subcontract manufactured components and finished products to over 145 companies in the U.S. for their medical and non-medical products.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Use of Estimates in the Preparation of Financial Statements</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Although actual results could differ from those estimates, management believes it has considered and disclosed all relevant information in making its estimates that materially affect reported performance and current values.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Principles of Consolidation</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The consolidated financial statements include those of the Company and its subsidiaries.&#160; All intercompany accounts and transactions have been eliminated in consolidation. </p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Cash and Cash Equivalents</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>For purposes of the consolidated statement of cash flows, the Company considers cash on deposit and short-term investments with original maturities of three months or less to be cash and cash equivalents.</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Investments</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The Company classifies its investments as &#147;available-for-sale.&#148;&#160; Securities classified as &#147;available-for-sale&#148; are carried in the financial statements at fair value.&#160; Realized gains and losses, determined using the specific identification method, are included in operations; unrealized holding gains and losses are reported as a separate component of accumulated other comprehensive income.&#160; Declines in fair value below cost that are other than temporary are included in operations.&#160; As of December 31, 2017 the Company retained a freely tradeable investment in Citigroup (C) (see note 3). </p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Concentration of Credit Risk</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The primary concentration of credit risk consists of trade receivables.&#160; In the normal course of business, the Company provides credit terms to its customers.&#160; Accordingly, the Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses which, when realized, have been within the range of management's expectations as reflected by its reserves. </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company's customer base consists of hospitals, medical device distributors, physician practices and others directly related to healthcare providers, as well as other manufacturing companies.&#160; Although the Company is affected by the well-being of the global healthcare industry, management does not believe significant trade receivable credit risk exists at December&nbsp;31, 2017 except under an extreme global financial crisis.</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company maintains its cash in bank deposit accounts in addition to Fidelity Investment accounts.&#160; The Company has not experienced any losses in such accounts and believes it is not exposed to a significant credit risk on cash and cash equivalent balances. </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Accounts Receivable</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Accounts receivable are amounts due on product sales and are unsecured.&#160; Accounts receivable are carried at their estimated collectible amounts.&#160; Credit is generally extended on a short-term basis; thus accounts receivable do not bear interest although a late charge may be applied to such receivables that are past the due date.&#160; Accounts receivable are periodically evaluated for collectibility based on past credit history of customers and current market conditions.&#160; Provisions for losses on accounts receivable are determined on the basis of loss experience, known and inherent risk in the account balance and current economic conditions (see note 2).</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Inventories</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>In 2017, the Company adopted Accounting Standard Update (ASU) 2015-11, &#147;Inventory-Simplifying the Measurement of Inventory,&#148; which changed how inventory is valued.&#160; Finished products, work-in-process, raw materials and supplies inventories are stated at the lower of cost and net realizable value (NRV) computed on a first-in, first-out method.&#160; Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160; The adoption of ASU 2015-11 did not have an impact on the Company&#146;s financial statements (see note 2). </p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Property and Equipment</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Property and equipment are stated at cost.&#160; Depreciation and amortization are computed using the straight-line method over estimated useful lives as follows:</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="522" style='border-collapse:collapse'> <tr align="left"> <td width="522" colspan="2" valign="top" style='width:391.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Building and improvements</p> </td> <td width="124" style='width:92.7pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>15 - 40 years</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="124" style='width:92.7pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>3 - 10 years</p> </td> </tr> </table> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u><font lang="EN-CA">Long-Lived Assets</font></u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>The Company evaluates its long-lived assets in accordance with Accounting Standards Codification (ASC) 360, &#147;Accounting for the Impairment of Long-Lived Assets.&#148;&#160; Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable.&#160; When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts.&#160; Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets, and is recorded in the period in which the determination was made. </p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Intangible Assets</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Costs associated with the acquisition of patents, trademarks, trade names, customer relationships, regulatory approvals &amp; product certifications, license rights and non-compete agreements are capitalized, and are being amortized using the straight-line method over periods ranging from 5 to 20 years. UTMD&#146;s goodwill is tested for impairment annually, in the fourth quarter of each year, using a fair value measurement test, in accordance with ASC 350. UTMD also performs impairment tests contemporaneously, if circumstances change that would more than likely reduce the fair value of goodwill below its net book value.&#160; If UTMD determines that its goodwill is impaired, a second step is completed to measure the amount of the impairment loss. UTMD does not expect its goodwill to become impaired in the foreseeable future.&#160; Estimated future amortization expense on intangible assets currently held, using the 2017 year-end 1.3523 USD/GBP and.7815 USD/AUD currency exchange rates, is about $1,981 in 2018, $1,980 in 2019 and 2020, $1,974 in 2021, and&#160; $1,973 in 2022 (see note 2).</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Revenue Recognition</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company recognizes revenue at the time of product shipment as UTMD meets its contractual performance obligations to the customer at the time of shipment. Revenue recognized by UTMD is based upon the consideration to which UTMD is entitled from its customers as a result of shipping a physical product, in accordance with the documented arrangements and fixed contracts in which the selling price was fixed prior to the Company&#146;s acceptance of an order. Revenue from service sales, which are immaterial to UTMD, is generally recognized when the service is completed and invoiced. As demonstrated by decades of experience in successful and consistent collections, there is very minor and insignificant uncertainty regarding the collectability of invoiced amounts reasonably within the terms of the Company&#146;s contracts. There are circumstances under which insignificant revenue may be recognized when product is not shipped, which meet the criteria of ASU 2014-09: the Company provides engineering services, for example, design and production of manufacturing tooling that may be used in subsequent UTMD manufacturing of custom components for other companies.&#160; This revenue is recognized when UTMD&#146;s performance obligations have been completed according to a fixed contractual agreement.&#160; UTMD includes handling fees charged to customers in revenues. </p> <p style='margin:0in;margin-bottom:.0001pt'>&#160;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Income Taxes</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company accounts for income taxes under ASC 740, &#147;Accounting for Income Taxes,&#148; whereby deferred taxes are computed under the asset and liability method. </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In November 2015, the FASB released ASU 2015-17, Income Taxes (Topic 740):&#160; Balance Sheet classification of Deferred Taxes.&#160; ASU 2015-17 requires that all deferred income taxes are classified as noncurrent in a classified statement of financial position.&#160; The Company adopted ASU 2015-17 retrospectively effective January 1, 2017.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>On December 22, 2017 the U.S. Tax Cuts and Jobs Act of 2017 (Tax Act) was signed into law.&#160; As a result of the Tax Act, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes.&#160; ASC 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, UTMD was required to revalue its deferred tax assets and liabilities at December 31, 2017 at the new rate.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Tax Act contains a deemed repatriation transition tax (Transition Tax) on accumulated earnings and profits of the Company&#146;s non-U.S. subsidiaries that have not been subject to U.S. tax.&#160; The Company plans to elect to pay its net Transition Tax over eight years.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>On December 22, 2017, the SEC issued SAB 118 which provides guidance on accounting for the impact of the Tax Act.&#160; SAB 118 provides a measurement period of up to one year from enactment for a company to complete its tax accounting under ASC 740.&#160; Once a company is able to make a reasonable estimate and record a provisional amount for effects of the Tax Act it is required to do so.&#160; Such provisional measurement amounts may change as remaining data is obtained, calculations are prepared and analysis and review are completed.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>During the fourth quarter of 2017, the Company recorded a provisional tax charge for the Transition Tax of $6,288 and a provisional tax charge of $228 for the re-measurement of its U.S. deferred tax balances.&#160; Both provisional tax amounts are the Company&#146;s reasonable estimate of the impact of the Tax Act based on its understanding and available guidance.&#160; These provisional amounts may change as the Company receives additional clarification and implementation guidance.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, in Utah, in the United Kingdom, in Australia, in Ireland and in Canada. </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:6.0pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company recognizes interest accrued related to unrecognized tax benefits in interest expenses and any related penalties in income taxes. The Company did not recognize any tax-related interest expense or have any tax penalties in any of the three years 2015 through 2017. </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Legal Costs</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&#160; The Company maintains a reserve for legal costs which are probable and estimated based on previous experience and known risk.&#160; The reserve for legal costs at December 31, 2017 and 2016 was &#160;$182 and $134, respectively (see note 2).</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Earnings per Share</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The computation of basic earnings per common share is based on the weighted average number of shares outstanding during each year. </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The computation of earnings per common share assuming dilution is based on the weighted average number of shares outstanding during the year plus the weighted average common stock equivalents which would arise from the exercise of stock options outstanding using the treasury stock method and the average market price per share during the year.</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in'>The shares (in thousands) used in the computation of the Company&#146;s basic and diluted earnings per share are reconciled as follows:</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="586" style='border-collapse:collapse'> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Weighted average number of shares outstanding &#150; basic</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,718</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,751</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,752</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Dilutive effect of stock options</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Weighted average number of shares outstanding, assuming dilution</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,737</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,766</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,772</p> </td> </tr> </table> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Presentation of Sales and Similar Taxes</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Sales tax on revenue-producing transactions is recorded as a liability when the sale occurs.&#160; UTMD is not required to withhold sales tax on OUS sales, and at least 90% of domestic 2017 sales were to customers who are tax exempt or who are in jurisdictions where UTMD is not required to withhold sales tax.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Stock-Based Compensation </u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>At December 31, 2017, the Company has stock-based employee compensation plans, which are described more fully in note 9.&#160; The Company accounts for stock compensation under ASC 718, <i>Share-Based Payment</i>.&#160; This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors.&#160; In 2017, the Company recognized $129 in stock-based compensation cost compared to $92 in 2016 and $87 in 2015.</p> <p style='margin:0in;margin-bottom:.0001pt'>&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Translation of Foreign Currencies</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Assets and liabilities of the Company&#146;s foreign subsidiaries are translated into U.S. dollars at the applicable exchange rates at year-end.&#160; Net gains or losses resulting from the translation of the Company&#146;s assets and liabilities are reflected as a separate component of stockholders&#146; equity.&#160; A negative translation impact on stockholders&#146; equity reflects a current relative U.S. Dollar value higher than at the point in time that assets were actually acquired in a foreign currency.&#160; A positive translation impact would result from a U.S. dollar weaker in value than at the point in time foreign assets were acquired.&#160; Year-end translation gains or losses of non-functional currency bank account balances, e.g. EUR and AUD balances held by the UK subsidiary, are recognized as non-operating income or expense, as applicable.</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631853744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Note 2 - Detail of Certain Balance Sheet Accounts</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Note 2 &#150; Detail of Certain Balance Sheet Accounts</u></p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="146" colspan="4" valign="bottom" style='width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accounts and other receivables:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accounts receivable</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,713</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,289</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Income tax receivable</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accrued interest and other</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>14</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Less allowance for doubtful accounts</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(104)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(96)</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total accounts and other receivables</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,623</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,211</p> </td> </tr> </table> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&#160;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Inventories:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Finished products</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,313</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,327</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Work-in-process</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,270</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>942</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Raw materials</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,661</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,273</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total inventories</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,244</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,542</p> </td> </tr> </table> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Other intangible assets:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Patents</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,183</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,161</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Non-compete agreements</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>135</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>123</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Trademarks &amp; trade names</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,921</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,074</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Customer relationships</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,669</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,822</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Regulatory approvals &amp; product certifications</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>12,897</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,767</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total other intangible assets</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>34,805</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>31,947</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accumulated amortization</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(16,961)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(13,683)</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other intangible assets, net</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>17,844</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>18,264</p> </td> </tr> </table> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&#160;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Accrued expenses:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Income taxes payable</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,259</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>799</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payroll and payroll taxes</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,199</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,117</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Reserve for litigation costs</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>182</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>134</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,706</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>66</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total accrued expenses</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,346</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,116</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746011664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Note 3 - Investments</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 3 &#150; Investments</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company&#146;s investments, classified as available-for-sale, consist of the following:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="146" colspan="4" valign="bottom" style='width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Investments, at cost</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>42</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>42</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Equity securities:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>-Unrealized holding gains</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>38</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>-Unrealized holding (losses)</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Investments, at fair value</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>During the three years 2015 through 2017, UTMD did not have any proceeds from sales of available-for-sale securities.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the realized and unrealized gains and losses reported in the statement of income which have resulted from the sale and holding of marketable securities, respectively, as well as the sale or disposal of cost method investments. Such amounts would include realized gains and losses on the sale or disposal of trading, available-for-sale, and held-to-maturity securities, unrealized gains and losses on trading securities, unrealized gains and losses on available-for-sale and held-to-maturity securities transferred to the trading securities category, realized gains and losses on the sale or disposal of cost method investments, and losses recognized for other than temporary impairments (OTTI) of such investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27405-111563<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877573&amp;loc=d3e87990-122713<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6901598112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Fair Value Measurements and Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Note 4 - Fair Value Measurements and Financial Instruments</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 4 &#150; Fair Value Measurements and Financial Instruments</u>&nbsp; </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:6.0pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt'>The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.&#160; The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).&#160; A financial instrument&#146;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company uses the following valuation techniques to measure fair value for its assets and liabilities:</p> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Level 1 - Quoted market prices in active markets for identical assets or liabilities;</p> <p style='margin:0in;margin-bottom:.0001pt;margin-left:1.0in;text-indent:-1.0in'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Level 2 - Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);</p> <p style='margin:0in;margin-bottom:.0001pt;margin-left:1.0in;text-indent:-1.0in'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Level 3 -&#160; Unobservable inputs for the asset or liability, which are valued based on management&#146;s estimates of assumptions that market participants would use in pricing the asset or liability.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The following table provides financial assets carried at fair value measured as of December 31 for the past two years:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="607" style='border-collapse:collapse'> <tr align="left"> <td width="192" valign="top" style='width:2.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="108" colspan="4" valign="top" style='width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Level 1</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="108" colspan="4" valign="top" style='width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Levels 2 &amp; 3</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="108" colspan="4" valign="top" style='width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Total</p> </td> </tr> <tr align="left"> <td width="192" valign="top" style='width:2.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="192" valign="top" style='width:2.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Equities</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> </tr> <tr align="left"> <td width="192" valign="bottom" style='width:2.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>None of the Company&#146;s financial instruments, which are current assets and liabilities that could be readily traded, are held for trading purposes.&#160; Detail on investments is provided in note 3 above.&#160; The Company estimates that the fair value of all financial instruments at December 31, 2017 does not differ materially from the aggregate carrying value of its financial instruments recorded in the accompanying consolidated balance sheet.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6735872656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Note 5 - Property and Equipment</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 5 &#150; Property and Equipment</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment consists of the following:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="462" style='border-collapse:collapse'> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="150" colspan="4" valign="bottom" style='width:112.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="1" valign="top" style='width:1.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Land</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="59" valign="top" style='width:44.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,339</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="60" valign="top" style='width:45.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,289</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Buildings and improvements</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,350</p> </td> <td width="1" valign="top" style='width:1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,914</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,696</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,759</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Construction-in-progress</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>13</p> </td> <td width="1" valign="top" style='width:1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,061</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>32,398</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>30,023</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accumulated depreciation</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,777)</p> </td> <td width="1" valign="top" style='width:1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,057)</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment, net</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,621</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,966</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Included in the Company&#146;s consolidated balance sheet are the assets of its manufacturing and administrative facilities in Utah, Canada, England, Australia and Ireland.&#160; Property and equipment, by geographic area, are as follows:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="547" style='border-collapse:collapse'> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="321" colspan="10" valign="top" style='width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>December 31, 2017</p> </td> <td width="1" style='border:none;border-bottom:solid windowtext 1.0pt'><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p></td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>U.S. &amp; Canada </p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>England &amp; Australia </p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Ireland</p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" colspan="2" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Total</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Land</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>926</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>413</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,339</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Buildings and improvements</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,583</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,361</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,406</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,350</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>14,124</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>427</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,145</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,696</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Construction-in-progress</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>13</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>21,643</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,791</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,964</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>32,398</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accumulated depreciation</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(17,270)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(346)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,161)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,777)</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment, net</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,373</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,445</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,803</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,621</p> </td> </tr> <tr align="left"> <td width="202" style='border:none'></td> <td width="11" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="56" style='border:none'></td> <td width="1" style='border:none'></td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="547" style='border-collapse:collapse'> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="321" colspan="10" valign="top" style='width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>December 31, 2016</p> </td> <td width="1" style='border:none;border-bottom:solid windowtext 1.0pt'><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p></td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="57" valign="bottom" style='width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>U.S. &amp; Canada</p> </td> <td width="20" valign="bottom" style='width:14.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>England &amp; Australia </p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Ireland</p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" colspan="2" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Total</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Land</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>926</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>362</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,289</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Buildings and improvements</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,523</p> </td> <td width="20" valign="top" style='width:14.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>523</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,869</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,914</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>14,233</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>529</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>996</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,759</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Construction-in-progress</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="20" valign="top" style='width:14.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,057</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,061</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>21,682</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,109</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,231</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>30,023</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accumulated depreciation</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(17,063)</p> </td> <td width="20" valign="top" style='width:14.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(376)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(2,617)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,057)</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment, net</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,619</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,733</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,614</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,966</p> </td> </tr> <tr align="left"> <td width="202" style='border:none'></td> <td width="11" style='border:none'></td> <td width="12" style='border:none'></td> <td width="57" style='border:none'></td> <td width="20" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="56" style='border:none'></td> <td width="1" style='border:none'></td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619124304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Long-term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Note 6 - Long-term Debt</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 6 &#150; Long-term Debt</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In March 2011, the Company obtained a $14,000 loan from JPMorgan Chase Bank, N.A. and a $12,934 loan from JP Morgan Chase, London Branch to help finance UTMD&#146;s purchase of Femcare.&#160; The notes were fully paid off in February 2015.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745320032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Note 7 - Commitments and Contingencies</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt'><u>Note 7 &#150; Commitments and Contingencies</u></p> <p style='margin:0in;margin-bottom:.0001pt'><u>Operating Leases</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has a lease agreement for land adjoining its Utah facility for a term of forty years commencing on September 1, 1991.&#160; On September 1, 2001 and subsequent to each fifth lease year, the basic rental was and will be adjusted for published changes in a price index.&#160; The Company also leases an automobile for an employee in Ireland, and prior to late 2017, leased its UK facility. Rent expense charged to operations under these operating lease agreements was approximately $160, $175 and $184 for the years ended December&nbsp;31, 2017, 2016 and 2015, respectively.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Future minimum lease payments under its lease obligations as of December 31, 2017 were as follows:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="469" style='border-collapse:collapse'> <tr align="left"> <td width="384" valign="bottom" style='width:4.0in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Years ending December 31:</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="53" valign="bottom" style='width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Amount</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;border:none;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2018</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="53" valign="top" style='width:.55in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>83</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2019</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2020</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2021</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2022</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Thereafter</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>398</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total future minimum lease payments</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="53" valign="top" style='width:.55in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>661</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Purchase Obligations</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has obligations to purchase raw materials for use in its manufacturing operations.&#160; The Company has the right to make changes in, among other things, purchase quantities, delivery schedules and order acceptance.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Product Liability</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Except for its Filshie Clip System, the Company is self-insured for product liability risk. &#147;Product liability&#148; is an insurance industry term for the cost of legal defense and possible damages awarded as a result of use of a company&#146;s product during a procedure which results in an injury of a patient.&#160; The Company maintains a reserve for product liability litigation and damages consistent with its previous long-term experience.&#160; Actual product liability litigation costs and damages during the last three reporting years have been immaterial, which is consistent with the Company&#146;s overall history. Femcare&#146;s product liability indemnity limit through an independent insurer is &#163;5 million each claim and in the annual aggregate.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The Company absorbs the costs of clinical training and trouble-shooting in its on-going operating expenses.</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Warranty Reserve</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company&#146;s published warranty is: &#147;UTMD warrants its products to conform in all material respects to all published product specifications in effect on the date of shipment, and to be free from defects in material and workmanship for a period of thirty (30) days for supplies, or twenty-four (24) months for equipment, from date of shipment.&#160; During the warranty period UTMD shall, at its option, replace any products shown to UTMD's reasonable satisfaction to be defective at no expense to the Purchaser or refund the purchase price.&#148; </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>UTMD maintains a warranty reserve to provide for estimated costs which are likely to occur. The amount of this reserve is adjusted, as required, to reflect its actual experience. Based on its analysis of historical warranty claims and its estimate that existing warranty obligations are immaterial, no warranty reserve was made at December 31, 2017 or December 31, 2016. </p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'><u>Litigation</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&#160; Presently, there is no litigation or threatened litigation for which the Company believes the outcome may be material to its financial results. The Company applies its accounting policy to accrue legal costs that can be reasonably estimated.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631627504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Note 8 - Income Taxes</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 8 &#150; Income Taxes&#160; </u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>Deferred tax assets (liabilities) consist of the following temporary differences:</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="78%" style='width:78.84%;border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="144" colspan="4" style='width:107.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" style='width:31.5pt;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" style='width:31.45pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Inventory write-downs and differences due to UNICAP</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>56</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.45pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>98</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Allowance for doubtful accounts</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>25</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accrued liabilities and reserves</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>89</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>147</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Other - foreign</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(23)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Depreciation and amortization</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,789)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(4,277)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Unrealized investment gains</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>66</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>105</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Deferred income taxes, net</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,558)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,925)</p> </td> </tr> </table> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The components of income tax expense are as follows:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="249" colspan="7" valign="top" style='width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Current</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,944</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,467</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,877</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Deferred</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(367)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(1,173)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(1,175)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,577</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,294</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,702</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Income tax expense differed from amounts computed by applying the statutory federal rate to pretax income as follows:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="249" colspan="7" valign="top" style='width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Federal income tax expense at the statutory rate</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,086</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,998</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,704</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>State income taxes</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>299</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>291</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>262</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Foreign income taxes (blended rate)</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,444</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,270</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>990</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>ETI, manufacturing deduction and tax credits</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(303)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(287)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(257)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Deemed repatriation transition tax </p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,288</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Effective federal rate change</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(228)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Other</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(9)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,577</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,294</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,702</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The domestic and foreign components of income before income tax expense were as follows:&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="249" colspan="7" valign="top" style='width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Domestic</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,124</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,688</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,973</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Foreign</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,958</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,734</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,572</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19,082</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16,422</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,545</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6891669296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Note 9 - Options</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 9 &#150; Options</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has stock option plans which authorize the grant of stock options to eligible employees, directors and other individuals to purchase up to an aggregate of &#160;307 thousand shares of common stock, of which 54 thousand are outstanding as of December 31, 2017.&#160; All options granted under the plans are granted at current market value at the date of grant, and may be exercised between six months and ten years following the date of grant.&#160; The plans are intended to advance the interest of the Company by attracting and ensuring retention of competent directors, employees and executive personnel, and to provide incentives to those individuals to devote their utmost efforts to the advancement of stockholder value.&#160; Changes in stock options were as follows:</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&#160;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Shares (000&#146;s)</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="157" colspan="5" valign="top" style='width:118.1pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Price Range Per Share</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'><b>2017</b></p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;border:none;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.8pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="18" valign="top" style='width:13.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="50" valign="top" style='width:37.65pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Granted</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>- - -</p> </td> <td width="50" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expired or canceled</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>12</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>49.18 - 58.50</p> </td> <td width="50" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Exercised</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 49.18</p> </td> <td width="50" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total outstanding at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>54</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 58.50</p> </td> <td width="50" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total exercisable at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>39</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 58.50</p> </td> <td width="50" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.8pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="42" colspan="2" valign="top" style='width:31.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'><b>2016</b></p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.8pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="42" colspan="2" valign="top" style='width:31.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Granted</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>28</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>58.50 - 58.50</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expired or canceled</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>3</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>49.18 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Exercised</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>13</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total outstanding at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>75</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 58.50</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total exercisable at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>36</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 50.72</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" colspan="2" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" colspan="2" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" colspan="2" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'><b>2015</b></p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" colspan="2" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" colspan="2" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" colspan="2" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Granted</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>- - -</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expired or canceled</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>7</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>26.58 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Exercised</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>22</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>21.68 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total outstanding at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>62</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 50.72</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total exercisable at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>41</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 50.72</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" style='border:none'></td> <td width="12" style='border:none'></td> <td width="48" style='border:none'></td> <td width="43" style='border:none'></td> <td width="12" style='border:none'></td> <td width="36" style='border:none'></td> <td width="7" style='border:none'></td> <td width="11" style='border:none'></td> <td width="37" style='border:none'></td> <td width="5" style='border:none'></td> <td width="7" style='border:none'></td> <td width="43" style='border:none'></td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>For the years ended December&nbsp;31, 2017, 2016 and 2015, the Company reduced current income taxes payable by $38, $50 and $114, respectively, for the income tax benefit attributable to sale by optionees of common stock received upon the exercise of stock options.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'><u>Stock-Based Compensation</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In 2017, the Company recognized $129 in equity compensation cost, compared to $92 in 2016 and $87 in 2015.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="264" colspan="7" valign="top" style='width:198.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expected dividend amount per quarter</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="60" valign="top" style='width:45.35pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="54" valign="top" style='width:40.3pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>0.2775</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="59" valign="top" style='width:44.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expected stock price volatility</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>28.0%</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Risk-free interest rate</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1.30%</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expected life of options</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4.7 years</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>The per share weighted average fair value of options granted during 2016 is $12.15. No options were granted in 2017 or 2015.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt'>All UTMD options vest over a four-year service period.&#160; Expected dividend amounts were estimated based on the actual cash dividend rate at the time the options were granted and an estimate of future dividends based on past dividend rate changes as well as management&#146;s expectations of future dividend rates over the expected holding period of the options.&#160; Expected volatility is based on UTMD&#146;s historical volatility over recent periods of time and trends in that volatility, giving weight to more recent periods.&#160; Risk free interest rates were estimated based on actual U.S. Treasury Securities Interest rates as reported by the Federal Reserve Bank for periods of time equivalent to the holding periods estimated for the options on the dates the options were granted.&#160; Expected term of options were estimated based on historical holding periods for similar options previously granted by UTMD to employees and directors.&#160; </p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The following table summarizes information about stock options outstanding at December 31, 2017:</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="604" style='border-collapse:collapse'> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="90" colspan="5" valign="bottom" style='width:67.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="253" colspan="6" valign="bottom" style='width:189.4pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Options Outstanding</p> </td> <td width="19" valign="top" style='width:14.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="165" colspan="4" valign="bottom" style='width:123.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Options Exercisable</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="90" colspan="5" valign="bottom" style='width:67.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Range of Exercise Prices</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Number Outstanding</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Weighted Average Remaining Contractual Life (Years)</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Weighted Average Exercise Price</p> </td> <td width="19" valign="top" style='width:14.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Number Exercisable</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Weighted Average Exercise Price</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="36" colspan="2" valign="bottom" style='width:27.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&#160; </p> </td> <td width="18" colspan="2" valign="bottom" style='width:13.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="36" valign="bottom" style='width:27.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="19" valign="top" style='width:14.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>$</p> </td> <td width="36" valign="top" style='width:26.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>24.00</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="36" colspan="2" valign="top" style='width:27.35pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>33.30</p> </td> <td width="42" valign="top" style='width:31.7pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16,361</p> </td> <td width="20" valign="top" style='width:15.2pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2.92 </p> </td> <td width="19" valign="top" style='width:14.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>27.42</p> </td> <td width="19" valign="top" style='width:14.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16,361</p> </td> <td width="19" valign="top" style='width:14.35pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>27.72</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>49.18</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="36" colspan="2" valign="top" style='width:27.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>58.50</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>37,979</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7.44</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>53.28</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22,264</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>51.02</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>$</p> </td> <td width="36" valign="top" style='width:26.65pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>24.00</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="36" colspan="2" valign="top" style='width:27.35pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>58.50</p> </td> <td width="42" valign="top" style='width:31.7pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>54,340</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6.08</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45.50</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>38,625</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>41.02</p> </td> </tr> <tr align="left"> <td width="12" style='border:none'></td> <td width="36" style='border:none'></td> <td width="0" style='border:none'></td> <td width="18" style='border:none'></td> <td width="0" style='border:none'></td> <td width="36" style='border:none'></td> <td width="42" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> <td width="20" style='border:none'></td> <td width="67" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6630858416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GeographicInformationTextBlock', window );">Note 10 - Geographic Information</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 10 &#150; Geographic Information</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company had sales in the following geographic areas based on the customer&#146;s country of domicile:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>United States</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20,286</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19,488</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20,364</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Europe</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,519</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,989</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,720</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Other</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>12,609</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,821</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>12,073</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GeographicInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Geographic Sales Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_GeographicInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637431824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Geographic Long-Lived Assets Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GeographicLongLivedAssetsInformationTextBlock', window );">Note 11 - Geographic Long-Lived Assets Information</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 11 &#150; Long-lived Assets by Geographic Area</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company&#146;s long-lived assets by geographic area were as follows:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>United States</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,866</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,151</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,097</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>England</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>28,604</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>26,710</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>31,901</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Ireland</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,803</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,614</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,761</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Australia</p> </td> <td width="24" valign="top" style='width:.25in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>525</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>513</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>543</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Canada</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>759</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>729</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="24" valign="top" style='width:.25in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GeographicLongLivedAssetsInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Geographic Long-Lived Assets Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_GeographicLongLivedAssetsInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631829920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Revenues by Product Category<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RevenuesByProductCategoryTextBlock', window );">Note 12 - Revenues by Product Category</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 12 &#150; Revenues by Product Category</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company had revenues in the following product categories:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="240" valign="top" style='width:2.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Product Category</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;border:none;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Obstetrics</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,499</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,532</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,587</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Gynecology/Electrosurgery/Urology</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>23,175</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20,683</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22,356</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Neonatal</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,154</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,007</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,299</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Blood Pressure Monitoring and Accessories</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,586</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,076</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,915</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RevenuesByProductCategoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues by Product Category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_RevenuesByProductCategoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6898504096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Product Sale and Purchase Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProductSaleAndPurchaseCommitmentsTextBlock', window );">Note 13 - Product Sale and Purchase Commitments</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 13 - Product Sale and Purchase Commitments</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has had license agreements for the rights to develop and market certain products or technologies owned by unrelated parties.&#160; The confidential terms of such agreements are unique and varied, depending on many factors relating to the value and stage of development of the technology licensed.&#160; Royalties on future product sales are a normal component of such agreements and are included in the Company&#146;s cost of goods sold on an ongoing basis.</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In 2017, 2016 and 2015, UTMD received royalties of $86, $91 and $93, respectively, for the use of intellectual property of Filshie Clip System as part of Femcare&#146;s exclusive U.S. distribution agreement with CooperSurgical Inc. </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>UTMD had $2,191 in operating lease and purchase commitments as of December 31, 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProductSaleAndPurchaseCommitmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Sale and Purchase Commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ProductSaleAndPurchaseCommitmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640754784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 - Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Note 14 - Employee Benefit Plans</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 14 &#150; Employee Benefit Plans</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company sponsors a contributory 401(k) savings plan for U.S. employees, and contributory retirement plans for Ireland, UK, Australia and Canada employees.&#160; The Company&#146;s matching contribution is determined annually by the board of directors.&#160; Company contributions were approximately $153, $151 and $161 for the years ended December 31, 2017, 2016 and 2015, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6600388992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 15 - Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Note 15 - Recent Accounting Pronouncements</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Note 15 &#150; Recent Accounting Pronouncements</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In March 2016, new accounting guidance was issued to simplify several aspects of accounting for employee share-based payment (including stock option) transactions, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as classification in the statement of cash flows. Under the guidance, entities recognize all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement. UTMD adopted this standard on January 1, 2017, which had an insignificant impact on its consolidated financial statements. UTMD made a determination to continue to account for forfeitures by estimating the number of awards that are expected to vest.&#160; Because UTMD primarily issues incentive stock options, excess tax benefits and tax deficiencies have historically been minimal.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In May 2014, new accounting guidance (ASU 2014-09) was issued that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&nbsp; The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract.&nbsp; UTMD adopted this new standard on January 1, 2018, using a full retrospective approach. In accordance with ASU 2014-09, UTMDs revenue recognition is based on its contracts and the performance obligations identified in them. With very insignificant and limited exceptions, the Company&#146;s performance obligation is met when it ships a physical product to a customer. The basis on which UTMD recognizes revenue was updated on January 1, 2018, but it did not result in a change to the process and timing of revenue recognition, because the previous revenue recognition method complies with ASU 2014-09.&#160; Therefore, the adoption of ASU 2014-09 did not have an impact on UTMD&#146;s financial statements.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In February 2016, new accounting guidance was issued which requires recording most leases on the balance sheet. The new lease standard requires disclosure of key information about lease arrangements and aligns many of the underlying principles of this new model with those in the new revenue recognition standard noted above. This guidance becomes effective for annual reporting periods beginning after December 15, 2018, with early adoption permitted. UTMD has yet to assess the impact that this standard will have on its consolidated financial statements when it is adopted. The only significant lease the Company anticipates it will have at that time is for the parking lot at its Utah facility (see Note 7).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640754784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 16 - Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Note 16 - Subsequent Events</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt;margin-bottom:6.0pt'><u>Note 16 &#150; Subsequent Events</u></p> <p style='margin:0in;margin-bottom:.0001pt'>The Company evaluated its December 31, 2017 financial statements for subsequent events through the date the financial statements were issued.&#160; The Company is not aware of any subsequent events which would require recognition or disclosure in the financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636349872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Use of Estimates in The Preparation of Financial Statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in The Preparation of Financial Statements</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Use of Estimates in the Preparation of Financial Statements</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Although actual results could differ from those estimates, management believes it has considered and disclosed all relevant information in making its estimates that materially affect reported performance and current values.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6752255584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Principles of Consolidation</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The consolidated financial statements include those of the Company and its subsidiaries.&#160; All intercompany accounts and transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6900488480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Cash and Cash Equivalents</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>For purposes of the consolidated statement of cash flows, the Company considers cash on deposit and short-term investments with original maturities of three months or less to be cash and cash equivalents.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640902272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Investments (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Investments</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The Company classifies its investments as &#147;available-for-sale.&#148;&#160; Securities classified as &#147;available-for-sale&#148; are carried in the financial statements at fair value.&#160; Realized gains and losses, determined using the specific identification method, are included in operations; unrealized holding gains and losses are reported as a separate component of accumulated other comprehensive income.&#160; Declines in fair value below cost that are other than temporary are included in operations.&#160; As of December 31, 2017 the Company retained a freely tradeable investment in Citigroup (C) (see note 3).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66011266&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2,12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877573&amp;loc=d3e87990-122713<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75025870&amp;loc=d3e40691-111596<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640899952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Concentration of Credit Risk (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Concentration of Credit Risk</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The primary concentration of credit risk consists of trade receivables.&#160; In the normal course of business, the Company provides credit terms to its customers.&#160; Accordingly, the Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses which, when realized, have been within the range of management's expectations as reflected by its reserves. </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company's customer base consists of hospitals, medical device distributors, physician practices and others directly related to healthcare providers, as well as other manufacturing companies.&#160; Although the Company is affected by the well-being of the global healthcare industry, management does not believe significant trade receivable credit risk exists at December&nbsp;31, 2017 except under an extreme global financial crisis.</p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company maintains its cash in bank deposit accounts in addition to Fidelity Investment accounts.&#160; The Company has not experienced any losses in such accounts and believes it is not exposed to a significant credit risk on cash and cash equivalent balances.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637431824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Accounts Receivable (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Accounts Receivable</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Accounts receivable are amounts due on product sales and are unsecured.&#160; Accounts receivable are carried at their estimated collectible amounts.&#160; Credit is generally extended on a short-term basis; thus accounts receivable do not bear interest although a late charge may be applied to such receivables that are past the due date.&#160; Accounts receivable are periodically evaluated for collectibility based on past credit history of customers and current market conditions.&#160; Provisions for losses on accounts receivable are determined on the basis of loss experience, known and inherent risk in the account balance and current economic conditions (see note 2).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e4975-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632587760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Inventories (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Inventories</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>In 2017, the Company adopted Accounting Standard Update (ASU) 2015-11, &#147;Inventory-Simplifying the Measurement of Inventory,&#148; which changed how inventory is valued.&#160; Finished products, work-in-process, raw materials and supplies inventories are stated at the lower of cost and net realizable value (NRV) computed on a first-in, first-out method.&#160; Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#160; The adoption of ASU 2015-11 did not have an impact on the Company&#146;s financial statements (see note 2).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631823392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Property and Equipment</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Property and equipment are stated at cost.&#160; Depreciation and amortization are computed using the straight-line method over estimated useful lives as follows:</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="522" style='border-collapse:collapse'> <tr align="left"> <td width="522" colspan="2" valign="top" style='width:391.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Building and improvements</p> </td> <td width="124" style='width:92.7pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>15 - 40 years</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="124" style='width:92.7pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>3 - 10 years</p> </td> </tr> </table> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637611248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Long-lived Assets (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u><font lang="EN-CA">Long-Lived Assets</font></u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>The Company evaluates its long-lived assets in accordance with Accounting Standards Codification (ASC) 360, &#147;Accounting for the Impairment of Long-Lived Assets.&#148;&#160; Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable.&#160; When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amounts.&#160; Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets, and is recorded in the period in which the determination was made.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640914528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Intangible Assets</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Costs associated with the acquisition of patents, trademarks, trade names, customer relationships, regulatory approvals &amp; product certifications, license rights and non-compete agreements are capitalized, and are being amortized using the straight-line method over periods ranging from 5 to 20 years. UTMD&#146;s goodwill is tested for impairment annually, in the fourth quarter of each year, using a fair value measurement test, in accordance with ASC 350. UTMD also performs impairment tests contemporaneously, if circumstances change that would more than likely reduce the fair value of goodwill below its net book value.&#160; If UTMD determines that its goodwill is impaired, a second step is completed to measure the amount of the impairment loss. UTMD does not expect its goodwill to become impaired in the foreseeable future.&#160; Estimated future amortization expense on intangible assets currently held, using the 2017 year-end 1.3523 USD/GBP and.7815 USD/AUD currency exchange rates, is about $1,981 in 2018, $1,980 in 2019 and 2020, $1,974 in 2021, and&#160; $1,973 in 2022 (see note 2).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640912352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Revenue Recognition</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company recognizes revenue at the time of product shipment as UTMD meets its contractual performance obligations to the customer at the time of shipment. Revenue recognized by UTMD is based upon the consideration to which UTMD is entitled from its customers as a result of shipping a physical product, in accordance with the documented arrangements and fixed contracts in which the selling price was fixed prior to the Company&#146;s acceptance of an order. Revenue from service sales, which are immaterial to UTMD, is generally recognized when the service is completed and invoiced. As demonstrated by decades of experience in successful and consistent collections, there is very minor and insignificant uncertainty regarding the collectability of invoiced amounts reasonably within the terms of the Company&#146;s contracts. There are circumstances under which insignificant revenue may be recognized when product is not shipped, which meet the criteria of ASU 2014-09: the Company provides engineering services, for example, design and production of manufacturing tooling that may be used in subsequent UTMD manufacturing of custom components for other companies.&#160; This revenue is recognized when UTMD&#146;s performance obligations have been completed according to a fixed contractual agreement.&#160; UTMD includes handling fees charged to customers in revenues.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637431824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Income Taxes (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Income Taxes</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company accounts for income taxes under ASC 740, &#147;Accounting for Income Taxes,&#148; whereby deferred taxes are computed under the asset and liability method. </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>In November 2015, the FASB released ASU 2015-17, Income Taxes (Topic 740):&#160; Balance Sheet classification of Deferred Taxes.&#160; ASU 2015-17 requires that all deferred income taxes are classified as noncurrent in a classified statement of financial position.&#160; The Company adopted ASU 2015-17 retrospectively effective January 1, 2017.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>On December 22, 2017 the U.S. Tax Cuts and Jobs Act of 2017 (Tax Act) was signed into law.&#160; As a result of the Tax Act, the U.S. statutory tax rate was lowered from 35% to 21% effective January 1, 2018, among other changes.&#160; ASC 740 requires companies to recognize the effect of tax law changes in the period of enactment; therefore, UTMD was required to revalue its deferred tax assets and liabilities at December 31, 2017 at the new rate.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Tax Act contains a deemed repatriation transition tax (Transition Tax) on accumulated earnings and profits of the Company&#146;s non-U.S. subsidiaries that have not been subject to U.S. tax.&#160; The Company plans to elect to pay its net Transition Tax over eight years.&#160; </p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>On December 22, 2017, the SEC issued SAB 118 which provides guidance on accounting for the impact of the Tax Act.&#160; SAB 118 provides a measurement period of up to one year from enactment for a company to complete its tax accounting under ASC 740.&#160; Once a company is able to make a reasonable estimate and record a provisional amount for effects of the Tax Act it is required to do so.&#160; Such provisional measurement amounts may change as remaining data is obtained, calculations are prepared and analysis and review are completed.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>During the fourth quarter of 2017, the Company recorded a provisional tax charge for the Transition Tax of $6,288 and a provisional tax charge of $228 for the re-measurement of its U.S. deferred tax balances.&#160; Both provisional tax amounts are the Company&#146;s reasonable estimate of the impact of the Tax Act based on its understanding and available guidance.&#160; These provisional amounts may change as the Company receives additional clarification and implementation guidance.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, in Utah, in the United Kingdom, in Australia, in Ireland and in Canada. </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:6.0pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company recognizes interest accrued related to unrecognized tax benefits in interest expenses and any related penalties in income taxes. The Company did not recognize any tax-related interest expense or have any tax penalties in any of the three years 2015 through 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636201984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Legal Costs (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Legal Costs</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>The Company has been involved in lawsuits which are an expected consequence of its operations and in the ordinary course of business.&#160; The Company maintains a reserve for legal costs which are probable and estimated based on previous experience and known risk.&#160; The reserve for legal costs at December 31, 2017 and 2016 was &#160;$182 and $134, respectively (see note 2).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636151664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Earnings Per Share (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Earnings per Share</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The computation of basic earnings per common share is based on the weighted average number of shares outstanding during each year. </p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>The computation of earnings per common share assuming dilution is based on the weighted average number of shares outstanding during the year plus the weighted average common stock equivalents which would arise from the exercise of stock options outstanding using the treasury stock method and the average market price per share during the year.</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in'>The shares (in thousands) used in the computation of the Company&#146;s basic and diluted earnings per share are reconciled as follows:</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="586" style='border-collapse:collapse'> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Weighted average number of shares outstanding &#150; basic</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,718</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,751</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,752</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Dilutive effect of stock options</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Weighted average number of shares outstanding, assuming dilution</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,737</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,766</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,772</p> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636588400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Presentation of Sales and Similar Taxes (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PresentationOfSalesAndSimilarTaxesTextBlock', window );">Presentation of Sales and Similar Taxes</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Presentation of Sales and Similar Taxes</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Sales tax on revenue-producing transactions is recorded as a liability when the sale occurs.&#160; UTMD is not required to withhold sales tax on OUS sales, and at least 90% of domestic 2017 sales were to customers who are tax exempt or who are in jurisdictions where UTMD is not required to withhold sales tax.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PresentationOfSalesAndSimilarTaxesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Presentation of Sales and Similar Taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PresentationOfSalesAndSimilarTaxesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640909520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'><u>Stock-Based Compensation </u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>At December 31, 2017, the Company has stock-based employee compensation plans, which are described more fully in note 9.&#160; The Company accounts for stock compensation under ASC 718, <i>Share-Based Payment</i>.&#160; This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors.&#160; In 2017, the Company recognized $129 in stock-based compensation cost compared to $92 in 2016 and $87 in 2015.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631985440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Translation of Foreign Currencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Translation of Foreign Currencies</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'><u>Translation of Foreign Currencies</u></p> <p style='margin:0in;margin-bottom:.0001pt;line-height:50%'>&nbsp;</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Assets and liabilities of the Company&#146;s foreign subsidiaries are translated into U.S. dollars at the applicable exchange rates at year-end.&#160; Net gains or losses resulting from the translation of the Company&#146;s assets and liabilities are reflected as a separate component of stockholders&#146; equity.&#160; A negative translation impact on stockholders&#146; equity reflects a current relative U.S. Dollar value higher than at the point in time that assets were actually acquired in a foreign currency.&#160; A positive translation impact would result from a U.S. dollar weaker in value than at the point in time foreign assets were acquired.&#160; Year-end translation gains or losses of non-functional currency bank account balances, e.g. EUR and AUD balances held by the UK subsidiary, are recognized as non-operating income or expense, as applicable.</p> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>Income and expense items are translated at the weighted average rate of exchange (based on when transactions actually occurred) during the year.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640925824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="586" style='border-collapse:collapse'> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Weighted average number of shares outstanding &#150; basic</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,718</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,751</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,752</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Dilutive effect of stock options</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20</p> </td> </tr> <tr align="left"> <td width="398" valign="top" style='width:4.15in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'> Weighted average number of shares outstanding, assuming dilution</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,737</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,766</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,772</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6609766992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts and Other Receivables</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left;line-height:50%'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="146" colspan="4" valign="bottom" style='width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accounts and other receivables:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accounts receivable</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,713</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,289</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Income tax receivable</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accrued interest and other</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>14</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Less allowance for doubtful accounts</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(104)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(96)</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total accounts and other receivables</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,623</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,211</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642284352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current</a></td>
<td class="text"><!--egx--> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Inventories:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Finished products</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,313</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,327</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Work-in-process</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,270</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>942</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Raw materials</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,661</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,273</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total inventories</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,244</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,542</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6609766992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><!--egx--><p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Other intangible assets:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Patents</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,183</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,161</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Non-compete agreements</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>135</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>123</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Trademarks &amp; trade names</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,921</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,074</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Customer relationships</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,669</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,822</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Regulatory approvals &amp; product certifications</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>12,897</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,767</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total other intangible assets</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>34,805</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>31,947</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accumulated amortization</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(16,961)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(13,683)</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other intangible assets, net</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>17,844</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>18,264</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642284352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><!--egx--> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p align="left" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:left'>Accrued expenses:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Income taxes payable</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,259</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>799</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payroll and payroll taxes</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,199</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,117</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Reserve for litigation costs</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>182</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>134</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Other</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,706</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>66</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total accrued expenses</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,346</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,116</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6633608048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="599" style='border-collapse:collapse'> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="146" colspan="4" valign="bottom" style='width:109.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Investments, at cost</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>42</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>42</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Equity securities:</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>-Unrealized holding gains</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>38</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>-Unrealized holding (losses)</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="442" valign="top" style='width:4.6in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Investments, at fair value</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754137808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="607" style='border-collapse:collapse'> <tr align="left"> <td width="192" valign="top" style='width:2.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="108" colspan="4" valign="top" style='width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Level 1</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="108" colspan="4" valign="top" style='width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Levels 2 &amp; 3</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="108" colspan="4" valign="top" style='width:80.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Total</p> </td> </tr> <tr align="left"> <td width="192" valign="top" style='width:2.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="192" valign="top" style='width:2.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Equities</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="29" valign="top" style='width:.3in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> </tr> <tr align="left"> <td width="192" valign="bottom" style='width:2.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="29" valign="top" style='width:.3in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>80</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="38" valign="top" style='width:.4in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>64</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636364080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Property and Equipment: Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="462" style='border-collapse:collapse'> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="150" colspan="4" valign="bottom" style='width:112.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-justify:inter-ideograph;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="1" valign="top" style='width:1.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Land</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="59" valign="top" style='width:44.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,339</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="60" valign="top" style='width:45.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,289</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Buildings and improvements</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,350</p> </td> <td width="1" valign="top" style='width:1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,914</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,696</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,759</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Construction-in-progress</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>13</p> </td> <td width="1" valign="top" style='width:1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,061</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>32,398</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>30,023</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accumulated depreciation</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,777)</p> </td> <td width="1" valign="top" style='width:1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,057)</p> </td> </tr> <tr align="left"> <td width="282" valign="top" style='width:211.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment, net</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="59" valign="top" style='width:44.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,621</p> </td> <td width="1" valign="top" style='width:1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="30" valign="top" style='width:22.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="60" valign="top" style='width:45.0pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,966</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6630687344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Property and Equipment: Property Plant and Equipment by Location (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PropertyPlantAndEquipmentByLocationTextBlock', window );">Property Plant and Equipment by Location</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="547" style='border-collapse:collapse'> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="321" colspan="10" valign="top" style='width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>December 31, 2017</p> </td> <td width="1" style='border:none;border-bottom:solid windowtext 1.0pt'><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p></td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>U.S. &amp; Canada </p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>England &amp; Australia </p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Ireland</p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" colspan="2" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Total</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Land</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>926</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>413</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,339</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Buildings and improvements</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,583</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,361</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,406</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,350</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>14,124</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>427</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,145</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,696</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Construction-in-progress</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>13</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>21,643</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,791</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,964</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>32,398</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accumulated depreciation</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(17,270)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(346)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,161)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,777)</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment, net</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,373</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,445</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,803</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,621</p> </td> </tr> <tr align="left"> <td width="202" style='border:none'></td> <td width="11" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="56" style='border:none'></td> <td width="1" style='border:none'></td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="547" style='border-collapse:collapse'> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="321" colspan="10" valign="top" style='width:240.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>December 31, 2016</p> </td> <td width="1" style='border:none;border-bottom:solid windowtext 1.0pt'><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p></td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="57" valign="bottom" style='width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>U.S. &amp; Canada</p> </td> <td width="20" valign="bottom" style='width:14.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>England &amp; Australia </p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Ireland</p> </td> <td width="19" valign="bottom" style='width:.2in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="bottom" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="58" colspan="2" valign="bottom" style='width:.6in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Total</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Land</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>926</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>362</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,289</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Buildings and improvements</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,523</p> </td> <td width="20" valign="top" style='width:14.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>523</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,869</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,914</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Furniture, equipment and tooling</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>14,233</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>529</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>996</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,759</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Construction-in-progress</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="20" valign="top" style='width:14.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,057</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,061</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Total</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>21,682</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,109</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,231</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>30,023</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accumulated depreciation</p> </td> <td width="11" valign="top" style='width:8.6pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(17,063)</p> </td> <td width="20" valign="top" style='width:14.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(376)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(2,617)</p> </td> <td width="19" valign="top" style='width:.2in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(20,057)</p> </td> </tr> <tr align="left"> <td width="202" valign="top" style='width:2.1in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Property and equipment, net</p> </td> <td width="11" valign="top" style='width:8.6pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.75pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="57" valign="top" style='width:42.95pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,619</p> </td> <td width="20" valign="top" style='width:14.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,733</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,614</p> </td> <td width="19" valign="top" style='width:.2in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="58" colspan="2" valign="top" style='width:.6in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,966</p> </td> </tr> <tr align="left"> <td width="202" style='border:none'></td> <td width="11" style='border:none'></td> <td width="12" style='border:none'></td> <td width="57" style='border:none'></td> <td width="20" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="58" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="56" style='border:none'></td> <td width="1" style='border:none'></td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PropertyPlantAndEquipmentByLocationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure by location of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PropertyPlantAndEquipmentByLocationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6900121888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="469" style='border-collapse:collapse'> <tr align="left"> <td width="384" valign="bottom" style='width:4.0in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Years ending December 31:</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="53" valign="bottom" style='width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Amount</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;border:none;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2018</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="53" valign="top" style='width:.55in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>83</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2019</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2020</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2021</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>2022</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Thereafter</p> </td> <td width="21" valign="top" style='width:15.85pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="53" valign="top" style='width:.55in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>398</p> </td> </tr> <tr align="left"> <td width="384" valign="top" style='width:4.0in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total future minimum lease payments</p> </td> <td width="21" valign="top" style='width:15.85pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="53" valign="top" style='width:.55in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>661</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6600388992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="78%" style='width:78.84%;border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="144" colspan="4" style='width:107.95pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" style='width:31.5pt;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" style='width:31.45pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Inventory write-downs and differences due to UNICAP</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>56</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.45pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>98</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Allowance for doubtful accounts</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>25</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Accrued liabilities and reserves</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>89</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>147</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Other - foreign</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(23)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Depreciation and amortization</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,789)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(4,277)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Unrealized investment gains</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>66</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.45pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>105</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Deferred income taxes, net</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,558)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="42" valign="top" style='width:31.45pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,925)</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642302576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="249" colspan="7" valign="top" style='width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Current</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,944</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>5,467</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,877</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Deferred</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(367)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(1,173)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(1,175)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,577</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,294</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,702</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642366992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="249" colspan="7" valign="top" style='width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Federal income tax expense at the statutory rate</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,086</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,998</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,704</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>State income taxes</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>299</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>291</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>262</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Foreign income taxes (blended rate)</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,444</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1,270</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>990</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>ETI, manufacturing deduction and tax credits</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(303)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(287)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(257)</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Deemed repatriation transition tax </p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,288</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Effective federal rate change</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(228)</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Other</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(9)</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,577</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,294</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,702</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618173328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="249" colspan="7" valign="top" style='width:186.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Domestic</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,124</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,688</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,973</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Foreign</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>9,958</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,734</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,572</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19,082</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16,422</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="43" valign="top" style='width:.45in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>15,545</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6900377104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&#160;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Shares (000&#146;s)</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="157" colspan="5" valign="top" style='width:118.1pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Price Range Per Share</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'><b>2017</b></p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;border:none;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.8pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="18" valign="top" style='width:13.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.5pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="50" valign="top" style='width:37.65pt;border:none;border-top:solid windowtext 1.0pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Granted</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>- - -</p> </td> <td width="50" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expired or canceled</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>12</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>49.18 - 58.50</p> </td> <td width="50" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Exercised</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 49.18</p> </td> <td width="50" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total outstanding at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>54</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 58.50</p> </td> <td width="50" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total exercisable at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>39</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="3" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 58.50</p> </td> <td width="50" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> </table> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="596" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.8pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="42" colspan="2" valign="top" style='width:31.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'><b>2016</b></p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.8pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="42" colspan="2" valign="top" style='width:31.5pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Granted</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>28</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>58.50 - 58.50</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expired or canceled</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>3</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>49.18 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Exercised</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>13</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total outstanding at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>75</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 58.50</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total exercisable at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>36</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 50.72</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" colspan="2" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" colspan="2" valign="top" style='width:.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" colspan="2" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'><b>2015</b></p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" colspan="2" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" colspan="2" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" colspan="2" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="43" valign="top" style='width:.45in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Granted</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>- - -</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expired or canceled</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>7</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>26.58 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Exercised</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>22</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>21.68 - 49.18</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total outstanding at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>62</p> </td> <td width="43" valign="top" style='width:32.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 50.72</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Total exercisable at December 31</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:36.35pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>41</p> </td> <td width="43" valign="top" style='width:32.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="96" colspan="5" valign="top" style='width:71.8pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>24.00 - 50.72</p> </td> <td width="50" colspan="2" valign="top" style='width:37.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" style='border:none'></td> <td width="12" style='border:none'></td> <td width="48" style='border:none'></td> <td width="43" style='border:none'></td> <td width="12" style='border:none'></td> <td width="36" style='border:none'></td> <td width="7" style='border:none'></td> <td width="11" style='border:none'></td> <td width="37" style='border:none'></td> <td width="5" style='border:none'></td> <td width="7" style='border:none'></td> <td width="43" style='border:none'></td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618173328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="264" colspan="7" valign="top" style='width:198.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Years ended December 31,</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expected dividend amount per quarter</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="60" valign="top" style='width:45.35pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="54" valign="top" style='width:40.3pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>0.2775</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="59" valign="top" style='width:44.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expected stock price volatility</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>28.0%</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Risk-free interest rate</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>1.30%</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="336" valign="top" style='width:3.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Expected life of options</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="60" valign="top" style='width:45.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="54" valign="top" style='width:40.3pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4.7 years</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="59" valign="top" style='width:44.25pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619226480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range</a></td>
<td class="text"><!--egx--><p style='margin-top:0in;margin-right:0in;margin-bottom:6.0pt;margin-left:0in;margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" width="604" style='border-collapse:collapse'> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="90" colspan="5" valign="bottom" style='width:67.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="253" colspan="6" valign="bottom" style='width:189.4pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Options Outstanding</p> </td> <td width="19" valign="top" style='width:14.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="165" colspan="4" valign="bottom" style='width:123.8pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Options Exercisable</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="90" colspan="5" valign="bottom" style='width:67.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Range of Exercise Prices</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Number Outstanding</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Weighted Average Remaining Contractual Life (Years)</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Weighted Average Exercise Price</p> </td> <td width="19" valign="top" style='width:14.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Number Exercisable</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>Weighted Average Exercise Price</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="36" colspan="2" valign="bottom" style='width:27.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&#160; </p> </td> <td width="18" colspan="2" valign="bottom" style='width:13.5pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="36" valign="bottom" style='width:27.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="19" valign="top" style='width:14.35pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;border:none;border-top:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="bottom" style='width:.7in;border:none;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>$</p> </td> <td width="36" valign="top" style='width:26.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>24.00</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="36" colspan="2" valign="top" style='width:27.35pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>33.30</p> </td> <td width="42" valign="top" style='width:31.7pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16,361</p> </td> <td width="20" valign="top" style='width:15.2pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2.92 </p> </td> <td width="19" valign="top" style='width:14.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>27.42</p> </td> <td width="19" valign="top" style='width:14.35pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>16,361</p> </td> <td width="19" valign="top" style='width:14.35pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>27.72</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="36" valign="top" style='width:26.65pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>49.18</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="36" colspan="2" valign="top" style='width:27.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>58.50</p> </td> <td width="42" valign="top" style='width:31.7pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>37,979</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7.44</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>53.28</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22,264</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>51.02</p> </td> </tr> <tr align="left"> <td width="12" valign="top" style='width:9.0pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>$</p> </td> <td width="36" valign="top" style='width:26.65pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>24.00</p> </td> <td width="18" colspan="2" valign="top" style='width:13.5pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>-</p> </td> <td width="36" colspan="2" valign="top" style='width:27.35pt;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>58.50</p> </td> <td width="42" valign="top" style='width:31.7pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>54,340</p> </td> <td width="20" valign="top" style='width:15.2pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6.08</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>45.50</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>38,625</p> </td> <td width="19" valign="top" style='width:14.35pt;border:none;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="67" valign="top" style='width:.7in;border:none;border-bottom:double windowtext 1.5pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>41.02</p> </td> </tr> <tr align="left"> <td width="12" style='border:none'></td> <td width="36" style='border:none'></td> <td width="0" style='border:none'></td> <td width="18" style='border:none'></td> <td width="0" style='border:none'></td> <td width="36" style='border:none'></td> <td width="42" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> <td width="20" style='border:none'></td> <td width="67" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> <td width="19" style='border:none'></td> <td width="12" style='border:none'></td> <td width="67" style='border:none'></td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6618858528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Geographic Information: Schedule Of Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfGeographicInformationTextBlock', window );">Schedule Of Geographic Information</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>United States</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20,286</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>19,488</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20,364</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Europe</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,519</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,989</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,720</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Other</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>12,609</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,821</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>12,073</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfGeographicInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographic Sales Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfGeographicInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745235440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock', window );">Schedule Of Long-Lived Assets By Geographic Area</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="bottom" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>United States</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>10,866</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,151</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>11,097</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>England</p> </td> <td width="24" valign="top" style='width:.25in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>28,604</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>26,710</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>31,901</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Ireland</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,803</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,614</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>2,761</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Australia</p> </td> <td width="24" valign="top" style='width:.25in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>525</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>513</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>543</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Canada</p> </td> <td width="24" valign="top" style='width:.25in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>759</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>729</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>-</p> </td> </tr> <tr align="left"> <td width="264" valign="top" style='width:2.75in;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="24" valign="top" style='width:.25in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="31" valign="top" style='width:23.05pt;background:white;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:white;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Long-lived Assets By Geographic Area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfLongLivedAssetsByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642508192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfRevenuesByProductCategoryTextBlock', window );">Schedule Of Revenues By Product Category</a></td>
<td class="text"><!--egx--><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <table border="0" cellspacing="0" cellpadding="0" style='border-collapse:collapse'> <tr align="left"> <td width="240" valign="top" style='width:2.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Product Category</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2017</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2016</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;border:none;border-bottom:solid windowtext 1.0pt;padding:0'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>2015</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;border:none;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Obstetrics</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;border:none;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,499</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,532</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,587</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Gynecology/Electrosurgery/Urology</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>23,175</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>20,683</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>22,356</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Neonatal</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,154</p> </td> <td width="31" valign="top" style='width:23.05pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,007</p> </td> <td width="37" valign="top" style='width:28.1pt;background:#CCEEFF;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;background:#CCEEFF;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,299</p> </td> </tr> <tr align="left"> <td width="240" valign="top" style='width:2.5in;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>Blood Pressure Monitoring and Accessories</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>7,586</p> </td> <td width="31" valign="top" style='width:23.05pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>8,076</p> </td> <td width="37" valign="top" style='width:28.1pt;padding:0'> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> </td> <td width="12" valign="top" style='width:8.65pt;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="48" valign="top" style='width:.5in;padding:0'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>6,915</p> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfRevenuesByProductCategoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Revenues By Product Category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ScheduleOfRevenuesByProductCategoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6630666208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Building Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Building Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754007056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD', window );">Foreign Currency Exchange Rate Translation GBP to USD</a></td>
<td class="nump">1.3523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD', window );">Foreign Currency Exchange Rate Translation AUD to USD</a></td>
<td class="nump">0.7815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">$ 1,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Three</a></td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">1,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">$ 1,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency AUD to reporting currency USD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ForeignCurrencyExchangeRateTranslationAUDtoUSD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency GBP to reporting currency USD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_ForeignCurrencyExchangeRateTranslationGBPtoUSD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6893083680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Income Taxes (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount', window );">Effective Income Tax Rate Reconciliation TaxCuts And Jobs Act Of 2017 Transition Tax On Accumulated Foreign Earnings Amount</a></td>
<td class="nump">$ 6,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit', window );">TaxCuts And Jobs Act Of 2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit</a></td>
<td class="nump">$ 228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6888450704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Legal Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6596494144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">3,718<span></span>
</td>
<td class="nump">3,751<span></span>
</td>
<td class="nump">3,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">3,737<span></span>
</td>
<td class="nump">3,766<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6887780592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6907602448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts Receivable, Gross, Current</a></td>
<td class="nump">$ 3,713<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income Taxes Receivable, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivableAndOtherAssets', window );">Interest Receivable and Other Assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for Doubtful Accounts Receivable, Current</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts and Other Receivables, Net, Current</a></td>
<td class="nump">$ 3,623<span></span>
</td>
<td class="nump">$ 3,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest receivable and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640578848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">$ 1,313<span></span>
</td>
<td class="nump">$ 1,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Inventory, Work in Process, Gross</a></td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Inventory, Raw Materials, Gross</a></td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">2,273<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 5,244<span></span>
</td>
<td class="nump">$ 4,542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6633058288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedPatentsGross', window );">Finite-Lived Patents, Gross</a></td>
<td class="nump">$ 2,183<span></span>
</td>
<td class="nump">$ 2,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedNoncompeteAgreementsGross', window );">Finite-Lived Noncompete Agreements, Gross</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedTrademarksGross', window );">Finite-Lived Trademarks, Gross</a></td>
<td class="nump">9,921<span></span>
</td>
<td class="nump">9,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedCustomerRelationshipsGross', window );">Finite-Lived Customer Relationships, Gross</a></td>
<td class="nump">9,669<span></span>
</td>
<td class="nump">8,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross', window );">Regulatory approvals &amp; product certifications</a></td>
<td class="nump">12,897<span></span>
</td>
<td class="nump">11,767<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets</a></td>
<td class="nump">34,805<span></span>
</td>
<td class="nump">31,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Other intangible assets - accumulated amortization</a></td>
<td class="num">(16,961)<span></span>
</td>
<td class="num">(13,683)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 17,844<span></span>
</td>
<td class="nump">$ 18,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of regulatory approvals and product certifications.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_FiniteLivedRegulatoryApprovalsAndProductCertificationsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedCustomerRelationshipsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date to an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedCustomerRelationshipsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedNoncompeteAgreementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of payments made to third parties in exchange for their agreement not to engage in specified competitive practices in specified geographic territories for a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedNoncompeteAgreementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedPatentsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedPatentsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedTrademarksGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedTrademarksGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6752296336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued Income Taxes, Current</a></td>
<td class="nump">$ 1,259<span></span>
</td>
<td class="nump">$ 799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee-related Liabilities, Current</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Estimated Litigation Liability, Current</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,706<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 4,346<span></span>
</td>
<td class="nump">$ 2,116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6396582&amp;loc=d3e15243-108350<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6614250912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Available-for-sale Securities, Amortized Cost Basis</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesEquitySecurities', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity securities categorized neither as held-to-maturity nor as trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26610-111562<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62557-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636201984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueDisclosure', window );">Equity, Fair Value Disclosure</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueDisclosure', window );">Equity, Fair Value Disclosure</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the entity's equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6891759936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 5 - Property and Equipment: Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 1,339<span></span>
</td>
<td class="nump">$ 1,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="nump">15,350<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">15,696<span></span>
</td>
<td class="nump">15,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">32,398<span></span>
</td>
<td class="nump">30,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(20,777)<span></span>
</td>
<td class="num">(20,057)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">$ 11,621<span></span>
</td>
<td class="nump">$ 9,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755841184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 5 - Property and Equipment: Property Plant and Equipment by Location (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 1,339<span></span>
</td>
<td class="nump">$ 1,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="nump">15,350<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">15,696<span></span>
</td>
<td class="nump">15,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">32,398<span></span>
</td>
<td class="nump">30,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(20,777)<span></span>
</td>
<td class="num">(20,057)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">11,621<span></span>
</td>
<td class="nump">9,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=fil_U.S.AndCanadaMember', window );">U.S. and Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="nump">6,583<span></span>
</td>
<td class="nump">6,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">14,124<span></span>
</td>
<td class="nump">14,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">21,643<span></span>
</td>
<td class="nump">21,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(17,270)<span></span>
</td>
<td class="num">(17,063)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">4,373<span></span>
</td>
<td class="nump">4,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=fil_EnglandAndAustraliaMember', window );">England and Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="nump">4,361<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2,057<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">4,791<span></span>
</td>
<td class="nump">3,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">4,445<span></span>
</td>
<td class="nump">2,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=fil_IrelandMember', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="nump">4,406<span></span>
</td>
<td class="nump">3,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">5,964<span></span>
</td>
<td class="nump">5,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="num">(3,161)<span></span>
</td>
<td class="num">(2,617)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">$ 2,803<span></span>
</td>
<td class="nump">$ 2,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=fil_U.S.AndCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=fil_U.S.AndCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=fil_EnglandAndAustraliaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=fil_EnglandAndAustraliaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=fil_IrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=fil_IrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637509536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 6 - Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_JPMorganChaseBankNAChaseNoteMember', window );">JP Morgan Chase Bank NA (Chase) Note</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 14,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=fil_JPMorganChaseLondonBranchNoteMember', window );">JP Morgan Chase London Branch Note</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 12,934<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_JPMorganChaseBankNAChaseNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_JPMorganChaseBankNAChaseNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=fil_JPMorganChaseLondonBranchNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=fil_JPMorganChaseLondonBranchNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6891616592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating Leases, Rent Expense, Net</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6907514224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Operating Leases, Future Minimum Payments, Due in Three Years</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">Operating Leases, Future Minimum Payments, Due in Four Years</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">Operating Leases, Future Minimum Payments, Due in Five Years</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Operating Leases, Future Minimum Payments, Due Thereafter</a></td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Operating Leases, Future Minimum Payments Due</a></td>
<td class="nump">$ 661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632469200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Deferred Tax Assets, Inventory</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Deferred Tax Assets, Other</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Deferred Tax Liabilities Depreciation and Amortization</a></td>
<td class="num">(3,789)<span></span>
</td>
<td class="num">(4,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UnrealizedInvestmentLoss', window );">Unrealized investment loss</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="num">$ (3,558)<span></span>
</td>
<td class="num">$ (3,925)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities from depreciation and amortization of property, plant, equipment, and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UnrealizedInvestmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences from unrealized investment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_UnrealizedInvestmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642445632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 10,944<span></span>
</td>
<td class="nump">$ 5,467<span></span>
</td>
<td class="nump">$ 4,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DeferredIncomeTaxExpense', window );">Deferred Income Tax Expense</a></td>
<td class="num">(367)<span></span>
</td>
<td class="num">(1,173)<span></span>
</td>
<td class="num">(1,175)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 10,577<span></span>
</td>
<td class="nump">$ 4,294<span></span>
</td>
<td class="nump">$ 3,702<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DeferredIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Deferred Income Tax Expense, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_DeferredIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637431824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</a></td>
<td class="nump">$ 3,086<span></span>
</td>
<td class="nump">$ 2,998<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</a></td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities', window );">Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Amount</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount', window );">Effective Income Tax Rate Reconciliation TaxCuts And Jobs Act Of 2017 Transition Tax On Accumulated Foreign Earnings Amount</a></td>
<td class="nump">6,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit', window );">TaxCuts And Jobs Act Of 2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit</a></td>
<td class="num">(228)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 10,577<span></span>
</td>
<td class="nump">$ 4,294<span></span>
</td>
<td class="nump">$ 3,702<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act of 2017.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reasonable estimate for income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act of 2017 for which accounting for tax effect is incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6907863520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (Loss) from Continuing Operations before Income Taxes, Domestic</a></td>
<td class="nump">$ 9,124<span></span>
</td>
<td class="nump">$ 8,688<span></span>
</td>
<td class="nump">$ 7,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (Loss) from Continuing Operations before Income Taxes, Foreign</a></td>
<td class="nump">9,958<span></span>
</td>
<td class="nump">7,734<span></span>
</td>
<td class="nump">7,572<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before provision for income taxes</a></td>
<td class="nump">$ 19,082<span></span>
</td>
<td class="nump">$ 16,422<span></span>
</td>
<td class="nump">$ 15,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6644403472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="nump">307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Employee Service Share-based Compensation, Tax Benefit from Exercise of Stock Options</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6744282784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRangePerShareGranted', window );">Price Range Per Share Granted</a></td>
<td class="text">- - -<span></span>
</td>
<td class="text">58.50 - 58.50<span></span>
</td>
<td class="text">- - -<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRangePerShareExpired', window );">Price Range Per Share Expired</a></td>
<td class="text">49.18 - 58.50<span></span>
</td>
<td class="text">49.18 - 49.18<span></span>
</td>
<td class="text">26.58 - 49.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRangePerShareExercised', window );">Price Range Per Share Exercised</a></td>
<td class="text">24.00 - 49.18<span></span>
</td>
<td class="text">24.00 - 49.18<span></span>
</td>
<td class="text">21.68 - 49.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRangePerShareOutstanding', window );">Price Range Per Share Outstanding</a></td>
<td class="text">24.00 - 58.50<span></span>
</td>
<td class="text">24.00 - 58.50<span></span>
</td>
<td class="text">24.00 - 50.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PriceRangePerShareTotalExercisable', window );">Price Range Per Share Total Exercisable</a></td>
<td class="text">24.00 - 58.50<span></span>
</td>
<td class="text">24.00 - 50.72<span></span>
</td>
<td class="text">24.00 - 50.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of employee stock options, shares</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRangePerShareExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of Price Range Per Share Exercised, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRangePerShareExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRangePerShareExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of Price Range Per Share Expired, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRangePerShareExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRangePerShareGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of Price Range Per Share Granted, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRangePerShareGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRangePerShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of Price Range Per Share Outstanding, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRangePerShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PriceRangePerShareTotalExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the description of Price Range Per Share Total Exercisable, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_PriceRangePerShareTotalExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6888207424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments</a></td>
<td class="nump">$ 0.2775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6744463648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit</a></td>
<td class="nump">$ 24.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit</a></td>
<td class="nump">$ 58.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options | shares</a></td>
<td class="nump">54,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageRemainingContractualLifeYears', window );">Weighted Average Remaining Contractual Life (Years)</a></td>
<td class="nump">6.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 45.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | shares</a></td>
<td class="nump">38,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 41.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=fil_Range1Member', window );">Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit</a></td>
<td class="nump">24.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit</a></td>
<td class="nump">$ 33.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options | shares</a></td>
<td class="nump">16,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageRemainingContractualLifeYears', window );">Weighted Average Remaining Contractual Life (Years)</a></td>
<td class="nump">2.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 27.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | shares</a></td>
<td class="nump">16,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 27.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=fil_Range2Member', window );">Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit</a></td>
<td class="nump">49.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit</a></td>
<td class="nump">$ 58.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options | shares</a></td>
<td class="nump">37,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WeightedAverageRemainingContractualLifeYears', window );">Weighted Average Remaining Contractual Life (Years)</a></td>
<td class="nump">7.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 53.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | shares</a></td>
<td class="nump">22,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price</a></td>
<td class="nump">$ 51.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WeightedAverageRemainingContractualLifeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Weighted Average Remaining Contractual Life (Years), as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_WeightedAverageRemainingContractualLifeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=fil_Range1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=fil_Range1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=fil_Range2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=fil_Range2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745239504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 10 - Geographic Information: Schedule Of Geographic Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySalesInTheUnitedStates', window );">Company Sales in the United States</a></td>
<td class="nump">$ 20,286<span></span>
</td>
<td class="nump">$ 19,488<span></span>
</td>
<td class="nump">$ 20,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySalesInEurope', window );">Company Sales in Europe</a></td>
<td class="nump">8,519<span></span>
</td>
<td class="nump">7,989<span></span>
</td>
<td class="nump">7,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanySalesOther', window );">Company Sales Other</a></td>
<td class="nump">$ 12,609<span></span>
</td>
<td class="nump">$ 11,821<span></span>
</td>
<td class="nump">$ 12,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySalesInEurope">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services to customers in Europe during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySalesInEurope</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySalesInTheUnitedStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services to customers in the United States during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySalesInTheUnitedStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanySalesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services to customers outside of the United States and Europe during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanySalesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6744017936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongLivedAssetsInTheUnitedStates', window );">Long-lived assets in the United States</a></td>
<td class="nump">$ 10,866<span></span>
</td>
<td class="nump">$ 11,151<span></span>
</td>
<td class="nump">$ 11,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongLivedAssetsInEngland', window );">Long-lived assets in England</a></td>
<td class="nump">28,604<span></span>
</td>
<td class="nump">26,710<span></span>
</td>
<td class="nump">31,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongLivedAssetsInIreland', window );">Long-lived assets in Ireland</a></td>
<td class="nump">2,803<span></span>
</td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">2,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongLivedAssetsInAustralia', window );">Long-lived assets in Australia</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongLivedAssetsInCanada', window );">Long-lived assets in Canada</a></td>
<td class="nump">$ 759<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongLivedAssetsInAustralia">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in Australia.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongLivedAssetsInAustralia</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongLivedAssetsInCanada">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in Canada.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongLivedAssetsInCanada</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongLivedAssetsInEngland">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in England.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongLivedAssetsInEngland</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongLivedAssetsInIreland">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in Ireland.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongLivedAssetsInIreland</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongLivedAssetsInTheUnitedStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets in the United States.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_LongLivedAssetsInTheUnitedStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755000144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyRevenueObstetrics', window );">Company Revenue Obstetrics</a></td>
<td class="nump">$ 4,499<span></span>
</td>
<td class="nump">$ 4,532<span></span>
</td>
<td class="nump">$ 4,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyRevenueGynecologyElectrosurgeryUrology', window );">Company Revenue Gynecology/Electrosurgery/Urology</a></td>
<td class="nump">23,175<span></span>
</td>
<td class="nump">20,683<span></span>
</td>
<td class="nump">22,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyRevenueNeonatal', window );">Company Revenue Neonatal</a></td>
<td class="nump">6,154<span></span>
</td>
<td class="nump">6,007<span></span>
</td>
<td class="nump">6,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CompanyRevenueBloodPressureMonitoringAndAccessories', window );">Company Revenue Blood Pressure Monitoring and Accessories</a></td>
<td class="nump">$ 7,586<span></span>
</td>
<td class="nump">$ 8,076<span></span>
</td>
<td class="nump">$ 6,915<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyRevenueBloodPressureMonitoringAndAccessories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services in the Blood Pressure Monitoring and Accessories category during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyRevenueBloodPressureMonitoringAndAccessories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyRevenueGynecologyElectrosurgeryUrology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services in the Gynecology/Electrosurgery/Urology category during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyRevenueGynecologyElectrosurgeryUrology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyRevenueNeonatal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services in the Neonatal category during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyRevenueNeonatal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CompanyRevenueObstetrics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sales of goods and services in the Obstetrics category during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CompanyRevenueObstetrics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6887591056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 13 - Product Sale and Purchase Commitments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty income</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual Obligation</a></td>
<td class="nump">$ 2,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6902134848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 14 - Employee Benefit Plans (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined Contribution Plan, Employer Discretionary Contribution Amount</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>106
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_O"[";O>V(/]Q\970=G"K[N07U!+ P04    "  $?&9,F5R<(Q &  "<)P
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M-O]:N?<C<U-Q;EK*JDDS_Q:5]BF"3-JGQ+/S@.& YEO1/!]/[>*I[KJZ&@\
M]G7=^;[(Y&.?W,$7N]M#Z??=<)OV]\WU8.3ZT-7GZ= GOIT\K?\#4$L#!!0
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MAWZX3.UU.[UUF&YZ<YG?J 3WUSJ;_P%02P,$%     @ !'QF3)A:$:[_ 0
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MHAG'4B9L( 0,Q$@#(:W[*Q-*\=HB&%,J]Q^,%D<.VMA'"/@(R;Z1@(^DD@S
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M<PUAF"I)TYBX'TE3I2*^""63,M</!J\"Y#7BL9+HY5C=*<E5"A5?ZX%J8>)
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M2>EZ4A?G_G.9=_MFM_D?4$L#!!0    (  1\9DS/?DXNL@$  -(#   8
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M!7UXV=3_&M%#D+*Y"2/4A@\V&PIJ'X_WX6S',1L-C]WT@]C\C8N?4$L#!!0
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ML-E04/MXO MG.X[9:'CLIA_$YF]<_ )02P,$%     @ !'QF3,_,$4ZS 0
MT@,  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&UL?5-A;]L@$/TKB!]0
M$B=KHLBVU'2:-FF3HDY;/Q/[;*,"YP&.NW\_P-2S-F]?@#ONO7=W'/F(YL5V
M (Z\*JEM03OG^A-CMNI <7N'/6A_TZ!1W'G3M,SV!G@=04JR;+.Y9XH+3<L\
M^BZFS'%P4FBX&&('I;CY>0:)8T&W],WQ)-K.!0<K\YZW\!7<M_YBO,5FEEHH
MT%:@)@::@CYL3^=]B(\!WP6,=G$FH9(KXDLP/M4%W82$0$+E @/WVPT>0<I
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M?S;3F$V&PW[^06SYQN4?4$L#!!0    (  1\9DR%81YCM $  -(#   9
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;'U3VV[<(!#]%<0'A#6[25<KVU(V
M4=5(K;1*U>:9M<<7!1@'\#K]^P)V'"MQ^P+,,.?,F6%(!S3/M@%PY%5);3/:
M.-<=&+-% TK8*^Q ^YL*C1+.FZ9FMC,@R@A2DO'-YH8IT6J:I]%W,GF*O9.M
MAI,AME=*F#]'D#AD-*%OCL>V;EQPL#SM1 T_P?WJ3L9;;&8I6P7:MJB)@2JC
MM\GAN OQ,>!W"X-=G$FHY(SX'(R',J.;( @D%"XP"+]=X ZD#$1>QLO$2>>4
M ;@\O[%_C;7[6L["PAW*I[9T34;WE)10B5ZZ1QR^P53/-253\=_A M*'!R4^
M1X'2QI44O76H)A8O18G7<6]UW(?QYCJ98.L /@'X#-C'/&Q,%)7?"R?RU.!
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MRFTKM",7X_%E8_\;8SQ@*LD-CE"''VPQ)#0^'-_CV4YC-AG>]/,/8LLW+O\
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M,/=S3\G<_%>X@,3TH 1K5$:Z^"75X+Q1,PM*4?QM.H6.YSCS7V';@'0&I#<
M-A6*RI^XYV5NS4CL-/N>ARM.#BG.I@K!.(KX#\4[C%Y*O-"<70+1G'.<<M)5
M3K)D,&1?2J1;)8[I?_!T&[[?5+B/\/VZ^L=LFR#;),@B0?9/B\E-BULYMRK9
M:J8*;!NWR9'*##IN\BJZ+.Q#&N_D;_JT[=^X;85VY&P\WFR<?V.,!Y2RN\,5
MZO"!+8Z$Q@?S/=IV6K/)\::?7Q!;GG'Y!U!+ P04    "  $?&9,?2R2+;<!
M  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6QM4]MNW" 0_17$
M!P0OZURZLBUE$T6MU$JK5$V?67MLHX#'!;Q._[Z '==-_0+,<,Z9"T,VHGFU
M+8 C;UIU-J>M<_V!,5NVH(6]PAXZ?U.CT<)YTS3,]@9$%4E:,9XD-TP+V=$B
MB[Z3*3(<G)(=G RQ@];"_#Z"PC&G._KN>)9-ZX*#%5DO&O@.[D=_,MYBBTHE
M-7168D<,U#F]WQV.:<!'P(N$T:[.)%1R1GP-QI<JITE("!24+B@(OUW@ 90*
M0CZ-7[,F74(&XOK\KOX4:_>UG(6%!U0_9>7:G-Y14D$M!N6><?P,<SW7E,S%
M?X4+* \/F?@8)2H;5U(.UJ&>57PJ6KQ-N^SB/DXWMS<S;9O 9P)?"'<Q#IL"
MQ<P?A1-%9G D9NI]+\(3[P[<]Z8,SMB*>.>3M]Y[*7BRS]@E",V8XX3A*\QN
M03"OOH3@6R&._#\ZWZ;O-S/<1_I^'?U3NBV0;@JD42#]I\3T0XE;F.L/0=BJ
MIQI,$Z?)DA*'+D[RRKL,[#V/;_(7/DW[-V$:V5ER1N=?-O:_1G3@4TFN_ BU
M_H,MAH+:A>.M/YMIS";#83__(+9\X^(/4$L#!!0    (  1\9DP\T#:BM $
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M4/M@/J!MIS6;'&_Z^06QY1D7?P!02P,$%     @ !'QF3.T&O+"R 0  T@,
M !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL;5/;;IPP$/T5RQ\0@Y>V
MR0J0LHFB5FJD5:HFSUX8P(HOU#9+^O>U#4O0EA<\,YQSYN)Q/FKS;CL ASZD
M4+; G7/]GA!;=2"9O=$]*/^GT48RYUW3$ML;8'4D24%HDGPEDG&%RSS&CJ;,
M]> $5W TR Y2,O/W $*/!4[Q)?#"V\Z% "GSGK7P"]SO_FB\1Q:5FDM0EFN%
M##0%OD_WARS@(^"5PVA7-@J=G+1^#\Z/NL!)* @$5"XH,'^<X0&$"$*^C#^S
M)EY2!N+:OJ@_Q=Y]+R=FX4&+-UZ[KL"W&-70L$&X%SU^A[F?+QC-S?^$,P@/
M#Y7X')46-GY1-5BGY:SB2Y'L8SJYBN<XZU]HVP0Z$^@5@4R)8N6/S+$R-WI$
M9II]S\(5IWOJ9U.%8!Q%_.>+MSYZ+FEREY-S$)HQAPE#5YAT01"OOJ2@6RD.
M]#\ZW:;O-BO<1?ING?TNVQ;(-@6R*)"M\Z?)58M;F.LFR6JF$DP;M\FB2@\J
M;O(JNBSL/8UW\@F?MOV9F98KBT[:^9N-\V^T=N!+26[\"G7^@2V.@,8%\YNW
MS;1FD^-T/[\@LCSC\A]02P,$%     @ !'QF3+QIY@:Y 0  T0,  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL;5/;;IPP$/T5RQ\0+X9DTQ4@91-%
MJ=1*JU1MGKTP@!5?B&V6].]K&T)1PHOM&9]SYN)Q/FKS:CL A]ZE4+; G7/]
M@1!;=2"9O=(]*'_3:".9\Z9IB>T-L#J2I"!TM[LADG&%RSSZ3J;,]> $5W R
MR Y2,O/W"$*/!4[PA^.9MYT+#E+F/6OA%[C?_<EXBRPJ-9>@+-<*&6@*?)<<
MCEG 1\ ?#J-=G5&HY*SU:S"^UP7>A81 0.6" O/;!>Y!B"#DTWB;-?$2,A#7
MYP_UQUB[K^7,+-QK\<)KUQ7X%J,:&C8(]ZS')YCKN<9H+OX'7$!X>,C$QZBT
ML'%%U6"=EK.*3T6R]VGG*N[C=+._F6G;!#H3Z$*XC7'(%"AF_L <*W.C1V2F
MWO<L/'%RH+XW57#&5L0[G[SUWDM)$YJ32Q":,<<)0U>89$$0K[Z$H%LACO0+
MG6[3T\T,TTA/U]&_9=L"V:9 %@6RE4"Z_U3A5PA-TD\QR*JE$DP;A\FB2@\J
M#O+*N\SK'8U/\A\^#?M/9EJN+#IKYQ\VMK_1VH%/97?E)ZCS_VLQ!#0N'/?^
M;*8IFPRG^_D#D>47E_\ 4$L#!!0    (  1\9DQ<;[[\LP$  -(#   9
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M-BYX;6QM4]MNW" 0_17$!P0OZ^:RLBUE4T6MU$JK5&V?67MLHX#' ;Q._CZ
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M=/YE8_]K1 <^E>3*CU#K/]AB**A=.-[XLYG&;#(<]O,/8LLW+MX!4$L#!!0
M   (  1\9DS,,RZ^L@$  -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#,W
M+GAM;&U3VXZ;,!#]%<L?L$X,VTL$2)M=5:W42M%6W3X[,("U-J:V"=N_[]@0
M2E->\,QPSIF+Q]EH[*MK 3QYTZIS.6V][P^,N;(%+=R=Z:'#/[6Q6GAT;<-<
M;T%4D:05X[O=.Z:%[&B1Q=C)%ID9O)(=G"QQ@];"_CZ",F-.]_0:>)9-ZT.
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MAZ\P]7-+R=3\=SB#\O!0B<]1H++Q2XK>.M23BB]%B[?QE&T\ATG_0ELG\(G
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M4FIHG30ML5!E]'Z[/R0!'P&_)0QN89/0R<F8E^!\*S.Z"06!@L('!8''&1Y
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M5#Z8G]"VXYJ-CC?=](+8_(SS_U!+ P04    "  $?&9,:.M,5K,!  #2 P
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M]H<TY,>$7QP&N[!1Z.2D]5MPOE<Y3H(@$%"ZP,#\<88'$"(0>1E_)DX\EPS
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M=',O<VAE970T-"YX;6QM4VUOFS 0_BN6?T"=.*2K(D!J.DV=M$E1IVV?'3C
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M"YP$02"@<H&!^>,,3R!$(/(R?L^<>"D9@&O[POX2>_>]G)B%)RU^\=IU!7[
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MPQ%J\(/-AH+*A^,!SW8<L]'PIIM^$)N_<?X'4$L#!!0    (  1\9DPT:J4
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MO$/;CFLV.MYTTPMB\S/._P!02P,$%     @ !'QF3%JA]]*S 0  T@,  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL;5/;CILP$/T5RQ^P3ARRJ2)
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M.8 T0T:W]!)X:>O&AP#+TT[4\!/\K^YHT6.S2MDJT*XUFEBH,OJPW1^2@(^
MWRT,;F&3T,G)F+?@/)<9W82"0$+A@X+ XPR/(&40PC+>)TTZIPS$I7U1_Q9[
MQUY.PL&CD:]MZ9N,WE-20B5ZZ5_,\ 13/[>43,U_AS-(A(=*,$=AI(M?4O3.
M&S6I8"E*?(QGJ^,Y3/H7VCJ!3P1^16!CHECY5^%%GEHS$#O.OA/ABK=[CK,I
M0C".(O[#XAU&SSF_WZ;L'(0FS&'$\ 7F$\%0?4[!UU(<^']TOD[?K5:XB_3=
MDI[<K@LDJP))%$C^:9%?M;B&V5TE88N9*K!UW"9'"M/KN,F+Z+RP#SS>R2=\
MW/8?PM:M=N1D/-YLG']EC <L97.#*]3@ YL="94/YA>T[;AFH^---[T@-C_C
M_"]02P,$%     @ !'QF3 <Z\(*S 0  T@,  !D   !X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL;5-M;YLP$/XKEG] G3BDJR) :CI5G;1)4:=MGQTXP*K-
M,=N$[M_/-H2RC"_X[GB>YUY\3@<T;[8!<.1=J]9FM'&N.S!FBP:TL'?80>O_
M5&BT<-XU-;.= 5%&DE:,;S;W3 O9TCR-L9/)4^R=DBV<#+&]UL+\.8+"(:-;
M>@V\RKIQ(<#RM!,U? ?WHSL9[[%9I90:6BNQ)0:JC#YN#\<DX"/@IX3!+FP2
M.CDCO@7G2YG132@(%!0N* A_7. )E I"OHS?DR:=4P;BTKZJ/\?>?2]G8>$)
MU2]9NB:C#Y244(E>N5<<7F#J9T_)U/Q7N(#R\%")SU&@LO%+BMXZU).*+T6+
M]_&4;3R'2?]*6R?PB<!O"&Q,%"O_+)S(4X,#,>/L.Q&N>'O@?C9%",91Q'^^
M>.NCEYP_)"F[!*$)<QPQ?('9S@CFU><4?"W%D?]'Y^OTW6J%NTC?+>G)?ET@
M615(HD#R3XO[FQ;7,/<W2=ABIAI,';?)D@+[-F[R(CHO["./=_(!'[?]FS"U
M;"TYH_,W&^=?(3KPI6SN_ HU_H'-CH+*!?.3M\VX9J/CL)M>$)N?<?X74$L#
M!!0    (  1\9DP7$>(/M $  -(#   9    >&PO=V]R:W-H965T<R]S:&5E
M=#4U+GAM;&U3;6^;,!#^*Y9_0)TXM,TB0&HZ59NT25&G;9\=.,"JC9EM0O?O
M=S:$L8PO^.YXGN=>?$X'8]]< ^#)NU:MRVCC?7=@S!4-:.'N3 <M_JF,U<*C
M:VOF.@NBC"2M&-]L'I@6LJ5Y&F,GFZ>F]TJV<++$]5H+^_L(R@P9W=)KX%76
MC0\!EJ>=J.$;^._=R:+'9I52:FB=-"VQ4&7T:7LX)@$? 3\D#&YAD]#)V9BW
MX'PN,[H)!8&"P@<%@<<%GD&I((1E_)HTZ9PR$)?V5?TE]HZ]G(6#9Z-^RM(W
M&=U34D(E>N5?S? )IG[N*9F:_P(74 @/E6".PB@7OZ3HG3=Z4L%2M'@?3]G&
M<YCTK[1U I\(_(; QD2Q\H_"BSRU9B!VG'TGPA5O#QQG4X1@'$7\A\4[C%YR
MOG],V24(39CCB.$+S'9&,%2?4_"U%$?^'YVOTW>K%>XB?;>D)_?K LFJ0!(%
MDG]:W-^TN(;Y<).$+6:JP=9QFQPI3-_&35Y$YX5]XO%._L+';?\J;"U;1\[&
MX\W&^5?&>,!2-G>X0@T^L-E14/E@/J)MQS4;'6^ZZ06Q^1GG?P!02P,$%
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M4DH-K978$@-51N^WQU,2\!'P(F&PBS,)E5P07X/QI<SH)B0$"@H7%(3?KO
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MVV9:L\EQNI]?$%F><?D?4$L#!!0    (  1\9DP&VJ\<]0$  ,@%   9
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MW^C0Q4,2H&K?0C0IY*7S_6L1G=O48^P?XE_XV..^,E6WG29G:>QS]H^NDM*
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MYAH1I"-1U4JM%%W5ZV^'; (Z&U/;"=>WKVT(QQGK_L3V,C,[N\%+,3#^*AH
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M@CWC<\Y<\#CIN7B5-8#RWBAA,O5KI=H#0C*O@6+YP%M@^J3D@F*E35$AV0K
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MG@*8*0*0(C#QX3(>)7""$$P0F@31.QN)96/48*/I1ALH#2TGD @C&"4"42(
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M!7$!=<!\)!$@M533)FU2U&G=;R=Y":@&,]L)W=W/-H11X^T/_N"<X^<UV-G
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MJCX?+Z-Q(%D_W;-HONR+/U!+ P04    "  $?&9,0TTF<-D!  #<!   &0
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M,Y?3KS(56@S^%L#S553]!5!+ P04    "  $?&9," W/*4,"   <!P  &0
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M;S4A(;GC!!#A+(=1(A E E R!V72Q,M18A('#@N@"O(P@F%B$"8&8!S+NQB
M27)G$U20*HW?F9D$A$G6,*GC>9>LAR$.R5J"@R2$05(0) 5 0@<D78U",,F=
MA:P 51!@ L-D($P&P#CG:Y>MAOF @S1U=G@%RH+XG9.4@SCY"B=RURA?GY$P
MP<X$5FM5GB^NE@D%+>XI\VY\I^+<]-+;<Z6O/'LQG3A73"<,'K2Q6C]5]T;+
M3LI44UT7TX4]-10?YK<(W1_$\B]02P,$%     @ !'QF3.C&6T'6 P  >A(
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MI':Y!E3^TL-@$X!LO/1R[H9<X@-10I[9)<Q( HQD94<<?VZF@82\>P]A1!)
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M<.BLWV[<7L<?,P96#=/,D7GPZS]02P,$%     @ !'QF3#GFQ][M 0  V@0
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M275TS0&K&9.@_-P756^C;M EH%!+/4W4G$_WR!1(-LQ7)%[NZ>(_4$L#!!0
M   (  1\9DP4:R:^,0(   8'   9    >&PO=V]R:W-H965T<R]S:&5E=#<X
M+GAM;'V5;:^;(!B&_XKQ^SE4\;51D]5EV9(M:<ZR[3-M:34'Q0&M9_]^@-9Y
M@.Z+O'@_]W,]B%",E+WR!F/AO76DYZ7?"#%L >#'!G>(/],!]_+-F;(."3ED
M%\ 'AM%)!W4$A)M- CK4]GY5Z+D]JPIZ%:3M\9YY_-IUB/W984+'T@_\^\1+
M>VF$F@!5,: +_H[%CV'/Y @L+J>VPSUO:>\Q?"[]#\&VSI5>"WZV>.2KOJ<J
M.5#ZJ@9?3J6_44"8X*-0#D@V-UQC0I21Q/@]>_I+2A6X[M_=/^G:92T'Q'%-
MR:_V))K2SWSOA,_H2L0+'3_CN9[8]^;BO^(;)E*N2&2.(R5</[WCE0O:S2X2
MI4-O4]OVNAUG_WN8.R"< \(E((C^&P#G &@$@(E,E_H1"505C(X>FS[6@-2>
M"+90+N913>JUT^]DM5S.WBJ8!P6X*:-9LYLTX4H3OE?4M@+^DP )L%"$3HI0
MQ\-U?)"Z#:#3 &J#Z%T9!N1NTB1:TVM-G!AUV)(\<V-$3HS(@0$-C$D3KW($
M)H8M"6,W1NS$B!T8D8$16SFRW,"P)4'TX*LD3H[$P1$;'(F5Q""M;<53"-T8
MJ1,C=6 82[Y+[20PM5;$H8K"],&:9$Z8S &3&C"9E28QMX@M"38/]DCNY,@=
M')G!D5N_PQ.,8T-5NU2YM6'!ZD12-\0WQ"YMS[T#%?)PTT?0F5*!I>/F6=;5
MR$MI&1!\%JJ;RCZ;CN9I(.@PWSI@N?JJOU!+ P04    "  $?&9,X=*^QR\"
M  ! !@  &0   'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q]55V/FS 0_"N(
M]Y[Y,'")"-(E4=5*K11=U?;9(9N SF!J.^'Z[VL;PE'CNY?87F9F9Q>\R7O&
M7T0%(+W7AK9BXU=2=FN$1%E!0\0#ZZ!53\Z,-T2J([\@T7$@)T-J*(J"($4-
MJ5N_R$WLP(N<726M6SAP3UR;AO"_6Z"LW_BA?P\\UY=*Z@ J\HY<X ?(G]V!
MJQ.:5$YU ZVH6>MQ.&_\IW"]3S7> '[5T(O9WM.5'!E[T8>OIXT?:$- H91:
M@:CE!CN@5 LI&W]&37]*J8GS_5W]LZE=U7(D G:,_JY/LMKXC[YW@C.Y4OG,
M^B\PUI/XWEC\-[@!57#M1.4H&17FURNO0K)F5%%6&O(ZK'5KUG[4O]/<A&@D
M1!,A3#\DQ",A?B/@#PEX)&"+@(923&_V1)(BYZSW^/!V.Z(_HG"-5?=+'33-
M-L]4>X2*WHIXM<K130N-F.V B6:8<$(@I3ZEB%PIMM&"'OV?8+=$Q!9DOX1D
MB=M$[*PS-OQXGB+,W +8*8"- )X)X""P&C5@4H-IAT8%*XRM:I>H!*>95>\2
MA!^S=PPG3L.)PW!H&1XPR2S+I]BVLG. PC"++<-NU#OO*'4Z3A>.5[;AU-'A
M)+,=+U$X6EFO8;\$Q5D067[1[!XUP"]F1@FO9-=6ZL]Q%IW&X%.D[Z$5WZKQ
M.$RS-YEAMGXG_%*WPCLRJ6ZYN8MGQB0HC\&#ZF>EQOETH'"6>INI/1^&VG"0
MK!OG-9K^-(I_4$L#!!0    (  1\9DQ-1;%MG (  !D)   9    >&PO=V]R
M:W-H965T<R]S:&5E=#@P+GAM;'U676^;,!3]*XCW%3#FJTHBE433)FU2U*G;
MLYLX"2I@9CM)]^]G&TKIY:8OP3;GW'/NC?'UXBKDBSIQKKW7IF[5TC]IW=T'
M@=J=>,/4G>AX:]X<A&R8-E-Y#%0G.=L[4E,') S3H&%5ZZ\6;FTK5PMQUG75
M\JWTU+EIF/Q7\EI<EW[DORT\5L>3M@O!:M&Q(__%]5.WE686C%'V5<-;58G6
MD_RP]!^B^TWD" [QN^)7-1E[-I5G(5[LY/M^Z8?6$:_Y3ML0S#PN?,WKVD8R
M/OX.0?U1TQ*GX[?H7UWR)IEGIOA:U'^JO3XM_=SW]OS SK5^%-=O?$@H\;TA
M^Q_\PFL#MTZ,QD[4ROUZN[/2HAFB&"L->^V?5>N>UR'^&PTGD(% 1D*4?DJ(
M!T+\3J"?$NA H( 0]*FXVFR89JN%%%=/]G]OQ^PNBNZIJ?[.+KIBNW>F/,JL
M7E8T)(O@8@,-F++'D DF&A&!B3Y*$$RB)#,Z$%C/$3& ;.:0+,%-Q&B>L>/'
M4XDHPP-0- !U >B'0L6@4#TF=9BV%PGS%"0[!Y&BR$&Z""@+*>XW0?TFB%\*
M_/:8Y*,58!?#1, M@DD);C9%S::(V02836<B$:4@HS4",H4#=N>@H@AQNQEJ
M-T/L@K^YS&8B7V*X8=8(B.09L(N!DAM[-T?]YC._,8%^\YE*2O(<5RE0E0)1
M ;F4!9(+N:$2A?B)%2+5ASH#Z(,0W-D(AL!C!\'$-]S>.%^CF5OX^90#9OJU
M1V&29=#O'$9)0:'C.2K.0O@U!I/^T'!Y=+U7>3MQ;K4]9B>K8W]_(+:_@/72
M]GW7=][#])>&GTP>JU9YST*;[N5ZS$$(S8W)\,X4]&3N*>.DY@=MAYD9R[Y9
M]Q,MNN$B$HRWH=5_4$L#!!0    (  1\9DPYB!(^,0(  #\&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@Q+GAM;'U5[8Z;,!!\%<0#G/DF1(!T252U4BM%
M5[7][9!-0&<PM9UP??O:AG"<L>Y/L)>9V=F-O>0#9:^\!A#.6TLZ7KBU$/T6
M(5[5T&+^1'OHY)L+92T6<LNNB/<,\%F36H("STM0BYO.+7,=.[(RIS=!F@Z.
MS.&WML7LWPX('0K7=Q^!E^9:"Q5 9=[C*_P$\:L_,KE#L\JY::'C#>T<!I?"
M??:WAT3A->!W P-?K!U5R8G25[7Y=BY<3QD" I50"E@^[K '0I20M/%WTG3G
ME(JX7#_4O^C:92TGS&%/R9_F+.K"W;C.&2[X1L0+';["5$_L.E/QW^$.1,*5
M$YFCHH3K7Z>Z<4';245::?';^&PZ_1PF_0?-3@@F0C 3_.130C@1PG="]"DA
MF@B104!C*;HW!RQPF3,Z.&S\=WNL#I&_C63W*Q74S=;O9'NXC-[+R-ODZ*Z$
M)LQNQ 0+C#\CD%2?4P2V%+M@10\^)MBO$:$!.:PA:6PW$5KK##4_7*;P4[M
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M971S+W-H965T.#,N>&ULC9;;CMHP$(9?)<H#;.(<. F0"%'52JV$MFI[;<!
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M\P^<*Z8EAB]:W$GWC?V@9 =E7L?Z7;3-4SM0O.D:PZ#O3I?_ 5!+ P04
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M,(ZVXT*PWHSMX?3;8?,/4$L#!!0    (  1\9DS&CQL#+@(  $,&   9
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M^<#&4D)/%[,R7W^U!QWT@(B#!PW58JS8.7=X$UUG-L#1+I:F.%>&FZ<$F67
M+P]*CN?)@3/(\^PFRT7@PSGWU8$A^?CL@6-ECM!^K%KA8,O'[+=OH-+$*RG(
M-O&][ +K!EVKFX^ M,\3@#T4.4B6J50NNF2N4'-S*0RU!DC9.5X;W<R+4WYO
M)HJF^0R(S+DAB?H4.%+E,6/"8$"8?A;(81,#I'@[1[4E^BWS&9$Y9OL4 7I#
M&9,/K$]XH$TMSL2ZX1/\/:C&T6NX>?P:0C?=#<>%DU=/M$A4[*5$J9)<1J<C
M=0948')'2QEN&LRD,!G,E )E@$Z"#S6S32T@O.GEB5X4W@WZE>+:XU(BW*T(
M<ZV=T&E"C'NTG@XQF7^ZNCLT2AJT!PX-M *S51@/%6[Q$WZ,,?"'3>R>W&:D
M2/[SXB^<R-:=^+B/9%= $6@P8QX9)#L50%'X(BC"P:@;]+KA#$2YK1$4T'P\
M&^./"?#>1^2#QSY<(FK!;:&L-0"VN O2#[^503\<S*986:8+(H\M.BSL8)*]
M?C><3";[]$MW!+_XCT5+#CV0#WOP"\A)8V1A33BSWYNNY=JU)5;1+P:M9GH9
M-\5S+6$*VQY5?A2=[L>D^<$1Q.38:=W9#;!6,9QBM+Y'%3X\<'[5MGJ^>?6D
M4&)$)SE\9'[YT"Q"V3SY8@1:9OVQ8+"A$J '&Z%F'(Y Q 4)"*YX& Z[8P5'
MVP%H&/;Z0Q I)BB3#4<*HMI!J<MA.QJ!PZ4/<>[)K >R^0S0K8!7.UR!> "R
M/\ 52&SX+PKF^P;<-D,9['(RH)]#6"[*>]/NP$!?_3+&KW<9@W%_ER<,EP&O
M"O\?A-/Q;/>W/ S[ ^PX"V8[O.D#?-*C"4@O]M/&ZP#!&8ZT.T-5"5#FK<\<
MKJ,['N!%3/ Z^N&XM_NC'T+K&5W#9,!:EG%OJ'& %X&/8>TF]^QQ?-/(2"?-
M!$>[;=%A\1,E@X?;[;FV"^7[ C+8&SA.K'219L K$OGZR\6G#/.3!4>84"]X
M'ZV^A,%9Y[ C7B=O>OUP-A@Z/0*[2X@K6<")O<=D2_<<"Y^NA>;%KH.JY.TC
MXP3G_6+BS0E.25G,-A)*O)G=HH<RM+S)R1</^2 _]9O X1W5BI@<;2ABHGK)
M66[L&IBL^!_1\;/I7!"1M<O2G+'NAI'Q[QE[(I$7#N8KTYG'V#N+KA =,3.$
M)E8<H%$XYK2LF,03<Q?1ZX6+[<UF/?)(<S[M=[L]"675;L?H[H;F\-ODMKR7
M%7*P#@('6SZ1B8/W\2@)OR3X)=!R,25VP/I;I,6T_!4C'8BZB&O.=A3$D_))
MH96@*K-E=H-IOVG#*V,[,]XMH;@#BI,_!82SPD1\;>GT?M%GA\[]*^- 8CDA
M6UX:VM,7 4[?8>VJ"MX\:B*_$M\(P/>F-Z:(DLE('""F0\W)\P5Q'+S'9DBX
M5?PH1J[71 >0'<79('E>5DM9B<[SR\NE0$[ZPO;@;D@60E+9O&)1W;^JY>%6
MK?;O@D/VP$-G5A0"!AQ ,QQ1_(S\[,G//OXD;_[H%AW;D' Q)KW=N 60*P#G
M7JA7?F[MH/YF:A$P&C.XT=EXZB+)-9D=.QM,?7CRA",?3N6P:(#7]>5%E<D=
MYOQ0*_A;%6%P3,)9>"3G'=947%3*#D\!)E;<B<Y>%WS49O43SHRAE!F>-&XN
MED9M2YS> C5C85)2>M.HQEC/GCWL$']1_U:\X,E[,:!Q(@XPX70@C&H4(,^E
M@ E[!:%K(+XD>H8JD\LB6D9X9-%C9!P'C,=UQ8A<^XAJ+"_K$O-4Q.K-!<(-
M2Y J<QAY=\&_OU><6B$*)&7@;IY3S=.QU.7D5R+KM^)I*$()[T,[4*6:CAI7
M*LPCP3%;FZ803RIK(LL@EW)N"E0&FU1JC#Q,.(:)/5+"==)<K4=*H'AE0-62
MEJ*CB&G]!LRR$4\O5[R!95)JK32=/S ^B-#(BHO E^,R8*SQX,<1//4TI8!
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M04YU'&R5L18+FPKUXF0@DD)#\F8@E=#GY=2JMNLO(SI6/+G8X.4L\"_B^U+
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MVK.3:O#6RAF)' )GB00FM""4U!RJC![&^F)JY<]7QV]_>G^! -Z93#%^!S[
M>FBZ@)I;BB_DLM[(][[IA;-I3^)S,2X=_^[*WS/Q6>YW^8O)D+_H]T)Q@:94
M*?Q9_SNPC1*K@UH ;6YOQW&>UCLT:2NIK#WIK!!A1'9*O7"ON*]"W%_C6'()
MSJU0PS9/,?&+THBQ-HM)O'?I.M'\W0K?U)1-A_:W.#&JUMIGD;!739OJ)OG$
M!:PEC6?-G\R+9XC697,J<8#DONY<=)M\C1>6)YU#)%UQ"HDD-]>)@3V"B\G"
MRIX;G)S5G!>75)+P<:E1:M+*F4QW*A%AZ"IRK.,VA5)E- ?'L'[A(8,O%F2M
M  I(6<HC49,NXGFT8#N<5;29%7W(B5!2,HZ84/D_E;I%^0-RDCKR(0242+Y0
MBYHWH>T&BHEX<NTS+X.IC* 4*\/+U9HS2RZU]. ZR,D;^",7*4YV3&P=0L%*
M6$EOZJQ5O2S18]6/6KTP4742)"*BYZ'PF?&^,"<<W&#-F^^=WS(1(]F.8])S
M*Y=<#B**OT9XEVB**ZB"Y4HK+(2_<;7D2M(2EP+:@JJ ;#D/B4N\D[A8:<;L
M+%>X!&-;$_7[-6>/Y&-*BL81.<G56S",L6U8P*H,,*PX=A\E)W05]DE5 F:K
M'(ZV6M"V;V-F E3B;<?!6GF.O!9_:V4=W,3:MJ<Q=(:P$;U3==?)U&+5VQVV
MR8SVL$8I!N^ WKM)CRB:*Z,MT $C+ _9WCM/6@=UN@K.4/Y'TX9),_/A\.H]
M.;T0RC<*GTE8.ZCK;)W,<?'[[VJ%.FOA+617E<52WXX]K/%W8F5RFIJM.0=&
M.W2LZ,"0FR0XZ MLOG4<((SRB8O4*LU60[/IK,IR]T9%M782K46X4+9\;2+J
M]RV[,6>.B+X&1Y60I[]D-P4F?\954;,]_!H^X$@-1 RQ%#U.HT?"\S:UQ$&E
M0VAF< .0R+R.@Y'F4A'AP>@'$B)Z/[3N9.HF+A<U04>!J+DGC4 XK:R*G""A
M5]<SQZ7 %FQM@R6[(I%: 2[ &_J120_[3TO&9).[EN<0_2A:7SQ903W.:4V;
MG7 ^Y#"L,TG+81)NDE2]B^U9"_>NS=\PPKY8$K0/@RXT+SB>(G[\! YE2KY$
MNP@VO01"K*QL(>7*S>\Q.]E3>ZHX;@,Q1SQ2KCUIMXZ>M.SCKECTA90N181*
M'Q SC%V='"F'\JO#]T&O-Q42J8F>]JC.&C%"EF^S"[\=/9@>)G)$30,IG/P/
MRXE1KAZ"9PT]DJ%:>851'!B3(=H[08E9DH-T<=-HD-&=25KAA%?D;1G9.:-U
M6AY.VXH$CG//LV4)B=I2QYSQ.RAJ>Q;#J@W:BRPH,CB+2IVGC&6?A&*?D D0
M\8H>B$HYLHC*",=5A5C" +CH>95:&9?9IS56.88DNS/O!!6'FGP0_7;2<#?5
M!?X,79S"W]D$I0=E6Z*"A3H<W@9O. <H+:RM-S;K]Z<F!#\^6+JV(_([IU!J
M&S]HZW/P'I!:8W1UL*KT5>UM^B[?$NH;(.U&\Q"HF=PTN#WE[N5&K16Q!XKJ
MMUT[[9@UEB:<"TA?;BBN:/=3.I[(":=SD08RA2N=Y=K!0;<)YU31,:) $:M\
MI3$YG;;*U?H[P$N!AB:R*>E"8*ZK\R]P$(ML21_K0&SZ2V7PD-S:')?=:9.8
MC=U:DBI;#BGHEJ9Y6"?B,EF9CMK9F"<U+BWPL:0&2-Q4N>YB3""2CKU=$?4]
M4 /5I\*3UO5X<5W.3%8HS,8"OZ_#[WZDK-ZL=MU@8S&M-GSU+Y)LW>]?X];S
ML).9F[7 T[MALS^:ZYI9L'1HF"548U.V^G.]E&M"2?Z9_+P(A^B/B=-Y@T6W
M6<TUJ.5H_ ZJKA/%FYA,INTPT&S<VF*MAV,7<)1$-/O/U:!BNZU*'DE=ZK:3
M1I) $Z6MTOQ:V;@D8D!KL3N^);1/3E$4-$Z2ZN0.W[X<[$C\RCJM"O\P3@)-
MRR?:"07"D-K8U )MS:KIK,$H<DN5N(X;BZU!A66HE=@ECJUDC;6M\,'*EO?H
M77(^Y6)?JR;*YM%[2"L#! =;I)7#,YO9(PF 6F$JKL6F/%*_/>N")(*,US (
M)\"#PK^C'OW;#XX)#!YL8<8]Z-XLH(*YSYLV]  :3#B8X+_C,?X[Z;^2$P15
MGM#G?Z4]U*XD9]\V5<>.([RPFWR.5##3NIP#UH41N-G!'+;]DVOA:3V&49AB
M>B<JCZ+,*Z+3LSEME9A#'/9D]O//5TIK2[P QT26P:S[@R2"X_3M!'#<D\+\
M'(W4XWW&/"1ETHB7:[) JT\IC-VP1P5K<)ZQSM=!_)QS]Z:9<[<=#-JZ^-MY
MTOD>>HB?*SGH[/(RC<[EXJ3V)=G6UJN#N#C/DYM8K()<U%'5;9YUVE5P_)*=
MP2V9$'4@1,1D,Q><1.95SI\DG]2$'TK>?RY^,=_LF[>U[[,[*.-[777B1]>J
M:H(C(!#$RSQ*:<4B&&!I9%]%XT+^HW,6HQSS(#90)D;VB.,($N.AR9HO;0=G
M>N;LS&>Q:5$*$351SO0;HE&L_/$%CRGIICO!8;#"X@-('.QU&,^WUKXF"4AD
M93U)>2PZM6,Z-3%BWP-A4?$K<HSK+&$]IR01CG1L)N>0(L4ZQ9D*+B&5J*YW
M(19:W ,K0?U[4.''I''DZBCVI<)<T1>JTR +;5^AFME=)*^M0YFMR;1LKZ%^
M_7 9J!^[K59S)>8J0S.YR]=<:S'53N>N$YQ\ON2<@Y^/]5?L026.4Y]_,9#\
M%&H^0Z1&5BP?F(1J(@>2#8>$.8IP,&#=48IQ*XX5!)EXV7@C<E -1C 7U8)^
M'WN:_V0B9U-$?=-$\> T]QM\VG>2%("(2)U*'*"1G?9,<S^JBL(U>8DWT1E]
M_%8-UL!>SYIE)U_-_UT,(V8N/<98M93BMB0EI6NC4=[Y[IUJGWT$94Y5>VFY
M^[==Z.Y#['9;+;GNG:'92F$%([SS1AQ0)2 JZ#Z@&N*GMD)+MSH()KI$EU$O
MZ5EZ0\R8^Y$RRVPI][77ZP[W@[W96-6EBC8NFM8U[LOZ>KU7OD_C4J^K;.UR
MA\UNN]V;%4/PKNF63W7<!W07\+,_"7YSO?15Y:EA/[ATW/7[(=;][<.WJN"3
M[;./U<+Z5#5L&(Z&K_TB<!=E+&ZZ'D_('4YS\Q"[G2P_I(8'%PA[[!1)9<!Z
M4RX&CQDCS_S.BKW!*.@!N%UK%TKQ@[3\*+$65;\'_W8G0[A_GTLE?#D>SX)I
M..W#93W7NQ(37D]G$TSN/!E/5-D5_PZ#P3"<=D>4ZWE(CU2;V=P:>+UQ.!OW
ML"K< #,6[[<=F2IR!Y+(E* &F/[^>/CZB)20R8G2-.^(.IU.NX&&ZJ64VN\L
M'!>;BC#XZ/HCS 0]F<U0LLFSE#V"UO([M^^%/?@>_@6L>VDK->N5B5%MV1L,
M54;S<-(=8W5!C?6<1='K' RY;%VO-_8>]X"*1>H(^]J)-H+E[?#Z2]$3B<%V
MI]-^QH#?1+:L+84J^ //H\__G+" 4.BYWP4'G]NBZP>8HM_[_1XSS5PEKSZE
MY1_[)IAVL9*Z'^(QW^\';/PK-;8BM)B F:PYI^A\5GDNRG0/;2GSHR6+R;#$
MX%[BOHE]?4\A=CMAU&^:8K?+_(CIL(,>_P0:)!A-42"'H12NTGQ&=\K$24Y;
MRN\<6)^H G^M+;PW-.*\YI[0(Q/^%%*VY;(>!=5RLAM[?1/D?R2S!E+[P8P1
M$'!@*@:I\ 4AA8-1E\J  LNU-0@)FH]G8_R!N?R/R!V2W>F$J[C+B:W H@!=
MH(E\X(-^.)@!!]\-NT (;8*RL..Q]OI=8+"IF"6TQ'J6_L@N34]ZP,?UJ,[C
M;.S';[M<G??F0&[]F,TWH[9=!WCIA9(6@-^ Y,U611GX0Y-:6UES^;@%!F;]
ML0#W4'& @XVP, Y'P,X,J7K),!QVQPHZMH/%D"IM#H'#!#(V'"DX:0>0+L>S
MZ;<-5SG$N2>S'C"7,WB; C3MT +L!#"O "U Y/!?9,+V#1!MAAW8Y63 M1J&
M(R*16,E"PU2CW/7K7<9@W-_E8<)EP%O!_P?A%!B_G5_H,.P/L.,LF.WP4@_P
MH8XFP=!YL'@=P&O D79GR.MC0<!MCQ>NHSO&>K2#"5X'%@79_2D/H?6,"^L.
MF*/&DB+RLOW1CA-8NUU3@M(VJ2QJHH"W"1A':GS"S,[5$@C4"C<JZF;65)]K
M_=-'3M2Y$V%\_KB[X0-=B0X[6O (0C=[/:$#(5*N 0=T#$<4SR$_>_*SCS_)
MD9M3:.*3XCN6T)6E+)P34Z[5NH$8COVB<;V^N'O,MMMI&Z.PR['N,,XW<XC_
MKD"^J0+Y"R[_R"GQ;-HI\2K8D](4^SO!P.[#/?-%Q?_,ZN@O.%=3J=LZA$O4
M8+] "-MUL-<]TW\77?^.1==? %*G3OUUTRXT]=-)^)3CW$V%^9PA7Q>\_HE%
MW]USO;(*HMB&^9"] 52G$+U7DP?*UKS#T3Y[U-U.]]^EM_]=>ON[EMY^^=L1
M!CHXQ!(Q#3#_524/1-90)V1^[DMZP1ROB[7^I8M(OQK>8R1S6)7W6<Y9&<C]
MQSYN+E46HM*D5G"5$=$WXLAO7\&.)J-_%[[]%RY\:P'L^6U;G=NMD-;:]45>
M$?_:U6W=$VLV?=^L6[O+^>TRT*N<YO]7Q6W=P]8MWWMJV>YRR)L&V.UP_W?4
MO'VE='=LLVY>B9/^3?]Q:FMZ_T<I#Y]E)0JQ7 @JG1#SUWO"[1 1?]EJHJ^^
MU:A,=8UX%'T(K1L9[-#3/VFO9=+7RJJEK@T@ELJ?2'!%?3I@XCJ:@?M\=1SL
MO6G<M Q5_[CF"(SLA0C[I'.QW88QT0]J&Z^.OV$0=,%L&62C4TR(:F6C7CQ1
M?I=G\=<RN'Z,TP=Z;>5]<X<O&A=9%1@W>\W1,)#O%<?[D%7Y:PX'?;Y#]HP=
M07AG'2)\3LD3#NWD">>2/*$63'R^<@Q""DRU'RM;*IK.J!MFH-5Q-+FU^2.&
M]M.56?:%%<'KT0V+:OCUPS?U>1\$@@FVG;P.<?QH''J4':.EIOT_WG'8VI8X
MQLJ/35O;/NZY[5V+OB#S7<<XEC"UYD#!X>+WB@T<W[@@F>,[1_L\&V+0O#2/
M].9]@PJ8_X.=D9^_DV:V]S#X"=C HLW/U4WL8W=K;2_J#2NAO%F^/R6F:[\[
M5O8[[VI;IMU\5$@WR]:^W\'%^-DW8PVBW89_PM*VM'2<1EP1-_5$=V*<Y4(E
M_::KW= !O8P_*2_CEN;?V7WXV2?E#'BA,J)ZE^XT/<M6RAWX4+L#[]+QVDJV
MNKVU=A>^=#.P>GL^VW'XN?P/P,YW]^M]"1:B(9SD7FV/\T3B(75B"<OEH+W3
M1AK?VHWPQO=VS'W^<6T:7K.X1)$ [?H</+<.83&-!*>V^\)/44+%@LF,"'?U
MS+'%N==\]*_J=?M\1&1-:"\X-&/[1&R$/VNKQ[KNY*;Q3U?K"D<6G]S7]HM]
M]M[1C:Y-F\'G;FLQ6K#?IVA^GZPPV69-E>)M;?O,"9$CG[F6YENT-=X^]CNP
MW7U"_(OK1;!>RY(JP_K9AAO=AU_3#_;9MT9.D^281SK2!G2*&I:VJ'2K#>Z!
MU;'>;6$98](F4R6>X_BFW%D>_LM%\"G+[Z(5RI8H+V)XZ]EAL$=_[E/]Y*:*
M!R8P^ "?%1 OOY!;'Q^6N8 S? \"]/S>._IN7HTON(6Z_V%(7HJVBL</-/\(
M#\L=;ZNYA=IL>IKC:B>EU<X#AC@BK>TQ8\/N*PQ%&:=>:3#44KW:6*@?>HVQ
MC,?I-]WD]W) ??83\HP:&CELI];XN_Y"OSTE9"GS15Z18+1%0/T.$PJ+W.Y?
MZY_$R\$Z+>V#;[BTVH2M03R\'JVIAXQZ5]:&U5[/A?794*2D]6>XLIJ]-3M]
M5T_2YZLY=QTZ*K4WZ)7V^:SU"5NHZJZ3A.(G2B\_FSLJ8I%AOFETI>FNMSL6
MY_$RP?I>WSK+L?)"#8/_AF?*>98O3 9SY>WW[3.)LDSK55N/Z#NXEKY =45#
M[GT$5+#/*5.8+:G8X4;G,FPL :]>+>)U1_5[M3:<IEIV^]92MJ,3 PSHT;Z'
M6\ZE55E\:&HV($._P0>NH2XW3E/?83;M:^<HY7D-;6H9$.RY5D.[OQ="N:!3
MOL<3*X.?X^7W/?=$#IMT@1>45SEL6F&H27",#]+(WJ_F=]?F;_PB2\_W/1G1
M.,,CNHTINLTC7?O<DL4IMMZ8_&/K'SINO]]S>^27*[A"[W&W_8A+;\/UPO:D
M:_N2?M:_=+R!=UV#N PWQK(=GQM?VK[%NTUD/?JVJ;P;=ER,O^]%:O_(-JSD
MWQD[2EO=7_ZF7^0'W>:,9+NQC%O<6%[A "UEH[6LT#@='RMW9R7K_3,6\:OQ
MF$:6J %E4X"R'_Z!"T.'[> #*@:,1=.S+O+?_F><UW6<-WW"Q%=\&BQ)RX)>
MCHOHR:]R_V?YCN_R&B:&!RM\.<Y:3_AY:_0M, 0!!0L>\VH_)LNFT\KWG/SS
M>OW/F]RPFSZ7^?\)_'?Q I?X?^2F/%OQ\'YNWW_.H=L! -L._7NNR+..9Y_8
MZWC_/U^E(REO.<&R6WV!_="W]F#7_LW-V@W%W]VA__FF.E]UYZW'XNTE!J*=
MVK;8B;QM6XU-WM9^X]7K>_6_&/A4943CD;^MY5;'_&T#*!?];>UV]M?W'^^
M[99T4/@2J-=%E<_)IF8;IUYR>H96G.OR>OYUH+N UD HW0+AM)<9$[!H$!.K
MY*;2"#)4<^1DI<_) (S^AT[+NF+N;5&4?_Y_4$L#!!0    (  1\9DSI5IQ
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MR& *&0J%8NMT Q4RF$*&0J%H)E3(8 H9"H7^>S$A^^WPEH*9F$*&0J'8U,-
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MOM<6@&WY8EM MN6;;0':EJ^V!6Q;OML6P&WY<EM M^7;;0'>EJ^W +V%K[<
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M[PCTCGR](] [\O6.0._(USL"O>,"LX)H6)"O=P1Z1[[>$>@=^7HGH'?BZYV
MWHFO=P)Z)[[>">B=^'HGH'?BZYV WHFO=P)Z)[[>">B=%ICU1L/>?+T3T#OQ
M]=X O3=\O3<3O4M3]WG_8^A/[;'<N^2?Q;^LF<!=AH]SOG_&;=4O]Y\H/8R[
M9'/[O/L_V&W5/Q%F6E&>?@-02P,$%     @ !'QF3&9&/-!" @  \#,  !,
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MOY+\',?]ZWPQ_]'GYC=02P$"% ,4    "  $?&9,'R// \     3 @  "P
M            @ $     7W)E;',O+G)E;'-02P$"% ,4    "  $?&9,9O,+
M8((   "Q    $               @ 'I    9&]C4')O<',O87!P+GAM;%!+
M 0(4 Q0    (  1\9DQ;OR%H[@   "L"   1              "  9D!  !D
M;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  1\9DR97)PC$ 8  )PG   3
M              "  ;8"  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ !'QF3%JEN)NL @  !@H  !@              ( !]P@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  1\9DR"[(])Z@,  (42   8
M              "  =D+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    "  $?&9,'E<-&S8"  "4!P  &               @ 'Y#P  >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ !'QF3%HVI:G\ P
MXA$  !@              ( !91(  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    (  1\9DR86A&N_P$  'H%   8              "  9<6
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  $?&9,B:.;
MF_($   '&0  &               @ ',&   >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ !'QF3$%9ZWT-!0  OQL  !@
M ( !]!T  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  1\
M9DS/?DXNL@$  -(#   8              "  3<C  !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    "  $?&9,'O<0=[,!  #2 P  &
M        @ $?)0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ !'QF3%P'+9NT 0  T@,  !D              ( !""<  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  $?&9,@[YMS+0!  #2 P
M&0              @ 'S*   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    (  1\9DSZWB2.M0$  -(#   9              "  =XJ  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ !'QF3-.#4>2S
M 0  T@,  !D              ( !RBP  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    "  $?&9,!SYFOK0!  #2 P  &0
M@ &T+@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (  1\
M9DQ-X)8VM $  -(#   9              "  9\P  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ !'QF3,_,$4ZS 0  T@,  !D
M         ( !BC(  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    "  $?&9, ^J/9;4!  #2 P  &0              @ %T-   >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  1\9DR%81YCM $  -(#
M   9              "  6 V  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ !'QF3(4',7"U 0  T@,  !D              ( !2S@
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  $?&9,Q_<,
MG+4!  #2 P  &0              @ $W.@  >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    (  1\9DSOK9YRM0$  -(#   9
M  "  2,\  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
M!'QF3(!&9=*V 0  T@,  !D              ( !#SX  'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    "  $?&9,J#NWM+0!  #2 P  &0
M            @ '\/P  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    (  1\9DQ]XY(:LP$  -(#   9              "  >=!  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ !'QF3*<18PFS 0
MT@,  !D              ( !T4,  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    "  $?&9,B\G$DK(!  #2 P  &0              @ &[
M10  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  1\9DQ]
M+)(MMP$  -(#   9              "  :1'  !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ !'QF3#S0-J*T 0  T@,  !D
M     ( !DDD  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  1\9DQ'P!:ZL@$  -(#   9              "
M 2M3  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ !'QF
M3#*$=@.S 0  T@,  !D              ( !%%4  'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    "  $?&9,X22S4K@!  #2 P  &0
M        @ '^5@  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   (  1\9DRBKEB>MP$  -(#   9              "  >U8  !X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ !'QF3,PS+KZR 0  T@,
M !D              ( !VUH  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    "  $?&9,3\0\2K0!  #2 P  &0              @ '$7
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  1\9DS$*$EP
MM $  -(#   9              "  :]>  !X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ !'QF3,QX,%VR 0  T@,  !D
M ( !FF   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  $
M?&9,:.M,5K,!  #2 P  &0              @ &#8@  >&PO=V]R:W-H965T
M<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (  1\9DS*IQC"M $  -(#   9
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M970T-BYX;6Q02P$"% ,4    "  $?&9,)^&]F[(!  #2 P  &0
M    @ '_;0  >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (
M  1\9DRL8W[;MP$  -(#   9              "  >AO  !X;"]W;W)K<VAE
M971S+W-H965T-#@N>&UL4$L! A0#%     @ !'QF3#1JI0"S 0  T@,  !D
M             ( !UG$  'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"
M% ,4    "  $?&9,V5;E)K,!  #2 P  &0              @ ' <P  >&PO
M=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (  1\9DQ:H??2LP$
M -(#   9              "  :IU  !X;"]W;W)K<VAE971S+W-H965T-3$N
M>&UL4$L! A0#%     @ !'QF3&W& -^T 0  T@,  !D              ( !
ME'<  'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  $?&9,
MZ3JS9K(!  #2 P  &0              @ %_>0  >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;%!+ 0(4 Q0    (  1\9DP'.O""LP$  -(#   9
M      "  6A[  !X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%
M  @ !'QF3!<1X@^T 0  T@,  !D              ( !4GT  'AL+W=O<FMS
M:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  $?&9,T)R*[+(!  #2 P
M&0              @ $]?P  >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+
M 0(4 Q0    (  1\9DREV.I5L@$  -(#   9              "  2:!  !X
M;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ !'QF3)X>)3>X
M 0  T@,  !D              ( !#X,  'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6Q02P$"% ,4    "  $?&9,+6[ T+,!  #2 P  &0
M@ '^A   >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (  1\
M9DPB9H<"L@$  -(#   9              "  >B&  !X;"]W;W)K<VAE971S
M+W-H965T-C N>&UL4$L! A0#%     @ !'QF3 ;:KQSU 0  R 4  !D
M         ( !T8@  'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4
M    "  $?&9,\Q_8,?T!  ##!0  &0              @ ']B@  >&PO=V]R
M:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (  1\9DR%$QJ/S0$  #H$
M   9              "  3&-  !X;"]W;W)K<VAE971S+W-H965T-C,N>&UL
M4$L! A0#%     @ !'QF3+<\5\.O 0  T ,  !D              ( !-8\
M 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    "  $?&9,C^4<
MG2 "   W!@  &0              @ $;D0  >&PO=V]R:W-H965T<R]S:&5E
M=#8U+GAM;%!+ 0(4 Q0    (  1\9DQ=F\0X[ $  -@$   9
M  "  7*3  !X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @
M!'QF3*]W?L@! @  T04  !D              ( !E94  'AL+W=O<FMS:&5E
M=',O<VAE970V-RYX;6Q02P$"% ,4    "  $?&9,>W,<F/4!  !Q!0  &0
M            @ '-EP  >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4
M Q0    (  1\9DQ9Z!2O7 (  *H'   9              "  ?F9  !X;"]W
M;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ !'QF3"7,2CH( @
M^ 4  !D              ( !C)P  'AL+W=O<FMS:&5E=',O<VAE970W,"YX
M;6Q02P$"% ,4    "  $?&9,0TTF<-D!  #<!   &0              @ '+
MG@  >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (  1\9DRM
M%KR>Q $  )8$   9              "  =N@  !X;"]W;W)K<VAE971S+W-H
M965T-S(N>&UL4$L! A0#%     @ !'QF3 @-SRE# @  ' <  !D
M     ( !UJ(  'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  1\9DP4:R:^,0(   8'   9              "
M 96O  !X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ !'QF
M3.'2OL<O @  0 8  !D              ( !_;$  'AL+W=O<FMS:&5E=',O
M<VAE970W.2YX;6Q02P$"% ,4    "  $?&9,346Q;9P"   9"0  &0
M        @ %CM   >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0
M   (  1\9DPYB!(^,0(  #\&   9              "  3:W  !X;"]W;W)K
M<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ !'QF3*NDU!-& @  ^08
M !D              ( !GKD  'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q0
M2P$"% ,4    "  $?&9,IVGJHKD"  "I"@  &0              @ $;O
M>&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (  1\9DP2R*!&
MZ@$   8%   9              "  0N_  !X;"]W;W)K<VAE971S+W-H965T
M.#0N>&UL4$L! A0#%     @ !'QF3%FG5&T% P  1PP  !D
M ( !+,$  'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"% ,4    "  $
M?&9,QH\; RX"  !#!@  &0              @ %HQ   >&PO=V]R:W-H965T
M<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    (  1\9DS,IEV:. (  .<&   9
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M"2 ! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  $?&9,6+FR?8P%  !3.P
M#P              @ &6(@$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M!'QF3)AR$2>X @  DS4  !H              ( !3R@! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ !'QF3&9&/-!" @  \#,  !,
M             ( !/RL! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     &,
,8P G&P  LBT!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>57</ContextCount>
  <ElementCount>266</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>17</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEET</Role>
      <ShortName>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDBALANCESHEETParenthetical</Role>
      <ShortName>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOME</Role>
      <ShortName>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000050 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFINCOMEANDCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000060 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF CASH FLOW</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFCASHFLOW</Role>
      <ShortName>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF CASH FLOW</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000070 - Statement - UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_UTAHMEDICALPRODUCTSINCCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000080 - Disclosure - Note 1 - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000090 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccounts</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000100 - Disclosure - Note 3 - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote3Investments</Role>
      <ShortName>Note 3 - Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000110 - Disclosure - Note 4 - Fair Value Measurements and Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstruments</Role>
      <ShortName>Note 4 - Fair Value Measurements and Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000120 - Disclosure - Note 5 - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipment</Role>
      <ShortName>Note 5 - Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000130 - Disclosure - Note 6 - Long-term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt</Role>
      <ShortName>Note 6 - Long-term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000140 - Disclosure - Note 7 - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingencies</Role>
      <ShortName>Note 7 - Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000150 - Disclosure - Note 8 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxes</Role>
      <ShortName>Note 8 - Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000160 - Disclosure - Note 9 - Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9Options</Role>
      <ShortName>Note 9 - Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000170 - Disclosure - Note 10 - Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformation</Role>
      <ShortName>Note 10 - Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000180 - Disclosure - Note 11 - Geographic Long-Lived Assets Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformation</Role>
      <ShortName>Note 11 - Geographic Long-Lived Assets Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000190 - Disclosure - Note 12 - Revenues by Product Category</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategory</Role>
      <ShortName>Note 12 - Revenues by Product Category</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000200 - Disclosure - Note 13 - Product Sale and Purchase Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments</Role>
      <ShortName>Note 13 - Product Sale and Purchase Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000210 - Disclosure - Note 14 - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans</Role>
      <ShortName>Note 14 - Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000220 - Disclosure - Note 15 - Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote15RecentAccountingPronouncements</Role>
      <ShortName>Note 15 - Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000230 - Disclosure - Note 16 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote16SubsequentEvents</Role>
      <ShortName>Note 16 - Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000240 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Use of Estimates in The Preparation of Financial Statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesUseOfEstimatesInThePreparationOfFinancialStatementsPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Use of Estimates in The Preparation of Financial Statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000250 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPrinciplesOfConsolidationPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000260 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000270 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Investments (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInvestmentsPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Investments (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>000280 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Concentration of Credit Risk (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesConcentrationOfCreditRiskPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Concentration of Credit Risk (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>000290 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Accounts Receivable (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesAccountsReceivablePolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Accounts Receivable (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>000300 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Inventories (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesInventoriesPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Inventories (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>000310 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>000320 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Long-lived Assets (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLongLivedAssetsPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Long-lived Assets (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>000330 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>000340 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesRevenueRecognitionPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>000350 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Income Taxes (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Income Taxes (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>000360 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Legal Costs (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Legal Costs (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>000370 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Earnings Per Share (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerSharePolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Earnings Per Share (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>000380 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Presentation of Sales and Similar Taxes (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPresentationOfSalesAndSimilarTaxesPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Presentation of Sales and Similar Taxes (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>000390 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>000400 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Translation of Foreign Currencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesTranslationOfForeignCurrenciesPolicies</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Translation of Foreign Currencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>000410 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>000420 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>000430 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>000440 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>000450 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesTables</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>000460 - Disclosure - Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables</Role>
      <ShortName>Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>000470 - Disclosure - Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables</Role>
      <ShortName>Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>000480 - Disclosure - Note 5 - Property and Equipment: Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables</Role>
      <ShortName>Note 5 - Property and Equipment: Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>000490 - Disclosure - Note 5 - Property and Equipment: Property Plant and Equipment by Location (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables</Role>
      <ShortName>Note 5 - Property and Equipment: Property Plant and Equipment by Location (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>000500 - Disclosure - Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables</Role>
      <ShortName>Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>000510 - Disclosure - Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>000520 - Disclosure - Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>000530 - Disclosure - Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>000540 - Disclosure - Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>000550 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables</Role>
      <ShortName>Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>000560 - Disclosure - Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables</Role>
      <ShortName>Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>000570 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables</Role>
      <ShortName>Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>000580 - Disclosure - Note 10 - Geographic Information: Schedule Of Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables</Role>
      <ShortName>Note 10 - Geographic Information: Schedule Of Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>000590 - Disclosure - Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables</Role>
      <ShortName>Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>000600 - Disclosure - Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables</Role>
      <ShortName>Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>000610 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentPolicies</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>000620 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsDetails</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIntangibleAssetsPolicies</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>000630 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>000640 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Legal Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesLegalCostsDetails</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Legal Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>000650 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesDetails</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Earnings Per Share: Schedule of Weighted Average Number of Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesEarningsPerShareScheduleOfWeightedAverageNumberOfSharesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>000660 - Disclosure - Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationDetails</Role>
      <ShortName>Note 1 - Summary of Significant Accounting Policies: Stock-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote1SummaryOfSignificantAccountingPoliciesStockBasedCompensationPolicies</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>000670 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesDetails</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accounts and Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>000680 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentDetails</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Inventory, Current (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfInventoryCurrentTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>000690 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Finite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfFiniteLivedIntangibleAssetsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>000700 - Disclosure - Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Note 2 - Detail of Certain Balance Sheet Accounts: Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote2DetailOfCertainBalanceSheetAccountsScheduleOfAccountsAndOtherReceivablesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>000710 - Disclosure - Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationDetails</Role>
      <ShortName>Note 3 - Investments: Schedule of Available-for-sale Securities Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote3InvestmentsScheduleOfAvailableForSaleSecuritiesReconciliationTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>000720 - Disclosure - Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Note 4 - Fair Value Measurements and Financial Instruments: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote4FairValueMeasurementsAndFinancialInstrumentsScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>000730 - Disclosure - Note 5 - Property and Equipment: Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Note 5 - Property and Equipment: Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>000740 - Disclosure - Note 5 - Property and Equipment: Property Plant and Equipment by Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationDetails</Role>
      <ShortName>Note 5 - Property and Equipment: Property Plant and Equipment by Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote5PropertyAndEquipmentPropertyPlantAndEquipmentByLocationTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>000750 - Disclosure - Note 6 - Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebtDetails</Role>
      <ShortName>Note 6 - Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote6LongTermDebt</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>000760 - Disclosure - Note 7 - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesDetails</Role>
      <ShortName>Note 7 - Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>000770 - Disclosure - Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails</Role>
      <ShortName>Note 7 - Commitments and Contingencies: Schedule of Future Minimum Rental Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote7CommitmentsAndContingenciesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>000780 - Disclosure - Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>000790 - Disclosure - Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfComponentsOfIncomeTaxExpenseBenefitTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>000800 - Disclosure - Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>000810 - Disclosure - Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignDetails</Role>
      <ShortName>Note 8 - Income Taxes: Schedule of Income before Income Tax, Domestic and Foreign (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote8IncomeTaxesScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>000820 - Disclosure - Note 9 - Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsDetails</Role>
      <ShortName>Note 9 - Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>000830 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Note 9 - Options: Schedule of Share-based Compensation, Stock Options, Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationStockOptionsActivityTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>000840 - Disclosure - Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Note 9 - Options: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>000850 - Disclosure - Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeDetails</Role>
      <ShortName>Note 9 - Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote9OptionsScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>000860 - Disclosure - Note 10 - Geographic Information: Schedule Of Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationDetails</Role>
      <ShortName>Note 10 - Geographic Information: Schedule Of Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote10GeographicInformationScheduleOfGeographicInformationTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>000870 - Disclosure - Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaDetails</Role>
      <ShortName>Note 11 - Geographic Long-Lived Assets Information: Schedule Of Long-Lived Assets By Geographic Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote11GeographicLongLivedAssetsInformationScheduleOfLongLivedAssetsByGeographicAreaTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>000880 - Disclosure - Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryDetails</Role>
      <ShortName>Note 12 - Revenues by Product Category: Schedule Of Revenues By Product Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote12RevenuesByProductCategoryScheduleOfRevenuesByProductCategoryTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>000890 - Disclosure - Note 13 - Product Sale and Purchase Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitmentsDetails</Role>
      <ShortName>Note 13 - Product Sale and Purchase Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote13ProductSaleAndPurchaseCommitments</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="utmd-20171231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>000900 - Disclosure - Note 14 - Employee Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlansDetails</Role>
      <ShortName>Note 14 - Employee Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.utahmed.com/20171231/role/idr_DisclosureNote14EmployeeBenefitPlans</ParentRole>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>utmd-20171231.xml</File>
    <File>utmd-20171231.xsd</File>
    <File>utmd-20171231_cal.xml</File>
    <File>utmd-20171231_def.xml</File>
    <File>utmd-20171231_lab.xml</File>
    <File>utmd-20171231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>112
<FILENAME>0001096906-18-000127-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001096906-18-000127-xbrl.zip
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M.-^!E[B(0_@H=5ZT*MV93 N;C&2<>,$]+P5BF<GB\@G1CR/N017$YS,P-RT
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MJS-^65T<S= K8TR4JR9K"?1%;XM]I[B>V'^!0,I#)20(B0M;+G9-LLAI@[)
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M3*KC/$$V^54^N:*L6#0=&&?[+%WODDV:N)YP-E)G%UW../17SB1DF&#SR'^
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MVA&\2P#A;PR PAYQUX&%<VUL\A!'YA+1-TYO74_P-43%[(YYQ$PA%.O\7+
M0@#T6 <@N,4>=%&DFJ"?C-(MCU)$\8I,,HYR,XXJ5N?*(>[=: :8B(+;JD5P
M.;FE2-3 +P(H7T8IAG440,GE@L<Y*%EQ_98?(?@K(Q< ;N])/Q59"M:?EZN'
MJ_FDDD7D J) RJ7#12FLW5[KD(_6<E39AO1+PH0M\K\E3TL6?A)K[T=KB(HC
MB CA.6&SP76 65^VQ%<*TM "&MX4.%[>WE,AL:P];:]H$"0J=^=@!9'MV+R"
M\$;%*_DZ5+V?KI@01PK\C;98#FJDP$@@X0E_9?CLI0("/+9G6+(O*G91]D,:
M,2$;2Y=Y#@&3#?K3$-_(R5MV$(8!N(+B&@PYY_/+9(\N:16^^UJARG%%46$)
MF2J*U-(@]S,7:0_K(?23DZOB.?7IE*VJ=%@==PY$E_X5Y_%\(>Y E.N:RC@-
M@7M<4)<P^WT0PQ*"UD36029(/;UU</:EK@_2?9*K>]G,@;=#@ISP@A5,E)9-
MPU TH4059DGTI@#M"B7GV0(M*/!^=!](][?)32F#SK BACI44XHYKAU'6T+
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MJRVM@I;VRXR%C$XP4:GMK;:W.^:AE.X1ZXXW)6#/UD*+(_+(9-/FI#;@%V+
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M5EY=K/=]@B!3%<QUJ'EIS+Y[$6[#$<_*:LON2VT^2(MMU53B6?GL$['LJM?
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MZ('ZFP6QYQ2D/ 5%!-L+%^1'!*.HS2:2D67H!_AS%MY!9"HHE./IBG"0SH6
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M-*B9/O3T&6,H]]D"4:QJCTUPA*!,"];;A(F?QWMS$:$K@40^*1IO(G5E:?5
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MXS/QVE'\D/]/9GAC<1US5.+S"KM8A2VKJ+?.=8:$-6!*WFTCM;!H*)D%XJ.
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M8>C'!CD^]-^5/[ ,A7Y A9)0(3@0C[6\DB&[R!]LK!<8G][U=$U5T8SF$]3
M_P<$6]-VIW,8GEZA@/O%PY8*'9BU"7^F3!X4(,D5(%512R\$:.! @$T3H K1
M^WH2C'WD/;.INL1W]TAC]X.%Z_>N]49?BZ?465FN/NCB0+>"TNT$2OZJA;E!
M_^G;[&E5F8Y-T-B!8J6A6+.,7$&_%S2+*IZ5G@F\]DPA$S)/120$Z<I$;UX:
M@<T!)'[./H'JL1+LX'3TTNRJ/3E9SY:](L]=N]Z=M4)W:+'UZ-NW:.$Z"_PI
MZNFIUIB]YML"&552,Z;C+MD"D;RM$V]9^)'3]HEE3TA"+J&M"$"]:/L,E+T8
M4,=SS*T([VE&L:X%:;Q9=+M(?H<6:'V/O,%$5813RN'FM'=S!+,Z&\&+-BZ-
M+-6DFN81@M_AQX8$)%[75CMX(<H0$3Y!&"=/Y1M[B.JB/!763=VD7OIPR.@D
M/Z -KI6!%=!8*IB'78Y$E<[< F<&4*M0VQ5PC'7=I'SU[ZT=O S\V.D!I3^R
MIWQ!Z0]0H214V%G-=OC5\1"&ZC]H.7AR5^3;@T?+AHZC/=$<)C/0<X%LI2-;
M 7M1M\&97ZU<WT<^1Z,M4#H..^UDR)T:@HH,U-H):NVL*KWK)'ZP;(^ N872
M=\@DR@[3&(/2#?3=7?JNJ8=9M82WXN2Y:\R,_TYX,>N!=N&DL^\^(LO?>FCY
MV;DE2W@8:9>6;W/W/&OD-C6826>.IP4'WU0FG3KGOOS::-P/S528] =U',F;
M(S+I2K<_WILL(FRBT ?TC%8#CGF9VIP7+:/)T;YN<6@":+\GM.\/M-0HLK))
MS' 1X")T\R+0>K>F_!>@ TE _A-^DUOO=$JTRL_=-:!9H-G::9:CPA0T$B#O
M#I-W[2Q9R&,'\NX2>7.,B@3N#>0M&WF?4Z$6\MB!O+M$WHT5_E7VB;00XZ95
M)S:T.SH_\8N$'I[\C8JL'O(W@+I%S-ZH1T\7:;MP#> :G)AQW0:/AUL MT#L
M6P"R &Y!1V^!: H_7 .X!J)9!DWX@ ZT:FPF->90 I#T-6OGI'+A9JZWP-JE
M=MP E8I I2WX9/JA;0 YBT#.S?M6@)J!F@6D9N#-0,V"4_-9%6(@9R#G,_DL
MRFO1:Z@?3Q>FWWCN!GG!R\W*<@+\,9)GLB&M0SI<;:Z;6L'1-E5MKLWXLXK4
M0[3:GKT^&7-#KW%<-&%RYU0C)J+3)[>H# 4B)];),+@%KHX45\?@5KYT/352
M0LS[<6)>-2]&U'T($7QV2V4:[_3L%I,;*[HAXXUH+!7[!,[?0L+J!\M9MG%%
M!(JX<IARU<6!0/M5E<EDWCR_%S.YNF\46YU="[1?5=%F913;%4W\<FO3'M3^
M '/A@;W>>.XSHLU.A=',!7$85F;$YZ-A0YD8/&[?:FQ7:AXK%0E6YJSG(\&Q
M,E<;2R\36Z^]WGJ.'6P]I Q0Y >F7#9PL?7A//9,@VC7%R+0QC$;-N<\/4!
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MNM;&*D<?9)V_!&*/*D3$JVAV49O4W&&4E-.^GA!_V8[#)ZA&=;R "!]BRIH
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M4TY-DV+7A_OZ&GJM9)<#:#]"TZ.W]J*TE/#VS-(Z_>K0DR*M"RLB=:=I6NT
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MO4..N[:=@F_E(8T^L_/.F]<Q> 5[88.9TBC8X/\J0@ CXU__Z_\!4$L#!!0
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M@+%.P/9]M_,3OSMX-KB3NHV'Z,4!^B,;-?(%$I;?[D=@KN-,65Q+R-3J_8_
M3!2D$S*S>G_(WTV4>=@#- 2LG[&NTK:\_P'8^;QTB.':[G39L8GA4[9_-25T
M^4CYP^T\YG;Z 1A_(*Z#P6O8SF'R]@=@Y=IV79-5]F![C_<NZ#J7>6=LD6D8
M\)3GM6_GLV#7'T')M (67[$M+%0SJ1:%&5K N*CT#6]="IZ>$U;R,99Q$'0
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MVB:>(=_R% +.IJT2KK-$1"6]F:2/!QNDTU[BY2.F*I&FTHUA1AAW 8KJC[,
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M,&NH;&W/H;RUUU79[N8/5D YV-I[N=F50DT=7 D0L%J61%VSJ#O3R5KT%&$
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MB29JRL34Z4FEGU4LMK]4D7YY;I'H>VYQ]WR4CDEB$0:P$\3%@&M7<;NM2(^
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M[NS^SC*O:5>S/9&\U;9#O2"A[N>/T?,;C_K@ #^''V#<?UX9=_:KOYS*IRS
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M0.6=(ZFA/1:G!<J+.>LCSIN4S(O"657^1 JPXLDJ(F_%-B?'6;+A^ 8<8L8
M6N>E/X#VH TZ@+:-(RJ 5A"TS*M:U6P$T"HM.Y\'\(SHCN#[\N_8D6]PPHRZ
MR&&W,JJ^H6=]V-M-ND1@&UPB12&D&%UO%-O)@1&?PRF:"VP;K8VIP+92 /A7
MY00CA2"OI!BV(?T9L*$ZR WG$O--BT,A[K+=+N#;UIY8I=YN6 ?7E0OCQ9Q'
M\B8?--NNV75-4'?"06,SX^74=L>.1R#(=7SJ)[LH<8+KS644/O)]H]@M:H9:
MCB&%OFI"R(_QTLNBSHT\;%CFIAB[-"Y]L ,[XQ:R#-[6<]J.#NA-9J\L*,C
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M"MD7/F:S@!<V@=G5H>>G=5G>9\[JO-#RQCD1\=TGMNV*]]6G>HX,H-A*=W3
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M#L'X\*@+P.@(/67*^^'?,:%.K9Q08?:"H"7CJE2Q&GNBMN:,.:'Y)_L]=2!
M^A".[!N??>!C]VG?F<@^C 8Z W2,Q*C$SV)ON2)5G@?GW(*O)0Z(LE8CO7/T
M "^2W'S#MJ),P*[23*K6!M.3VZ0PEG\LB=M90*?'"!W)P\JQF,^/:F>;_';U
MU ^@GH=N[,!0*EB_&RDUQA\;Q_'R : 99; B4A2#)Y()=>X\H1A7?(DY.M)X
M];F+\?/%YW1#O"ZD[V$T)IK/W1+/.)LYWT_#I;MMING0&L,\8W8_7-JUGM':
M6J S]IO<4+GY0,XRSVE1L9%WK[#HG$&,4.PKW<,S<%JM7 EW )WG,YV>^&!&
M;>EP 8V"S8K'(J3U^J3 S#+?&F"89E#CL'$;?^]3(IN4Z9R:&<S:73&W14/E
M,X)T<[VI9BZ;SU.>0JF^/#&%<@(CU=(4Y:%VJEZQC?+.):"HVE_?JBEH<-<B
M7NW*1_Z!*%5&F)@#L#*ILRELJXZGZ6HH7+(BA6S5&!=+ILVTME;C8AEWL"6F
M8N.-CGUZ*\]T ^?<,&KF)M<H+4S-HI9'7+Y5JPA@[4P993CUE!@__HL@(F9I
M%M/W?NAOL^TM;"0".9,A-[K((KR$$H>#,1(1M VB)N(U-(:CR$4A4A8BA,F_
M.B)!OZRO)02R=M88,&L'W*(ASYDQ\\M)GMA$A__ J>V9[:]#720\O;[H'+$A
M$J(2QQ@'OOCS'RJ\+//E009II'X-'K,9+XX.I>C!"5"U1E\0=4N!NA0"TO9M
M*7HT;MSV:!A^QBV!_QCZ&]^%FR?7!1 9ML#FAN[]YNMU1G_4!\F(Q[(C1^0N
MVVX!5P=.BB5W4K(GECKC,%LU/L7#!W3F](*$)TIZ*H>L-C$2F%_CAW&N$X?]
MTZ4KF01M\(5\K*0"X>DN=>)4]0ANJ]!GH1(+3%_DQ1(%:FJW1O&WN?$"]4$O
M_9!>L!^5V;O-AL9J?S9XHTYD1:7/'X NX81MBP]6JZXLY]EN]_D\A7THLFT6
M &X<!X6!Q).8/M$P\9^I@(/I?,/6[X_UJ\&28MRMPDP4I2,'[,B%C5A @RU4
M]\IQ@[E(YI L4G+.#%"]N,X3KU5;C"$4#&84Z4J+<5FXQ'V@(=WX*7'2-/8?
MLI0G]Z<1H3D6P  LS87S=71-UI&[,VB$9\94:YE:'\*8.@%@"GP3!1"]],[Q
MP\LH2:[#.^IFL<"#B_V$_>F4XWZ*/#^FJ<+;I^!D!+UM&NTQLZ=D3QX98_(J
M8*Q?DR@D?ED 7E2G]?Z:B7];-GDFM&PK?MR$CK7\9 2ASZ.8LB.U* ?G[N]C
M)TP<ES^+AA[_ERB5O"X\XHH*C-J!\Q');*HI:<8&J&P*P9VXDCU)2XYZ$_'3
ML\4SC1^BA*K.QYTF"6D%.IK]\+,O(#7?"0()!VW;]WY::^NN6@:GWXSAQ='>
M"=*]T. J"J/\?4VQ]JC;HT./^R1!!2(+XG:"K_9JWHA/UAJ$V>%]01J(7!7[
MY3Z,ZIY.AN!]>V3"^)0XT N/(J^HX/#:-K1I/3LHD'UU!F<1A-4;)[Z.^>V7
MQ]-2V?Z/WY>J7MDU>AK$8>V3S@ TJX3X99RL1,(98(P.8%6ML5H*6;H+?JJM
MI5D$:6,P3B5JM KM5P7V&T8%DJ^ _86XC^@3 9ON!%#J&[[Y*VTJ_*SXLZDJ
MF28\*J=EV?C75505MESJ!87'B\J:\3U;I_:VZ)>1+@E0GRQ!DCB<@6T;I$ZU
M&T\;O9:?%OK[EC[ZP)2=&YU&X0QE,SS0=SM?C%-(?.^2, '*EOA&G^)-+.\.
MBX_/U#N5"5ZP!>=<*ME,BB5"NQLF0V^(7"BD.\E'9'X*AZFPLF4E&6J2:L[:
MX+%:&LD5"5Q=R:I? !"^A;N5@/!J*Z&"7V8!A*_(_N\$"*\>LED X7L\&U%$
MM6"5G[[O 2^G D#?\@72Z(0JG:HM$^YD7/@WP!*+24(XIVK5 U-U1(WJ-+"$
MJ$<3-_;%-(?RH7J:?V)U0[4-?% R=)@GFYQG9R\[/VZ$('6W-3NK:A*8GTR2
MP613:(0"4\P<*<:G/E]JUNR>)FT>.=_>53Q=W#LOMQ34] -1UU4^SY9_90-P
MZF\V%([SOJ.Z9AM+#;NW1&J!.IXS<E ]-(]1Y<G=P(@<RK(B>21!O5U5HA59
M\]K4EKBW(?O6-W8FW&3Q*<*?6R!MG7$.BC94=4P;2F6B*=$G]3Q3@4LAL ]
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M?UG_J.! ! M+7$G7$BTQ_OU#,F<"=,CWPID37#\$_F/^7MNV3K6WQ2<_=TB
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MDDGR1&E*/*C=Q/X2MQD5TCG:36I37H>!<:GF>9B:57->OZ24^6Y:OFPP*3D
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MLAG"=MD!MHL?LK,)9V29O^F;0Q/@1356BP3G\QI!D(L5TR<:)OXS+3_^8JO
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M#64[$K8YY/&U;+?YM\R7&U 7XFY%>G+1##:E+2-AT[ZP?SBKNSO-:6%PDE[
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M4I]MVW?\G&[3?7ZO-:O7^'H>N?0'<1W'(")_C-N736Z</?QJ_=&)O<-(GEX
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M,C,Q+GAS9%!+ 0(4 Q0    (  1\9DR":KSN(Q$  )8$ 0 5
M  "  3C*  !U=&UD+3(P,3<Q,C,Q7V-A;"YX;6Q02P$"% ,4    "  $?&9,
MX[968SL4   *2@$ %0              @ &.VP  =71M9"TR,#$W,3(S,5]D
M968N>&UL4$L! A0#%     @ !'QF3!/F/+H/30  ]+0# !4
M ( !_.\  '5T;60M,C Q-S$R,S%?;&%B+GAM;%!+ 0(4 Q0    (  1\9DQP
M3L>7JBX  "9O P 5              "  3X] 0!U=&UD+3(P,3<Q,C,Q7W!R
;92YX;6Q02P4&      8 !@"* 0  &VP!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
